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Abstract 
 
 
Although many lives are saved in intensive care, patients frequently fail to make a 
good recovery. In addition to physical weakness and cognitive impairment, patients 
suffer from clinical anxiety, depression and PTSD. The aim of this PhD was to 
establish the prevalence of poor mental health after intensive care and identify 
clinical, psychological and socio-demographic risk factors. First I carried out a 
systematic review of post-ICU psycho-social outcomes but found the quality of 
studies was variable and few consistent risk factors were identified. 
 
I subsequently conducted a prospective cohort study of 157 intensive care patients 
who were assessed for mood, stress, delirium and memory in the ICU. Clinical and 
socio-demographic data were recorded. At three months, 64% completed valid 
measures of PTSD, depression and anxiety, and socio-economic circumstances 
(SEC). Incidence of mood disturbance, delirium and physical stress in the ICU were 
78%, 66% and 77% respectively. At three months, prevalence of PTSD was 27.1% 
(95%CIs: 18.3, 35.9%), depression 46.3% (95%CIs: 36.5, 56.1%) and anxiety 
44.4% (95%CIs: 34.6%, 54.2%). A total of 55% of patients had at least one 
outcome. PTSD was predicted by number of organs supported, drug groups used 
and sepsis bio-markers. Strongest clinical predictors were days of sedation (PTSD), 
benzodiazepine usage (depression), inotropes (anxiety) and steroids (better 
physical HRQL). SEC was a risk factor for depression, anxiety and mental HRQL. 
Psychological predictors including ICU mood, stress, delirium and memories were 
highly correlated with outcomes and partially mediated the relationships between 
clinical factors and outcomes. 
 
A qualitative study of 17 patients with intrusive memories of ICU at three months 
revealed patients had highly disturbing hallucinatory flash-backs or distressing 
recurring images of bleeding, choking, tubes and pain. The PhD highlighted the 
need to reduce ICU stress and identified modifiable risk factors that could inform 
clinical interventions to help patients.  
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Chapter 1  Introduction and literature review:  
                 background to intensive care and outcomes              
 
1.1  Introduction  
As the medical specialty of intensive care has developed over the past fifty years, 
the lives of increasing numbers of seriously ill people have been saved. Due to 
advances in the prevention and reversal of organ failure, it has become possible to 
keep some of the sickest patients, who previously could not have survived, alive 
(Audit Commission, 1999). But there is a serious question about what happens to 
such patients once they leave hospital. There is evidence that the health-related 
quality of life (HRQL) of intensive care survivors is often poor (Dowdy et al., 2005). 
Clearly patients’ HRQL or well-being will be affected by their physical, cognitive and 
psychological state. It is known that in addition to physical problems such as 
muscle weakness, breathlessness and the inability to eat,  former intensive care 
patients may also suffer from cognitive impairment, anxiety, post-traumatic stress 
disorder (PTSD) or depression, (Hopkins & Jackson, 2006; Davydow, 2010).  
 
Clinicians are increasingly interested in discovering more about these psycho-social 
outcomes and intervening to improve them. Additionally, a recent clinical guideline 
from the National Institute of Health and Clinical Excellence (Tan et al., 2009) on 
rehabilitation after critical illness, promoted “optimisation of recovery” of ICU 
patients rather than mere survival as a key therapeutic objective. It states that all 
patients should be assessed by intensive care unit (ICU) staff for their risk of 
physical and psychological morbidity, and offered rehabilitation for any problems 
detected both in hospital and after discharge. However there is a lack of good 
evidence to guide rehabilitation efforts, about the HRQL of intensive care patients 
and about the prevalence, nature and extent of psychological morbidity in the 
months after intensive care.  
 
There is even less evidence available about the risk factors or underlying causes 
that contribute to adverse psycho-social outcomes of intensive care (Jackson et al., 
2007).  Are certain patient groups at risk of morbidity because of the nature of 
their critical illness, or because of background vulnerability factors such as chronic 
physical illness, drug and alcohol use, past traumas, past psychiatric illness, age, 
gender, socio-economic circumstances or lack of social support? Or is it the nature 
of what happens to them in the ICU that puts them at risk? Patients in the ICU 
experience treatments that cause discomfort and distress, invasive monitoring and 
the effects of powerful psychoactive drugs. At the same time they are often unable 
to communicate (due to intubation for mechanical ventilation) and suffer both 
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sensory deprivation and sensory overload (Dyer, 1995; Russell, 1999). It has been 
suggested that these experiences often result in acute psychological stress, 
disorientation, and delirium while a patient remains in the ICU (Granberg et al., 
1998). They may also lead to longer-term dysfunction including disturbing intrusive 
memories of intensive care and serious psychological distress long after a patient 
has left the ICU. 
 
Factors relating to the ward transfer and the post-hospital recovery period must 
also be considered. After being discharged from an ICU, patients’ anxiety may 
increase, as they leave the relative safety of one-to-one care, and are transferred 
to a medical or surgical ward where the nurse-patient ratio is lower. Once at home, 
many patients and families believe they will have a brief recovery period and swiftly 
return to normal life. In reality patients report that they are shocked by their 
weakness, and their inability to perform even the simplest activities such as walking 
up stairs. This can lead to depression and anger, and to conflict with relatives who 
find it difficult to cope with the debilitated patient (Griffiths & Jones, 1999).  
 
It is becoming increasingly evident that a proportion of ICU patients need additional 
support at all stages of their illness – in the ICU, on the hospital ward and after 
their return home (Tan et al., 2009). Discovering which patients are most at risk of 
specific psycho-social outcomes, may enable staff to intervene to help those who 
are most vulnerable to psychological distress and poor HRQL after leaving the ICU. 
 
The aims of this PhD were  
(i) to determine what is already known about the prevalence and nature of post-
ICU psycho-social outcomes and the identity of important risk factors, by carrying 
out a systematic review 
(ii) to add to existing evidence by conducting a high-quality prospective cohort 
study of intensive care patients to investigate psycho-social outcomes at three 
months and to identify the most important clinical, psychological or socio-
demographic risk factors  
(iii) to explore the characteristics and content of patient’s intrusive memories (IMs) 
of the ICU in a qualitative interview study, as the formation of IMs may be an 
important psychological process in the development of post-ICU psychological 
morbidity. 
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1.2  Overview of intensive care  
 
Before examining the prevalence and causes of adverse psycho-social outcomes of 
intensive care, it is important to understand the nature of critical illness and the 
activities and interventions that take place in ICUs. This will help to build a picture 
of patients’ experiences in intensive care, to inform the consideration of underlying 
causes of psycho-social outcomes. Intensive care can be defined as a service for 
patients with life-threatening but potentially recoverable conditions, who need 
constant monitoring and support to maintain organ function during recovery 
(Intensive Care Society, 2003). Patients admitted for intensive care usually require 
support for hemodynamic instability (hypertension or hypotension), airway or 
respiratory compromise, acute renal failure, potentially lethal cardiac arrhythmias, 
or the cumulative effects of multiple organ system failure. They may also be 
admitted for intensive and invasive monitoring, particularly in the hours after major 
surgery.  
 
ICUs are also known as intensive therapy units (ITUs) or, as currently 
recommended by the Department of Health, Critical care units (CCUs). The term 
Critical care encompasses both intensive care, the highest of four levels of care (0-
3) available in a hospital, and High Dependency Care, the next highest level 
(Department of Health, 2000). ICUs are characterized by high staff-patient ratios, 
with intensive care (level 3) patients in the UK usually receiving one-to-one care 
from a nurse. ICU staff are very highly trained, and provision of facilities includes 
specialist technical equipment and medicines required to manage critically ill 
patients. 
 
1.2.1  Critical care provision in UK and other countries 
The proportion of seriously ill patients in hospital is growing in the UK, due to 
factors such as the ageing population and the increasing complexity of surgery, and 
therefore there is a growing demand for critical care beds (Hinds & Watson, 2008). 
There are currently around 3,700 critical care beds in England, with 1,989 beds in 
use for intensive care and 1,673 beds for high dependency care on the last census 
day (Department of Health, 2010). Some beds can be used interchangeably for 
level 2 or 3 patients, so the exact number of intensive care beds fluctuates. 
Approximately 110,000 people are admitted to critical care units in England and 
Wales each year (Tan et al., 2009). Around 56% of patients admitted during 2008-
2009 were male, and mean age was 60.5 (Icnarc, 2010). They spent 5.0 days on 
average in a critical care unit and 23.3 days in hospital. 
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The costs of intensive care were estimated at £1000 - £1800 per bed-day, more 
than a decade ago (Edbrooke et al., 1999) and of course costs have risen since 
then. Intensive care is thought to be three or four times as expensive as ordinary 
ward care, and is equivalent to other costly health care such as heart 
transplantation. However, in spite of this expenditure, Edbrooke (1999) described 
intensive care in the UK as “neglected and under-resourced”, and UK services still 
appear to be under-funded and under pressure in comparison with other developed 
countries. The UK spends 0.05% of GNP on intensive care, whereas the US spends 
up to 1% of GNP (Hinds & Watson, 2008). In the US between 6-20% of total 
hospital beds are dedicated to intensive care, compared to 1-2% of beds in the UK.  
The UK also has the smallest number of acute hospital beds allocated to critical 
care in Europe (The Intensive Care Society, 2006). As a result, patients who are 
admitted to ICUs in the UK are likely to be more severely ill than those admitted in 
other countries. There is usually a higher nurse:patient ratio in the UK than 
elsewhere in Europe where one nurse may care for either two or three patients. 
This may be because European units tend to be larger and to admit lower-risk 
patients.  
 
1.2.2  Evolution of critical care 
Critical Care is a relatively new branch of medicine, and was given the status of a 
specialty in the UK in 1999 (Intensive Care Society, 2003). Its evolution owes much 
to the development of new life-saving techniques in the twentieth century, together 
with improved understanding of the nature of critical illness. A significant step was 
made by medical staff treating severely injured soldiers during the two World Wars 
and the Korean War (The Society of Critical Care Medicine Ethics Committee, 1994; 
Intensive Care Society, 2003). They recognised the danger of septic shock and 
pioneered intra-vascular replacement using saline or colloid solutions. War-time 
surgeons improvised new procedures in the fields of neurosurgery and burns, and 
found that extensive supportive therapy was needed if patients were to survive. 
Another important innovation occurred in response to the poliomyelitis epidemic in 
Copenhagen in 1952 (Intensive care Society, 2003). Due to a shortage of negative 
pressure ventilators, (“iron lungs”) doctors treated polio patients with manual 
positive pressure ventilation through a tracheostomy. The effect of this life-saving 
new treatment and of caring for patients in a separate area of the hospital rather 
than general wards, was that mortality was reduced from 90% to 40% (Bennett & 
Bion, 1999). In the early 1960s it also became apparent that cardiac surgery 
patients, who had high mortality rates, would benefit from post-operative care in 
specialized units, while ventilated patients’ needs were better met in respiratory 
care units (Hinds & Watson, 2008). In 1962, the Progressive Patient Care report 
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(Ministry of Health, 1962) recommended “the systematic grouping of patients 
according to their illness and dependence on the nurse, rather than by classification 
of disease or illness.” This was followed by the provision of funding to establish 
ICUs. There was to be “generous provision of working space” and 2-5% of acute 
beds should be allocated to intensive care, an optimistic prediction as we have 
seen. The trend in the UK was to establish general ICU units with some separate 
provision for neonatal, paediatric and occasionally other specialties. 
 
1.2.3  What is critical illness? 
Since the establishment of ICUs both their organisation and the medicine practised 
in them have evolved rapidly, resulting in new treatments for organ support and 
advances in the ability to save lives (Audit Commission, 1999). The modern concept 
of “critical illness” developed through the 70s and 80s. The focus of critical care 
specialists was on the identification and correction of physiological disturbance and 
the support of failing organ systems. Research and clinical experience provided a 
greater understanding of sepsis and multiple organ failure (MOF). It is now known 
that most illness and death in intensive care patients is caused by sepsis and 
systemic inflammation (Evans & Smithies, 1999). It is helpful at this point to 
consider definitions of sepsis, septic shock, systemic inflammatory response 
syndrome and multiple organ failure. 
 
Sepsis is defined as a systemic response to infection manifested by signs including 
raised temperature, raised heart rate, tachypnoea and changes in white blood cell 
count (Bone et al., 1992). Septic shock is hypotension induced by sepsis despite 
adequate fluid replacement. Systemic inflammatory response syndrome (SIRS) is 
similar to sepsis, but is produced by the body’s response to endothelial 
inflammation. Inflammation of the vascular endothelium has a number of possible 
causes such as pancreatitis, ischaemia, multiple trauma or infection. Activation of 
inflammatory cascades may lead to disruption of the microcirculation ensuring 
oxygenation of an organ, and of intracellular mechanisms that regulate use of 
oxygen. These may result in tissue hypoxia and ultimately to multiple organ failure. 
There is no consensus on the definition of the MOF syndrome, but organ 
dysfunction is defined as the presence of altered organ function in an acutely ill 
patient such that homeostasis cannot be maintained without intervention (Bone et 
al., 1992). Patients who develop multiple organ failure are highly likely to die; 
Those with prolonged three-system failure have a 50% mortality rate, while more 
than 90% of those with six-system failure die (Barton & Cerra, 1989). Thus there is 
increasing emphasis on the need to prevent critical illness rather than to react once 
organ failure is established. 
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1.2.4  Admission to intensive care 
Patients are admitted to intensive care for a wide variety of clinical indications 
including both medical and surgical disorders. ICU admissions are categorized for 
data collection as either elective surgical, emergency surgical or medical patients. 
In 2008-2009 there were 22.6% elective surgical patients, 18.1% emergency 
surgical and 59.4% medical patients (Icnarc, 2010). Common medical indications 
for admission include respiratory failure, meningococcal infection, severe diabetic 
ketoacidosis, coma or obstetric emergencies. Surgical emergencies include acute 
intra-abdominal catastrophe such as ruptured abdominal aortic aneurysm or 
perforated viscus with faecal soiling of the peritoneum (Hinds & Watson, 2008). 
Many cases may be complicated by sepsis or septic shock. Elective surgical patients 
who require intensive care include cardiothoracic surgery and major head and neck 
surgery patients, especially when there is co-existing cardiovascular or respiratory 
disease. Patients with acute cardio-respiratory disorders often develop failure of 
other organ systems, prolonging the need for intensive care treatment. The most 
common reasons for ICU admission are shown in tables 1.1 and 1.2 below.  
 
Table 1.1  Top five primary reasons for admission to ICU  
                        (Icnarc, 2006) 
  
 
 
                    
 
 
 
 
 Table 1.2  Top five primary systems involved in ICU admissions 
                         (Audit Commission, 1999) 
 
 
 
 
 
 
 
Admission to ICU is usually from theatre/recovery (46%), wards (23%), other 
hospitals, including other ICUs (16%) or A&E (15%) according to the Audit 
Commission (1999). The Department of Health’s admission guidelines (1996) 
stated that patients will be admitted to intensive care if they need support of two or 
more organ systems; or have chronic impairment of one organ system with acute 
failure of another, or need advanced respiratory care. Before being admitted to an 
ICU, all critically ill patients are assessed by a senior member of the medical team 
to determine the likelihood of the patient surviving a possibly protracted and 
Pneumonia (no organism isolated)           5.5% 
Aortic or iliac dissection or aneurysm       4.2% 
Large bowel tumour                                3.9% 
Septic shock                                          3.1% 
Bacterial pneumonia                               3.1% 
Cardiovascular                              27.5% 
Gastro-intestinal                   21% 
Respiratory     20.5% 
Neurological             14% 
Others             17% 
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difficult illness. Patients who have an acute severe illness with a background of 
extensive chronic illness where the perceived benefit from ICU care is minimal, and 
patients without hope of recovering to an acceptable quality of life, should not be 
admitted according to the guidelines (Department of Health, 1996). However in 
practice it is not usually acceptable to refuse ICU admission to a critically ill patient. 
The long-term prognosis of patients is frequently uncertain and a precise diagnosis 
of underlying disorders may be difficult on initial referral (Hinds & Watson, 2008). 
 
1.2.5  ICU interventions 
 
The information on types of ICU interventions in this and the following sections 
(1.2.6-1.2.8) was synthesised from a number of standard ICU text-books (Bersten 
& Soni, 2008; Hinds & Watson, 2008; Irwin & Ripp, 2008; Singer & Webb, 2009). 
Only very specific additional references are given in these sections. The immediate 
priority of interventions with all critically ill patients is to preserve life and prevent 
or minimise damage to vital organs. The key issue is usually to optimise respiratory 
and cardiovascular function in order to maintain perfusion pressure and deliver 
sufficient oxygen to the tissues to prevent organ dysfunction. Intensive care in the 
UK is categorized into nine types of organ system support (Department of Health, 
2006). These are listed and described in table 1.3 below. There is a lack of 
rigorous, conclusive scientific evidence about the clinical effectiveness of many of 
the interventions carried out in Critical Care Units. This is probably due to the pace 
of change, to the heterogeneity of patients and to financial, logistical and ethical 
problems in carrying out large-scale randomized controlled trials using intensive 
care patients (Gunning & Rowan, 1999). The alternative has been to use 
observational methods that study the outcome of care patients receive as a natural 
part of their treatment.  In order to draw inferences about outcomes of treatment 
in such studies, characteristics such as age and illness severity of the patients 
admitted to intensive care have to be taken into account. This is known as 
adjusting for case mix (Icnarc, 2010). 
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Table 1.3  Categories of organ support (Critical care minimum data set) 
                      (Department of Health, 2006) 
 
1.2.5(i)  Respiratory support 
The respiratory system is the most commonly supported organ system in ICU 
(Smith & Nielsen, 1999). Most ICU patients require some form of respiratory 
support due to hypoxaemia or respiratory failure (Esteban et al., 2000). Support 
may be in the form of oxygen therapy using a face mask, nasal prongs or cannulae. 
If high flow oxygen is not sufficient, a tight-fitting CPAP (continuous positive 
airways pressure) mask may be used or non-invasive ventilation can be delivered 
with a nasal or face mask. Alternatively it may be necessary to institute endo-
tracheal intubation and ventilation. Indications for intubation and ventilation include 
profound hypoxaemia, as in pneumonia or acute respiratory distress syndrome; or 
postoperative care after major complicated or prolonged surgery. Several modes of 
ventilation may be employed from continuous mandatory ventilation, where 
breathing is completely controlled by the machine, to pressure support ventilation 
in which patients may initiate spontaneous breathing.  
 
Complications caused by endotracheal intubation include nosocomial pneumonia 
and over-distention of the ventilated lung (Pinhu et al., 2003). Ventilation itself 
may damage delicate lung tissue or cause cardiovascular complications. Finally 
there are non-pulmonary complications including dysfunction of the renal, 
gastrointestinal and central nervous systems. Continuous monitoring of heart rate 
and blood pressure is essential during invasive ventilation. Patients mostly find it 
difficult to tolerate intubation and ventilation, and therefore require sedation with 
Organ system support Description 
Respiratory Advanced Invasive mechanical ventilator support including BIPAP 
(biphasic positive airway pressure) or CPAP(continuous 
positive airway pressure) via a tracheal tube. 
Respiratory Basic More than 50% oxygen with face mask. Mask CPAP or non-
invasive ventilation. Suction to clear secretions at least two 
hourly. Intubation to protect airway without ventilator 
support 
Cardiovascular Advanced Multiple vasoactive and/or rhythm controlling drugs to 
support arterial pressure, cardiac output or organ perfusion. 
Intra-aortic balloon pumping. Observation of cardiac output 
e.g. pulmonary artery catheter, oesophageal Doppler. 
Cardiovascular Basic Treatment of circulatory instability due to hypovolaemia. Use 
of CVP (Central Venous Pressure) line or arterial line for 
monitoring or access. Single vasoactive drug. 
Renal Acute renal replacement therapy e.g. haemodialyis, 
haemofiltration. 
Neurological CNS depression sufficient to prejudice airway and protective 
reflexes. Severely agitated or epileptic patients requiring 
constant nursing attention or heavy sedation. Invasive 
monitoring 
Gastro-Intestinal. Feeding with parenteral or enteral nutrition. 
Dermatological Major skin rashes, exfoliation or burns. Multiple trauma 
dressings. Complex dressings e.g. open abdomen or large 
skin area. 
Liver Extracorporeal liver replacement device, bio-artificial liver or 
charcoal haemoperfusion. 
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opiates and anxiolytic or anaesthetic agents (Gehlbach & Kress, 2002). Sedatives 
commonly used are benzodiazepines such as midazolam, lorazepam and diazepam, 
or anaesthetics including propofol and clonidine. Opiates in common use in ICUs 
include morphine and fentanyl. Sedation may have adverse effects including 
hypotension, withdrawal symptoms and sleep deprivation. The sedative drugs may 
accumulate and thus have more prolonged action in patients with renal impairment. 
 
Tracheostomies are usually performed if ventilation is likely to be prolonged.  
Complications of a tracheostomy include tracheal erosion, haemorrhage or 
migration of the tube orifice. However patients tolerate tracheostomies better than 
endotracheal intubation, so sedation can be reduced, weaning is more rapid and the 
stay in intensive care may be shorter (Griffiths et al., 2005). Several techniques 
can be used to wean patients off the ventilator. Patients should not be weaned until 
they are conscious and responsive, adequately oxygenated and able to meet the 
increased work of breathing. Weaning involves the patient breathing spontaneously 
for increasing periods or levels of ventilatory support gradually being reduced. If 
the patient is not well-prepared for weaning or is excessively anxious, weaning 
from the ventilator may fail, necessitating a longer stay in the ICU (MacIntyre et 
al., 2001).  
 
1.2.5(ii)  Cardiovascular support 
Cardiovascular or circulatory support is required for hypotension, shock and to 
prevent complications in patients at risk of organ failure. Shock is a life-threatening 
medical emergency and can be defined as acute circulatory failure with inadequate 
or inappropriately distributed tissue perfusion resulting in generalised cellular 
hypoxia (Bersten & Soni, 2008). Shock may be caused by a variety of conditions 
such as acute myocardial infarction (cardiogenic shock), pulmonary embolus 
(obstructive shock), haemorrhage (hypovolaemic shock) or sepsis and anaphylaxis 
(distributive shock). The objective of treatment for shock is to restore oxygen 
delivery to the tissues while correcting the underlying cause. This should be done 
with minimum delay to prevent irreversible peripheral vascular failure and defects 
in oxygen use which can result in organ dysfunction. Shock treatment involves 
early respiratory support and cardiovascular support.  
 
The aim of cardiovascular support is to maintain adequate cardiac output and blood 
pressure to maintain perfusion of vital organs. Volume replacement within minutes 
is essential in all cases. Fluids for volume replacement include blood, crystalloids, 
colloids (starches or gelatins) and in rare cases albumins. This can lead to the rapid 
restoration of cardiac output and tissue perfusion pressure and therefore reduce the 
risk of serious organ damage, particularly acute renal failure. If signs of shock 
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persist despite volume replacement, vasoactive drugs may be given to improve 
cardiac output and blood pressure. Some patients are given inotropes or 
vasopressors to restore cardiac output and blood pressure, while others are given 
inodilators to redistribute blood flow. Another group of patients who may benefit 
from intensive circulatory support are high risk surgical patients. Morbidity and 
mortality in these patients have been reduced by preoperative admission to 
intensive care to optimise cardiovascular function by volume replacement and 
administration of ionotropes or vasopressors (Hinds & Watson, 1999). 
 
1.2.5(iii)  Renal support 
Renal failure is a common complication of acute illness or trauma. Acute renal 
failure is defined as a sudden, normally reversible impairment of the kidney’s ability 
to excrete the body’s nitrogenous waste products of metabolism, commonly 
accompanied by oliguria. In critically ill patients renal failure is not usually due to 
primary renal disease, but may result from hypovolaemia, impaired renal perfusion, 
sepsis, certain drugs, hepatic dysfunction or vascular occlusion. Management 
consists of optimising circulation and oxygenation, using ventilation if necessary 
and ensuring adequate intravascular volume, cardiac output and perfusion 
pressure. Renal replacement therapy may then be considered. Most critically ill 
patients in the UK are treated by continuous methods of haemofiltration (such as 
continuous veno-venous haemofiltration) rather than haemodialysis (Short & 
Cumming, 1999). As the patient recovers, urine volume will increase, but the 
kidney will have a reduced ability to conserve sodium, potassium, bicarbonate and 
water for some months.  
 
1.2.6  Invasive monitoring  
In addition to organ support, most patients in intensive care require continuous 
invasive monitoring to assess their condition and alert staff to changes. Variables 
monitored both invasively and non-invasively usually include heart rate, respiratory 
rate (RR), oxygen saturation (SaO2), pulse oximetry, blood gases, arterial blood 
pressure (ABP), central venous pressure (CVP), urinary output, electrolyte levels 
and temperature. In some cases cardiac output, intra-cranial pressure (ICP), 
jugular bulb oxygen saturation or abdominal compartment pressure may also be 
measured. As well as allowing early recognition of changes in the patient’s 
condition, monitoring is used to establish or confirm a diagnosis, to gauge the 
severity of  the condition, to follow the evolution of the illness, to guide 
interventions and to assess the response to treatment. However invasive 
monitoring is associated with significant risk of complications as well as cost and 
patient discomfort. Therefore it should only be used when there are clear benefits 
and monitors should be removed as early as possible (Hinds & Watson, 2008). 
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1.2.7  Other supportive care 
Other interventions required in intensive care to maintain organ function and 
prevent further damage include chest physiotherapy to improve respiratory 
function, and mobilization to counter muscle wasting and weakness (Bersten & 
Soni, 2008). Patients also require frequent turning and repositioning to prevent 
pressure sores, and regular care to prevent damage to eyes and mouth. Most 
patients are too sick to eat, so they may require enteral or parenteral nutrition or 
both. Finally patients in intensive care are five times more likely to develop a 
nosocomial infection than other hospital patients (Adam & Forrest, 1999), so a 
vigorous infection control policy is needed. Specific causes of infection in the ICU 
are multiple vascular access sites; endo-tracheal tubes; sedation, ventilation and 
immobility leading to pneumonia; urinary catheters, compromised immune 
function, poor nutrition, overcrowding and high use of antibiotics. 
 
1.2.8  Environment and organisation 
As well as illness and interventions, other factors such as the environment and 
organisation of ICUs are thought to have an effect on patient outcomes. A few 
background details about design, equipment and staffing factors will suffice here, 
as the ICU environment will be discussed more fully in Chapter Three. 
 
1.2.8(i)  Design  
The ideal size of an ICU is between four and about 20 beds, although larger units 
may operate effectively if they are adequately staffed. The average size of a UK 
District General Hospital’s ICU is between six and ten beds. It is recommended that 
ICU facilities should be both spacious and light (Hinds & Watson, 2008). There 
should be large open-plan areas containing several beds, to make the most efficient 
use of nursing staff, with some adjacent single rooms to prevent cross-infection, 
and to accommodate long-stay patients. Each bed space should be of 20-21m² 
(Intensive Care Society, 1997). All bed areas should be well lit with natural daylight 
and ideally patients should have a view of the outside world from a window (Wilson, 
1972). Noise levels in an ICU also need to be considered. One study (Bentley et al., 
1977) found that ICUs were noisier than any other hospital ward, with noise levels 
reaching 70 decibels, equivalent to the sound of heavy traffic. In reality of course 
not all ICUs conform to ideal standards, particularly in old hospital buildings. 
 
 
1.2.8(ii)  Equipment for monitoring and intervention 
Part of the patient’s environment in the ICU is determined by the presence of large 
amounts of equipment, some of it attached to themselves and much of it arranged 
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around their bed spaces. Equipment used for monitoring in the ICU includes 
cannulae in the veins and arteries to measure venous and arterial pressure and to 
allow blood gas and acid-base analysis; urinary catheters; oxygen saturation 
monitors on fingers or ears; naso-gastric catheters to measure gastric mucosal 
pressure, and more rarely nowadays, pulmonary artery catheters.  Each bed space 
is equipped with monitors, suction apparatus, piped oxygen and air, and a vacuum 
supply. Equipment for respiratory therapy includes oxygen masks, self-inflating 
bags for manual ventilation, humidifiers, ventilators, anaesthetic machine and 
bronchoscope. For cardiovascular therapy there will be infusion pumps, syringe 
pumps, pacemakers, defibrillators and intra-aortic balloon pumps. Additionally 
there may be equipment for continuous veno-venous haemodiafiltration and 
possibly access to a haemodialysis machine.  
 
1.2.8(iii)  Organisation and staffing 
Research has shown that the organisation and staffing of ICUs also has an impact 
on outcomes. For example excessive unit workload seems to increase mortality 
(Tarnow-Mordi et al., 2000). Frequent night-time discharges are also associated 
with worse outcomes (Goldfrad & Rowan, 2000). The under-provision and under-
resourcing of intensive care was highlighted in section 1.2.1 above. In Critical to 
Success, the Audit Commission (1999) concluded that intensive care medicine in 
the UK was fragmented, overcrowded, expensive and under pressure. ICU services 
had evolved in an ad hoc haphazard manner since the 1960s and there existed 
great diversity in ICUs in terms of quality, care management, unit management and 
efficiency.  
 
In spite of modernisation and extra money (Department of Health, 2000) ICU bed 
and staff shortages are still common in the UK. A shortage of ICU beds may lead to 
high occupancy rates, cancelled elective surgery, frequent refused admissions and 
premature discharge of patients. An excessive workload will exacerbate the 
occupational stress of ICU staff, which is already considerable. Causes of work 
stress in ICUs include death and dying, staff shortages, fatigue, increasingly 
sophisticated technology, conflict between staff and families, and difficulty 
communicating with patients (Hinds & Watson, 2008). Although moderate stress 
can be helpful, excessive, prolonged stress may lead to the syndrome of “burn-out” 
which has been documented in ICU staff (Roberts, 1986). This could have an 
impact on the quality of care, particularly psychological care, which staff are able to 
give to patients.  
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1.3  Intensive care outcomes 
 
1.3.1  Mortality  
In the early days of intensive care, the emphasis was, quite understandably, on 
saving lives, and mortality was the main outcome of interest. The most recent UK 
mortality statistics available were based on almost 90,000 admissions to 180 units 
between April 2008 and March 2009 (Icnarc 2010). In those 12 months ICU 
mortality was 17.1% of patients, while ultimate hospital mortality was 25.8%. In 
non-surgical patients, both ICU mortality (23.8%) and hospital mortality (34.4%) 
were higher than for surgical groups, both planned and emergency. A further group 
of patients are likely to die at home after hospital discharge. Of a UK cohort of 370 
general ICU patients (Eddleston et al., 2000), 29% of patients died in the ICU, 39% 
of patients had died by three months after discharge from the ICU, 41% by six 
months and 43% by one year. Death rates do not return to normal population 
levels until two-four years after intensive care (Griffiths & Jones, 1999). 
 
It has been argued that death is “a sensitive, appropriate and meaningful” measure 
of outcome, given the high mortality amongst intensive care patients (Gunning & 
Rowan, 1999, p.32). However mortality rates are difficult to compare between one 
ICU and another. One audit showed that mortality across units varied more than 
three-fold. This may be in part because patients admitted to intensive care units 
are a heterogeneous group with a wide range of conditions. Intensive care units 
admitting a large proportion of high risk patients would be expected to have higher 
mortality. Therefore the characteristics of patients or “casemix” must be taken into 
account or adjusted for.  One method of doing this is to use a scoring method to 
quantify case mix. The most commonly used scoring system in ICUs is the Apache 
(Acute physiology and chronic health evaluation) II system (Knaus et al., 1981). 
This system assigns up to four points for the most abnormal values of 12 
physiological variables during the first 24 hours in the ICU. Points are also given for 
age, clinical history and surgical status, yielding a score ranging from 0-71 with 
higher scores representing greater severity of illness. Even after adjusting for case 
mix, variation in mortality rates of ICUs has been found,  suggesting that some 
differences may be due to clinical approach (Audit Commission, 1999). However an 
alternative explanation would be that the Apache II score does not address casemix 
adequately or completely. 
 
Survival rates from intensive care have improved over time. Enhanced 
understanding of the nature of critical illness has led to a sharp decline in mortality 
rates for conditions such as sepsis and the acute respiratory distress syndrome 
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(ARDS) over the past two decades (Milberg et al., 1995; Martin et al., 2003). 
However the Audit Commission national survey (1999) found that although 63% of 
ICU patients (N not provided) survived until 6 months, only 16% of patients had 
made a good recovery by that time.  As many as 38% of the original cohort had 
some limitations to daily living, while 9% had severe limitations. With ever more 
people surviving intensive care, it is recognised that HRQL, as well as survival, is an 
important outcome. Key questions should be: Do intensive care survivors have 
optimal long-term outcomes and would ICU decisions change if more were known 
about such outcomes? There has been a call for more critical care research that 
studies the effects of treatments on endpoints that are important to patients and 
society (Rubenfeld et al., 1999). It is now recommended that clinical trials of ICU 
therapies should include long-term follow-up of survival, HRQL, morbidity, 
functional status and costs of care (Angus et al., 2003). 
 
1.3.2  Quality of life (HRQL) 
A serious problem with research on quality of life is that there is little consensus 
about what it is, and no adequate theory to explain it. It is a subjective concept 
consisting of physical, emotional, psychological, social, economic, occupational and 
spiritual parameters. Different political, philosophical and health-related definitions 
exist. Health-related quality of life (HRQL) is a multi-dimensional construct relating 
health status to key components of quality of life. The core components of HRQL 
assessment should be physical, functional, psychological/emotional and 
social/occupational (Fallowfield, 2009). Many different instruments have been 
developed to assess it. Both the SF-36 (Ware, Jr. & Sherbourne, 1992) and the EQ-
5D (Brooks et al., 2003) have been recommended as suitable tools for ICU outcome 
research (Rubenfeld et al., 1999).   
 
A systematic review (Dowdy et al., 2005) of studies of HRQL of ICU survivors 
concluded that, compared with the general population, ICU survivors had lower 
HRQL in nearly all domains at baseline and at six months to 14 years after 
discharge. However HRQL improved over time after ICU discharge but not uniformly 
across domains. The scores in two important domains (mental health and perceived 
general health) did not show improvement between baseline and 6-12 months after 
discharge. Assessing the HRQL of ICU survivors is complicated by factors such as 
age and diagnostic category on admission to the ICU. Some sub-groups of intensive 
care patients such as younger patients and trauma patients (Ridley et al., 1997) 
are more likely to have had good HRQL before an ICU admission. Other groups, 
such as medical patients, may have had poor HRQL before going into ICU due to 
chronic illness. Therefore the first group are more likely to have a decrease in HRQL 
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after intensive care, whereas the second group are more likely to have an 
improvement in HRQL. Average HRQL statistics may not make much sense of these 
opposing trends.  
 
1.3.3  Physical morbidity 
The HRQL of intensive care survivors is influenced by both physical and 
psychological recovery after illness. Physical morbidity, cognitive impairment, 
psychological adjustment and support received during recovery will all have an 
effect. It is known that intensive care survivors have a range of physical problems 
during recovery. These may include residual pulmonary dysfunction, muscular 
weakness and wasting, reduced cough power, joint stiffness, numbness, taste 
changes, sleep disturbance, and breathlessness (Griffiths & Jones, 1999b). Patients 
in intensive care may lose up to 2% of muscle mass a day during their illness and 
rebuilding muscle loss may take up to a year (Herridge et al., 2003). In the early 
days after intensive care, patients may struggle to eat, swallow and cough, and are 
at increased danger of falls as muscle loss and peripheral neuropathies can affect 
balance. On returning home they may find they are too debilitated to climb stairs or 
carry out household jobs. Even at six months physical weakness may still hamper 
self-care activities such as getting out of the bath or delay returning to work. 
Patients can also have minor but distressing physical problems such as fatigue, hair 
loss and skin dryness (Eddleston et al., 2000).  
 
1.3.4  Cognitive impairment 
Additionally, it is now becoming clear that some patients have neuro-cognitive 
impairments after intensive care. Additional research is needed but early reports 
are alarming (Hopkins & Brett, 2005). Most of the evidence for cognitive 
impairment is found in specific sub-populations of ICU patients. For example, in 
patients with ARDS (acute respiratory distress syndrome) chronic cognitive 
impairments may be as high as 75% one year after ICU discharge (Hopkins et al., 
1999)  and 25% at six years (Rothenhausler, 2001). In an informal review of the 
evidence from 9 cohorts of ICU patients (mainly with ARDS), Hopkins & Brett 
(2005) concluded that neuro-cognitive impairments were extremely common at 
hospital discharge, and that despite improvement between six and 12 months, 
many patients had significant cognitive impairment at time-points between six 
months and six years. Domains most commonly affected were memory, attention 
and executive function. 
 
Only a few small studies have been carried out to examine cognitive outcomes in a 
general cohort of intensive care patients with mixed diagnoses. In one of these, a 
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neuropsychological study of 34 mechanically ventilated patients in a medical 
intensive care unit (Jackson et al., 2003), 32% of patients were found to have 
significant cognitive impairment six months after intensive care. Deficits were found 
in several domains including psychomotor speed, visual and working memory, 
verbal fluency and visuo-construction. The rate of neuropsychological deficits in the 
ICU population was markedly higher than population norms for mild dementia. A 
neuro-cognitive evaluation of 32 critically ill medical patients who underwent 
mechanical ventilation for five days or more, found that 91% of patients at hospital 
discharge and 41% at 6 months, had cognitive impairments. The cognitive 
functions primarily affected were attention, memory, mental processing speed and 
executive function (Hopkins & Brett 2005). In a study of 45 general ICU patients, 
Sukantarat (2005) found that three months after ICU 35% of the cohort scored at 
or below the level of the lowest 5% of the normal population on tests of executive 
function and fluid intelligence. At nine months, cognitive performance remained 
below normal but there had been improvements since three months. 
 
The study of the causes of cognitive dysfunction in critical care patients is at an 
early stage, but some evidence suggests that neurotransmitter abnormalities and 
occult diffuse brain injury could explain the dysfunction (Milbrandt & Angus, 2005). 
One hypothesis is that neurotransmitter abnormalities could be associated with 
drugs with anticholinergic properties that are commonly used in the ICUs. Examples 
are opiates, furosemide, digoxin, glucocorticoids and benzodiazepines.  Excess 
GABA activity, such as that occurring after withdrawal from chronic alcohol or 
benzodiazepine use, or after ICU use of benzodiazepines and probably propofol for 
sedation, is known to lead to delirium. Whether it might also lead to long-term 
cognitive deficits is unknown. The possibility has been raised that long-term 
impairment is also caused by occult diffuse brain injury, as a consequence of 
hypoxia, hypoperfusion, inflammation and microvascular thrombosis, all of which 
commonly occur in critically ill patients (Sharshar et al., 2005). 
 
1.3.5  Psychological adjustment and morbidity 
It has frequently been observed that following their return home from  the ICU, 
patients may undergo further considerable stress caused by physical disability, 
cognitive impairment, a prolonged recovery period, and conflict with families 
(Griffiths & Jones, 1999).  Patients may become irritable or angry with relatives on 
whom they are dependent, show less affection to their partners and become 
socially isolated as they begin to avoid company and stop going out. Many worry 
that they will not return to normal health and will not be able to go back to work (if 
employed). Patients also suffer from sleep problems, sexual dysfunction, and 
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unusual psychological symptoms such as delusional memories (hallucinations and 
nightmares from the ICU) and flashbacks of traumatic experiences in the ICU 
(Bennun, 2001; Jones et al., 2001; Jones et al., 2004). If not resolved, these 
problems and reactions may contribute to depression, panic attacks or other 
anxiety disorders. Several studies have found that survivors of intensive care units 
frequently suffer from psychological disorders after leaving hospital. A review by 
Weinert (2005) found that up to 35% of patients discharged from ICUs had 
psychiatric symptoms and disorders including depression and PTSD.  
 
1.3.6  Post-traumatic stress disorder 
Most studies investigating post-ICU psychological distress have focused on PTSD as 
the main outcome. PTSD is an “anxiety disorder that often follows exposure to an 
extreme stressor that causes injury, threatens life or physical integrity” (American 
Psychiatric Association, 1994). To meet diagnostic criteria for PTSD, the person’s 
response to the event or series of events must involve intense fear, helplessness or 
horror. Symptoms include persistent re-experiencing of the traumatic event in 
intrusive memories or nightmares, avoidance of stimuli associated with the trauma 
for example by emotional numbing or amnesia, and increased arousal symptoms 
such as insomnia, the startle response and hyper-vigilance. The disorder must be 
present for more than a month, and must cause distress or impaired functioning. 
PTSD is commonly accompanied by negative emotions such as sadness, anger, guilt 
and shame (Brewin & Holmes, 2003). 
 
As well as being a highly unpleasant disorder involving extreme fearfulness and 
traumatic memories, PSTD has negative implications for physical health. People 
with PTSD report more chronic health problems and perceive their health as worse, 
compared to people without PTSD. Generally people who have experienced trauma 
use medical services more and have higher morbidity and mortality (Ballenger et 
al., 2000). It is known that PTSD sufferers experience physiological changes. For 
example high rates of circulating adrenaline and noradrenaline have been recorded, 
as well as a decreased cortisol response to stress. These changes to the HPA axis 
could help to explain problems with physical health. One study of Vietnam veterans 
found that having PTSD was as powerful a risk factor for long-term health problems 
as elevated white blood cell counts and other biological markers of disease risk 
(Boscarino, 2008). 
 
Estimates of the prevalence of PTSD in the months after discharge from intensive 
care range from 0% to 62% (Griffiths et al., 2007; Jackson et al., 2007). However 
many PTSD studies have been of low quality or based on small samples of patients 
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(see chapter two for systematic review of post-ICU psychological morbidity 
studies). Furthermore some studies were carried out in specific populations such as 
acute respiratory distress syndrome (ARDS) and sepsis patients, who may be 
expected to have higher rates of PTSD. For example Schelling (1999) reported 
PTSD rates of 38% among 54 septic shock survivors. Another study found that 
27.5% of ARDS survivors had PTSD (Schelling, 1998). These ICU rates compare to 
6-month prevalence estimates of PTSD in the community of 0.4% (Davidson et al., 
1991) and 0.9% in elderly people (van Zelst et al., 2003). Prevalence of sub-
threshold PTSD in the community was rated at 6.6% (Davidson et al. 1991). 
Lifetime prevalence of PTSD has been estimated as 1 - 9.2% (Hidalgo & Davidson, 
2000). Prevalence of PTSD after other medical conditions has been estimated at 0-
16% after myocardial infarction, 11-18% after cardiac surgery and 2-14% in cancer 
(Tedstone & Tarrier, 2003). 
 
Risk factors for developing PTSD include socio-demographic factors (younger age, 
female gender, poor socioeconomic circumstances, lack of education, low 
intelligence, minority status), comorbidity (with a previous or current anxiety or 
depressive disorder) and past experience of trauma (having been abused as a 
child; having lived through other life-threatening events in the past; having 
recently been in a war zone or other area of social unrest or violent conflict). 
Factors operating during or after the trauma such as trauma severity, lack of social 
support and additional life stress had stronger effects than pre-trauma factors 
(Brewin et al., 2000). 
 
Why should PTSD be particularly prevalent after ICU? According to current 
theoretical models, PTSD develops as a result of the abnormal cognitive processing 
of stressful events. The appraisal of continued threat is thought to be central to the 
disorder; Patients with PTSD continue to detect and react to threats in the 
environment even when a traumatic event is over (Ehlers & Clark, 2000). Ehlers 
and Clerk also found that PTSD patients react to the initial traumatic experience 
with “mental defeat” – a form of extreme helplessness and fatalism. This leads to 
negative thoughts of being weak, ineffective and unable to help one-self. Such 
thoughts impede psychological recovery as patients believe they are constantly 
vulnerable to danger and react accordingly. 
 
Many psychological processes, including memory, attention, mood, beliefs and 
coping strategies are found to be disturbed in PTSD. However the most 
characteristic features of PTSD, compared to other disorders, are the unusual 
memory phenomena centred on the traumatic event (Brewin & Holmes, 2003). 
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Patients frequently recall vivid, emotional “snapshot” memories related to the 
trauma they have experienced but find it difficult to retrieve autobiographical, 
detailed memories of the incident (Brewin & Holmes, 2003). There is an unusual 
combination of experiencing some memories that are vivid and long-lasting (Rubin 
& Kozin, 1984) and others that are vague and lacking in detail (Loftus & Burns, 
1982). Most notable are the reliving experiences or “flashbacks” to the trauma. 
They are dominated by sensory detail including visual images, sounds and other 
sensations. The images and sensations tend to be disjointed and fragmentary. They 
involve time distortion as they seem to be happening in the present rather than the 
past like ordinary memories and are often triggered involuntarily by some specific 
reminder of the trauma (e.g. a police siren).  
 
There have been many theories to explain these phenomena (Brewin & Holmes 
2003). One of the earliest theories - stress response theory (Horowitz, 1976) -
proposed that after a trauma people experience information overload as they try to 
assimilate thoughts and memories about the traumatic event with their pre-trauma 
assumptions and world-view. If they use defence mechanisms such as denial and 
avoidance to keep trauma at bay, traumatic memories will break into consciousness 
in the form of flashbacks and nightmares. If people manage to work through this 
oscillation between denying and remembering, they will finally integrate the trauma 
information and recover. Those who do not may develop PTSD. Horowitz was 
influential as one of the first theorists to point out the impact of trauma on a 
person’s beliefs about the world and the self, but the theory did not account for 
important phenomena of PTSD such as flashbacks (Brewin & Holmes, 2003). 
 
Dual representation theory (Brewin et al., 1996; Brewin, 2001) draws on neuro-
cognitive findings to explain the difference between ordinary memories and PTSD-
type flashback memories. The theory proposes two different types of memory 
system that work in parallel using different pathways in the brain. Verbally 
accessible memories (VAM) are integrated with other autobiographical memories 
and can be deliberately retrieved as and when required. These memories are 
processed like all normal memories by the hippocampus which is responsible for 
laying down integrated, coherent representations of experience that are based on 
limited data registered by the conscious mind. However flashbacks are an example 
of situationally accessible memories (SAM) that contain information from a lower 
level processing of sights and sounds related to the trauma that were not 
consciously registered at the time. The SAM system is also thought to store 
information about physical responses to the trauma, so SAMs are more detailed and 
emotional than ordinary memories. SAMs tend to be triggered automatically by 
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perceptual reminders of the event and to bypass the hippocampus, taking a “direct” 
route to the amygdala. There is evidence that intense stress, associated with high 
levels of cortisol, impairs the functioning of the hippocampus (McEwen & Magarinos, 
1997). This might be a mechanism that favours memory processing via the 
amygdala (LeDoux, 1996) after a stressful experience, heightening the risk of 
having automatic, vivid, emotional memories (i.e. flashbacks).  A recent revision of 
this theory (Brewin et al., 2010) will be discussed later in the thesis (chapter 7). 
 
It is perhaps not surprising that PTSD has been investigated as a potential outcome 
of treatment in an ICU. According to the literature, ICU survivors experience many 
of the vivid emotions and unusual memory processes known to occur in PTSD. 
Some are reported to have memory distortions after leaving ICU (Jones et al., 
2001; Jones et al., 2007). Some patients have partial memories, while others have 
total amnesia for the ICU. Some have “delusional” memories of hallucinations or 
unreal experiences in the ICU but no recall of actual events. Others have traumatic 
but real memories of unpleasant procedures and pain (Schelling, 1998). 
Furthermore, being diagnosed with a life-threatening illness was added to the list of 
traumas that can be triggers for PTSD in the Diagnostic and Statistical Manual of 
Mental Disorders (DSM-IV; American Psychiatric Association, 1994). Most ICU 
patients have been exposed to this “trauma” and may of course have been exposed 
to other stressors, either in the past, immediately before or during their ICU stay. 
 
1.3.7  Depression  
Very few studies have quantified the prevalence of other anxiety disorders or 
depression after intensive care. One study (Weinert & Meller, 2006), in which the 
SCID (First et al., 1998), a structured interview tool for DSM-IV disorders,  was 
administered to 153 general ICU patients by mental health care professionals, 
found that 32% of patients had a depressive disorder two months after intensive 
care. Other studies have found prevalence rates of depression in former ICU 
patients ranging from 2.8 - 47%. This is in contrast to studies world-wide that have 
estimated prevalence of depression in the general population at 4 - 10%  for major 
depression and 2.5 - 5% for dysthymia (Waraich et al., 2004). The high rates of 
depression estimated for post-ICU patients, if confirmed, would have serious 
implications for their well-being and recovery.  Table 1.4 outlines the main 
symptoms of depression and other psychological outcomes after ICU. An important 
issue is the link between depression and suicide (Fawcett et al., 1987) as between 
10 and 15 per cent of people with major depressive disorder are likely to commit 
suicide. Physical recovery is also threatened, as depression is associated with 
increased mortality due to medical problems or accidents. Heart disease is a 
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specific risk; It is known that depressive symptoms predict future coronary heart 
disease in originally disease-free samples (Stansfeld et al., 1993) and a worse 
prognosis after myocardial infarction (Ziegelstein, 2001). 
Table 1.4   Possible psychological outcomes of ICU  
 
Name of disorder Defining symptoms* 
Depression Low mood or loss of interest usually 
accompanied by one or more of:  
low energy; changes in appetite, weight or 
sleep pattern; poor concentration; feelings of 
guilt or worthlessness; suicidal ideas 
General Anxiety Disorder Over-arousal; irritability; poor concentration; 
poor sleeping; worry about several areas most 
of the time 
Panic Disorder  Intermittent episodes of panic or anxiety; 
taking avoiding action to prevent these 
feelings. 
Post Traumatic Stress Disorder 1.  Persistent re-experiencing of a  traumatic  
     event 
2.  Avoidance of stimuli associated with the  
      trauma 
3.  Increased arousal symptoms such as  
      insomnia or hypervigilance 
*Sources: NICE clinical guidelines 22 (National Institute for Health and Clinical 
 Excellence, 2004) and 26 (Middleton et al., 2005) 
 
Depression can be difficult to diagnose in patients who are or have been seriously 
ill. It may be unclear whether somatic symptoms (such as changes in appetite, 
weight, sleep and energy) are due to depression or underlying illness. Depression in 
seriously ill patients will be more readily manifested by the psychological or 
cognitive symptoms such as dysphoria, depressed mood, sadness, lack of pleasure, 
sense of worthlessness, hopelessness, helplessness, guilt and despair, tearfulness 
and loss of self-esteem (Block, 2005). Risk factors for depression include genetic 
vulnerability, poor social conditions, low levels of support, low self-esteem, 
childhood adversity, a family history of depression and a prior personal history of 
depression (Kendler et al., 1995). Advanced disease is also known to increase the 
likelihood of depression: The more symptoms, such as dyspnea, nausea, bowel 
problems or bladder problems, experienced, the more likely patients are to become 
depressed (Fine, 2001).  
 
The traditional, though now controversial, distinction made between endogenous 
and reactive depression, stemmed from the idea that at least some depression 
occurs in reaction to stress. Research following a volcanic eruption found that the 
incidence of depression, as well as generalised anxiety disorder and PTSD, 
increased in the year after the disaster (Shore et al., 1989). Chronic stressors such 
as poverty, unemployment and care-giving are all associated with increased risk of 
depression (Schulz et al., 1995). However not all individuals become depressed 
after exposure to stress. Depression probably comes about through an interaction 
between chronic stress, acute stress and individual vulnerability factors. For 
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example Beck’s cognitive model of depression (2008) suggests that people with 
negative early life experiences develop unhealthy core beliefs that predispose them 
to react to stressful events with depression (a negative view of the self, the world 
and the future). Learned helplessness (Miller & Seligman, 1975) is an alternative 
theory of depression that may have relevance for intensive care patients. It posits 
that people will become depressed and unmotivated when they are faced with 
stressful events that they cannot control.  
 
1.3.8  Anxiety  
The few studies that measured anxiety as an outcome of intensive care found that 
between 5% and 34% of patients had a “probable” anxiety disorder between three 
and nine months after leaving intensive care (see Chapter Two, systematic review). 
Anxiety has been defined as a state of emotional distress “resulting in feelings of 
being unable to predict, control, or obtain desired outcomes” (Barlow, 2004). It 
involves feelings of apprehension and fear often characterised by physical 
symptoms such as palpitations, sweating and feelings of stress. Anxiety may be 
experienced as agitation, insomnia, restlessness, tachycardia, hyperventilation, 
panic disorder, worry or tension. Some anxiety is a normal part of life, but the 
primary feature of an anxiety disorder is abnormal or inappropriate anxiety when a 
person’s heart races, breathing increases and muscles tense without any reason for 
them to do so. Anxiety disorders are chronic, growing progressively worse if not 
treated.  
 
There are a number of common anxiety disorders, such as GAD (generalised 
anxiety disorder) which involves worry about many areas of life most of the time, 
together with irritability, hyper-arousal, poor concentration and poor sleeping 
(American Psychiatric Association, 1994). The lifetime prevalence of GAD in the 
community is 5-6%. In panic disorder a patient will have recurrent unexpected 
panic attacks that lead to at least one month of persistent fear of more attacks, 
worry about the consequences, and behaviour change to avoid panic attacks 
(American Psychiatric Association 1994). Panic attacks are defined as “a discrete 
period of intense fear or discomfort, in which at least four of the following 
developed abruptly and reached a peak within ten minutes”: palpitations, pounding 
heart or accelerated heart rate; sweating; trembling or shaking; sensations of 
shortness of breath or smothering; feeling of choking; chest pain or discomfort; 
nausea or abdominal discomfort; feeling dizzy, unsteady, lightheaded or faint; 
derealisation or depersonalisation; fear of losing control or going crazy; fear of 
dying; numbness or tingling; chills or hot flushes. Lifetime prevalence of panic 
disorder is 1-3% (Kumar & Malone, 2008). 
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1.3.9  Co-morbidity of outcomes 
Identifying the nature of psychological morbidity can be complicated by the high 
rate of co-morbidity between psychological disorders. Depression and anxiety often 
co-exist (Gorwood, 2004), and a case has been made for a diagnosis of mixed 
anxiety-depression. In a US co-morbidity survey, 88% of men and 79% of women 
with PTSD were also diagnosed with another psychological disorder, including 
somatisation disorder, psychosis, anxiety disorder and depression (Davidson et al. 
1991). The most frequent co-diagnoses are depression, GAD and substance abuse. 
Many authors have pointed out that there is a substantial symptom overlap with 
many depressive symptoms appearing in the DSM criteria for PTSD (e.g. markedly 
diminished interest in significant activities, restricted affect, sense of foreshortened 
future, difficulties with sleep, guilt). However it has been argued that distinctive 
features of PTSD are the exaggerated startle, the re-experiencing symptoms and 
physiological reactivity to trauma-related cues (Brewin et al., 1996; Brewin et al., 
1996).  
 
1.3.10  Conclusion 
There are few studies that have examined the extent and nature of psychological 
morbidity after intensive care. Many are based on small samples of intensive care 
patients and are not generally of high quality. However, when results are 
considered along with evidence of poor HRQL (Dowdy et al. 2005), and clinical 
accounts by intensive care staff, it must be concluded that adverse psycho-social 
outcomes of intensive care are a matter for concern. The provision of psychological 
support to patients while they are undergoing intensive care has been advocated, 
as well as the establishment of follow-up clinics to provide both physical and 
psychological ICU after-care (Department of Health, 2000). A national survey 
(Griffiths et al., 2006b) found that only 80 ICUs (30%) had follow-up clinics; and of 
these, only 47 (59%) were funded. Evidence for the efficacy of follow-up clinics and 
their effect on long-term outcomes is lacking. A recent multi-centre randomised 
controlled trial of nurse-led follow-up clinics compared with standard care, showed 
no improvement of physical or psychological quality of life or cost effectiveness 
benefit in the first year after ICU discharge (Cuthbertson et al., 2009). It is not 
known to what extent ICUs provide psychological support in the acute setting; but 
few units have the services of a psychologist available to them (Bennun, 2001). 
However it is possible that a preventative, early intervention approach could prove 
more successful than the follow-up programmes. Increased knowledge about the 
nature of adverse psycho-social outcomes after intensive care and modifiable risk 
factors, is essential to inform the development of supportive interventions for ICU 
patients. 
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Chapter 2  Systematic review: psychological morbidity 
                 and poor HRQL after intensive care 
 
2.1  Introduction  
 In chapter one it was argued that many former patients suffer severe psychological 
distress in the months after leaving intensive care. However little is known about 
the nature and extent of poor psychological outcomes after intensive care, nor 
about possible causal risk factors.  As the first step in an investigation of post-ICU 
psychological morbidity, I carried out a systematic review of observational studies 
that estimated the prevalence of adverse psycho-social outcomes among general 
ICU patients and identified likely risk factors. 
2.1.1  Prevalence of psycho-social outcomes of intensive care 
Three previous systematic reviews (Jackson et al., 2007; Griffiths et al., 2007; 
Davydow et al., 2008) summarised evidence about the prevalence of post-
traumatic stress disorder (PTSD) after  intensive care. In a review of 15 studies of 
patients from general ICUs (medical, surgical or mixed) Davydow et al. (2008) 
reported that the median point prevalence of PTSD symptoms was 22% (range 8%-
51%), while clinician-diagnosed PTSD was 19% (10% to 39%). Griffiths et al. 
(2007) found that the range of prevalence of PTSD reported in 30 studies of 
general ICU patients and sub-groups (ARDS, trauma, septic shock and cardiac 
surgery) was 0-64%. However the review concluded that the true prevalence of 
PTSD could not be known due to the poor design, methodology and reporting of the 
included studies. In a review of 16 studies of medical ICUs, Jackson et al. (2007) 
argued that the rates of PTSD (up to 63%) reported were likely to be over-
estimates due to the methodological shortcomings of many studies.  
These reviews provided useful data, but there is no empirical, clinical or theoretical 
reason to assume that PTSD is the only or even the most important psycho-social 
outcome occurring after intensive care treatment. Indeed after my systematic 
review was completed a review of studies of post-ICU depression was published 
(Davydow et al., 2009). Another systematic review by Dowdy et al. (2005) focused 
on evidence of the quality of life (or HRQL) of former intensive care patients from 
21 studies of medical or surgical ICU patients. The majority of studies were rated 
high quality. Conclusions were not clear-cut because studies used four different 
measures to assess HRQL at diverse time-points, including pre-ICU, and no 
quantitative synthesis was possible. As already summarised in chapter one, Dowdy 
et al. (2005) concluded that the HRQL of former ICU patients was much lower than 
the general population from six months after discharge and up to 14 years later but 
that there was improvement over time. 
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The present systematic review built on work done in the previous reviews by 
encompassing studies that covered all adverse psycho-social outcomes reported for 
surviving ICU patients, including depression, anxiety disorders and cognitive 
dysfunction in addition to HRQL and PTSD. Anxiety disorders and depression are 
known to be important consequences of serious illness in other populations such as 
patients with heart disease (Davidson et al. 2004, Denollet et al. 2006) or cancer 
(Pirl, 2004). Anxiety and depression were measured as primary or secondary 
outcomes in a number of studies of ICU survivors. The review by Davydow et al. 
(2009) concluded that the median point prevalence of “clinically significant” 
depressive symptoms was 28% (using questionnaires) and 33% based on clinician 
diagnoses. The prevalence of post-ICU anxiety has not previously been estimated in 
a systematic review.  
The existence of severe cognitive impairment has been highlighted in a number of 
studies of sub-groups of ICU patients. For example, patients with acute respiratory 
distress syndrome (ARDS) 75% had chronic cognitive impairment at 1 year 
(Hopkins et al., 1999), and 25% at 6 years (Rothenhausler at al., 2001). A small 
number of studies suggest that general ICU patients may also be at risk of 
cognitive impairment after discharge. These studies were not included in previous 
systematic reviews of psychological morbidity after ICU, but were included in my 
review.  
By covering all known adverse psychological outcomes in one systematic review, 
my aim was to present a comprehensive picture of the possible consequences for 
patients who have undergone treatment in an ICU. This would provide valuable 
information to clinicians, especially those in the UK who are now required by the 
National Institute for Health and Clinical Excellence (NICE) to screen ICU patients 
for psychological morbidity and provide rehabilitation and follow-up in the 
community if necessary (Tan et al, 2009). 
An important issue affecting the prevalence estimates from previous PTSD reviews 
is that all three included studies of diagnostic sub-groups of ICU patients as well as 
studies of mixed-diagnosis ICU patients. Griffiths et al. (2007) included 17 studies 
of ARDS, cardiac surgery, trauma or septic shock patients. Seven out of 16 studies 
reviewed by Jackson et al. (2007) were of sub-groups of patients (ARDS, septic 
shock or acute lung injury). The review by Davydow et al. (2008) included two 
studies of patients with sepsis. The inclusion of these sub-groups of patients would 
be likely to increase heterogeneity as some patient groups are likely to have much 
higher PTSD rates than general ICU patients. For example, rates for ARDS patients 
range from 29-43% (Deja, 2006; Kapfhammer et al., 2004; Schelling, 1998) and 
for sepsis patients from 39% to 64% (Schelling et al., 1999; Schelling, 2001). In 
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my systematic review I excluded studies of diagnostic sub-groups in order to 
estimate average PTSD prevalence rates of the general ICU population. The only 
sub-groups included are in studies of mechanically ventilated ICU patients. I 
included them because mechanical ventilation is the most common intervention in 
the ICU (68.3% of all admissions were mechanically ventilated within the first 24 
hours (Icnarc 2007)) and outcomes of mechanically ventilated patients are of 
particular concern due to the invasive nature of treatment. 
2.1.2  Predictors of psycho-social outcomes post-ICU 
The second aim of the systematic review was to establish what is known about 
psychological, clinical and socio-demographic risk factors for adverse psycho-social 
outcomes after ICU. The reviews by Jackson et al. (2007), Davydow et al. (2008) 
and Dowdy et al. (2005) also considered the evidence for consistent risk factors of 
post-ICU psychological outcomes. Griffiths et al. (2007) did not report on risk 
factors. Their findings are summarised in table 2.1 below.  
Table 2.1  Risk factors of post-ICU psycho-social outcomes from three reviews 
 Psychological  Clinical/Healthcare Socio-
Demographic 
History 
Jackson et al. 
2007 
(PTSD) 
Delusional 
memories  
Factual memories  
Social support 
Length of stay 
Duration of MV  
Levels sedation  
Younger age  
Female 
Psychological 
history 
Davydow et al. 
2008 (PTSD) 
Early delusional 
memories 
Later traumatic 
memories  
Benzodiazepine 
administration  
 
Younger age  
Female  
 
Psychological 
history 
Dowdy et al. 
2005(HRQL) 
 Severity of illness 
 
Older age   
 
The most consistent risk factors for PTSD according to the systematic reviews were 
memories of ICU (traumatic, delusional or factual), sedation, psychological history, 
younger age and female gender. However these factors were only found to be 
significant in one or few studies. Additionally there were some discrepancies 
between reviews concerning risk factors of PTSD. For example, Davydow et al. 
(2008) reported that there were no associations between length of stay and PTSD, 
or between duration of mechanical ventilation and PTSD, while Jackson et al. 
(2007) reported that those associations had been found. There was inconsistency in 
the way studies operationalised memory of the ICU. Memories were measured 
prospectively (a few days after leaving the ICU) in some studies or cross-sectionally 
(at follow up) in others. They were categorised in different studies as delusional, 
psychotic, frightening, traumatic or factual, yet it is not clear in some studies how 
those categories were differentiated or overlapped. The review by Dowdy et al. 
(2005) found few consistent predictors of HRQL across studies. Only severity of 
illness and old age were found to predict some HRQL domains. The only risk factor 
identified for post-ICU depression was early post-ICU depression (Davydow et al., 
2009). In this review I tried to evaluate risk factors in the most detailed, 
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comprehensive way possible to establish more clearly where gaps in our knowledge 
lie. 
2.1.3  Quality of previous reviews 
In deciding to carry out a new systematic review, I considered the quality and 
coverage of the previous reviews. Quality was considered according to guidance for 
conducting and reporting systematic reviews in the Quorom statement (Clarke, 
2000), recently updated by the Prisma statement (Moher et al., 2009). Strengths of 
the review by Griffiths et al. (2007) included explicit search and selection strategies 
and the use of quality assessment items including outcome assessment. However 
study quality assessment was not taken into account when reporting the range of 
prevalence estimates.  
There were methodological weaknesses in the review by Jackson et al. (2007). The 
reviewers did not use explicit or systematic search and selection strategies, as 
recommended in Quorom (Clarke 2000). Quality scores were given to studies but 
the aspects of quality assessed were not described. It should also be noted that 
studies of medical ICUs only were included, so that results may not apply equally to 
general ICUs. The review by Davydow et al. (2008) conformed to recommended 
standards for search and selection strategies, but did not assess the quality of 
studies. Dowdy et al. (2005) conducted and reported the review of HRQL correctly. 
However there was very limited synthesis of results, and conclusions, due to the 
heterogeneity of included studies.  
2.1.4  Summary  
Previous reviews of psychological morbidity in the ICU had some methodological or 
other shortcomings. The current review adheres to recent recommendations (Moher 
et al., 2009) for carrying out systematic reviews by working from a protocol 
(Appendix 1) and using systematic and explicit methods to identify, select and 
critically appraise studies. The risk of bias in studies was assessed, including quality 
of outcome assessment. The review would be useful to clinicians because it includes 
studies of all recognised psycho-social outcomes after ICU and a comprehensive 
evaluation of risk factors. As no studies of diagnostic sub-groups of ICU were 
included, therefore estimates of prevalence were not inflated by patient groups with 
exceptionally high rates. 
 
 The aim of the review was to provide accurate estimates of the proportion of all 
ICU patients who suffer from adverse psycho-social outcomes in the months 
following hospital discharge and to investigate the nature of these outcomes. The 
review also examined the severity of psychological symptoms found in studies, and 
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determined whether consistent risk factors for adverse psycho-social outcomes 
could be identified.  
2.1.5  Review questions 
1. What proportion of ICU survivors suffer to what extent from adverse psycho-
social outcomes (including PTSD, anxiety, depression, cognitive impairment 
and poor quality of life) in the months after intensive care?  
2. What are the clinical, psychological and socio-demographic risk factors for 
adverse psychosocial outcomes in the months after ICU treatment? 
2.2  Methods 
2.2.1  Criteria for study selection 
Three criteria were used to decide which studies should be selected for inclusion in 
the systematic review. 
Type of studies: Prospective cohort studies, retrospective cohort studies, and cross-
sectional surveys were included in the review. (A retrospective cohort study is 
defined here as one in which patients were recruited at the time when outcomes 
were measured and data from their ICU stay were then collected retrospectively.) 
Data from the control groups in RCTs of interventions to reduce psychological 
morbidity in ICU patients were also considered eligible. 
Types of participants: The study populations were ICU patients who received  
intensive care >24 hours in general, medical or surgical ICUs. Studies of sub-
groups of ICU patients such as patients with ARDS or pancreatitis were not eligible 
as they are not representative of general ICU patients. However studies that 
focused on ICU patients receiving mechanical ventilation (advanced respiratory 
support) were included, as it is the most common intervention received in an ICU. 
Patients who receive advanced respiratory support suffer from many different 
underlying conditions so they are approximately representative of the general ICU 
population.  
Types of outcome measures: Studies were selected if they used reliable and 
validated questionnaires or interviews for PTSD, anxiety, depression, other 
psychological morbidity, cognitive impairment or quality of life. Studies that used 
single item measures or unvalidated bespoke questionnaires were excluded. 
2.2.2  Search strategy 
The search strategy for identification of studies followed the Guidelines for Meta-
Analyses and Systematic Reviews of Observational Studies (MOOSE, Stroup et al., 
2000). Studies were identified in December 2007 from the following databases: 
Medline                  (Ovid, 1950-2007) 
Embase                  (Ovid, 1980-2007) 
Psycinfo                  (Ovid, 1806- 2007) 
Cinahl                     (EBSCO Host, 1982 – 2007) 
Web of Science        (ISI Web of Knowledge, 1981-2007) 
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The initial search was carried out on Medline using the following strategy (figure 
2.1). Similar searches were carried out on the other four databases.   
Figure 2.1  Search strategy 
1. MEDLINE 
 Search terms 
 1950 to December 2007 
#1 (Explode “Critical Care” in MIME, MJME, PT) or (explode “ intensive care-+”) in MIME, MJME, PT) 
#2 ((Critical Care) in ti, ab) or (( intensive care) in ti, ab)  
#3 #1 or #2 
#4 “Stress-Disorders-Post-Traumatic”/all SUBHEADINGS in MIME, MJME, PT 
#5 ((Post*traumatic stress or PTSD) in ti, ab) 
#6 Explode Stress, Psychological or Psychopathology or Depression or Anxiety or Affective disorders 
in MIME, MJME, PT) 
#7 ((psycholog* or  psychiatr* or psychopathology or psycho*social or anxi* or depressi* or mental 
or emotion*) in ti, ab) 
#8 “Quality of Life”/ all SUBHEADINGS in MIME, MJME, PT) 
#9 ((SF-36 or NHP  or SIP or EuroQol* or HRQL) in ti, ab) 
#10 #4 or #5 or #6 or #7 or #8 or #9 
#11 Explode “Cohort” in MIME, MJME, PT 
#12 ((cohort or prospective or follow-up or long-term or longitudinal) in ti, ab) 
#13 #11 or #12 
#14 #3 + #10 + #13 
#15 (#14) and (AGE:MEDS = ADULT) 
  
2.2.3  Quality assessment  
It has been reported that 50% of systematic reviews of observational studies do 
not carry out any quality assessment, i.e. a systematic appraisal of the internal and 
external validity of the studies included (Mallen et al., 2006). Previous researchers 
may have overlooked the issue of quality assessment because there is no accepted 
method of assessing the quality of non-randomised trials. A multiplicity of methods 
and checklists have been used but none of the latter have been validated or tested 
for comparability. However without assessing the methodological rigour of each 
study, all would be given equal weight regardless of quality, which would lead to 
inaccurate conclusions.  
 
In the absence of a gold standard for quality assessment of observational studies,  
the NHS Centre for Reviews and Dissemination (Khan et al., 2001) recommended 
that reviewers select components from available checklists that are most relevant 
to the topic and purpose of the systematic review. I based my quality assessment 
on the methodology checklists developed by the Scottish Intercollegiate Guidelines 
Network (SIGN, 2004) for study designs including cohort studies. Although SIGN 
checklists were designed for reviewing papers for the preparation of clinical 
guidelines rather than for systematic reviews, I chose to use them because of their 
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clear description of each quality criterion. For example rather than simply asking 
what is the “representativeness of the sample”, as in other checklists, the SIGN 
item spells out exactly what has been assessed for representativeness: “A clear 
definition of source population and clear eligibility criteria for selection of subjects 
are used, to ensure the sample is representative.”  This guided me in making the 
assessment, and should also help to make the reasons for my assessment of 
quality more transparent. 
 
As the systematic review had a particular focus on psycho-social outcomes of ICU 
survivors, quality criteria regarding the robustness of outcome data were used. 
Studies that did not use reliable validated questionnaires were not eligible for the 
review; However there were distinctions to be made between questionnaires that 
were more or less appropriate for this research question. For example a study that 
used the Impact of Events-Revised Scale (Weiss & Marmar, 1997) to assess PTSD 
scored more highly than one using the Impact of Events Scale (Horowitz, Wilner & 
Alvarez, 1979) as the latter only includes two of the three symptom clusters of 
PTSD (APA 1994). Another criterion – controlling for other factors which may be 
relevant to the outcomes – was considered particularly important for evaluating the 
quality of follow-up studies. To determine the strength of the association between 
risk factors and outcome, a further criterion selected was the use of an appropriate 
statistical analysis in a study. The quality criteria are listed in figure 2.2. 
Figure 2.2  Quality criteria 
 
Each separate criterion was assessed as a) poorly addressed b) adequately covered 
or c) well covered. As no definitions of these assessment levels were given in the 
guidance for using SIGN checklists, subjective judgments had to be made. 
The sample 
1.  A clear definition of source population and clear eligibility criteria for selection of 
subjects are used, to ensure the sample is representative. 
2. Comparison is made between full participants and those lost to follow up 
3. A power calculation is reported. If not, sample size is small, medium or large 
Outcome 
4. The likelihood that some subjects might have the outcome at baseline is accounted for. 
5. The outcomes are clearly defined. 
6. Evidence is used to demonstrate that measure of outcome is valid and reliable.  
7. Follow-up is long enough for outcome to occur. 
Risk factors-outcome analysis  
8. The study addresses an appropriate and clearly focused question  
9. Any measures of risk factors are reliable 
10. Main potential confounders are identified and taken into account in design and 
analysis 
11. Confidence intervals have been provided. 
12. Appropriate statistical analyses have been carried out 
Overall assessment 
How well was study done a) to minimise risk of bias and b) to establish a causal 
relationship between exposure and effect.  
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Initially,as recommended by SIGN, an overall quality assessment of the study was 
indicated by:  
              -    (did not meet most criteria; poor quality) 
–    +    (met an adequate number of criteria; medium quality)  
–  ++    (met all or most criteria; high quality).  
–  
I assigned two quality ratings based on the above – one for the quality of the 
estimate of prevalence given, and one for the quality of any associations reported 
between predictors and outcomes. Using this system the majority of studies were 
judged to be of medium quality, with few that were very poor and few that were 
very good. It was therefore difficult to distinguish between them. In order to 
construct tables demonstrating the relative quality of studies (tables 2.3 and 2.7), I 
assigned a more detailed numerical score to each study based on the number of 
poor (0), adequate (1) and good (2) ratings for four key criteria: the 
representativeness of the sample, power of the study/sample size, the robustness 
of outcome assessment, and the appropriateness of analysis of size of association. 
The first three criteria applied to prevalence; the fourth to analysis of associations. 
This enabled me to make finer distinctions about the quality of the studies. The 
range of scores was 0-6 out of 6 for the prevalence rating, and 0-2 out of 2 for the 
analysis of association rating. 
 
2.2.4  Inter-rater reliability  
Three supervisors also assessed three papers each for risk of bias. There was 100% 
agreement between all raters in the quality assessment of the nine papers (20% of 
the total of 45 papers). 
 
2.2.5  Data extraction strategy 
The same data were systematically extracted for each study using a data 
extraction sheet (see Appendix 2). 
 
2.2.6  Synthesis of extracted evidence 
For most outcomes such as PTSD and other psychological morbidity and some 
measures of HRQL, it was not possible to carry out a meta-analysis due to the 
heterogeneity of the results and the lack of consistency in reporting results. 
Heterogeneity was probably due to differences in ICU populations (illness severity, 
length of stay, exclusions), different measures used with different diagnostic 
thresholds and different lengths of follow-up. Therefore I examined ranges of 
estimates and identified reasons for variation in results, using quality criteria. 
However I carried out a random effects meta-analysis for the studies that assessed 
the quality of life of former ICU patients using the SF-36, as results were consistent 
and well-reported. I excluded repeats (some studies reported multiple results at 
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different time-points) and outliers from the meta-analysis. Synthesis of information 
about risk factors was difficult as few studies reported results in a comprehensive 
manner. Non-significant results were rarely reported and p-values rather than 
effect sizes were reported. It was not clear how many tests had been carried out in 
most studies. Therefore I was merely able to summarise the number of times 
associations were found or not found across studies. 
2.3  Results 
A total of 4,204 papers were retrieved as a result of the search outlined above 
After removing duplicates, 3113 titles and then 847 abstracts were screened until 
147 papers were found eligible for full paper review. Of these 45 papers were  
included in the review. Of these, 18 had PTSD or depression as the primary 
        outcome, and 27 had HRQL as the primary outcome. 
Figure 2.3  Flowchart of reference retrieval, exclusions and inclusions 
 
 
 
 
 
 
 
 
 
 
Title screening 
 
 
 
Abstract screening 
 
 
 
 
Full paper review 
 
 
 
 
 
 
 
Total retrieved (Dec.07) 
      N = 4,204 
   Total without duplicates  
       N = 3,113 
          Eligible on title 
             N= 847 
    Eligible for full  
      paper review  
           N= 147               
          Synthesis                   
           N = 45 
Excluded:  700 (Inclusion criteria not 
met e.g. unvalidated questionnaires, 
sample not all ICU patients)  
 
Excluded: 2266  
(Inclusion criteria not met e.g. 
neonatal/paediatric settings; 
withdrawal of treatment studies; no 
psychosocial outcomes; trials of 
medical techniques)  
373 duplicates automatically 
removed;  
718 manually removed 
          Primary outcome = 
              quality of life (HRQL) 
                   N = 27 
        Primary outcome =  
      psychological morbidity    
                N =18 
 
Excluded: 102 (Inclusion criteria not 
met: e.g. not general ICU but 
specialist ICU or sub-groups in terms 
of age, disease, long-stay or 
prolonged mechanical ventilation) 
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2.3.1  Characteristics of studies of psychological morbidity  
There were 16 cohorts of patients in 18 studies with a primary outcome of 
psychological morbidity (see table 2.2). Two cohorts were both included in two 
studies each with different outcomes, as indicated by asterisks in table 2.2. A total 
of 2087 unique patients were enrolled in these studies. They were recruited from 
general ICUs in 14 studies, from medical ICUs in two, from a surgical ICU in one, 
and from both medical and surgical in one study. Most of the studies (ten) were 
carried out in the UK, while three were in the USA and five in Europe (Germany, 
Italy and Sweden). A variety of study designs were included in the review. There 
were 13 prospective studies, two retrospective cohorts, two cross-sectional studies 
and one RCT. Follow-up rates varied from 15.6% to 100%. In total, psychological 
outcomes were assessed for 1351 participants out of the 2087 that were enrolled. 
This means that 64% of the participants across studies were followed up.  
 
2.3.2  Patient characteristics 
Inclusion. Minimum time spent in the ICU by a patient to qualify for inclusion in a 
study ranged from 24 hours in most studies to 72 hours in a few, to 30 days in one 
study. In five studies, only mechanically ventilated patients were included.  
Exclusion. The most common reasons for excluding participants were previous 
psychiatric disorders including psychosis, neurological disease, cognitive 
dysfunction and attempted suicide. As it is thought that prior psychological history 
may be a risk factor for outcomes such as PTSD, it would be better practice to 
include this factor as a covariate in the final model rather than exclude participants. 
The prevalence estimates of such studies may be too low.  
 
The socio-demographic composition of study cohorts varied considerably in several 
ways. Age differed from mean 41.7 years in one study to median 69 years in 
another (some studies reported means, and others reported medians). Gender 
composition ranged from 43% male in one study to 76% male in another. Age and 
gender are known risk factors for psychological morbidity and quality of life, 
therefore differences in prevalence estimates could be expected to occur when 
cohorts vary considerably in these factors. Data on ethnicity or socio economic 
status were rarely reported in the studies.  
 
Illness severity of patient cohorts ranged between Apache II scores of 11.93 - 25 
(mean or median scores). The Apache II score is a general measure of disease  
severity, based on current physiologic measurements, age and previous health 
condition. The range of possible scores is 0-71 and a high score is associated with 
an increasing risk of hospital death (Knaus et al., 1981).  Mean or median length 
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of stay (LoS) in the ICU ranged from five to 51.9 days. As the mean LoS of UK ICU 
patients is five days and median two days (Icnarc 2010), it can be seen that some 
cohorts were atypical for this variable. Differences in Apache II and LoS results 
suggest a wide range in physical condition and ICU experience between cohorts.  
 
Table 2.2  Characteristics of studies of psychological outcomes of ICU 
 
* FU=follow-up  **same study population *** same study population. C=controls, MV=mechanical ventilation, 
h=hours, d=days . Age, LoS (length of stay in ICU) and Apache II (Knaus et al., 1981) scores were means or medians, 
as reported in studies. If cells are empty, data were not reported in studies. 
Study 
reference  
N at 
FU* 
 
ICU 
Setting 
(Inclu-
sions) 
Exclusions Design 
 
Outcome Age 
 
Sex  
% 
men 
LoS 
ICU 
Apache 
II 
score  
Capuzzo et 
al. (2005) 
63  General 
Italy 
(> 3d) 
Psychol-
ogical 
history 
Prospective PTSD  69 
 
60  5  
 
14  
 
Cuthbertson 
et al. (2004) 
78 
 
General 
UK 
None Prospective PTSD  58  
 
56  6 
 
18  
 
Girard et al. 
(2007) ** 
43  Medical 
US (MV) 
Neurol-
ogical 
disease 
Prospective PTSD  52 
 
47 10  25 
 
Griffiths et 
al.(2006a) 
108  General 
 UK 
(> 3d) 
 Cross 
sectional  
PTSD  57  66  14   
Jackson et 
al.(2003)** 
34 
 
Medical 
USA 
(MV) 
Neurol. 
Psych.  
disorders 
Prospective Cognitive 
deficits 
53  
 
53  10 
 
25 
 
Jones et al. 
(2001) 
30  General 
UK(MV>
24h) 
Psychosis, 
suicide, 
head injury 
Prospective PTSD  57  44  8  17  
Jones et al. 
(2003) 
 44 
  
General   
3 in UK 
(MV>48h 
Neuro-
surgery, 
psychosis 
RCT  
(controls) 
PTSD  59 
 
57 13  16 
Jones et al. 
(2007) 
238  General  
6 Europe 
(>48h) 
Psychosis, 
suicide 
Prospective PTSD  54- 
73 
 
 5- 
13  
13- 
19 
 
Nickel et al. 
(2004) 
41  Medical  
Germany 
(>24h) 
 Cross 
sectional 
PTSD  47  69 12 12 
Perrins 
(1998) 
41    
 
General  
UK  
(>48h) 
Past 
mental 
illness 
Prospective  PTSD  49 
 
 6   
Rattray 
 (2005) 
80  
 
General 
 UK 
(>24h) 
 Prospective PTSD     
Richter 
 (2006)  
37  Surgical 
Germany 
(> 30 d) 
 Retro-
spective  
 
PTSD  42 
 
76  51.
9 
20 
Samuelson 
(2007) 
226 
 
General  
Sweden 
>24h MV 
Psychosis, 
suicide, 
head injury 
Prospective PTSD  63 
 
52 5.7
5 
18 
Scragg et 
al.(2001) 
80  General  
UK  
Trauma Retro-
spective  
PTSD  57  47 
 
  
Sukantarat 
(2005)*** 
45 
 
General 
UK 
(>72h) 
 Prospective Cognitive 
deficits 
58 43 17 15 
Sukantarat 
(2007)*** 
45 
 
General   
(>72h) 
 Prospective PTSD   
 
58 43 17 15 
Twigg et al. 
(2008) 
44  General  
UK, 2 
sites 
Dementia, 
Confusion, 
Overdose 
Prospective PTSD 56  45 11  
7  
16 
14 
Weinert & 
Meller 
(2006) 
153 
 
Medical-
surg.US 
>36hMV 
Chronic 
cognitive  
deficits 
Prospective Depression 55  51  6 
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2.3.3  Outcome assessment (psychological morbidity) 
The shortest time at which outcomes were assessed was two months after ICU 
discharge, whereas the maximum time was 35 months (see table 2.4). Clearly 
psychological outcomes such as PTSD might be expected to change across time and 
this might account for some variation. Many different PTSD measures were used in 
the studies, including self-report questionnaires such as the Posttraumatic 
Diagnostic Scale (PDS; Foa et al., 1997), the Impact of Events Scale (IES; Horowitz 
et al., 1979), the Impact of Events Scale-revised (IES-R; Weiss & Marmar, 1997), 
the Davidson Trauma Scale (DTS; Davidson et al., 1997), the Post-traumatic Stress 
Syndrome 10-Questions Inventory (PTSS-10; Stoll, 1999), the UK Post-traumatic 
Stress Syndrome 14-Questions Inventory (PTSS-14; Twigg et al., 2008), the 
Trauma Screening Questionnaire (TSQ; Brewin et al., 2002), a clinical interview - 
the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID; First et al., 
1998) and others. It is of concern that seven out of 18 studies in this review used 
the (unrevised) IES as a measure of PTSD, for although it is a good measure of 
distress related to life events, it is not a measure of PTSD. It includes only two of 
the three clusters of symptoms needed to diagnose PTSD (Weiss & Marmar, 1997). 
This could lead to inflation of PTSD prevalence. Only one study used the PDS (Foa 
et al., 1997) the only questionnaire that is diagnostic for PTSD using DSM-IV 
criteria (APA 1994).  
 
Measures of depression and anxiety used, including the Hospital Anxiety and 
Depression Scale (HADS; Zigmond & Snaith, 1983), the Center for Epidemiologic 
Studies Depression Scale, (CES-D; Radloff, 1977), the Geriatric Depression Scale 
(GDS; Yesavage et al., 1983), the Structured Clinical Interview for DSM-IV Axis I 
Disorders (SCID; First et al., 1998) and the State Trait Anxiety Inventory 
(Spielberger et al., 1983), were all valid and reliable. However there is always some 
doubt as to whether questionnaires measuring psychological constructs such as 
depression and anxiety are precisely comparable with each other. Even studies that 
used the same measure sometimes used different cut-points with different 
meanings (such as likely disorder, possible disorder, probable disorder, borderline 
disorder etc.) so that results are difficult to compare. For example in studies using 
the IES (Horowitz et al., 1979), some used a cut-point of 19, some of 26 and 
others of 30 or 35. Where a lower cut-point is used, higher prevalence rates will 
inevitably be found in those studies. 
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Table 2.3  Quality assessment of studies of psychological outcomes of ICU   
    * N at follow-up   **Sample size ratings: poor: 30-59  adequate:60-150 good:>150  
 
2.3.4  Prevalence of post-ICU PTSD 
As I was not able to carry out a quantitative synthesis of PTSD results, it was not 
possible to test whether variation in PTSD estimates could be explained by study 
and patient characteristics such as mean age of the cohort, gender, illness severity, 
type of ICU, country, study design or follow-up period. I carried out informal 
assessment by constructing tables ordering results according to each of these 
factors but they did not produce any meaningful patterning of results. However it 
appeared that results did vary according to the method of outcome assessment 
used. As a rating for outcome assessment was an important part of overall quality 
assessment, a table of results was created in order of quality assessment (table 
2.4). This was used to inform the reporting of prevalence estimates for PTSD. 
 
2.3.4(i)  Quality assessment of PTSD studies 
I found that out of fifteen studies whose main outcome was PTSD there were: 
3 with a high score (5/6) for prevalence. 
6 with a medium score (3/4) for prevalence.  
Author N* F.U 
rate 
Represen-
tativeness 
Sample 
size** 
Outcome 
Assessment 
Analysis of 
association 
Prevalence 
rating 
(max=6) 
Association 
rating 
(max=2) 
Capuzzo et 
al. 2005 
63 75%  adequate adequate poor poor 2 0  
Cuthbertson 
et al. 2004 
78 70% good adequate good poor 5 0  
Girard et al. 
2007 
43 16% adequate poor adequate good 2 2 
Griffiths et 
al. 2006 
108 67% adequate adequate adequate adequate 3 1 
Jackson et 
al. 2003 
34 12% adequate poor good adequate 3 1 
Jones et al. 
2001 
30 66% poor poor poor poor 0 0 
Jones et al. 
2003 
44 
Cs 
77% adequate poor poor poor 1 0 
Jones et al. 
2007 
238 78% adequate good good good 5 2 
Nickel et al. 
2004 
41 82% adequate poor good adequate 3 1 
Perrins 
1998 
41    
 
57% adequate poor poor poor 1 0 
Rattray 
2005 
87 
 
73% good adequate adequate adequate 4 1 
Richter et 
al.2006 
37 100% good poor good poor 4 0  
Samuelson 
2007 
226 72% good good good adequate 6 1 
Scragg et 
al.2001 
80 56% good adequate poor adequate 3 1 
Sukantarat 
2005 
45 88% adequate poor good adequate 3 1 
Sukantarat 
2007 
45 88% adequate poor adequate poor 2 0 
Twigg  et 
al. 2008 
44 79% adequate poor good n/a 3 n/a 
Weinert & 
Meller 2006 
153 55% good good good adequate 6 1 
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6  with a low score (0-2) for prevalence. 
2.3.4 (ii) PTSD estimates 
The range of PTSD prevalence estimates found was 0 - 62% across all studies. 
According to the PTSD measure and cut-points used, different studies reported 
different categories or levels of PTSD severity or diagnosis, corresponding to “some 
impact of PTSD” (n=3; 23-32%) “possible PTSD” (n=5; 25–62%), “borderline/sub-
syndromal PTSD” (n=5, 8.4% - 32%) or “likely PTSD” (n=4,12-28%) while others 
were able to confirm a diagnosis of PTSD (n=4, 9.2%-19%).  
2.3.4(iii)  Forest plots of PTSD estimates 
The three forest plots shown on the next pages (figure 2.2) display the patterning 
of results when studies are arranged in order of quality (highest quality first); in 
order of length of follow-up (lowest to highest); and in order of publication date 
(most recent first).  Whereas table 2.4 includes multiple results for each study (for 
different time-points or for different severity levels of PTSD) the forest plots include 
just one result for each study. I chose to show results for the first follow-up point in 
each study (e.g. three months rather than six months for Cuthbertson et al. 
(2004)) and for the most stringent definition of PTSD (i.e. a score for likely PTSD 
rather than possible PTSD). Therefore the range of estimates is a little narrower 
than seen in table 2.4. 
 In Forest plot a) order of quality, it can be seen that the higher quality studies at 
the top cluster together without excessive variation (8-28) whereas the lower 
quality studies at the bottom look much more disparate, with outlying scores up to 
52. Therefore it looks as if the quality of studies accounted for some of the variation 
in PTSD results. However no decisive pattern emerged from the plot of studies 
arranged in order of length of follow-up. It would be expected that the rate of PTSD 
might increase or decrease over time but this is not clearly seen. There may be a 
trend for the rate of PTSD to increase between two and six months, and then 
decrease over the next two years, but there is too much variation between scores 
at similar time-points to be certain. Ordering by date of publication might reflect 
changes in ICU practice over time or improvements in study design or diagnostic 
instruments for PTSD. However forest plot c) did not yield a clear pattern leading to 
this interpretation. The top four studies (2007-8) appear to cluster more than the 
rest around a lower range of scores (8-16) but the fifth study, Sukantarat (2007), 
was from the same year with a much higher score (35). 
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Figure 2.4  Forest plots showing estimates of PTSD prevalence  
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The forest plots suggest that most important source of variation for PTSD results 
was in the quality of studies. Therefore I arranged table 2.4 below in order of 
quality scores. If only high quality studies (quality score 5 or 6) were included in 
the assessment (n=3), the range of prevalence rate estimates was much narrower, 
at 8.4% - 22%. The best interpretation of this range is that 22% of patients had a 
high number of PTSD symptoms; between 8.4% -12% had borderline or likely 
PTSD, while 9.2% had a full diagnosis of PTSD. However the result must be viewed 
with caution as the range of estimates was based on only three high-quality 
studies. 
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Table 2.4   Prevalence rates for PTSD 
                (arranged in order of quality score) 
 
Author Time of 
Follow 
up 
N at 
follow-
up 
PTSD  
measure 
Results as reported Interpretation 
of results 
 
Quality  
Scores 
 
(max=6) 
Samuelson 
2007 
2m or 
later 
226 IES-R 
(0-88) 
8.4% ≥ 30 
(95%CIs 4.78,12.02) 
8.4% borderline 
PTSD 
6 
Jones et 
al. 2007 
3m 238 PTSS-14, 
PDS  
9.2% had PTSD 
using PDS. 
(95% CIs 5.53,12.87  
9.2%  full 
diagnosis of 
PTSD 
5 
Cuthbert- 
son et al. 
2004 
3 m 78 DTS 22%  > 27 
(95%CIs12.81,31.19) 
12%  > 40 
(95% CIs0.79,19.21) 
22%  possible 
PTSD 
12% likely PTSD 
 
5 
Rattray  
2005 
6m 
 
 
 
12m 
 87 
 
 
 
80 
IES 
(0-60) 
 
6m:  29% ≥ 30  
(95%CIs19.46,38.54) 
        27% ≥ 30 
(95%CIs17.67,36.33) 
12m: 28%≥  35 
(95%CIs18.57,37.43) 
         24%≥  35 
(95%CIs15.03,32.97) 
29% borderline 
at 6m 
27% likely at 6m 
28% borderline 
at 12m 
24% likely at 
12m 
4 
Richter et 
al.2006 
35m 37 Semi-
structured 
psychiatric  
interview. 
32% (5/6 criteria) 
(95%CIs16.97,47.03) 
19% (6 criteria) 
(95%CIs3.97, 34.03) 
32% sub-
syndromal PTSD 
19% full 
diagnosis of 
PTSD 
4 
Scragg et 
al. 2001 
Variable:  
 3-21m 
80 IES  30% > (unknown) 
(95%CIs19.9, 40.04) 
15.6% >30  
(95%CIs7.65, 23.55) 
30%  possible 
PTSD  
15.6% 
borderline PTSD 
3 
Nickel et 
al. 2004 
Variable: 
3-15m 
41 PTSS-10.  
 
SCID 
17% >=35  
(95%CI: 5.50, 28.50) 
9.76% with SCID  
(95%CI: 0.70,18.90) 
17% likely PTSD 
 
9.8% full 
diagnosis of 
PTSD 
3 
Griffiths et 
al. 2006 
6m/12m  
chk 
108 Trauma 
Screening  
checklist 
52% “PTSD” 
(95%CIs42.58,61.42) 
52% likely PTSD  3 
Twigg et 
al. 2008 
3m 44 PDS, IES, 
PTSS-14 
16% six criteria  
(95%CIs5.02, 26.98) 
27% five criteria PDS 
16% full PTSD 
 
27% 
subsyndromal  
3 
Capuzzo et 
al. 2005 
3 m 63 ICUM (all)  
IES  
0% on IES subscales 
(95%CIs 0.00,0.00 ) 
0% possible 
PTSD  
 
2 
Girard et 
al. 2007 
6 m 43 PTSS-10  25% >= 27 
(95%CIs12.06,37.94) 
14% >=35  
 (95%CIs3.63,24.37) 
25% possible 
PTSD 
14% likely PTSD  
 
2 
Sukantarat 
2007 
3m (9m) 45 IES 3m: 35%>26 
(95%CIs21.06,48.94) 
9m: 62% >26 
(95%CIs47.82,76.18) 
3m 35% 
possible PTSD  
9m 62% 
possible PTSD  
2 
Perrins 
1998 
6m  41                                     IES 6m:   32% >19 
(95%CIs17.72,46.28) 
12m: 27%  >19 
(95%CIs13.41,40.59) 
 6m 32% some 
impact  
12m 27% some 
impact 
1 
Jones et 
al. 2003 
6m 102  
(44 
control) 
IES 48% > 19  
(95%CIs33.24,62.76 
 
48% some 
impact 
1 
Jones et 
al. 2001 
2m 30 IES 23% >19 
(95%CIs7.94, 38.06) 
23% some 
impact 
 
0 
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2.3.5  Results: Prevalence of anxiety, depression and other outcomes 
2.3.5(i)  Depression 
Eleven studies included depression as a primary (n=1) or secondary (n=10) 
outcome (see table 2.6). Four of these were rated high quality and five were rated 
medium quality. The estimates for prevalence of depression ranged from 2.8% to 
47% at times between two and 15 months. This variation may be explained by a 
number of factors. First, studies measured depression using different instruments, 
including the CES-D (Radloff, 1977), the HADS (Zigmond & Snaith, 1983), the 
Geriatric Depression Scale (Yesavage et al., 1983) and SCID (First et al., 1998). In 
addition it should be noted that two levels of depression were measured – possible 
depression (ranging from 7% to 47%) and probable depression (ranging from 2.8% 
to 35%). Even when quality criteria were taken into account, and estimates from 
only high quality studies were included, rates of depression still varied from 
between 2.8% to 32%. It is of interest that in the one study that used the gold-
standard instrument for diagnosing depression, the SCID, (Weinert & Meller 2006), 
the overall rate of depression was high, with 16% diagnosed with major depressive 
disorder and 16% given a “diagnosis of depression not otherwise specified”. It is 
also of concern that evidence from these studies suggests that depression does not 
appear to lessen and may even increase over time.  
 
2.3.5 (ii)  Anxiety 
Six studies reported estimates for the prevalence of anxiety as a secondary 
outcome among former ICU patients. Two were given a high quality rating, two 
were medium quality and two were low quality studies. All measured anxiety using 
the Hospital Anxiety and Depression scale (Zigmond & Snaith, 1983) but some 
gave rates of possible anxiety while others measured probable anxiety. There are 
further discrepancies because studies variously used 8, 10 and 11 as the cut-points 
for clinically significant levels of anxiety. Estimates for the prevalence of anxiety in 
ICU survivors range from 4.9% to 43% for possible anxiety and 4.9% to 34% for 
probable anxiety at times between two to15 months. Variation in anxiety or 
depression rates did not appear to be explained by measure used, time of follow-up 
or quality of study. 
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Table 2.5  Prevalence of anxiety, depression, other outcomes 
                    (arranged in order of quality score) 
        * same study population  FU= follow-up  
 
 
2.3.5(iii)  Cognitive impairment 
Only two fully reported studies were found of cognitive outcomes in former general 
ICU patients. Both were rated as medium quality in the quality assessment and 
both were based on small samples (n=34 and n=45). Using a battery of 
neuropsychological tests, Jackson et al. (2003) found that 32% of patients were 
cognitively impaired at six months in the domains of psychomotor speed, visual and 
working memory, verbal fluency and visuo-construction. Sukantarat (2005) found 
that three months after ICU 35% of patients scored at or below the level of the 
lowest 5% of the normal population on tests of executive function and fluid 
Author N F.U. Anxiety 
(measure) 
Depression 
(measure) 
Cognitive  Other 
psychological 
phenomena 
Quality 
score 
(max 6) 
Weinert & 
Meller, 
2006 
153 2m  32%  
depression 
SCID 
  6 
Samuelson 
2007 
226 2m 4.9% 
probable  
HADS 
 
7.5% 
probable 
 HADS 
 
  69%  
ICU memories 
 
6 
Chelluri  et 
al. 2004* 
231 1y  32%≥16(high) 
CES-D 
 
  5 
Eddleston 
et al.2000 
143 3m 4.9% possible  
7% probable  
HADS   
7% poss  
 2.8% prob  
HADS 
 27% flashbacks 
33% memory 
lapses  
44% sleep 
5 
Jones et 
al. 2007 
238 3m    57% delusional 
memories 
5 
Chelluri et 
al. 2002* 
232 2m  35%≥16(high) 
CES-D 
  4 
Rattray  
2005 
87 6m 
 
 
12
m 
6m 19% poss 
      22% prob  
12m27%poss 
     18% prob 
HADS 
6m  19% poss  
        7% prob 
12m 17% poss 
        17% prob 
HADS 
  4 
Boyle et 
al. 2004 
53 1m 
3m 
 1m 19.22(high) 
3m 13.79 mild 
CES-D 
 70% 
unpleasant ICU 
memories 
3 
Griffiths et 
al. 2006 
108 6 or 
12
m 
   Sexual problems 
44%  
3 
Jackson et 
al. 2003 
34 6m  36% depressed 
(impaired) 17% 
(non-impaired) 
GDS 
32%  
impaired 
 
 3 
Scragg et 
al. 2001 
80 3-
21
m 
43% (poss) 
HADS 
30% (poss) 
HADS 
  3 
Sukanta-
rat 2005 
45 3m 
 
   35% 
impaired  
 3 
Sukanta- 
rat 2007 
45 3m 
9m 
3m 24%  
9m 24%  
HADS 
3m: 35%  
9m: 47%  
HADS 
  2 
Jones et 
al. 2003 
44 
Cs 
6m 34% (poss) 
HADS 
12%(poss) 
HADS 
  1 
Jones et 
al. 2001 
30 2m    73% delusional 
memories 
0 
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intelligence; By nine months, only 4% were impaired to this extent, but cognitive 
performance remained below population norms. 
 
2.3.5(iv)  Other psychological symptoms 
Studies also reported the presence of a number of other troubling psycho-social 
symptoms affecting former ICU patients at high levels during their first year of 
recovery, including sexual dysfunction (44%, n=1), unpleasant or “delusional” 
memories (57-73%, n=4), flashbacks (27%, n=1), memory lapses (33%, n=1), 
and sleep problems (44%, n=1).  
 
2.3.6   Results: HRQL 
As well as studies of psychological morbidity, the review included 28 papers that 
were identified as using a validated HRQL measure with  intensive care survivors. 
One of these (Sukantarat 2005) was also included in the previous section on 
psychological morbidity as its outcomes were cognitive impairment and HRQL. 
 
2.3.6(i)  Characteristics of HRQL studies 
Of the 28 identified studies, 18 were prospective, 9 retrospective cohorts and one 
was cross-sectional (see table 2.6). Five studies were carried out in the UK, three in 
the USA, two in Australia and one in Hong Kong. The other 17 took place in 
European countries including Sweden, Norway, Germany, Finland, France, Spain, 
Switzerland, Belgium, Portugal, Slovenia and Holland. Patients were recruited from 
general ICUs (n=23), medical ICUs (n=4), surgical ICUs (n=2) and medical-surgical 
ICUs (n=2). A total of 7924 patients were followed up from a baseline sample of 
13035. From this it can be calculated that 60.79% of the total number of baseline 
participants from all studies were followed up. Follow-up rates within individual 
studies ranged from 28% - 95%. The average age of cohorts ranged from 33-65 
years. Gender composition of studies was between 44%-73% male. Several disease 
severity scoring systems – Apache II (Knaus et al., 1981), SOFA (Vincent et al., 
1996) and SAPS II (Le Gall et al., 1993) - were used so illness results are not easily 
comparable. The range of mean illness severity scores, according to studies that 
used the Apache II system, was 9.7 - 23.4, suggesting important differences in 
health status between cohorts. Length of stay in the ICU varied from 2 days 
(median) to 16.9 days (median). Exclusion factors from study cohorts included 
neurological, spinal, terminal, burns, tracheostomy, elective surgery, comatose or 
delirious, obviously brain injured, and non-coronary patients.  
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Table 2.6  Characteristics of studies of HRQL in former ICU patients 
*  or **same cohort  LS/SS = long/short stay. Age, Los in ICU and Apache II or similar: means or 
medians, as reported in study. If cells empty, results were not reported in study. SOFA= Sepsis-related 
Organ Failure Assessment (Vincent & Moreno, 1996) SAPS II = simplified acute physiology score (Le Gall 
et al., 1993) 
Author 
year  
N 
at 
F.U. 
Design Type 
ICU 
Inclusion 
Exclusion Out-
come 
Age Sex 
% M 
LoS 
in 
ICU 
Apache 
II/ 
other 
Badia et al. 
(2001) 
334 Prospective General 
Spain 
 EQ-5D 
12m 
57  
 
64  5  
 
28  
SAPS2 
Bell&Turpin 
(1994) 
60 Prospective General 
UK 
Transfers 
other unit  
NHP 
 3m 
54 
 
51  3  
 
12  
 
Boyle et al.  
(2004) 
53 Prospective General 
Australia 
(>48h) 
Neuro , 
spinal  
SF-36 
1m/6m 
59  63  7  16  
 
Chelluri  et al. 
(2002) * 
232 Prospective General 
 US (MV) 
Trans-
plants 
SF-36 
2m 
60  54  11  68. Ap-
ache 3 
Chelluri  et al. 
(2004)* 
231 Prospective General 
US (MV) 
Trans-
plants 
SF-36  
12m 
60 54 11 68 
A.3 
Cuthbertson  
et .(2005) 
201 Prospective General 
UK 
Terminal SF-36 
6m 
61  59  7  18  
Eddleston et 
al. (2000) 
136 Prospective General 
UK 
 SF-36 
3m 
49  53  4 19 
Flaatten & 
Kvale(2001) 
51 Retros-
pective  
General 
Norway 
Burns SF-36 
 13y 
33   5 19  
SAPS2 
Fok et al. 
(2005 
88 Cross-
sectional 
General 
HK 
Tracheo- 
stomies 
SF-36 
4w 
60 70  4  
Frick et al. 
(2002) 
85 Retros-
pective   
General 
Swiss 
 SIP  
 6m 
65   2 22 
SAPS 
Garcia- 
Lizana (2003) 
96 Prospective General 
Belgium 
Elective 
surgery 
EQ-5D 
18m 
60  
 
61  3  
 
3  
SOFA 
Gardner 
(2005) 
51 Prospective General 
Australia 
 SIP  
6m 
55.
4  
66  4 11 
Graf et al. 
 (2003) 
153 Prospective Medical 
Germany 
Coma 
delirious 
SF-36 
9m 
64 
  
73  3  26  
SAPS2 
Granja et al. 
(2002) 
275 Prospective Med-
surg 
Portugal 
 EQ-5D  
6m 
57 57  2 
 
13  
Granja et al. 
(2005) 
464 Retros- 
pective 
10 gen 
Portugal 
 EQ-5D 
6m 
58 
 
61 
  
4 
 
31 
SAPS2 
Hurel 
(1997) 
223 Prospective 4 
general 
France 
 NHP  
6m 
52 56 8 12 
SAPS2 
Jagodic et al. 
(2006) 
39  Prospective Surgical 
Slovenia 
 EQ-5D 
  2y 
45  64  11 11 
Kaarlola et al. 
(2003)** 
169 Prospective Med-sur 
Finland 
 Rand36 
1y 6y 
58 65   
Kvale et al. 
(2003) 
210
? 
Retrospec-
tive  
General 
Norway 
 SF-36 
6m 
51 ? 5 38 
SAPS2 
Lipsett et 
al.(2000) 
47 Prospective Surgical 
US(>6d)  
 SIP1,3,
6,9 m 
57  11 24 
 
Niskanen  
(1999) 
368 Retros-
pective 
Gen.Fin-
land >4d 
 NHP  
6 m 
56 66 13 12 
  
Orwelius 
(2005) 
343 Retrospec-
tive 
2 
general 
Sweden  
 SF-36 
6m 
57  4 16 
Pettila et 
al.(2000)** 
299 Retrospec-
tive 
Medsurg 
Finland 
 Rand 
at 12m 
53   5   13 
 Ridley et al. 
(1997) 
95 Prospective General 
UK 
 SF-36  
at 6 m 
    
Stricker et al. 
(2005) 
150 Retrospec-
tive 
General 
Swiss 
Major 
burns 
SF-36 
at 1y 
59 
L 
67S 
 15L 
 2S  
36L34S 
SAPS2 
Sukantarat 
(2005) 
45 prospective General 
UK>72 h 
Brain 
injury 
SF-36  
3m 9m 
58 44 17 15 
 
Tian  
(1995) 
365
5 
Prospective 36 ICUs 
Holland 
 SIP  
6m 
60  3 10 
Wehler et al. 
(2003) 
171 Prospective Medical  
Germany 
Non-
coronary 
SF-36  
6m 
57   11 18  
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Four HRQL measures were used in the 28 papers; the SF-36 (Ware, Jr. & 
Sherbourne, 1992), the EQ-5D (Brooks et al., 2003), the Nottingham Health Profile 
(Hunt et al., 1980) and the Sickness Impact Profile (Gilson et al., 1975).   The 
Rand-36, used in two studies, is the same as the SF-36. 
Table 2.7  Quality assessment  of HRQL studies 
 
    * N at follow-up   **Sample size ratings - poor: 30-59  adequate: 60-150 good: >150  
Author 
year  
N* F.U. 
rate 
% 
Represe-
ntative 
sample? 
Sample 
size** 
 
Outcome 
Assess-
ment 
Analysis of 
association 
Rating: 
Prevalence 
(max=6) 
Rating:  
Association 
(max=2) 
Badia  
2001  
334 89 adequate good good good 5 2 
Bell & Turpin 
1994 
60 63 adequate adeq-
uate 
adequate n/a 3 n/a 
Boyle et al. 
2004  
53 54 adequate poor good  adequate 3 1 
Chelluri et 
al. 2002  
232 28 Good  good adequate n/a 5 n/a 
Chelluri et 
al.2004 
231 28 good good good n/a 6 n/a 
Cuthbertson  
et al. 2005 
201 67 adequate good good n/a 5 1 
Eddleston 
et al. 2000 
143 95 good adeq-
uate 
good n/a 5 n/a 
Flaatten &  
Kvale 2001 
51 58 adequate poor good n/a 3 n/a 
Fok et al. 
2005 
88 93 adequate adeq-
uate 
adequate n/a 3 n/a 
Frick  et al. 
2002 
85 85 adequate adeq-
uate 
good n/a 4 n/a 
Garcia-
Lizana 2003 
96 66 good adeq-
uate 
good Adequate  5 1 
Gardner 
2002 
51 55 good poor good adequate 4 1 
Graf et al. 
2003 
153 62 good good good adequate 6 1 
Granja et al. 
2002 
275 77 good good good adequate 6 1 
Granja et al.  
 2005 
464 51 good good good adequate 6  1 
Hurel 1997 223 68 adequate good good n/a 5 n/a 
Jagodic et 
al. 2006 
39 
(?) 
50 good poor good n/a 4 1 
Kaarlola et 
al. 2003 
169 58 good good good n/a 6 n/a 
Kvale et al. 
2003 
210 61 adequate good good n/a 5 n/a 
Lipsett et al. 
2000 
47 81 good poor good n/a 4 1 
Niskanen 
1999 
368 78 good good good n/a 6 2 
Orwelius 
2005 
343 61 good good good good 6 2 
Pettila  et al. 
2000 
299 85 good good good good 6 2 
Ridley et al. 
1997 
95 57 adequate adequa
te 
good adequate 4 1 
Stricker et 
al. 2005 
150 63 good good good n/a 6 2 
Sukantarat 
2005 
45 88 adequate poor good adequate 3 1 
Tian  1995 365
5 
59 good good good adequate 6 2 
Wehler et al. 
2003 
171 54 adequate good good n/a 5 0 
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2.3.6(ii)  Quality Assessment of HRQL studies 
Using the same criteria to assess the risk of bias as described in section 2.2.3, 18 
out of 28 studies measuring the quality of life of ICU survivors were found to be 
high-quality with regard to prevalence. A detailed break-down of the quality 
assessment can be found in Table 2.7. 
 
2.3.7 Meta-analysis: SF-36 studies 
Most of the 16 studies that used the SF-36 (Ware Jr. & Sherbourne 1992) reported 
results in the form of means of the eight SF-36 domains. The results of the eight 
domains cannot be aggregated to give one HRQL score. Scores can be calculated 
for two overall measures, physical and mental component scores (PCS and MCS), 
but most studies in the review did not report these. I decided to conduct meta-
analyses to obtain pooled effect sizes for three domains of the SF-36. These were 
physical functioning (PF, which correlates highly with the PCS), mental health (MH, 
which correlates highly with the MCS) and general health perception (GH). When a 
meta-analysis was conducted under the random effects model for physical 
functioning (PF), the pooled ES was 58.83 (95% CIs: 56.23-61.42). I² was 
54.7%. When a meta-analysis was conducted under the random effects model for 
mental health (MH), the pooled Effect Size was 65.75 (95% CIs: 64.20-67.29). 
I² was 15.4%. Finally a random-effects meta-analysis was performed for General 
Health Perception (GH). The pooled effect size was 48.20 (95% CIs: 46.45-
49.94), and I² was 0%.  
 
I² represents the variation in effect size attributable to between-study 
heterogeneity (characteristics of sample or design that vary between studies) 
rather than within-study variability (due to sampling error). Heterogeneity was 
much higher for physical functioning (I²=54%) than for the other two domains. The 
results of the meta-analysis, with pooled effect sizes of 58.83 for PF, 65.75 for MH, 
and 48.20 for GH, demonstrate that the HRQL of ICU survivors in important SF-36 
domains was much lower than general population norms. Although norms vary 
from country to country, between men and women and age-groups, the best-
validated UK norms are 79.4 for PF, 75.9 for MH, and 68.4 for GH (Jenkinson et al., 
1996). PF and GH were around 20 points and MH 10 points lower in ICU survivors 
than the general population. 
 
Other trends in SF-36 scores can be observed in table 2.8. HRQL was very poor one 
month after leaving ICU but gradually improved over the months and years. 
However after a year HRQL was still impaired compared to the general population. 
In two studies that followed patients up after six and 13 years, there were still 
deficits in comparison with reference populations. It can be seen that HRQL did not  
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Table 2.8   Results of three SF-36 domains, in order of time of follow-up  
                     0= worst possible health, 100 = best possible health   
*L Long stay, S short stay   FU= follow up   
                     
Author N 
at 
FU  
Result 
reported 
 
Time 
of 
FU  
Mental 
Health  
Physical 
Function 
General  
Health 
Perception 
Quality 
Rating 
Max 6 
Overview  
Fok et al. 
2005 
88 SF-36 
means 
 
1m 43.7      
(27.6) 
53.5 
 (29)               
43.1 
(6.1) 
3 Scores very 
low especially 
MH, GH 
Graf et al. 
2003 
164 SF-36 
means 
1m  64.6 
(22.3) 
 
50.3 
(28.9) 
 
48.5 
(18.3) 
6 Low scores, 
esp. PF, GH 
Cuthbertson 
et al. 2005 
  
233 SF-36 
means 
3m 
 
75.5 
(20.1) 
59.4 
(24.1) 
58.0 
(23.7) 
5 PF and GH 
below norm; 
MH near norm 
Sukantarat 
2005 
51 SF-36 
means 
3m 
 
 
63.8 
(19.9) 
 
52  
(29.9) 
 
51.8 
(22.2) 
 
3 Impaired in all 
domains 
Boyle et al.  
2004 
53  
 
SF-36 
means  
6m 68.9  
(21.3) 
52.5 
(31.0) 
 
48.0 
(25.1) 
3 5/8 domains 
improved 
from 1m to 
6m; still 
below normal 
Cuthbertson 
et al. 2005 
201 SF-36 
means 
6 m 76.8 
(19.7) 
 
61.7 
(28.7) 
58.7 
(25.4) 
5 Little improve- 
ment since 
3m – same 
pattern 
Orwellius 
2005 
270 SF-36 
means 
 
6m 66 
 
61.5: 55 6 Large 
differences in 
all domains  
Ridley et al. 
1997 
95 SF -36       
means   
6m 62 62 61 4 Improvements 
in 4 domains 
from pre-ICU 
Kvale et al. 
2003 
210 SF-36 
domains 
6m Not well 
reported 
  5 Significantly 
lower than 
gen. 
population 
Eddleston 
et al.  
2000 
136 SF-36 
means  
3m No 
overall 
results 
reported  
No 
overall 
results 
No overall 
results 
5  Scores in all 
except MH 
much lower 
than gen. 
pop.  
Graf et al. 
2003 
207 SF-36 
means 
9m 65.7 
(20.9) 
55.6 
(28.4) 
48.0 
(18.7) 
6 Below norms 
at 9 months 
Sukantarat 
2005 
 
45 SF-36 
means 
9m 63.1 
(23.6) 
57.5 
(29.2) 
54.4 
(15.7) 
3 Improvement 
from 3m but 
still well below 
gen. pop. 
Cuthbertson 
2005  
173 SF-36 
means 
12 m 76.4 
(20.1) 
61.9 
(31.7) 
59.9 
(24.9) 
5 Little change 
since 3 
months 
Pettila  
2000 
299 
 
RAND36 
means 
12m  67.3 
(26.2) 
 61.9 
 (32,7) 
47.7 
 (24.9) 
6 All domains 
well below 
general 
population  
Stricker  
2005 
150 SF-36 
medians 
1 
year 
L*: 
76(76) 
S*: 
80(79) 
 
L: 65 
(79) 
S: 
80(79) 
L: 62(60) 
S: 67(62) 
 No significant 
difference re 
LoS. Both less 
than 
population 
norms 
Kaarlola 
2003 
169 
 
RAND36 
medians  
6 y 80 
(60-
88.5) 
70 
(41.3-
90) 
50 
(33.1-70) 
6 Since 1y, 
marked 
improvement 
in MH, not in 
GH 
Flaatten 
2001 
51 
 
SF-36 
means  
13y  71.9 
 
75.3 57.7 3 QoL 
significantly  
less than 
ref.pop. 
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improve evenly across domains. Mental health improved more than physical 
functioning and general health perception but was well below population levels in 
most studies. Physical functioning was much lower than population levels. The 
worst domain of the three was general health perception which stayed at very low 
levels even after several years. 
 
2.3.8  Studies using other HRQL measures 
The Euroqol or EQ-5D (Brooks et al., 2003) is a health outcome measure that 
expresses results as no problems, moderate problems or extreme problems in five 
domains. All five studies that used the EQ-5D reported the percent of patients with 
problems (moderate or extreme) in each of the domains. It can be seen in 
summary table 2.10 that the proportions of patients with problems in all domains 
were very high, with up to a half of patients impaired in Usual Activities, Pain and 
Discomfort and Anxiety/Depression. Follow-up times ranged from 6 months to 2 
years. These studies were generally of high quality (see table 2.9).  
 
Table 2.9  Studies measuring QoL with the EQ-5D  
                (% with moderate and extreme problems in 5 dimensions) 
 
Author Tool Time  
of 
FU 
Mobility 
 
Self-
Care 
Usual 
Activities 
Pain / 
Discomfort 
Anxiety 
Depression 
Qual 
score 
Badia 2001 EQ-5D 
 
12m  
 
31%  23%  52%  47%  34%  
 
5 
Garcia-
Lizana 2003 
EQ-5D 18m 33%  
 
22%  
 
48% 
 
63% 
 
47% 
 
5 
Granja et al. 
2002 
EQ-5D 
 
6m 37%   22%  46%  45%  54%  6 
Granja et al. 
2005 
EQ-5D 6m 46% 33% 64% 60% 55% 6 
Jagodic et 
al. 2006 
EQ-5D   2y 56%  26%  60%  56%  40% sepsis 
70%trauma  
4 
 
 
Table 2.10  Summary of EQ-5D results 
Domain of EQ-5D % with problems  
(moderate and extreme) 
Mobility 31%-56% 
Self-care 22%-33% 
Usual activities 46%-64% 
Pain 45%-63% 
Anxiety/Depression 34%-55% 
 
Few studies used the NHP (Hunt et al., 1980) or the SIP (Gilson et al, 1975) so only 
a short summary is given. Studies using the NHP showed severe impairment in 
most domains at 3-6 months, particularly Energy, Sleep and Emotion. SIP studies 
suggested that there was significant impairment in physical and psychological 
domains at three months, and moderate disability in both at six months. By 11 
months there were improvements in both domains but HRQL was still not within the 
normal, healthy range. 
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Table 2.11  Studies measuring HRQL with the Nottingham Health Profile 
                       (NB: 0= no handicap. 100= max handicap) 
 
 
Table 2.12  Studies measuring HRQL with the Sickness Impact Profile  
                    (0-5: normal, healthy, 5-15 moderate disability, >15 significant impairment) 
 
 
 
2.3.9  Results: predictors of psycho-social outcomes of ICU 
One of the aims of this systematic review was to identify a consistent set of 
predictors of psychological morbidity or HRQL. However the quality assessment 
scores for analysis of association showed that quality for this aspect was not very 
high (see table 2.13). Although studies collected a great deal of data on patients, 
many studies did not attempt to identify predictors, or reported only statistically 
significant results regarding one or two predictors. It was unclear how many tests 
had been performed regarding risk factors in most studies. Questions about 
predicted associations were not well-defined. When associations were reported, 
they were usually in the form of p-values only, as effect sizes, confidence intervals 
or standard errors were rarely presented.  
 
 
 
 
 
 
 
Author N Time 
of FU 
Scores Comparison w. 
population 
Over-view Quality 
score 
Hurel 
1997 
223 6 
months 
Energy 47.8 
emotion 28.9 
sleep 35 
Much lower 
scores than 
French 
population 
Mean scores show severe 
handicap in most 
dimensions.  
5 
Niskanen 
1999 
368 6 
months 
Only given for 
disease/age 
 sub-groups 
 Most limitations in trauma 
or respiratory failure 
patients 
6 
Bell & 
Turpin 
1994 
60 3 
months 
Energy 34 
pain 13 
emotion 18 
sleep 22 
social 9 
physical 18 
 Worst scores for energy 
and sleep 
3 
Author N Time 
of 
FU 
Scores Subscores Over-view Quality 
score 
Frick et al. 
2002 
85 6 m 7.3  Physical:        6.2  
Psychosocial:  6.1 
57% normal 
27% moderate  
16% severe 
4 
Gardner 2002 51 6m 13.07  Physical         10.7  
Psychosocial   12.5 
33% normal. 
Problems: sleep, 
leisure, emotion 
4 
Lipsett  et al. 
2000 
47 3m 
 
1y 
36.2(3m)  
 
11   (1y) 
Physical          33 
Psychosocial   21 
Physical            8 
 Psychosocial    5 
Severe at 3m 
 
 Moderate disability at 
one year 
4 
Tian 1995 3655 6m 8.5 (9.5) 6.9   (11.1) 
7.1  ((10.6) 
Moderate disability 6 
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Table 2.13   Quality Assessment:  analysis of association in studies. 
 
Therefore all that can be documented in tables 2.14 and 2.15 is whether studies 
found an association with a given factor – yes or no. The summary table 2.16 
shows how consistently those associations were found or not found across studies. 
Looking first at studies of psychological morbidity (PTSD, anxiety, depression, 
cognitive impairment), age, gender and psychological history were inconsistently 
found to be risk factors. Illness severity score and length of stay were consistently 
found not to be risk factors. Clinical factors were found to be risk factors in five 
studies and not to be risk factors in five studies. Examining clinical factors more 
closely, days of mechanical ventilation was mainly found not to be a risk factor; 
while sedation practice was an inconsistent risk factor. Other factors of interest 
such as the use of physical restraint or mode of admission to the ICU were only 
tested in single studies. 
 
The most consistent category of predictors of psychological morbidity was psycho-
social factors, mainly ICU psychological factors. The most consistent psychological 
predictor, found in four out of five studies, was “unpleasant memories of the ICU” 
such as traumatic or delusional memories. Another predictor (found in three 
studies) was “recalled mood in the ICU” – including moods such as fear, depression 
or agitation. Delirium was found not to be a predictor in the two studies that tested 
it.  
 
Predictors that were consistently identified in the HRQL studies were age, illness 
severity (Apache II score; Knaus et al., 1981) or presence of multiple organ 
dysfunction (MOD)) and prior health. Sex was not found to be a predictor of QoL. 
Length of stay in the ICU and diagnostic groups were inconsistent predictors. 
Diagnostic groups that seemed more at risk of poor HRQL were trauma, non-
scheduled surgery and respiratory patients. Two psycho-social factors, education 
and memories of ICU, were found to be predictors of HRQL, but were tested in 
single studies only. 
 
 
 
 
 
 
 
 
Analysis of Association High Quality(2) Medium Quality(1) Low Quality(0) No results 
reported 
Psychological morbidity  
 
2 7 7 1 
Quality of Life (HRQL) 
 
6 12 1 9 
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Table 2.14   Risk factors for psychological morbidity 
                    (yes = association reported, no = no association reported) 
 
MV = mechanical ventilation   DM = delusional memories  P/A/D= PTSD, anxiety, depression  
 
 
 
 
 
 
Author 
(outcome) 
Age  
 
Sex 
 
Illness 
severity 
in ICU 
Psycho-
logical 
history 
Clinical/ 
health 
 factors 
Psycho- 
logical 
factors 
Diag-
nosis 
 
LoS 
  
Qual- 
ity 
Score 
Cuthbertson 
et al. 2004 
(PTSD) 
Yes 
 
No  No  
 
Yes Yes 
Days MV   
 No  No 
 
0 
Girard et al. 
2007 
(PTSD) 
Yes Yes No   Yes 
Lorazepam           
No  other 
sedatives 
No  MV  
Yes 
Traumatic 
Memories 
No  
Delirium  
 No  
2 
Jones et al. 
2007 
(PTSD) 
   Yes Yes 
Sedation 
opiates 
Yes  
Physical 
restraint 
Yes  
Delusional 
memories 
(DMs) 
No   
2 
Nickel et al. 
2004 
(PTSD) 
 
 
 No No     1 
Richter et al. 
2006 
(PTSD) 
No  No No  
 
No Duration 
     of MV 
 No sedation 
 No 
 
 No 
 
0 
Samuelson 
2007 
(PTSD) 
 Yes   Yes 
Midazolam 
Yes 
ICU Fear 
Agitation   
ICU Stress  
  1 
Jones et al. 
2001(PTSD) 
   No  Yes 
 DMs 
 No   
0 
Jones et al. 
2003(PTSD)  
     Yes- 
DMs 
   
0 
Perrins 1998 
(PTSD) 
 
    Yes - 
Admission 
mode  
No 
ICU 
Memories 
Yes 
 
 
 0 
Rattray 2005 
 (P/A/D) 
Yes       Yes 
 Recall 
 Fear 
satisfaction 
 Yes  1 
Sukantarat 
2007  
(P/A/D) 
No  No      0 
Scragg et al. 
2001  
(P/A/D) 
Yes No      No 1 
Weinert & 
Meller 2006 
Depression 
   Yes Yes  
pre-ICU 
physical 
HRQL  
   1 
Jackson 03 
(Cognitive 
deficits) 
No  No   No. 
 
 No 
Days MV  
Yes ICU 
Depression  
No 
Delirium  
Yes 
Education 
No No  
 
1 
Sukantarat 
2005 
(Cognitive 
deficits) 
  
 
No     No 
 
1 
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Table 2.15   Factors associated with any aspects or domains of HRQL 
MOD=multiple organ dysfunction 
 
Table 2.16  Summary table of predictors of psychosocial outcomes  
 Factors 
 
 Outcome 
Age 
 
Sex Psychol-
ogical 
history 
Diagnosis 
In ICU 
Illness 
Severity 
Days 
In ICU 
 
Clinical 
Factors 
Psycho- 
  social 
 
Prior 
health 
 Psychological 
 morbidity 
 (4) 
 (3) 
 
 (2) 
 (3) 
 
    (3) 
    (3) 
 
 (1) 
 (5) 
 
 (0) 
 (7) 
 
 (1) 
 (6) 
 
 (5) 
 (5) 
 
 (9) 
 (4) 
 
   (1) 
 Quality  
 of Life 
 (7) 
 (2) 
 
 (1) 
 (3) 
 
  no data 
 
 (5) 
 (3) 
 
 (7) 
 (4) 
 
 (5) 
 (3) 
 
no data 
  
 (2) 
 
 
   (4) 
= significant effect found for factor (x) number of times 
  = no significant effect found for factor (x) number of times 
Author 
 
Age Sex Apache 
II  
(or MOD) 
Prior 
health 
LoS 
 
Diagnosis 
(worse 
group) 
Others Qual-
ity  
score 
Badia et al. 
2001 
 
     Yes  Trauma vs 
surgical  or 
medical  
 2 
Bell & 
Turpin 
1994 
 No      1 
Boyle et al. 
2004  
Yes       1 
Cuthbertson 
2005 
 
No   No  Yes 
chronic 
health 
No No   
Type of 
admission 
 1 
Garcia-
Lizana  
2003 
Yes Yes Yes  Yes Yes 
Multiple 
trauma 
Nonscheduled 
surgery 
 1 
Gardner  
2002  
  YES     1 
Graf et al. 
2003 
Yes  No      1 
Granja et al. 
2002 
 
Yes  Yes Yes 
previous 
health 
  Yes 
education 
1 
Granja et al. 
2005 
 
Yes 
 
 Yes  Yes Yes Yes 
memories 
1 
Jagodic et 
al. 2006 
 
     No 
Trauma or 
sepsis 
 1 
Lipsett et al. 
2000 
     No   1 
Niskanen 
1999 
 
Yes     Yes 
Trauma 
respiratory 
 2 
Orwellius 
2005  
No No  No  Yes No    2 
Pettila et al. 
2000 
 
Yes No Yes  
(MOD vs 
non- 
MOD) 
 Yes Yes  2 
Ridley et al. 
1997 
 
  Yes Yes 
(chronic 
v acute) 
Yes   1 
Stricker et 
al. 2005 
    Yes    2 
Tian 1995   No  No   2 
Wehler et 
al. 2003 
 
  Yes 
( MOD 
vs non- 
MOD) 
  Yes Acute 
renal or  
respiratory  
failure 
 0 
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2.3.9(i)  Summary of risk factors 
The only consistently found risk factors for psychological morbidity after the ICU 
were psychological symptoms - unpleasant memories of the ICU (traumatic or 
delusional) and mood in the ICU.  Consistent risk factors for HRQL post-ICU were 
socio-demographic and clinical factors - age, illness severity and prior illness. 
These results help to suggest areas for future investigation but overall this review 
demonstrates a lack of systematic investigation of predictors of psycho-social 
outcomes after intensive care.  
2.4  Discussion 
Using explicit and systematic strategies to identify observational studies of psycho-
social outcomes of ICU patients, I retrieved 18 studies of psychological morbidity 
and 28 studies of HRQL that matched my criteria.  
2.4.1  Prevalence of psychological morbidity 
Due to the heterogeneity of both methods (measures, interpretation and follow-up 
times) and results of studies of psychological morbidity after ICU, it did not make 
sense to aggregate results in a meta-analysis. Therefore I examined ranges of 
estimates and identified reasons for variation in results, using quality criteria. 
Based on a small number of high quality studies, the best estimate of PTSD 
prevalence possible is that up to 22% of former ICU patients have high levels of 
PTSD symptoms. Approximately half of these patients would have symptoms 
meriting a full diagnosis of PTSD. Rates of probable depression in ICU survivors in 
high quality studies range from 2.8% to 32%. Rates of probable anxiety in ICU 
patients are 4.9 to 34%. Additionally two small studies found that 32-35% of 
former ICU patients had cognitive impairments at three to six months. 
These results contrast with two previous systematic reviews which presented PTSD 
estimates of 0-64% (Griffiths et al. 2007) and 5-63% (Jackson et al. 2007). This 
review’s results are closer to the point prevalence rates of 19% for clinician-
diagnosed PTSD and 22% for PTSD symptoms calculated by Davydow et al. (2008). 
The 19% rate for diagnosable PTSD is higher than my estimate of 9-12%, possibly 
because the review by Davydow et al. (2008) included studies of a sub-group of 
patients with sepsis, who may have a higher rate of PTSD. Davydow et al. (2009) 
found that the prevalence of depression was 28% (by questionnaire) and 33% (by 
clinician diagnosis), rates that were similar to the upper end of prevalence 
estimates in my review. However I concluded that there is not yet sufficient good-
quality evidence to definitively establish the prevalence of PTSD and other types of 
psychological morbidity (including cognitive impairment) after intensive care. 
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2.4.2  Estimates of HRQL 
Of the 28 HRQL studies reviewed, 18 were of high quality by this review’s criteria. 
Four different HRQL instruments were used and results were reported in 
inconsistent ways.  Nevertheless, in common with the findings by Dowdy et al. 
(2005), a clear pattern emerged that former ICU patients had much poorer quality 
of life in physical and mental health domains than the general population at all time 
points covered (from one month to thirteen years in my review). However unlike 
Dowdy et al. (2005), my review was able to quantify some of the effects. It is the 
first review in which a meta-analysis of HRQL based on mean SF-36 scores of 
former ICU patients (between three months and one year) has been carried out. 
Effect sizes found were 58.83 for Physical Functioning, 65.75 for Mental Health, and 
48.20 for General Health Perception. These totals out of 100 are low compared to 
the UK population norms of 79.4 for Physical Function, 75.9 for Mental Health, and 
68.4 for General Health (Jenkinson et al. 1996).  
It is unfortunate that there were no pre-ICU HRQL levels to compare these scores 
to, but this is a common problem in psychological research on intensive care as 
most ICU stays are unplanned. However the results of the meta-analysis suggest 
that there is a greater deficit in physical functioning (PF) and general health 
perception (GH) than in mental health (MH). Several studies found that GH scores 
were particularly low (Cuthbertson et al. 2005; Fok et al. 2005) and that it 
improved less than PF and MH over time (Kaarlola et al., 2003). A study by Flaatten 
et al. (2001) that took place 13 years after intensive care found near-normal levels 
of MH at 72 and PF at 75, but GH was very low at 57.7. It is possible that the shock 
of undergoing life-threatening illness changes patients’ perception of their health in 
a profound way, so that they come to think of themselves as unhealthy even when 
their physical and mental health has improved. This could have detrimental effects 
on their chances of making a full recovery, as it is known that beliefs about health 
and illness can have effects on a range of outcomes and recovery (Weinman & 
Petrie, 1997).  
2.4.3  Risk factors for psychological morbidity and HRQL 
Some of the studies investigated potential risk factors of post-ICU psychological 
morbidity or HRQL. However in most of these studies, results were not well or 
consistently presented. The only risk factors that were consistently found for 
psychological morbidity after the ICU were psychological symptoms such as 
unpleasant memories of the ICU (traumatic or delusional) and mood in the 
ICU. No socio-demographic or clinical factors consistently predicted psychological 
morbidity in the studies in my review. The reviews by Jackson et al. (2007) and 
Davydow et al. (2008) reported the same finding that memories of the ICU was a 
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consistent risk factor, but they also found socio-demographic predictors (younger 
age, female gender) and clinical factors. However one review found that LoS in the 
ICU and mechanical ventilation were risk factors (Jackson et al., 2007) the other 
found that they were not (Davydow et al., 2008). Both reviews concluded that 
sedation practice was a risk factor. Consistent risk factors for HRQL after the ICU 
from my review were socio-demographic and clinical factors such as age, illness 
severity score and prior illness. Dowdy et al. (2005) also found that older age 
and severity of illness were predictors of worse HRQL. 
 
From this review it can be concluded that there may be psychological, clinical and 
socio-demographic risk factors for adverse psycho-social outcomes after the ICU 
but they have not yet been clearly identified. In chapter three I will report on a 
further literature review about ICU stress and the experiences of intensive care 
patients that I carried out after completing the systematic review. I did so in order 
to deepen and widen my thinking about possible causal risk factors for severe 
psychological distress after intensive care that I could test in a prospective study. 
 
2.4.4  Strengths of systematic review 
In conducting this review I adhered to recent recommendations (Moher et al., 
1999; Moher et al., 2009) for carrying out systematic reviews by working from a 
protocol, and using systematic and explicit methods to identify, select and critically 
appraise studies. The risk of bias in studies was assessed, including the quality of 
outcome assessment. The review should be useful to clinicians in mixed, general 
ICUs because it includes studies of all known psycho-social outcomes after ICU and 
a comprehensive assessment of risk factors. No studies of diagnostic or 
demographic sub-groups of ICU patients were included, and therefore estimates of 
prevalence have not been inflated by patient groups with exceptionally high rates 
and should be applicable to mixed general ICU patients. 
  
2.4.5  Limitations of systematic review 
Although the exclusion of studies of patient sub-groups improved the 
generalisability of the review, it meant that much of the evidence accrued and 
frequently referenced in discussions of psychological morbidity in ICU patients could 
not be weighed to produce this overview. However, the review did include eight 
studies of mechanically ventilated ICU patients and these could be said to form a 
sub-group of ICU patients who potentially have higher prevalence rates of 
psychological morbidity or poorer quality of life. However I decided to include them 
on the basis that the majority of level 3 intensive care patients, including patients 
with mixed diagnoses, receive mechanical ventilation. Additionally a small number 
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of studies took place not in general ICUs but in medical or surgical ICUs. Although 
samples from these ICUs were not completely representative of all ICU patients, it 
was decided to include them because patients had mixed diagnoses and body 
systems involved and received a range of ICU interventions. 
 
Another weakness of the review was that no statistical aggregation of most of the 
results was possible due to the heterogeneity of studies. Conclusions about 
prevalence of psychological morbidity were based on just three high quality studies 
of general ICU patients. While it was possible to carry out a meta-analysis of SF-36 
results, it was also based on a small number of studies (n=6), after repeats and 
outliers were excluded. In addition to the SF-36, the review included HRQL studies 
using three other measures, all with different domains, making results difficult to 
compare. 
 
Studies were carried out in many different countries (15 in the UK, six in the US, 
two in Australia, one in Hong Kong and 22 in 12 different European countries).  
Intensive care units are run, funded and organised in different ways, creating 
another source of variation that is hard to measure and control for. Studies were 
also carried out at different time-points after the patients’ stay in the ICU – ranging 
from one month to thirteen years. Clearly it would be surprising if these outcomes 
were not influenced by the effect of time. However the majority of studies took 
place from three to six months after intensive care, so the results are probably 
most generalisable to patients at about three to six months after discharge from an 
ICU. 
 
Finally I was unable to achieve an important aim of the review, to provide an 
adequate synthesis of information about predictors of post-ICU psychological 
morbidity. This was not possible because risk factors were inadequately tested and 
reported in many of the studies included in the reviews. 
 
2.4.5  Clinical implications of the review 
A NICE guideline applying to England, Wales and Northern Ireland (Tan et al. 2009) 
has stipulated that all intensive care patients should be assessed for psychological 
morbidity and if necessary offered rehabilitation both in and after the hospital stay. 
This review helps to clarify the type and prevalence of psycho-social outcomes that 
may be expected in former ICU patients and some of the possible risk factors for 
patients who may experience these outcomes. It could therefore help ICU clinicians 
to be aware of potential problems and plan assessment and rehabilitation services. 
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2.4.6  Research implications of review 
Studies carried out in this area have been compromised by problems such as very 
small samples, inadequate outcome assessment, a lack of testable hypotheses and 
failure to control for confounding variables. Therefore studies with larger numbers 
and clear hypotheses about associations between risk factor and outcome need to 
be carried out. In this way more accurate prevalence rates could be established, 
and consistent risk factors could be identified. Previous studies have emphasised 
PTSD while paying little attention to other psychological outcomes such as anxiety, 
depression and cognitive impairment. Future studies should assess all likely 
psychological and cognitive outcomes and not focus solely on PTSD.  
 
After carrying out this review, I decided that the main study for my PhD should be 
a prospective cohort study with a well-defined representative sample of level 3 ICU 
patients in order to measure the range and extent of psychological outcomes of 
intensive care, and to identify the strongest clinical, psychological and socio-
demographic risk factors. I also believed this would help to inform future 
interventions to target those ICU patients most at risk of future psychological 
morbidity and give appropriate preventative or treatment support. Such 
interventions should also be evaluated in future research. As ICU memory was the 
most commonly identified risk factor for future psychological morbidity, but has 
remained a vague concept in research to date, I also decided to carry out a 
qualitative study to examine the nature and content of patients’ memories after  
intensive care.  
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Chapter 3 Literature review: risk factors for adverse 
                 psycho-social outcomes of  intensive care 
 
3.1  Introduction  
As the systematic review showed that little was known about risk factors for 
psychological morbidity and poor HRQL after intensive care, I decided to carry out a 
further literature review to identify potential predictors. This review covered 
qualitative and quantitative literature on patients’ experiences of  intensive care; 
accounts of stress and psychological distress in  intensive care; and investigations 
of risk factors for delirium in  intensive care. Although ICU delirium has not been 
decisively linked to post-ICU psychological morbidity, it will be seen that both may 
be triggered by similar alterations in processes in the brain.  
 
Many factors (related to illness, treatment, socio-economic circumstances, 
psychological reactions, chronic health and patient vulnerability) were highlighted 
as potentially relevant to post ICU psychological distress in this literature review. To 
introduce some structure into a long list, I have tried to group variables in terms of 
stress processes. Although the studies of psycho-social outcomes of  intensive care 
reviewed in chapter two did not refer to stress theories, the assumption that 
seemed to underlie the studies was that  intensive care was a traumatic stressor or 
series of stressors that might lead to adverse psycho-social outcomes in the future. 
It seems reasonable to examine this implicit assumption by considering the 
relationships between potential risk factors of post-ICU psychological morbidity in 
terms of an ICU stress process. 
 
A huge body of psychological research has explored the relationship between 
stress, health and illness (e.g. Kiecolt-Glaser et al., 2002). Psychological stress 
theories have borrowed the concepts of “stress” (an external force applied to a 
system) and “strain” (the resulting change in the system) from physics. Stress 
models usually include stressors, external or internal factors that put pressure on 
people; stress responses, the emotional, behavioural, cognitive or physiological 
reactions elicited by the stressors; and stress outcomes (or chronic strain), the 
negative impact of the stress process on people, usually in the form of mental or 
physical disorders (Steptoe & Ayers, 2004). In this chapter I have categorised some 
ICU factors as potential stressors (critical care illness, ICU interventions, ICU 
environment); some as ICU stress responses (emotional and cognitive reactions); 
and some as background or vulnerability factors (socio-demographic factors such as 
age, gender and SEC, and chronic factors such as prior physical or psychological 
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health). All may be related to the stress outcomes of ICU such as depression, 
anxiety and PTSD that were discussed in chapter one.  
 
Finally I have depicted all the factors within an informal ICU stress model, (see 
figure 3.1 at the end of this chapter). This model should help to explore whether 
the acute stress of being a patient in intensive care may lead to outcomes such as 
depression and PTSD in the longer term, and whether intervening factors alter the 
relationship. 
 
3.2  Stress in the ICU 
Reports of extreme psychological reactions in intensive care patients began soon 
after the first units were set up nearly 50 years ago. Kornfeld (1969) described 
confused, agitated patients who would pull out catheters and drains, and whose 
high anxiety compromised their cardiovascular status and increased the risk to their 
life. Tomlin (1977) observed that beyond psychological distress known to be 
associated with severe illness, there were specific psychological problems related to 
being in intensive care; these included the apathetic depression of the prolonged 
stay patient and the extreme terror of ventilated patients who had to be “weaned” 
off the machines that helped them to breathe.   
 
Qualitative studies appeared in the nursing literature in which former ICU patients 
retrospectively described their psychological state. They recalled extreme anxiety, 
panic, depression, withdrawal, confusion, agitation, hallucinations, and delusions 
(Bergbom-Engberg & Haljamae, 1989; Granberg et al., 1998). This constellation of 
symptoms was labelled intensive care syndrome (Kleck, 1984) or, more 
controversially, ICU psychosis (Sitzman, 1993). Nahum (1965) named it the “new 
madness of medical progress”. In a much-cited paper, “Preventing ICU syndrome: 
How not to torture your patients” Dyer (1995) a senior ICU nurse, drew parallels 
between the ICU experience and the Amnesty International definition of torture – 
both involved pain, thirst, sleep deprivation, isolation, the administration of 
psychoactive drugs, physical restraint, disorientation, sensory overload and sensory 
deprivation. Dyer encouraged ICU staff to use psychological nursing interventions 
and to modify the environment and medical practices to reduce the stress on ICU 
patients and prevent damaging outcomes. 
 
Below I will review evidence that possible ICU stressors, stress responses and 
cognitive responses may be predictors of later psycho-social outcomes. I will then 
consider other risk factors that could affect the long-term stress response, such as 
SEC, social support, age, gender, past trauma and previous psychological history. 
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3.2.1  ICU stressors 
Several studies were carried out in which patients were asked which ICU 
experiences they found most stressful (Nelson et al., 2001; Nelson, 2004; Novaes 
et al., 1997; Rattray, 2005; Samuelson, 2007; Simini, 1999). Results of these 
quantitative studies were very similar and matched the conclusions of numerous 
qualitative studies (Stein-Parbury & McKinley, 2000). Patients reported physical, 
psychosocial and environmental stressors: 
 
Physical stressors: Pain, inability to sleep, having tubes in nose/mouth, hunger, 
thirst, difficulty breathing, being “trapped” and “tied down” by equipment. 
Psychosocial stressors: Seeing or hearing other patients suffer and die, feeling 
isolated, being unable to communicate. 
Environmental: Loud noise, unexplained noise, the absence of windows and 
natural daylight, the absence of a night/day cycle.   
These stressors may be seen as effects of illness; effects of interventions; and 
effects of the ICU social and physical environment. 
  
3.2.1(i)  Possible effects of illness 
Could subsequent psychological morbidity be related directly to the serious illnesses 
suffered  by intensive care patients? We already know that psychological morbidity 
is associated with some serious illness. For example, depression is known to be 
both a risk factor for coronary heart disease (Rumsfeld & Ho, 2005; Frasure-Smith 
et al., 2009) and a psychological consequence of CHD (Davidson et al., 2010). 
Major depressive disorder (MDD) develops in approximately 15% of cardiac patients 
with a further 20% experiencing minor depression or high levels of depressive 
symptoms. Depression has also been found to be highly prevalent in cancer 
patients. In a review of 350 studies, Pirl (2004) concluded that the prevalence of 
MDD in cancer patients was 10-25%. This compares to an estimated point 
prevalence of MDD in the general population of 2.2%. 
Anxiety is also associated with serious illness, although it has often been 
overlooked. It is known that depression in CHD is often accompanied by symptoms 
of anxiety (Denollet et al., 2006). But as with depression, it is unclear whether 
anxiety should be regarded as a predictor or consequence of medical illness. A 
recent study by Szekely et al. (2007) in which 180 patients who underwent cardiac 
surgery were followed up until four years post discharge, found that 42% of the 
sample had clinically significant anxiety symptoms before surgery. In this study 
anxiety and depression were strongly correlated, but only anxiety was significantly 
associated with increased mortality and morbidity. There is also strong evidence of 
high prevalence of anxiety in patients with respiratory disease. A review by 
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Mikkelsen et al. (2004) of anxiety and depression in patients with chronic 
obstructive pulmonary disease (COPD) found that the prevalence of anxiety 
symptoms in COPD patients was as high as 50%. Similarly high rates of depression 
were also detected. Patients with COPD and other pulmonary dysfunction also have 
particularly high rates of panic attacks and panic disorder (Smoller et al., 1996). 
There may be a pathophysiological relationship between dyspnea, hyper-ventilation 
and panic anxiety with physical and psychological symptoms fuelling each other.  
 
Medical illness may also be a risk factor for developing PTSD. A review of PTSD and 
cancer found that prevalence of current PTSD among adult survivors of cancer (all 
breast cancer patients) was between 1.9–14% (Smith et al., 1999). In a review of 
studies investigating PTSD and medical illness and treatment, Tedstone & Tarrier 
(2003) reported PTSD prevalence for myocardial infarction (0%-16%), cardiac 
surgery (10.8-18%), haemorrhage (32%) stroke (9.8%) and miscarriage (7-25%). 
Tedstone & Tarrier (2003) found that the highest prevalence rates of PTSD were 
reported in studies of intensive care (0-59%) and HIV patients (30 and 35%). 
 
How relevant are these studies of medical illness and psychological morbidity to ICU 
patients? The examples suggest that being seriously ill, as most ICU patients are, 
can lead to psychological outcomes such as MDD, an anxiety disorder or PTSD 
(although there is a question about the direction of the effect). However the 
strongest evidence is for depression and anxiety being linked to chronic illness such 
as coronary heart disease, cancer and COPD. Some ICU patients may of course 
have chronic underlying illness of this type, but it is not known how many. The 
Intensive Care National Audit and Research Centre (Icnarc), the main source of 
information about UK ICU patients, mainly publishes data about acute events 
(primary reasons for admission to a critical care unit) such as pneumonia, septic 
shock, or ruptured aortic aneurysm (Icnarc, 2010). Their data includes only 
extremely serious co-morbidities such as biopsy proven cirrhosis and metastatic 
cancer. Thus little is known about the chronic health status of ICU patients in the 
UK. Few studies have tested associations between acute medical illness and later 
psychological morbidity. However some studies have demonstrate high levels of 
depression and PTSD after myocardial infarction (Roberge et al., 2010) and 
haemorrhage (Sheldrick et al., 2006) and this suggests that acute medical illness 
may also be associated with psychological morbidity. 
 
Furthermore having a life-threatening illness (and all ICU patients are critically ill, 
whatever the cause) is now officially recognised as a precipitating trauma for post-
traumatic stress disorder (American Psychiatric Association,1994). There has been 
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controversy about whether a life-threatening illness is really comparable to other 
traumatic stressors such as war, rape or natural disaster. However it is argued that 
the onset of physical illnesses (e.g. myocardial infarction or haemorrhage) can be 
sudden and unexpected. Similarly a diagnosis of cancer can be a serious shock that 
comes out of the blue for many people (Smith et al. 1999). Patients may react to 
such events with extreme fear, helplessness and loss of control, as in other 
traumatic incidents. 
 
A specific pathway by which critical illness may trigger psychological morbidity may 
be related to the effects of extreme physiological disturbances on the brain. Critical 
illness often affects the functioning of the brain as well as other organs of the body, 
so that the patient suffers both physical stress and possible alterations to cerebral 
processes or even brain damage. Many pathophysiological mechanisms occurring as 
a result of critical illness such as sepsis or respiratory failure may lead to cerebral 
dysfunction (Milbrandt & Angus, 2005). Reductions or increases of 
neurotransmitters such as acetylcholine, dopamine or gamma-aminobutyric acid 
(GABA) may occur. Occult diffuse brain injury may be inflicted as the result of local 
and systemic hypoxia, hypoperfusion, hyperglycemia, cytokine-mediated 
inflammation and microvascular thrombosis, all of which may occur due to critical 
illness. Metabolic derangements such as hypernatraemia and hypercalcemia, 
endocrine effects on cortisol or thyroid hormone and the effects of sedatives and 
analgaesics (see section 3.3.1.iii) should also be considered.  
 
It is thought that any of the above abnormalities may precipitate delirium in the 
ICU, and potentially also lead to longer-term cognitive dysfunction (Hopkins & Brett 
2005). It can also be hypothesised that neurotransmitter abnormalities could lead 
to other psychological conditions such as depression or PTSD. It has been 
suggested that the effects of inflammatory stress on neurotrophins (proteins that 
induce the survival, development and function of neurons), neurotransmitters and 
their receptors could lead to problems with memory consolidation and retrieval 
processes (Weinert & Meller, 2007) providing a possible biological basis for ICU-
related PTSD and other disorders. 
 
Some patients become critically ill not as a result of disease but as a consequence 
of events such as road traffic accidents, poisoning or burns. It is known that 
patients who have suffered injuries and trauma may have poor psycho-social 
outcomes. For example, after a major injury patients had low scores on the quality 
of well being scale (QWB) at 12 and 18 months after a major injury (Holbrook et 
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al., 1999). There is known to be a high prevalence of psychological morbidity, 
including PTSD, among patients who have suffered burns (e.g. Baur et al., 1998). 
 
In the systematic review (chapter two) illness-related factors were found to be 
associated with quality of life but mainly not with psychological morbidity. HRQL 
was predicted by illness severity, by the existence of prior or chronic illness and by 
diagnostic group (for example, trauma, respiratory illness, neurological illness and 
renal illness) However the systematic review did not provide conclusive evidence 
for any of these associations and further research is needed to establish the most 
important illness-related risk factors for post-ICU psychological morbidity. 
 
3.2.1(ii)  Effects of  intensive care interventions and healthcare 
A small number of studies have found that ICU interventions may be predictors of 
psycho-social outcome after intensive care. As we saw in the systematic review in 
chapter two these include duration of mechanical ventilation (Cuthbertson et al., 
2004), aspects of sedation practice (Girard et al., 2007; Jones et al., 2007, 
Samuleson, 2007); and the use of paralysis or physical restraint for mechanically 
ventilated patients (Jones et al., 2007). Other health care factors that have been 
studied include length of stay in the ICU (LoS) and in the hospital, and type of 
admission. LoS in the ICU was negatively associated with HRQL in a number of 
studies in the systematic review. This suggests that greater “exposure” to intensive 
care results in more serious outcomes. Uncertain results have been obtained for 
type of admission or diagnostic groups – see systematic review. 
 
Several of the possible risk factors described above are related to mechanical 
ventilation. This is undoubtedly a stressful treatment. During positive-pressure 
ventilation (now the most common form of mechanical ventilation), air is forced 
into the lungs by an external overpressure. The pressure causes oxygen to flow in 
via an endotracheal tube inserted into the trachea through the mouth or nose, or 
via a tracheostomy tube surgically inserted into the trachea. When a ventilator 
breath is terminated, airway pressure drops and the chest passively pushes the air 
out. Mechanical ventilation is thought to be particularly burdensome for patients 
(Rotondi et al., 2002). Most patients have to be sedated in order to tolerate the 
endo-tracheal tube. Procedures such as “suctioning” to clear secretions from the 
lungs, can be uncomfortable, distressing and painful for some patients.  For many 
the weaning period brings fear of suffocation, panic and a feeling of dependency on 
the ventilator (MacIntyre, 1995). Some patients have said that in retrospect they 
would choose not to undergo ventilation again (Mendelsohn, 2002). 
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Many early qualitative studies highlighted the distressing nature of mechanical 
ventilation for patients (Bergbom-Engberg & Haljamae, 1989; Gries & Fernsler, 
1988; Johnson & Sexton, 1990). Patients reported that the endotracheal tube was 
uncomfortable and remembered having their hands restrained to stop them 
touching the tube, or being threatened with restraint. They felt they were going to 
suffocate during suctioning of secretions from the trachea and could not 
synchronise their breathing with the ventilator after suctioning. Patients frequently 
found the procedures of extubation and decannulation, following weaning from the 
ventilator, to be unpleasant and problematic (Bergbom-Engberg & Haljamae, 
1989).  
 
Communication difficulties were often highlighted by patients as the worst part of 
the experience of ventilation. Patients on ventilators are usually unable to talk when 
endo-tracheal or tracheostomy tubes are in situ as they generally have a cuff 
around the distal end of the tube inflated to  prevent air flow so effective ventilation 
can occur. A qualitative study by Russell (1999) highlighted the need for improved 
communication in the ICU. In this and other qualitative studies patients said they 
were unable to express their wishes, ask questions, seek advice or reassurance or 
just hold a simple conversation. They felt that nurses did not always try to enable 
them to communicate by other means. This led to feelings of extreme isolation and 
affected the quality of care. Patients found good communication therapeutic and 
reassuring, and a lack of communication distressing. Poor communication led to 
increased anxiety and slower recovery. 
 
Mechanical ventilation is one of the nine types of organ support that occur in  
intensive care (see table 1.3 in chapter one). The possible psychological effects of 
the other forms of organ support – basic respiratory, cardiovascular (advanced and 
basic), renal, neurological, gastro-intestinal, liver and dermatological have not been 
considered in the literature. However it can be hypothesised that most of them are 
also highly stressful for patients. Basic respiratory support does not involve invasive 
ventilation, yet many patients have subsequent nightmares of claustrophobia and 
suffocation due to tight-fitting oxygen masks that may be used (see chapter 
seven). It also involves the suctioning of secretions, a procedure that has already 
been documented above as stressful for some patients. Cardiovascular support 
involves the use of inotropic drugs that may have unpleasant side effects (see 
section 3.3.1.iii on drugs below) and invasive monitoring that often necessitates the 
insertion of arterial lines, central venous pressure (CVP), and rarely, pulmonary 
artery catheters. 
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Renal support involves highly invasive procedures such as blood purification 
techniques to control hyperkalaemia and uraemia. Blood may be purified using 
dialysis or, more commonly in ICUs, haemofiltration methods. Haemofiltration in 
ICU usually involves percutaneous cannulation of a large central vein so that 
continuous veno-venous haemofiltration (CVVH) can be commenced. Some ICUs 
have the facilty to perform haemodialysis, either via a central venous catheter or a 
pre-existing arteriovenous shunt. Rarely, peritoneal dialysis is performed.  
 . 
The most common form of gastro-intestinal support is enteral nutrition, involving 
feeding with a naso-gastric tube, which may be another source of discomfort for 
patients. Many patients are already malnourished on entry to hospital and undergo 
periods of starvation during their treatment, so enteral feeding is often instituted 
early during an ICU stay. A complication of enteral feeding is that most patients 
remain under-fed (De Jonghe et al., 2001), due to maladministration or to upper 
gastro-intestinal intolerance (Mentec et al., 2001). Abdominal distention and 
diarrhoea are also common discomforts during this type of nutrition. Parenteral 
nutrition is also commonly used in ICU. Total parenteral nutrition (TPN) is routinely 
administered via a large central vein as it can be uncomfortable to deliver via a 
peripheral cannula. Insertion of central venous lines to facilitate this feeding 
regimen can also be an unpleasant patient experience. 
  
Neurological support in ICU usually encompasses ventilation as patients often have 
a reduced level of consciousness. Assessment of intracranial and cerebral perfusion 
pressure (Grant & Andrews, 1999) may require a highly invasive form of monitoring 
using intracranial pressure devices that are placed into the right frontal region 
through a small burr hole. Neurological patients are often heavily sedated and may 
also require neuromuscular paralysis and anticonvulsant agents. The experience of 
patients receiving dermatological support has rarely been written about, yet it is 
likely that such treatment is stressful or traumatic.  These patients may have 
serious burns, multiple trauma dressings or complex dressings, for an open 
abdominal wound for example. Patients being managed with an open abdomen 
(usually for scheduled re-laparotomies for bacterial peritonitis and infected 
necrotising pancreatitis) can be the most distressed patients on an ICU unit 
(personal communication with clinicians). Patients who survived this aggressive 
surgical treatment had Sickness Impact Profile scores indicating that they suffered 
from depression (Bosscha, 2001). It is not known if receiving any of these forms of 
organ support are risk factors for adverse psychological outcomes, although 
descriptions of the invasive methods involved suggest plausible reasons why some 
of them might be. It can be hypothesised that the longer intensive care treatment 
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continues, and the greater the number of interventions received, the more serious 
the psychological outcomes may be.  
 
Although little research has been done about the longer-term psychological 
outcomes of ICU interventions, parallels may be drawn from literature on 
psychological morbidity following other medical procedures. PTSD has been 
identified after procedures such as heart catheterisation, craniotomy and 
haemorrhage following tonsillectomy (Shalev et al., 1993), and following abortion 
and gynaecological procedures (Tedstone & Tarrier, 2003). There is also evidence 
of adverse psycho-social outcomes such as depression following surgery, a 
procedure that at least 40% of ICU patients are known to have undergone (Icnarc, 
2010). In one study (Burker et al., 1995) 50% of patients reported clinically 
meaningful depression after a coronary artery bypass grafting (CABG).  Depression 
may stem from poor recovery and poor quality of life after surgery. Gundle et al 
(1980) reported that patients who had undergone coronary artery bypass surgery 
one to two years previously were functioning poorly; 83% were unemployed, and 
57% had sexual dysfunction.  
 
There is also good evidence that cognitive outcomes after major surgery can be 
poor. Neuro-cognitive impairments have been reported at six weeks and five years 
in patients who have undergone cardiopulmonary bypass surgery and percutaneous 
angioplasty (Newman et al., 2001; Wahrborg et al., 2004). Furthermore, in a study 
of 1218 patients after major non-cardiac surgery, cognitive impairments were 
found in 26% at one week and 10% at three months (Moller et al., 1998). Hopkins 
& Brett (2005) hypothesise that the process of surgery, including hospitalisation, 
surgical procedures, removal from a familiar environment, and inability to control 
decision-making, are partly responsible for post-surgical cognitive impairment. 
These factors are also relevant to critically ill patients. As intensive care patients 
undergo multiple medical procedures and operations, it is likely that they are highly 
at risk of poor outcomes. Fairly routine ICU procedures such as bladder 
catheterisation and restraints are already known to lead to delirium in the short-
term (Weinhouse et al., 2009); It is important to discover if there are also longer-
term effects of ICU procedures. 
 
3.2.1(iii)  Drug effects  
An important aspect of ICU treatment, which merits specific attention, is the 
administration of drugs. ICU patients are often given multiple drugs with possible 
psychoactive effects  that may cause emotional and cognitive symptoms as well as 
possible withdrawal syndromes and sleep deprivation. Drugs that are commonly 
given in ICUs which may cause psychological side-effects include benzodiazepines, 
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opiates, anti-cholinergics and corticosteroids. For a list of drugs that are frequently 
used in intensive care units and that may have psychoactive effects, see table 3.1. 
Simply scanning the lists of side effects from the British National Formulary (BNF, 
2008) makes it clear that ICU patients receive a cocktail of drugs that all have 
possible side effects such as hallucinations, confusion, disorientation, anxiety, 
depression, insomnia and aggression. All these mental states have been 
documented in ICU patients. 
 
Table 3.1  ICU drugs with possible psychoactive effects 
 
 
Sedation and analgesia are key elements of ICU care. They are given to help 
patients tolerate mechanical ventilation, and other diagnostic and therapeutic 
procedures routinely carried out in ICUs. The aim is to suppress tachycardia, 
hypertension, hyperventilation or respiratory efforts against mechanical ventilation 
(Behne, 1995). However, although sedatives and analgesics relieve anxiety and 
pain, they may be associated with delirium. In one study (Pandharipande et al., 
2006) it was found that lorazepam was an independent risk factor for daily 
transition to delirium (OR: 1.2; 95% CI 1.1 – 1.4, p=0.003). Fentanyl, morphine 
and propofol were associated with higher but not statistically significant odds ratios 
for delirium. Jones et al. (2007) found that high doses of benzodiazepines increased 
the risk of delirium (median dose 24 mg vs 13 mg, p = 0.03), although no 
Class of Drugs Use in ICU Possible ‘psychological’ side 
effects  (British National 
Formulary 2008) 
Examples 
used in ICU 
Benzodiazepines Anxiety reduction, 
Sedation for 
ventilated patient 
Hallucinations, confusion, 
amnesia, dependence, aggression, 
delirium 
Midazolam, 
Lorazepam 
Anaesthetics Sedation Memory impairment  Propofol 
Hypnotics Inducing Sleep Rarely – aggression, confusion, 
depression, hallucinations, 
amnesia 
Zopiclone  
Sympatho- 
mimetics 
Raising blood pressure 
and cardiac output 
Anxiety, restlessness, sweating Noradrenaline 
Adrenaline 
Anticholinergic 
drugs 
Oliguria 
Heart failure, 
arrhythmias 
Memory impairment, confusion, 
delirium, hallucinations, 
depression. 
Furosemide, 
Digoxin 
Antipsychotics Treat delirium  Haloperidol 
Opioids Analgesia Restlessness, mood change, 
disorientation, agitation, delirium, 
hallucinations, euphoria, mental 
detachment, anxiety, confusion, 
sleep disturbances. 
Morphine, 
Tramadol, 
Fentanyl 
Gabapentin Neuropathic pain Confusion, depression, hostility, 
insomnia, anxiety, amnesia. 
 
Glucocorticoids Anti-inflammatory 
effects 
Extreme psychiatric reactions – 
psychosis, insomnia, mood lability,  
suicidal thoughts, memory 
impairment. 
Prednisolone 
Anti-epileptics Convulsions Insomnia, nervousness, confusion, 
agitation, aggression, amnesia, 
depression, hallucinations 
Phenytoin, 
Levetiracetam 
 
Anti-depressants Depression Confusion, impaired concentration, 
abnormal dreams. Withdrawal – 
anxiety, sleep problems. 
Citalopram 
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individual benzodiazepine was identified. Patients receiving high daily doses of 
opiates (median dose 88 mg vs 43 mg, p=0.039) were also more likely to be 
delirious. Patients with withdrawal symptoms from sedation and analgesia were 
also more likely to be delirious (25 out of 30 patients, p<0.0001).  
  
There has been little research to examine prospective associations between ICU 
drugs and psychological outcome. In a trial of the practice of daily interruption of 
sedatives to allow patients to awaken to a conscious state, Kress (2003) found that 
intervention patients had a lower Impact of Events (Horowitz et al., 1979) score for 
PTSD-related symptoms, (11.2% v 27.3%, p=0.02) and a trend towards lower 
incidence of PTSD (0% vs 32%, p=0.06). Daily interruption of sedatives was also 
associated with shorter duration of mechanical ventilation and shorter ICU stay 
(Kress et al., 2000). In an analysis of data using structural equation modelling 
Jones et al. (2007) found that prolonged treatment with sedation and opiates was a 
predictor of PTSD, along with previous psychological problems and physical 
restraint. Sedation and opiates had both a direct effect on outcome, and an indirect 
effect mediated by delusional memories. In Girard et al. (2007) the total dose of 
lorazepam received during the ICU stay was associated with PTSD symptoms six 
months after discharge.  
 
3.2.1 (iv) Cumulative Stress 
In addition to considering the specific stresses and strains due to illness and 
interventions in intensive care, both may lead to an overload of the type of 
experiences that patients say they find stressful. These include pain, discomfort 
from procedures and invasive monitoring, hunger, thirst, fatigue, sleep deprivation, 
and perceived difficulty in breathing (Simini, 1999). There may be a cumulative 
effect of having several of these individual stressors, that adds up to an 
overwhelmingly stressful experience for some patients leading to extreme stress 
responses in ICU and to psychological morbidity following discharge. 
 
The presence of hunger may be explained by a post-operative period of starvation 
and inadequate enteral or parenteral nutrition. The thirst complained of by many 
patients may be due to dehydration caused by diarrhoea, pyrexia, sweating, 
drainage, unnecessary fluid restriction or inadequate fluid replacement (Hinds & 
Watson, 2008). Pain may result from the illness or operation the patient has been 
admitted for, from ICU procedures and interventions, or from immobility, 
uncomfortable positioning, restraint, constipation or endo-tracheal suction (Dyer, 
1995). Although pain should be well-controlled in ICU, many studies have found 
that patients reported severe pain and that nurses were not aware of it, particularly 
in sedated patients. For example in a study of 50 critical care patients with 
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tracheostomies by Nelson et al. (2004), 44% rated their pain as being at the 
“highest levels”.  In another study of mechanically ventilated patients, 13 out of 43 
had suffered “intolerable” pain (Pochard, 1995). In a study of post-surgical 
patients, 25% reported severe pain while in the ICU (Bohrer et al., 2002). 
 
An important function of intensive care is to monitor patient’s vital signs and this 
frequently involves invasive monitoring. Patients in intensive care tend to be 
connected to a variety of machines and to have their bodies punctured with lines in 
the arteries and veins, catheters, cannulae, drains, drips, nasal and oral tubes and 
infusion pumps. This can be an alienating and frightening experience for many 
people who recall feelings of being trapped and tied down by equipment (Stein-
Parbury & McKinley 2000). Insertion of cannulae and catheters can also be difficult 
and painful for patients.  
 
Sleep deprivation has long been known to occur in intensive care patients, and has 
recently been considered as a risk factor for ICU delirium (Weinhouse et al. 2009). 
ICU patients tend to be wakeful and to sleep lightly. They are typically deprived of 
the all-important REM (rapid eye movement) and delta (deep) stages of sleep 
(Cooper et al., 2000). There has been a debate over the degree to which practices 
and environment in the ICU contribute to sleep deprivation. It has been argued that 
patients are deprived of sleep because of environmental noise, unnatural lighting 
which does not allow them to establish a natural sleep/wake cycle or being woken 
up in the night for checks and observations (Freedman et al., 2001). Sleep 
disruption and delirium share many physiologic similarities such as inattention, 
fluctuating mental status and impaired cognition in the domains of memory, 
planning, creative thinking and judgment (Weinhouse et al. 2009). If sleep 
disturbances continue untreated for a long time, including after intensive care, they 
also constitute a risk for psychiatric disorders (especially major depression), 
memory impairment and compromised quality of life (Roth, 2001). 
3.2.1 (v)  Effects of ICU environment 
Many studies have considered aspects of the ICU social and physical environment 
as a source of stress for patients. The following quotation from a qualitative study 
of ventilated patients outlines an impression of one ICU that is mirrored by patients 
quoted in other studies, “It was cramped, you couldn’t move. And they had all the 
machinery there. And the alarms were going off all night long. There was no peace, 
there was no peace at all. Everything was a hundred mile an hour. Patients in and 
out, in and out.” (Wade, 2006, p.38). 
 
84 
 
Physical aspects of the ICU environment that may be stressful include unnatural 
lighting, loud noise, a lack of distinction between day and night and the presence of 
machines and equipment, that may look disturbing to patients (Brullmann, 1997). 
Patients whose bed is placed with a view of a window may be more oriented than 
patients who have no window. In one study (Wilson, 1972) it was found that 
patients with a view of a window had half the rate of delirium of patients with no 
window. If there is no window or if lighting is left on at night to enable procedures 
to take place, patients may become disorientated and sleep deprived, as they are 
unable to establish a normal day/night sleep cycle.  
 
Noise has also been highlighted as a disruptive environmental factor. The noise 
level in one ICU was measured at more than 70dB, equivalent to the noise of heavy 
traffic in one study (Bentley et al., 1977). The recommended maximum noise level 
for a hospital ward is 45 dB. In most interview studies patients talked about noise 
comes from machinery, alarms, telephones ringing (often unanswered, in the 
middle of the night) other patients groaning or shouting, and from staff 
conversations(Green, 1996). Some patients reported that they found staff having 
normal conversations comforting (Green, 1996), while others said that staff talking 
over them while carrying out procedures was demeaning.  A patient quoted by 
Russell (1999, p.787) criticised staff for “laughing, joking, talking about social life, 
what pub they were going to, where they were going for holidays – Bali etc”.  
 
Similarly the considerable amount of technology and equipment found in ICUs (see 
chapter one) may elicit a sense of safety and comfort in some patients, or be a 
source of fear and alienation to others. For example a patient interviewed by 
Russell (1999) p788 said, “Guess I wouldn’t be here if it wasn’t for it. The 
machinery is there for a purpose. I wouldn’t know what it was, but I’m sure glad it 
saved me.” However a patient interviewed in Granberg et al. (1998, p.304) 
described, “tubes and lines all over me, in my arms and legs, forcing me to lie still, 
they also had lines in my stomach so it was impossible for me lie on my side. I felt 
bound and controlled by the equipment, which was both alien and noisy.”  
 
Efforts have been made in some ICUs to manage and improve environmental 
aspects such as lighting and noise levels in order to regularise day-night cycles and 
improve patients’ psychological states (Bennun, 2001). However it may be more 
difficult to manage the social environmental aspects of the ICU. These social 
environmental aspects are mainly related to the perception of other patients. Many 
patients feel isolated because they are unable to talk to their fellow patients, yet 
they are aware of each others’ suffering and are quite likely to see or be aware of 
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another patient dying. In Granberg et al., (1998) patients reported being highly 
aware of other patients. One patient described another as “a very confused person 
who was noisy and who fought and was disorderly and wanted to get out of 
bed….who could not speak, only scream and who just kept on hitting the nursing 
staff” (p 301). Another patient felt great fear and unease when he realised the 
person in the next bed had died. He was “afraid of what was happening on the 
other side of the curtain” (p 301). These environmental social problems are not 
easily solvable. Staffing levels and space constraints dictate that it is often easier 
for staff to manage patients in small units with several bed spaces rather than in 
individual rooms (Hinds & Watson, 2008).  
 
Another social stressor is the difficulty involved in communication between staff and 
patients, particularly ventilated patients. Reviews of ICU communication studies 
have found that communication between staff and patients in ICU is generally poor 
(Llenore & Ogle, 1999). Nurses typically receive no or little training in non-vocal 
communication methods, or in the assessment and application of augmentative 
communication methods (Happ, 2001). These communication methods could 
enhance the experience of ICU patients and potentially lessen the stressfulness of 
being in intensive care, but they are rarely used in ICUs. However strategies should 
be adopted to train staff in better communication methods and make low-tech 
communication aids easily available in ICUs (Magnus & Turkington, 2006). 
 
3.3  Stress responses 
It is clear that a great many potential stressors are present in intensive care units. 
However according to psychological theories of stress, psychological outcome may 
be determined more by patients’ responses to the stressors, rather than the mere 
presence of stressors (Lazarus & Folkman, 1984). Stress responses include 
emotional, cognitive, behavioural and physiological effects (Steptoe & Ayers, 2004). 
Physiological stress responses involve activation of the autonomic nervous system, 
producing changes to breathing and heart rate, and of the neuro-endocrine system, 
leading to the release of stress hormones such as adrenaline, noradrenaline and 
cortisol (Axelrod & Reisine, 1984). The immune response to stress, which includes 
changes to natural killer cell and cytotoxic activity (Kiecolt-Glaser et al., 2002) 
could be extremely relevant to the outcome of seriously ill patients as a decrease in 
immunity could impede their recovery.  
 
Physiological stress responses have rarely been measured in intensive care, 
probably because patients are already undergoing a high burden of testing, 
monitoring and intervention. However ICU patients are frequently treated with the 
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stress hormones adrenaline and noradrenaline to restore blood pressure and 
cardiac output, and cortisol, to reduce inflammation. Schelling et al. (2008) 
reported on studies investigating the effects of exogenously administered stress 
hormones on ICU patient outcomes such as PTSD and traumatic memories. 
Administration of catecholamines was associated with an increased number of 
traumatic memories held by ICU patients, but cortisol was associated with fewer 
PTSD symptoms in the recovery period (Schelling, 2002). As little has been 
published about physiological or behavioural responses to stress in the ICU, I will 
focus on emotional and cognitive responses to ICU stressors, and evidence that 
these responses may be risk factors for psychological outcome or possibly factors 
that mediate between clinical stressors and outcome.  
3.3.1  Emotional responses 
Several studies have quantified ICU patients’ emotional responses. As might be 
expected there is a combination of anxiety and depression in many cases. Pochard 
(1995) assessed 43 patients 48 hours after weaning from the mechanical 
ventilator. He found that 38 patients (88%) had “subjective physical depression” 
with 70% intensity, 33 patients (77%) were delirious or confused, 25 (58%) felt 
unable to communicate and 22 (51%) had a diffuse anxiety disorder, with 16 
describing an intense fear of dying. Of 50 tracheostomy patients studied by Nelson 
(2004), more than 80% were anxious or depressed, with 60% reporting anxiety 
and depression at the highest levels (frequently or almost constantly); while 90% 
suffered severe distress due to inability to communicate. A study by Menzel (1998) 
reported that fear and anger were the predominant emotional responses in 
ventilated patients, mainly associated with communication difficulties. A study of 
ICU patients with cancer (Nelson et al., 2001) found that severe or moderate levels 
of depression were reported by 40% of patients, and anxiety symptoms by 55%-
75% of patients. 
Anxiety 
The overwhelming response to being in intensive care is usually said to be extreme 
fear and anxiety (Bennun, 2001). Granberg et al. (1998) described patients as 
being in a state of emotional chaos on regaining consciousness in intensive care, 
and being vulnerable to extreme fear reactions such as anxiety, panic and 
agitation. Fear of dying, fear of ICU equipment, fear of suffocating and fear of the 
future were all common manifestations of this anxiety (Wade, 2006). Anxiety rates 
of 55% and 62% were found in questionnaire studies of 114 medical ICU patients 
(Brullmann et al., 1997). In 20% of cases, nurses underestimated patients’ anxiety. 
In a study by Chlan (2003) the mean Stait-Trait Anxiety Inventory (STAI) score for 
state anxiety among ICU patients receiving mechanical ventilatory support was in 
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the clinically significant range (49.2). Those who received mechanical ventilation for 
more than 22 days had a higher mean score (54.2). Anxiety can be severe enough 
to prevent patients from being weaning off mechanical ventilation (Gimenez et al., 
2003). Anxiety may interfere with the patients’ ability to breathe by increasing 
sympathetic nervous system activity. This could lead to increasing heart rate and 
contraction, a faster breathing rate increasing the work of breathing, and muscle 
tension leading to fatigue. Any of these symptoms might help to sabotage the 
weaning process (Johnson & Sexton, 1990). 
Depression 
Bennun (2001) argued that an absence of fear and anxiety in ICU patients may 
indicate a potential withdrawn or depressed state. Some patients, rather than 
become anxious or panicky, simply stop responding, and refuse to communicate 
with staff and families, or to comply with treatment or even simple care such as 
washing. In a questionnaire study of 100 general surgical ICU patients (Bohrer et 
al., 2002) it was found that the main psychological symptom, experienced by 29% 
of patients, was helplessness, a symptom of depression. In a 1998 study of 
patients receiving mechanical ventilation for more than seven days, Higgins (1998) 
found that patients had Profile of Mood State (McNair, 1984) scores suggesting a 
“moderate” depressed mood state as well as suffering from fatigue, lack of nutrition 
and disruption of their sleep-rest patterns. Mendel & Khan (1980) observed that 
depression impaired motivation to return to spontaneous breathing in mechanically 
ventilated patients. The type of depression observed in these studies is reminiscent 
of the helplessness-depressions often associated with lack of control. The concept 
of learned helplessness in response to uncontrollable events (Miller & Seligman, 
1975) may be extremely relevant to understanding ICU patients’ emotional and 
behavioural responses in the ICU. A series of experiments showed that both 
animals and humans acted helplessly when faced with uncontrollable events (e.g. 
electric shocks or loud noise). On learning that stressful events were completely out 
of their control, people displayed motivational, cognitive and emotional deficits of 
passivity, slow learning and depressed affect. This has become known as the 
depression sub-type of “helplessness depression” (Abramson et al., 1978).  
 
The experience of being in intensive care could almost be defined by lack of control. 
Patients are subject to a cascade of physiological events, and to control by medical 
staff, who must intervene with a succession of invasive treatments to save their 
lives. Another useful concept is the idea of external locus of control (Rotter, 1966) 
which has often been associated with the “helplessness” concept of learning that 
outcomes are uncontrollable. Being an intensive care patient is all about handing 
over control to medical staff so locus of control must by definition be external. 
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However interventions to improve patients’ self-efficacy (Bandura, 1977) by giving 
them a sense of control over small matters such as when they should be washed 
have been discussed, particularly in the nursing literature (Dyer, 1995).  
Other emotional reactions documented in research studies included agony and 
insecurity (Bergbom-Engberg & Haljamae 1989), mainly among ventilated patients 
who were unable to talk. However in a small number of studies more positive 
responses were documented. A few studies found a positive effect of the 
psychological attribute of “mastery” or “personal control” (Moody et al., 1997). In 
their review of patients’ experiences in the ICU, Stein-Parbury et al. (2000) found 
that patients gained feelings of comfort and security from the emotional support 
and attention of nurses, whose care helped to reduce their anxiety. However the 
focus of research has been on negative emotional responses to the ICU, and there 
is little evidence about the protective effect that positive factors might have on ICU 
patients. A recent review of positive affect (PA) and general health (Pressman & 
Cohen, 2005) concluded that there was evidence to suggest an association between 
PA and lower morbidity, decreased symptoms and pain.  
 
Although many studies have documented extreme psychological reactions in ICU 
patients, few have tested whether these reactions predicted subsequent 
psychological outcomes. Samuelson et al. (2007) found that several psychological 
factors were predictors of high levels of PTSD symptoms at 2 months, including fear 
of the ICU (OR 6.95, 95%CIs: 2.22, 21.7, p=0.0002) and agitation in ICU (OR 
1.77, 95% CI: 1.21, 2.59, p=0.005). A higher depression score (using the GDS-SF) 
at hospital discharge was significantly associated with cognitive impairment at 6 
months (mean 6.2 v 3.7, p=.04) in a study by Jackson et al. (2003). Another 
psychological factor, ICU recall or memory, was reported to be a risk factor in five 
studies in the systematic review. Memory is best considered within the category of 
cognitive response, to be discussed in the next section. 
 
3.3.2 Cognitive responses 
Having described studies dealing with the acute emotional response to being in  
intensive care, I shall now look at the cognitive responses of ICU patients. 
Cognitive responses to stress include changes in perception, attention and memory 
processes (Sapolsky, 2000). Attentional processes are particularly vulnerable to 
stress, and failure to notice important stimuli under stressful conditions is often the 
cause of accidents. Stress also has many effects on memory. After a trauma people 
often have incomplete memories of the stressful event as well as emotionally 
charged memories that may lead to long-term stress disorders such as PTSD 
(Brewin et al., 1996). There is now a considerable amount of evidence that 
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cognitive processes may become severely distorted in the ICU (Ely et al., 2001c; 
Granberg et al., 1999) and this may be partly due to psychological and physical 
stress. Here we need to distinguish between cognitions and beliefs (see section 
3.3.2 (iv)) and cognitive function.  
 
A uniform picture of extreme cognitive dysfunction in many cases can be built up 
from early descriptions by clinical staff, subsequent qualitative studies where 
patients described their experiences, and more recent quantitative data that gives 
more precise statistics about the prevalence and nature of such responses. An early 
psychiatric report by Kornfeld (1969) referred to agitated, aggressive patients, as 
well as a high incidence of “psychosis” among another group of  intensive care 
patients. The psychosis was said to begin with perceptual distortions, to progress to 
auditory and visual hallucinations and from there to frank paranoid delusions. All 
this was accompanied by disorientation to time and place. Kornfeld and colleagues 
believed these to be the effects of sleep and sensory deprivation on patients whose 
capacity to handle stress was already impaired by the effects of illness and surgery. 
 
Interview studies confirmed that many ICU patients could remember and describe 
being in acute confusional states. Granberg et al. (1999) categorised these states 
as unreal experiences; disorientation (the distortion of day, time and place 
perception) and cognitive impairment (the inability to talk, think, remember and 
understand). The unreal experiences appeared to be triggered by conditions of 
extreme fear; when a patient felt a degree of self-control or trust and confidence in 
nurses, unreal experiences occurred less often. In many studies a combination of 
these emotional and cognitive reactions was described and labelled as “ICU 
syndrome” or “ICU psychosis”. 
 
An insider account of “ICU psychosis” was provided by a medical sociologist who 
spent seven weeks in intensive care with peritonitis and septicaemia, in an article 
entitled “Coming out of  intensive care crazy: dreams of affliction” (Richman, 
2000). He described his disturbed mental state as he regained consciousness. “I 
displayed psychotic and paranoiac symptoms. I believed firmly that the reason for 
my hospitalisation was that I was shot in the university car park. I believed that the 
$5 million I carried for a foreign agency was stolen and that their agents were set 
on assassinating me. I told my youngest son to camp out on the flat roof of the 
hospital building and if anyone came on the roof….he was not to ask questions but 
throw that person off the roof” (p87). 
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Richman also had constant nightmares that began when he was in a coma in the 
ICU and continued after his transfer to the HDU. He was so terrified of the 
nightmares that he tried to avoid them by not sleeping at night. “It was like 
existing in a gigantic kaleidoscope that was constantly shaken. Colours were 
heightened. Impending danger was constant. I was in continuous motion flying 
through the sky, above the sea, and over ragged, barren mountains. Space and 
time seemed eternal……I had no notion of body and self, yet, I felt my invisible 
body being shredded.” (Richman, 2000, p.94) Richman wrote that these 
experiences left him with severe depression and guilt that persisted several years 
after the events. 
 
Delirium 
It is now recognised that symptoms such as disorientation, agitation, confusion, 
inattention, aggression, hallucinations, delusions and nightmares occur commonly 
in ICU patients. In the medical literature these are commonly identified as a 
syndrome known as delirium (Ely et al, 2001a). The DSM-IV (APA 1994) describes 
delirium as featuring a disturbance of consciousness and attention and a change in 
cognition or perceptual disturbances, such as hallucinations, with rapid onset. 
Delirium may not always present with agitation or hallucinations. Some patients 
have hypoactive delirium, characterised by decreased mental and physical activity 
and inattention. At the other extreme are agitated and combative patients, with 
hyperactive delirium.  Mixed delirium has features of both (Marcantonio et al., 
2002). In addition many patients only exhibit some cognitive responses (for 
example hallucinations) and not the whole range of delirium features. This may be 
explained by the existence of a sub-syndromal form of delirium (Ouimet et al., 
2007); alternatively it can be argued that cognitive responses to ICU treatment 
may occur independently, not always in the specific cluster of symptoms that is 
needed to satisfy the diagnostic criteria for delirium. 
 
The prevalence of delirium has been reported as 20%, 70% or 80% of patients in  
ICU cohort studies (Bergeron, 2001; Ely et al, 2001; McNicoll et al., 2003),  but 
goes unrecognised by physicians and nurses in 32% to 66% of cases. It is often 
misdiagnosed as dementia, depression or simply regarded as an expected 
occurrence in the critically ill, especially the elderly (Inouye, 1994). However 
delirium should not be disregarded, as it has been shown to be a strong risk factor 
for mortality in both non-ICU and ICU samples, entailing a 3-fold higher risk of 
death, after pre-existing co-morbidities, illness severity, coma and the use of 
sedative and analgesics have been controlled for (Ely et al., 2004). It is often 
regarded as a transition state between coma and a normal state, but in fact it 
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occurs as frequently in those who have not been in a coma, as in those who have. 
It persists in 11% of patients at the time of hospital discharge (Ely et al. 2004). 
 
There is often the assumption of an underlying medical cause for delirium, such as 
metabolic disturbances, electrolyte imbalances, withdrawal syndromes, acute 
infection, seizures, head trauma or brain lesions (McGuire et al., 2000). However 
other studies and reviews provide evidence that environmental or psycho-social 
factors such as social isolation, stress, circadian disruption, light, noise and sleep 
deprivation also contribute to delirium (e.g. Weinhouse et al., 2009). 
 
Drug-induced delirium is of particular interest in the ICU context. With enough 
oxygen and nutrition, consciousness is generally very resistant to disruption by 
drugs, according to Ashton (2002). However drugs can disrupt consciousness 
leading to hallucinations and delirium in adverse conditions. For example the risk of 
drug-induced delirium is increased by hepatic encephalopathy, head injury, viral 
encephalitis and hypoxia. Drug-induced delirium may result from direct toxic effects 
of drugs on cerebral function or indirect effects on metabolism such as 
hypoglycaemia or electrolyte disturbance. More than 90 medications have been 
identified as having an association with delirium (Murray et al., 1993). Drugs that 
have been known to cause delirium include anticholinergic drugs (Perry & Perry, 
1995); drugs with anti-muscarinic actions including antipsychotics and 
antihistamines; noradrenergic drugs including adrenaline and monoamine oxidase 
inhibitors (MAOIs); selective serotonin reuptake inhibitors (SSRIs; Sternbach, 
1991); and barbiturates, benzodiazepines, zopiclone, anticonvulsants and 
ketamine. 
 
The neurophysiological changes that may underlie delirium are not yet well 
understood. One current theory is that two connected neural circuits that are 
important for attention and working memory are compromised in cases of delirium 
(Trzepacz, 1999). One circuit involves the prefrontal cortex, anterior cingulate and 
basal ganglia; the other involves the parietal lobes, superior colliculus and thalamic 
pulvinar. The malfunction may be due to the vulnerability of these circuits to a 
variety of insults, leading to cellular dysfunction. The malfunction causes an 
imbalance of neurotransmitter systems leading to a deficiency of cholinergic 
innervation and excess of dopaminergic stimulation, thought to be a common 
pathway for the development of symptoms of delirium. Evidence for this theory has 
come from studies that found a higher prevalence of delirium in patients who 
received many anti-cholinergic drugs (Tune, 2000).  
 
92 
 
However other authorities argue there is no common pathway but that delirium is 
the final common symptom that can result from aberrations in many different 
neurotransmitter pathways and pathological processes (Flacker & Lipsitz, 1999). 
For example van der Mast & Fekkes (2000) stressed the importance of serotonin 
and its precursor tryptophan in delirium. Both an excess of serotonin (serotonin 
syndrome) and diminished serotonin (as in alcohol withdrawal) are associated with 
delirium.  
 
Whether the “ICU syndrome” is seen to be a well-defined medical psychiatric 
condition, or a multi-factorial psycho-physiological one, it predicts adverse ICU 
outcomes including increased risk of death, cognitive impairment, longer hospital 
stay and higher costs (Ely et al., 2004, Ouimet et al., 2007). It is not yet known 
whether delirium or indeed individual symptoms of delirium such as disorientation, 
hallucinations or nightmares predict psychological outcomes in the months after 
discharge from ICU. In the systematic review (chapter two) two studies included 
delirium as a potential risk factor. In Girard et al. (2007) no significant correlation 
was found between duration of delirium (days) and PTSD symptoms. Jackson et al. 
(2003) found no association between days of delirium and cognitive impairment at 
six months. This is an issue that will be examined further in this PhD. 
 
3.3.3 Memory  
A specific aspect of cognition that may be of particular relevance to psychological 
outcomes after intensive care is memory. As mentioned above, several studies 
found that the nature of memories of ICU was associated with outcomes, 
particularly PTSD (e.g. Jones et al. 2001). This is perhaps not surprising, as it has 
been argued that a key feature of PTSD is the distortion of normal memory 
processes (Brewin 2001). The experience of intensive care is known to have several 
effects on memory. Some patients suffer total or partial amnesia for both admission 
to an ICU and for the duration of their stay. This amnesia may be explained by loss 
of consciousness or the effect of sedative drugs while in the ICU (Ghoneim, 2004b), 
yet this may not be a complete explanation, as it is also common for people 
undergoing other types of trauma that do not involve unconsciousness or drugs, to 
forget important parts of the experience (Brewin & Holmes, 2003). Some patients 
report that they remember events that happened before regaining consciousness in 
the ICU. For example in a study by Rundshagen et al. (2002), 17% of patients 
remembered the endotracheal tube or being on the ventilator while unconscious, 
21% reported dreams or dream-like sensations, 9.3% reported nightmares and 
6.6% recalled nightmares from that pre-conscious time. 
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For some ICU patients the most disturbing memories are of real experiences they 
had in intensive care, especially those involving pain and discomfort, such as 
extubation or endo-tracheal suctioning (Rotondi et al., 2002). Others are troubled 
by so-called “delusional” memories of “unreal” phenomena experienced in  
intensive care. Memories of hallucinations, paranoid delusions or nightmares appear 
to be particularly frightening for ICU patients (Griffiths & Jones, 2001). The 
experiences remembered are often persecutory; for example patients “remember” 
ICU staff trying to harm or kill them, or aliens taking the place of their relatives 
(Jones et al., 1994). 
 
Some patients have both factual and delusional memories. Both types of memory 
have been found to predict psychological outcome, although there are conflicting 
findings about which type is the strongest predictor. My systematic review (chapter 
two) included five studies that reported some form of ICU memory to be a predictor 
of psychological outcome. Rattray (2005) found that greater recall of ICU 
experiences was associated with higher anxiety and depression at 6 months. 
Similarly, Girard et al. (2007) found that the presence of “traumatic” memories (of 
pain, suffocation, panic and nightmares) was highly associated with PTSD. A study 
by Schelling (1998) of ICU patients with ARDS (excluded from the systematic 
review) suggested that the number of adverse memories a patient could recall from 
ICU was associated with PTSD. Since the systematic review was completed, Myhren 
et al. (2010) found that factual recall was a predictor of PTSD (OR:6.6, 95%CIs: 
1.4, 31.0) 
 
However Perrins et al. (1998) reported a trend for higher levels of PTSD symptoms 
to be experienced by those who had no memories of ICU. Jones et al. (2001) found 
that the presence of “delusional” memories two weeks after discharge, was 
predictive of PTSD symptoms while “factual memories”, however unpleasant, were 
protective against PTSD. This finding was repeated in three further studies (Jones 
et al. 2003; Jones et al. 2007; Weinert & Sprenkle, 2008). The authors of Jones et 
al. (2001) hypothesised that two processes contribute to memory problems 
experienced by former ICU patients. First, effects of illness and treatment such as 
delirium and sleep deprivation may cause confusion and amnesia, while drugs 
including benzodiazepines and opiates have known distorting effects on memory. 
Second, the physical and social effects of undergoing ICU treatment such as 
restraint and isolation, cause patients to focus on internally generated images at 
the expense of external ICU events. Therefore they clearly recall memories of 
hallucinations and nightmares, and have poor recall for the factual events that 
occurred in the ICU.  
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Another possibility is that, regardless of the content (factual or delusional), having 
early post-ICU memories that are intrusive and hard to control will predict future 
psychological morbidity. It is known from the wider literature on (non-ICU) PTSD 
that intrusive thoughts and memories often begin immediately after a traumatic 
experience (Brewin et al. 1996) and are an early predictor of PTSD. To my 
knowledge no studies have been carried out in the ICU setting to investigate 
whether early intrusive memories are potential risk factors for post-ICU 
psychological morbidity. 
3.3.4  Illness Perceptions 
As well as effects on cognitive function, ICU stress may alter patients’ illness beliefs 
or perceptions. Almost nothing is known about this because patients are rarely in a 
good condition to answer questions about beliefs while in  intensive care (it is 
somewhat easier to detect their moods with simple one word items such as those 
used in the Profile of Moods States (McNair et al., 1984)). The illness perception 
approach is based on patients’ experience of illness and their own model of their 
condition (Weinman & Petrie, 1997). Illness perceptions are defined as idiosyncratic 
beliefs about illness based on the patients’ cognitive representations of their 
symptoms or condition. These core beliefs concern the identity of the illness (what 
is it?); the causes of the illness, the suspected consequences of the illness, time-
line (how long will it last?) and cure/control (what will make it better?). Illness 
perceptions have previously been found to predict recovery, disability and health 
behaviours of diverse groups such as women with breast cancer, chronic fatigue 
sufferers and myocardial infarction patients (Weinman & Petrie, 1997). To my 
knowledge ICU patients’ illness perceptions have not been assessed in previous 
research. However a study by Sheldrick et al. (2006) that assessed illness 
perceptions after acute medical trauma may be relevant to intensive care. It found 
that certain illness perceptions (identity, timeline, consequences and emotional 
representation) predicted post-traumatic stress in survivors of acute medical 
trauma such as myocardial infarction or subarachnoid haemorrhage.  
 
It can be hypothesised that the severe nature of critical illness in addition to 
receiving highly intrusive medical treatment and the loss of psychological control is 
likely to profoundly alter patients’ illness perceptions. Additionally illness 
perceptions may be distorted by the effects that ICU has on cognitive function and 
memory described in previous paragraphs. More negative and possibly catastrophic 
illness perceptions about control or timeline may also have a negative effect on 
patients’ mental and physical recovery and HRQL. 
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3.4  Intervening variables  
As well as stimuli and responses, most current stress models include a number of 
intervening variables that have some effect on the stimulus-response relationship 
(Jones & Bright, 2001) and determine the way an individual will react to a stressor. 
However there is little agreement about which are the most important intervening 
variables, and different models focus on different types of variable. A group of 
intervening variables that have attracted particular interest are “psychosocial 
resources”, resources that are available to people to help them cope with demands 
made on them. In some models these are environmental factors such as social 
support or economic resources; other models emphasise personal factors such as 
previous experience, negative or positive affect, type A personality, pessimism, 
self-efficacy or coping strategies. Individual vulnerability is also indicated by 
experience of past traumas or past psychiatric history (Brewin et al., 2000). 
In the studies reviewed in chapter 2, three out of six studies that included 
psychological history in their models found that it was a risk factor for PTSD or 
depression after intensive care (Cuthbertson et al., 2004; Jones  et al., 2007; 
Weinert & Meller, 2006;). Cuthbertson et al. (2004) found that subjects who 
reported visiting a GP or mental health professional for psychological distress prior 
to their ICU admission had higher levels of PTSD three months after ICU. Jones et 
al. (2007) found that receiving prolonged sedation in the ICU and recalling more 
delusional memories from the ICU were possible mediators of the relationship 
between prior psychological history and PTSD.  It is possible that small samples or 
methodological problems prevented other studies from detecting the effect of 
previous psychological history. Certainly it is well known that previous episodes of 
depression make a future episode of depression more likely (Lewinsohn et al., 
1988). Alternatively it could be argued that the ICU may be a stressor of such 
magnitude that previous history has a weaker effect than might usually be 
expected. Few studies have included personality factors, although Myhren et al. 
(2010) found that optimism predicted fewer symptoms of PTSD, depression and 
anxiety one year after ICU. 
 
Important differences have also been found in the risk of developing mental or 
physical ill-health after exposure to adverse experiences, because of socio-
demographic factors including age and sex. Sex and age differences have been 
documented in both physical and mental health outcomes such as heart disease 
(Jousilahti et al., 1999) or depression (Bebbington et al., 2003). The different 
vulnerability due to age and sex may be explained by social, genetic or biological 
approaches. For example, as people age, biological changes occur that modify 
stress responses and an individual’s capacity to adapt homeostatically (Seeman & 
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Robbins, 1994). Age and sex are also established predictors of health-related 
quality of life in the general population. In the systematic review (chapter 2), age 
predicted post-ICU psychological morbidity in four out of seven studies that 
reported it, while sex was a risk factor for post-ICU psychological outcomes in only 
two out of five studies. The trend was for younger age and female sex to be 
associated with PTSD. Several studies found that older age was a consistent 
predictor of HRQL after intensive care while sex was not. Sex was found to be 
associated with clinical outcomes of intensive care such as duration of intubation 
and length of stay after coronary artery surgery (Butterworth et al., 2000). 
However sex was not associated with outcomes of mechanical ventilation including 
duration of intubation or success of weaning trials (Epstein & Vuong, 1999). 
 
No studies of psychological outcomes of ICU included data on ethnicity. However it 
has been found that higher rates of disease and poorer general health are more 
prevalent in some ethnic groups than others. For example, there is higher 
prevalence of hypertension and diabetes in Caribbean- and South Asian-born adults 
than representative samples of the general population. Higher risk factors for 
cardiovascular disease such as obesity and raised waist-hip circumference ratios 
have also been found in South Asian, African-Caribbean and some Irish-born adults 
(Landman & Cruickshank, 2001). However there are fewer coronary heart disease 
deaths among Caribbean-born adults and fewer cancer deaths among Caribbean, 
South Asian and East African-born adults in the UK. Irish- and Scottish-born adults 
have higher mortality from all causes. However it has been argued that social and 
economic inequalities are the fundamental causes of ethnic inequalities in health 
rather than cultural or genetic factors (Nazroo, 2001). 
 
“Psycho-social resources” also include social factors such as social support. There 
are two main theories of social support. In the “main effect model” it is 
hypothesised that social integration and participation in multiple social roles is 
associated with lower mortality and morbidity, regardless of the level of life stress 
(Berkman, 1997). In the “stress-buffering” model, social ties are viewed as 
protective against life stress.  Emotional support, practical support and information 
have been shown to mitigate the effect of adverse experiences such as serious 
illness (Cohen & Wills, 1985). There is also some evidence that social support may 
be helpful in recovery after surgery. In a study of post-operative recovery (Neuling 
& Winefield, 1988), recovery was associated with satisfaction with support from 
family, the surgeon or with both at different time points. 
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3.4.1.  Socio-economic circumstances 
People with more deprived socio-economic circumstances may be more at risk of  
intensive care stress. Therefore it is important to discover if SEC predicts worse 
psychological outcomes or quality of life after intensive care. In general terms, SEC, 
whether defined by occupation, income or educational attainment, is a particularly 
powerful predictor of health outcomes. A social gradient in health has been 
demonstrated for both morbidity and mortality from common illnesses throughout 
the developed world (Adler & Ostrove, 1999). A social gradient has been found for 
cardiovascular disease, metabolic syndrome, diabetes, chronic respiratory disease, 
gastrointestinal disease, lung cancer and accidental and violent deaths. 
Mixed results have been found for SEC and mental health. Social gradients have 
been demonstrated for the more severe mental disorders such as schizophrenia or 
bipolar disorder (Dohrenwend et al., 1992; Lorant et al., 2003). However findings 
have been inconsistent for less severe “common mental disorders” such as 
depressive symptoms and anxiety. While several studies showed an association 
between poor socioeconomic circumstances and more symptoms of general mental 
ill-health, other studies showed no association and some showed the reverse 
association, between higher SEC and more mental ill-health (Lahelma et al., 2006). 
However a systematic review by Fryers et al., (2003) found that results varied 
according to the indicator of socioeconomic circumstances used in studies. 
Occupational social class was found to be the least consistent marker, but 
consistent associations were found with mental ill-health when SEC markers such 
as unemployment, education and low income or standard of living were used. 
 
Some of the difference in health outcomes according to SEC is due to direct effects 
of poverty such as worse living and working conditions and exposure to pollutants 
and dangerous environments (Evans & Kantrowitz, 2002). Health behaviours such 
as smoking, poor nutrition and alcohol use contribute to the effect. It is also 
hypothesised that the effect of SEC on health outcomes may be due to stress-
related factors. Lower socioeconomic groups are likely to be subject to several 
forms of chronic stress such as low job control, financial problems, and living in 
neighbourhoods with increased crime and other social problems. Laboratory studies 
suggest that people from more deprived backgrounds show more prolonged 
cardiovascular reactions after exposure to a standardised mental stressor (Steptoe, 
2002). Impaired post-stress recovery is associated with heightened risk for 
cardiovascular disease (Schuler & O'Brien, 1997) and mortality in patients with 
existing CHD (Cole et al., 1999). This is an example of one of the pathways by 
which adverse socioeconomic circumstances may lead to worse health.   
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Mortality is the only outcome that has been studied in relation to SEC with  
intensive care patients. Mixed results have been found for SEC as a predictor of ICU 
mortality. Findlay et al., (2000) found that social deprivation (measured by the 
Carstairs score) did not influence outcome in 774 patients admitted to an  intensive 
care unit in Glasgow. A study of 51,572 admissions to 99 ICUs between 1995 and 
2000 by Hutchings et al. (2004), demonstrated a social gradient in mortality among 
one category of ICU patients, elective surgical patients, with lower SEC patients 
having a higher mortality rate. The SEC gradient for mortality was not explained by 
differences in case mix. The authors argued that the SEC gradient might be the 
result of unmeasured differences in health status at admission to an ICU. They also 
considered the possibility that patients received different care according to their 
SEC. 
 
Another study (Latour et al., 1991) of 847 patients in three Spanish ICUs found 
higher mortality among patients of lower SEC (OR=1.61, p=0.020). However the 
mortality excess in lower SEC patients was largely accounted for by higher age and 
illness severity at admission (measured by the Simplified Acute Physiology Score, 
SAPS, Le Gall et al., 1993). The authors also concluded that there was no difference 
in care received according to SEC, because the ratio of therapeutic effort (measured 
with TISS) to illness severity (the TISS/SAPS ratio) was the same for the high and 
low SEC groups. 
 
Welch et al. (2010) found an association between increasing deprivation, and an 
increased risk of mortality for all types of admission (medical, elective surgical and 
emergency surgical) to general ICUs in England. The sample consisted of 78,631 
patients admitted to English ICUs between April 2000 and April 2002. The 
association remained after adjusting for age, sex, acute severity, medical history, 
source of admission and reason for admission (adjusted OR for most vs least 
deprived quintile, 1.19; 95% confidence interval, 1.10-1.28).  
 
There has been no previous research on SEC in relation to psycho-social outcomes 
of intensive care. However, as associations have been found between both severe 
and common mental disorders and several indicators of SEC, a similar pattern could 
be expected for psychological morbidity occurring after intensive care. Worse 
socioeconomic circumstances have also been demonstrated to be a risk factor for 
post-traumatic stress disorder, with evidence from responses to traumatic 
situations including assault, air disaster and treatment for breast cancer (Brewin et 
al., 2000). Therefore SEC is likely to be a risk factor for post-ICU PTSD. 
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In the absence of studies examining associations between SEC and psycho-social 
outcomes of intensive care, are there parallels to be found in studies of other types 
of serious illness? The psychological response to cancer has been reported to vary 
according to SEC. Lower SEC patients with breast, prostate or colorectal cancer 
were more likely to have depression [OR:2.16, 95%CIs: 1.01-4.61, p<0.05], 
anxiety [OR: 2.59, 95%CIs: 1.49-4.51, p<0.001) and worse quality of life two 
months after diagnosis than patients with higher SEC (Simon & Wardle, 2008). 
Several other studies reported lower well-being in patients with cancer (including 
gynaecological and colorectal cancers) from lower SEC backgrounds (Dunkel-
Schetter et al., 1992; Ramsey et al., 2000). In the area of heart disease, Clarke et 
al. (2000) found that SEC was an independent predictor of an important domain of 
HRQL (severe limitations of activities of daily living) at 1 year for patients with left 
ventricular dysfunction (odds ratios in the 1.5-2.0 range).  
 
3.5 Conclusion 
It is proposed that the development of psychological morbidity and poor HRQL after 
intensive care can be seen as a stress process in which stressors including illness, 
treatments and ICU environment elicit acute cognitive and emotional stress 
responses in patients, which may in turn trigger the development of stress 
outcomes such as PTSD and depression. The development of adverse psycho-social 
outcomes will be also be affected by individual vulnerability to stress, and socio-
demographic factors. No consistent risk factors for psychological morbidity or poor 
HRQL after intensive care have been established by research so far. In this chapter 
I have reviewed the literature on the experience of ICU patients to help me identify 
the most likely potential predictors of ICU psychological outcomes. Clinical factors, 
healthcare factors, psychological factors and socio-demographic factors have all 
been identified as likely risk factors.  
 
Figure 3.1 (see next page) is a diagrammatic representation of ways in which 
clinical, psychological, socio-demographic and chronic factors could be related and 
result in adverse psychosocial outcomes after intensive care. Figure 3.1 is not 
intended to suggest a statistical model, and not all possible variables, arrows and 
directions are included, due to the number of possible interrelationships. Potential 
stressors include clinical variables. Psychological factors include acute emotional 
and cognitive responses in the ICU and illness perceptions. Background 
vulnerability factors such as chronic health and socio-economic circumstances are 
also included. Possible outcomes are PTSD, depression, anxiety and poor health-
related quality of life. As the discussion in this chapter suggests, there may be 
direct relationships between clinical, psychological and socio-demographic risk 
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factors and psycho-social outcomes, and indirect relationships between risk factors 
and outcome, possibly mediated by ICU psychological factors. 
 
Figure 3.1: ICU stress processes  
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Chapter 4 Methods, cohort study 
 
4.1  Aims, objectives and hypotheses 
 
4.1.1 Aims  
The aims of the cohort study were first, to achieve accurate estimates of the 
prevalence and extent of psychological morbidity and poor health-related quality of 
life of patients three months after discharge from intensive care. The second aim 
was to identify clinical, socio-demographic and psychological risk factors for adverse 
psycho-social outcomes three months after intensive care. The final aim was to 
identify how risk factors work together in the development of post-ICU 
psychological outcomes 
 
4.1.2 Objectives 
The objectives of undertaking this prospective cohort study were to: 
1. Investigate clinical reasons for patients’ admission to intensive care and 
interventions received in intensive care. 
2. Identify the age, sex, ethnicity and socio-economic circumstances of the 
study cohort. 
3. Assess patients’ acute psychological responses in intensive care. 
4. Find out how much patients remember from intensive care. 
5. Detect the presence of intrusive memories of intensive care. 
6. Follow up patients for presence and severity of PTSD, anxiety and 
depression three months after intensive care. 
7. Assess health-related quality of life three months after intensive care. 
8. Identify the strongest risk factors in each group – clinical, psychological and 
socio-demographic. 
9. Examine whether the strongest risk factors were independent of each other. 
10. Find out if a relationship between clinical factors and psycho-social 
outcomes was mediated by psychological factors. 
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4.1.3  Hypotheses 
 
Based on the literature about psychological outcomes of  intensive care reviewed in 
chapters one to three, the study had four broad hypotheses that encompassed a 
number of more specific hypotheses. 
H1. More negative psycho-social outcomes will be associated with these 
clinical factors 
a)  Higher TISS (therapeutic intervention score, (Keene AR, 1983)  
b)  Higher number of organs supported  
c)  More days as a Level 3 patient  
d)  More days of sedation 
e)  More specified drug groups administered 
f)   More days of each type of organ support  
g)  Receiving a specified drug group (e.g. benzodiazepines) 
h)  Sepsis 
H2. More negative psycho-social outcomes will be associated with these 
psychological factors 
a)  Higher ICU stress  
b)  Higher ICU mood  
c)   Little memory of the ICU stay 
d)   Early intrusive memories of the ICU  
e)   Higher delirium  
f)    Higher physical stress  
h)   Lower control  
i)    More negative illness perceptions  
H3. More negative psycho-social outcomes will be associated with these 
socio-demographic factors 
a)  Socioeconomic groups with less control and fewer resources 
b)  Younger age  
c)  Female gender 
d)  Ethnic minorities 
H4. The relationship between clinical risk factors and psycho-social 
outcomes will be partially mediated by ICU psychological factors 
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4.2  Study Design 
I carried out a prospective cohort study of level 3 intensive care patients who were 
admitted to the critical care unit at University College Hospital, London. Assessment 
of psychological responses and collection of clinical and socio-demographic data 
took place before patients were discharged from the unit (time one). A follow-up 
assessment of psychological outcomes and HRQL was carried out three months 
after patients were discharged from the Unit (time two). 
 
Risk Factors  Clinical, psychological, socio-demographic risk factors 
 
Outcome Variables  PTSD, Anxiety, Depression, HRQL   
 
The primary outcome  PTSD. Other outcomes were secondary 
 
Possible confounding factors Chronic illness, pre-ICU psychological problems 
                                                   
Possible mediating factors  Acute psychological factors (also risk factors) 
 
4.2.1  Justification for study design 
After carrying out a systematic review and a wider but more informal literature 
review, I concluded that psychological morbidity and poor HRQL were serious 
problems after intensive care, but their prevalence had not been established. In 
designing the study I wanted to ensure there would be adequate participants, a 
highly representative sample and good quality outcome assessment so that an 
accurate estimate of the prevalence of PTSD and other post-ICU outcomes could be 
made. I decided to follow up patients at three months as this was an adequate time 
period to allow for the development of PTSD symptoms. A longer time period would 
lead to more uncertainty that the outcome was related to ICU risk factors. 
 
I also concluded that little was known about the risk factors for intensive care. 
However the literature suggested that many aspects of critical illness and intensive 
care could be seen as potential stressors leading to stress outcomes. I therefore 
decided to test whether clinical factors that captured critical illness and ICU 
treatments, including drugs received, were predictors of poor psycho-social 
outcomes. It was also clear from the literature that patients experienced extreme 
emotional reactions and cognitive dysfunction in the ICU. I wanted to test whether 
these acute psychological responses were also risk factors for poor psycho-social 
outcomes. The literature also suggested that post-ICU psycho-social outcomes 
might vary according to age, sex or socio-economic circumstances. An alternative 
hypothesis to all the above was that post-ICU psycho-social outcomes were 
primarily related to chronic physical or mental health problems of ICU patients. 
Therefore I decided to include chronic ill health and previous psychological history 
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as possible confounding factors.  It was important to use a prospective design to 
achieve the key aim of identifying these potential groups of risk factors for post-ICU 
psychosocial outcomes. 
 
The study was designed to test multiple risk factors in three clusters – clinical, 
psychological and socio-demographic factors. After univariable analysis, all 
significant predictors were entered into multivariable linear regression models to 
identify the strongest risk factors. As this was an observational study, no causality 
could be assumed, but as outcomes were assessed three months after likely risk 
factors were measured, there was a greater likelihood of finding possible causal 
links than in a cross-sectional study. If a retrospective design had been chosen, 
measurement of some risk factors would be subject to recall bias, and there would 
be a risk of the cohort being less representative than in a prospective study. 
Chronic factors were also entered into the multivariable regressions as potential 
confounding variables. 
 
The ICU stress model (chapter three, figure 3.1) suggested that as well as direct  
relationships between clinical variables and outcomes, there could be indirect 
relationships mediated by ICU psychological factors. Therefore I decided to carry 
out analysis to test if psychological factors mediated the relationship between 
clinical variables and outcomes. Kraemer et al. (2001) noted that medical 
disorders, particularly in psychiatry, may often have multiple causal chains rather 
than a single cause. Often the effect of one risk factor may only be understood in 
relation to all the others. There are still many questions about which methodological 
tools should be used to tease out relationships between risk factors.  Moreover 
terminology in risk factor research is confused and in need of clarifying. Risk factors 
may variously be described as intervening variables, mediating variables, 
confounding variables and effect modifiers (among other commonly used terms). A 
full consideration of this vexed issue is beyond the scope of this PhD, but it is 
important to clarify the definitions I have used of mediating and confounding 
variables. I have used the definition of a mediator as a variable that accounts or 
partially accounts for the relation between the predictor and outcome and may be 
on the causal pathway between predictor and outcome (Baron & Kenny, 1986). A 
confounder is defined as “a variable that can cause or prevent the outcome of 
interest, is not an intermediate variable, and is associated with the factor under 
investigation” (Last, 1995, p.35). 
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4.3  Ethics 
I applied to the Joint UCL/UCLH Committees on the Ethics of Human Research 
(Committee Alpha) for ethical approval to carry out this study. The Ethics 
Committee had concerns that either the baseline psychological questionnaire or the 
follow-up questionnaire could be upsetting for some patients and wanted to know if 
an internal referral to a psychologist would be possible. This was my response: 
 
“In response to the committee’s judgement that the assessments may be upsetting 
for some patients, I have  met the clinicians at the Critical Care Unit to discuss 
what further psychological provision could be provided. Unfortunately the CCU has 
no resources to provide long-term psychological support for any of their patients 
but the following is what we propose: 
At Time 1 (in the ICU): If a patient gets distressed while answering the 
questionnaire given around the time of discharge from the CCU, the researcher will 
alert the local collaborator, Dr David Howell, or another CCU consultant. He will 
arrange for the patient to be seen by the unit’s part-time clinical psychologist, Dr 
Anthony Hazzard. If Dr Hazzard is not immediately available and the problem is 
acute, the patient could be seen by the acute on-call liaison psychiatry team, who 
are available to see patients immediately. 
At Time 2 (three months follow up): If I detect adverse psychological outcomes 
in a patient’s responses to the follow-up questionnaires, the patient will be offered 
an urgent appointment at the  intensive care follow-up clinic with Dr Howell and Dr 
Hazzard, where all concerns and issues can be raised. However the follow-up clinic 
cannot offer any former CCU patients continuing psychological treatment, due to a 
lack of resources. Their usual practice is to write to the GP if they believe further 
psychological support is appropriate, and they would do so in these cases. 
 
In the unlikely event that an acute incident is triggered by the follow-up 
assessment, the researcher will contact Dr Howell. In addition to being one of the 
Critical Care Consultants, Dr Howell is also one of the Acute Medical Physicians at 
UCLH and works closely with acute psychiatry services. If a patient assessed at 
home requires urgent review for an acute psychological deterioration, Dr Howell will 
be able to arrange for the patient to be seen by the on-call liaison psychiatry team 
in the emergency department at the hospital.” 
 
The Ethics Committee was satisfied with these arrangements and gave approval for 
the study to continue on September 10, 2008. The letter of approval is in Appendix 
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3. They also approved an amendment to the study based on changes made after 
the pilot stage on June 8, 2009 (Appendix 5).  
 
4.4   Setting 
The Critical Care Unit at University College Hospital is a 27-bedded unit providing 
both general adult intensive care and high dependency care. The hospital is sited in 
central London and serves a large and diverse local population. The CCU is a 
tertiary referral unit (accepting patients requiring intensive care over and above 
what can be offered to them locally). Its admission policy is based on the principle 
that “patients requiring our services are generally better off with us, accepting that 
nurse and doctor to patient ratio may not be as high as desired” and the declared 
aim is “the greatest good for the greatest number” (UCLH  intensive care, 2006, 
p.1). There were 1292 admissions to the unit in 2005, the most recently reported 
year (Icnarc, 2007). Mean age of patients was 54.9(19.6) and 43.3% of patients 
were male (Icnarc, 2007). 
 
In July-December 2005, admissions were 55.7% non-surgical, 35.5% elective 
surgical and 8.9% emergency surgical (Icnarc, 2007). Mean Apache II score on 
admission was 17.5 (7.3). The top five reasons for admission to the Critical Care 
Unit in July-December 2005 were septic shock, pneumonia, head or neck tumour 
(not intra-oral or intra-cranial), intro-oral or pharyngeal tumour, and large bowel 
tumour. Mortality was 13.7% within the Unit and 21.3% at ultimate hospital 
discharge. The critical care unit has an outreach team of nurses with critical care 
training and experience that visit patients on other wards after they leave critical 
care. All patients receive an after-care booklet after discharge from the ICU 
explaining about physical and psychological symptoms they may experience during 
their recovery period. All patients who were in critical care for three days or more 
are offered an appointment to attend a follow-up clinic run by a medical consultant, 
a nurse consultant and clinical psychologist three months after discharge from 
hospital. Of 352 patients offered a follow-up appointment, 100 accepted and 247 
declined. The other five had died. The clinical psychologist is also available to see 
patients in the unit one afternoon per week 
 
4.5  Participants 
Participants were all consecutive, eligible “level 3” patients who spent more than 24 
hours in the University College London Hospital critical care unit (CCU) between 
November 2008 and September 2009. Level 3 is defined as  
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a) Patients needing advanced respiratory monitoring and support (excluding 
patients needing short term i.e. less than 24 hour routine postoperative ventilation 
with no other organ dysfunction). 
b) Patients needing monitoring and support for two or more organs (one of which 
may be basic or advanced respiratory support) 
c) Patients with chronic impairment of one or more organ systems sufficient to 
restrict daily activities and who require support for an acute reversible failure of 
another organ system.  
 
This definition of level 3 (The Intensive Care Society, 2002) was revised towards 
the end of the data collection period (The Intensive Care Society, 2009) to clarify 
some aspects of the original version. The main revision was that “basic respiratory” 
and “basic cardiovascular” should not count as two type of organ support if they 
occur simultaneously. As this had not been clarified when I was recruiting patients, 
there may be patients in this study who would not be classified as Level 3 patients 
under the revised criteria.  
 
Complete inclusion and exclusion criteria were as follows:  
Inclusion criteria: 
• All patients who were “level 3” for more than 24 hours.  
• Ready for discharge from the CCU or just been discharged. 
• Awake, alert and orientated. 
• Able to communicate. 
Exclusion criteria: 
• Not English-speaking/no translator available. 
• Chronic or continuing acute confusion (prior diagnosis or nurse assessment). 
• Communication problems or sensory impairment due to e.g. deafness; 
inability to speak, read or write. Absence of hearing aid or reading glasses. 
• Receiving palliative or terminal care. 
• Reduced consciousness e.g. Glasgow Coma score<15 (Teasdale & Jennett, 
1976). 
• Patient less than 18 years of age. 
4.6.  Procedure 
4.6.1  Baseline assessment at discharge from the ICU (time one) 
During the recruitment period I visited the critical care unit every week-day (apart 
from annual leave) to identify eligible patients by checking the daily lists of patients 
in the Unit. It was also possible to track patients who were admitted at weekends 
by using the patient lists. It was necessary to consult the electronic patient notes to 
double-check that patients met Level 3 criteria, as the Unit’s system of categorising 
patients on the electronic record did not exactly fit with the ICS criteria (2002). If 
patients who were identified as Level 3 for more than 24 hours improved and were 
stepped down to level 2 or level 1 care, they were approached by a research nurse 
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who explained to them about the study, using the script written by me and 
reproduced in appendix 9. The research nurses also gave patients a patient 
information sheet (PIS) describing the study and a consent form to take part in the 
study (appendix 7). If patients felt unable to read the PIS the research nurse read 
them a shortened version of the PIS (appendix 8). 
 
Unless the patient told the research nurses immediately that they did not wish to 
participate, I visited them after 24 hours or at a time specified by the patient. I 
would ask if they had read and understood the PIS. Often, understandably, they 
had not read it, so I would go through it with them, and answer any questions they 
had about the study. I explained the consent procedure and emphasised that they 
could withdraw from the study at any time without giving a reason. If the patient 
gave their consent to take part in the study, I would ask them to sign the consent 
form (appendix 10). I asked if they wanted to answer the questionnaire now or 
later.  
 
Usually the assessment using the ICU baseline psychological questionnaire 
(appendix 12) took place soon before their discharge from the ICU, or occasionally 
soon after their discharge to another ward. Usually, due to patients’ ill-health and 
fatigue, I read the questionnaire to patients and wrote down their answers, but on 
some occasions patients preferred to complete the questionnaire alone and I waited 
with them in case of queries or misunderstandings, or collected it from them later. 
It usually took about fifteen minutes to complete the questionnaire. I told patients 
that I would be sending them a postal questionnaire about their ICU experiences 
after three months. 
 
Some Level 3 patients unfortunately deteriorated and died in the Unit; some others 
were transferred to another hospital such as the Heart Hospital (a sister hospital to 
UCH) before it was possible to approach them about the study. On some occasions 
when patients had expressed willingness to take part, I visited them and found that 
they were too confused to take part or were unable to communicate easily for a 
number of reasons. For example some patients who had had maxillofacial surgery 
(a specialism offered by UCH) were unable to talk, either temporarily or 
permanently. This combined with sight or hearing problems and an absence of their 
usual hearing aids or spectacles made communication too effortful for these 
patients. In some cases confused patients became more lucid as they began to 
recover and the effects of sedation and opiates wore off, and I was able to assess 
them on subsequent visits. In some cases I visited patients several times before 
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their discharge but was unable to carry out the assessment because on each 
occasion they were receiving clinical care or sleeping. 
 
If patients appeared tired or upset during the ICU assessment, I would ask them if 
they would prefer not to finish the questionnaire, or to finish it at another time. I 
would visit them at a time convenient to them to complete the questionnaire, if that 
was requested. If any patients appeared at all upset or anxious after finishing the 
questionnaire I stayed on to talk with them until they said that they felt calm or 
“okay”. Some patients were not upset but were very interested in talking about 
issues raised by the questionnaire, such as the experience of hallucinating in the  
intensive care unit, as nobody had told them that this was a fairly common 
experience. Only one patient appeared to be very upset by the questionnaire. This 
was an eighteen-year-old cancer patient and I fetched her father at her request, 
and talked to him afterwards to check that she was not in need of any further 
psychological support. As this was during the pilot period I also removed one item 
from the questionnaire – about “fear of dying” and changed the wording of another 
item – in response to this patient’s reactions. On a few occasions where I thought a 
patient was possibly in need of general psychological support (for example they 
were having very troubling intrusive memories about ICU after transferring to the 
ward) I would mention them to a member of the critical care outreach or follow-up 
team. 
 
4.6.2  Follow-up assessment three months after ICU discharge (T2) 
Three months after patients were discharged from the intensive care unit, I 
checked with hospital databases to find out if patients were still alive and where 
they had gone after leaving hospital. I then posted them a follow-up questionnaire 
about symptoms of PTSD, anxiety, depression and HRQL, and socio-economic 
circumstances (see Section 4.7.2 and Appendix 13) along with a letter (Appendix 
13) reminding them about their participation in the study while in the ICU, and a 
stamped addressed envelope. After ten days I sent reminder post-cards to patients 
if they had not sent back the questionnaire. If they had not returned the 
questionnaire after a further week, I phoned patients once to check that they had 
received the questionnaire and to find out if they wanted any help in answering the 
questions. This proved to be worthwhile as some patients had not received 
questionnaires due to the hospital holding the wrong address for them in their 
records, or to postal strikes which took place during this period. I was able to post 
new questionnaires to these patients and thus increase the follow-up rate. 
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4.6.3  Clinical data  
I collected most of these data after patients had given consent and completed the 
ICU baseline questionnaire, from electronic records held in the critical care unit. I 
recorded them on a patient data form (see Appendix 11). Data that were not  
Table 4.1  Clinical data collected  for cohort study (excluding drugs) 
accessible in electronic records were provided to me by the unit data manager from 
other databases. Some additional data were collected but were not eventually 
analysed in the study, to reduce the number of variables and for other specific 
reasons.   
Variable Categories or scoring Further notes/references 
Type of admission 
 
 
Elective surgical (elective/scheduled); 
Emergency surgical (emergency 
/urgent); Non-surgical 
Data collected by the CCU as part  
of ICNARC case mix programme 
(www.icnarc.org) 
Admitted to ICU 
from…. 
Theatre/recovery;  Ward; A&E; other Other other ICU, other 
hospital(non-ICU),  or other.    
Post-hospital 
discharge 
Discharged home; Transferred to other 
hospital; Residential care or rehab; 
Readmission(s);Not discharged from 
hospital. Died after ICU discharge. 
Readmissions to hospital since 
discharge home Not discharged 
still in UCH at 3m Died after ICU 
discharge–in ward or at home 
Illness severity – 
Apache II score 
(Knaus et al., 1981) 
Acute Physiology and Chronic Health 
Evaluation, scored from 0-71, used as 
measure of disease severity and 
predictor of mortality in ICU. 
Point score calculated from 12 
physiological measurements 
during first 24 hours, and prior 
health information  
Primary body 
system -reason for 
admission 
(www.icnarc.org) 
1 Respiratory2 CV 3 GI  4 Neurological 
5 Trauma  6 Poisoning 7 GU  
8 Endocrine 9 Haematological 10 
Musculoskeletal 11 Dermatological 
Each patient coded for primary 
reason admission, by ICU using 
Icnarc coding method with body 
system as 1 of 5 coding levels 
Hospital length of 
stay 
Number of days - this admission.   
ICU Length of stay  Total number of days patient spent in 
Critical Care Unit. 
Includes days spent as level 1, 2 
or 3 patient in ICU 
“Level 3” days Number of days in Critical Care Unit 
that patient received level 3 care. 
Number of level 3 days is rec-
orded by the CCU for the DoH  
TISS score  
(Keene et al., 1983) 
Therapeutic intervention scoring 
system. The TISS patient 
classification: Class 1<10 points, 2 10-
19 points 3 20-39 points 4 >40 points 
Points for each ICU activity e.g. 
monitoring, dressing changes, 
drugs and major interventions 
(e.g. ventilation, haemodialysis) 
Days advanced  
respiratory 
support (ARS) 
Number of days received (definition of 
ARS chapter one, Section 1.2.5) 
Number days organ support  
recorded by the CCU for the DoH  
Days basic 
respiratory support  
As for ARS  
Days advanced CV 
support (ACVS) 
As for ARS  
Days basic CV 
support 
As for ARS  
Days renal support As for ARS  
Days neuro support As for ARS  
Days GI support As for ARS  
Days dermatological   
support 
As for ARS  
Days liver support As for ARS  
Number types  
organ support  
Number organs supported Maximum = 9 (including 
advanced/basic ARS and ACVS) 
Number drug groups  Number of drug groups received in ICU  Maximum number – seven 
Sepsis 
(Dellinger et al., 2008) 
Sepsis diagnosed (1) not diagnosed (0) 
using biomarkers including CRP, WCC 
CRP=C-reactive protein, 
WCC=white cell count  
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Table 4.2  Drug data collected for cohort study 
 
 Three drug groups had too few participants who received them in the CCU to make 
analysis meaningful. These were non-opioid analgesics (gabapentin), anti-epileptics 
and anti-depressants. A variable about patients’ destinations after discharge from 
the CCU was not used, as 95% of patients were discharged to a ward, so other 
categories of the variable were too small. Comorbidities were intended to be used 
in the study as a variable that would capture important information about patient’s 
chronic health status. However the only data initially available for this (Icnarc 
2007) included only extremely severe conditions such as biopsy-proven cirrhosis 
and very severe respiratory disease. Therefore it was not a sensitive measure of 
chronic health problems; 17% of patients were recorded as having co-morbidities 
with this measure. Later another source of data on chronic health was used (see 
4.6.6) Data about reasons for admission to the critical care unit were entered, but 
it was not possible to code them in a meaningful way because of the large number 
of different conditions. Another intended variable, “consultants’ speciality” had too 
many categories and did not contribute helpful information to the clinical picture. 
 
4.6.4  Socio demographic factors 
During data collection I recorded patients’ age, date of birth, gender, and address 
including postcode from electronic notes held in the CCU. Postcode was later used 
to derive Index of Multiple Deprivation 2007 (Communities and Local Government, 
2010) quintiles. The ICU baseline questionnaire included questions about 
occupation, ethnicity (Office of National Statistics, 2010a) and education level (no 
qualifications, GCSE or equivalent, A’ level or equivalent, college or equivalent, 
degree or above). The follow-up questionnaire included questions pertaining to the 
National Statistics Socio-economic Classification (NS-SEC; Office of National 
Statistics, 2010b). 
Variable Categories/Scoring Notes/details 
Days of Sedation  Number of days patients were sedated 
with either benzodiazepines or 
anaesthetics as in rows below 
Staff record in electronic notes 
Hypnotics Coded 1 (received)or 0 (did not)  Zopiclone, temazepam 
Benzodiazepines 
for sedation 
Coded 1 (received) or 0 (did not) e.g.midazolam, diazepam, 
lorazepam  
Anaesthetics 
for sedation 
As above Propofol, ketamine, isoflurane, 
remifentanil, clonidine, 
Antipsychotics  As above Haloperidol, chlorpromazine  
Inotropes or 
vasopressors 
As above e.g.Adrenaline, noradrenaline, 
dobutamine, vasopressin 
Steroids  
received 
As above Methylprednisolone, 
prednisolone, hydrocortisone, 
dexamethazone 
Opioids 
received 
As above Fentanyl, methadone, morphine 
sulphate, tramadol, diamorphine 
hydrochloride, dihydrocodeine,  
Number drug groups  Number of drug groups with potential 
psychoactive effects received in ICU  
Maximum number – seven (as in 
rows above) 
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Contact details: During baseline assessment patients were asked to give a home 
number, mobile number and relatives’ numbers to increase the chances of being 
able to contact them for the follow-up assessment. If they could not remember 
them, any available phone numbers were noted from the electronic database in the 
CCU. It was not possible to contact some participants at the follow-up stage as they 
were homeless, moving between addresses, or all contact details given to the 
hospital were incorrect. 
4.6.5  Socio-economic circumstances 
4.6.5(i)  The National Statistics Socio-economic Classification (NS-SEC) 
Two socio-economic classifications have been widely used in the UK for official 
statistics and academic research: Social Class based on Occupation (SC, formerly 
Registrar General’s Social Class) and Socio-Economic Groups (SEG). However it has 
been recommended by the Economic and Social Research Council that a new 
occupationally-based classification, NS-SEC (Office of National Statistics, 2010) 
should replace both SC and SG. NS-SEC was developed from the Goldthorpe 
Schema (NS-SEC User Manual, ONS, 2010) a sociological classification that has 
been widely used in research because it is conceptually clear and accepted 
internationally. NS-SEC was constructed to measure employment relations and 
conditions of occupations. It is argued that these are central to showing the 
structure of socio-economic positions in modern societies and helping to explain 
variations in social behaviour. NS-SEC categories distinguish different ways by 
which employees are regulated by employers through employment contracts. There 
are three main forms of employment regulation. 
1. Service relationship. The employee’s service is compensated by immediate 
rewards (eg salary) and long-term, prospective benefits. This is typified by Class 1 
of the full eight-class version of NS-SEC; higher managerial and professional 
occupations.  
2. Labour Contract. Employee gives discrete amounts of labour in return for a wage 
calculated on amount of work or time. This is typical of Class 7, routine 
occupations.  
3. Intermediate. Aspects of both forms of employment regulation, typical in Class 3 
(intermediate occupations e.g. intermediate clerical and administrative jobs). 
The information required to create the full NS-SEC is a) occupation, coded to 353 
unit groups (OUGs) from the Standard Occupational Classification 2000 (Office of 
National Statistics, 2010c) and b) details of employment status: whether an 
employer, self-employed or employee; whether a supervisor; and the number of 
employees at a workplace. For this study it was necessary to use the self-coded, 
self-completion version of NS-SEC (Office of National Statistics, 2010) as it was 
part of a postal questionnaire. The self-coded version of NS-SEC has five classes: 1. 
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Managerial and professional occupations 2. Intermediate occupations. 3. Small 
employers and own account workers. 4. Lower supervisory and technical 
occupations. 5. Semi-routine and routine occupations. In the self-coded version, 
occupational class is derived using a matrix including occupation (the respondent 
ticks one of eight categories of occupation), employment status and size of 
organisation.  
 
The self-completion questionnaire was included in the follow-up questionnaire sent 
out to patients at three months (appendix 13). For complete coverage, I wrote and 
added further questions pertaining to students, retirement, spouse’s income and 
unemployment. Retired and unemployed people were asked to answer the 
questionnaire in reference to their last main job, or their spouse’s job if relevant, 
but many did not do so. A sixth category “not classified” was created to include 
students, those who gave inadequate employment details, and retired or 
unemployed people who did not answer questions about their previous job. A 
further problem using the self-employment questionnaire was that several 
participants self-classified their occupation incorrectly on the self-report 
questionnaire. This was discovered when checking their occupational self-
classification against the occupation they gave when answering the ICU baseline 
questionnaire. Where I had sufficient information about a person’s occupation from 
their baseline questionnaire I corrected the self-classification. It was initially 
decided that for the purposes of comparison and to strengthen conclusions drawn 
about the effect of socio-economic circumstances, another socio-economic indicator 
would also be used in the study. As I had already recorded patients’ postcodes 
during data collection it was possible to derive an area-level measure of deprivation 
using the Index of Multiple Deprivation, 2007. 
 
4.6.5(ii) Index of Multiple Deprivation, 2007 
The Index of Multiple Deprivation (IMD) 2007 is part of the UK government’s official  
measure of multiple deprivation at small area level (Communities and Local 
Government, 2010). It is based on Lower Super Output Areas (LSOAs); in most 
cases LSOAs are smaller than wards, with an average population of 1500 people. 
There are 32,482 LSOAs in England. The IMD is composed of 37 different indicators 
covering seven domains of deprivation; Income; Employment; Health and 
disability; Education; Skills and training; Barriers to housing and services, and 
Living environment and crime. These have been weighted and combined to create 
the overall IMD 2007. LSOAs are ranked by the IMD 2007 so that the LSOA ranked 
1 is the most deprived and that ranked 32,482 is the least deprived. For this study 
participants were categorised according to IMD 2007 quintiles, with quintile one as 
the least deprived quintile and five the most deprived quintile.  
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However, although I used the IMD measure when reporting descriptive data, 
ultimately I decided to use the NS-SEC (ONS, 2010) rather than the IMD 
(Communities and Local Government, 2010) to represent patients’ socio-economic 
circumstances in the statistical analysis. My reasons for this decision were that the 
majority of the cohort came from two London boroughs in which most areas are 
classified as being deprived. But area-level deprivation is not always an indicator of 
individual SEC. In Camden, according to the 2009 Camden health profile (The 
Association of Public Health Observatories, 2010a) 69% of residents live in areas of 
high deprivation (fourth and fifth quintiles) and none live in an area of least 
deprivation (first quintile). In Islington (The Association of Public Health 
Observatories, 2010b) 97.3% of people live in areas of high deprivation (fourth and 
fifthe quintiles). This could give rise to the ecological fallacy (Schwartz, 1994) that 
occurs when relationships between variables that hold at an area level are assumed 
to hold at the individual level. For example this cohort included five people from 
Camden or Islington whose occupations were correctly classified as 
managerial/professional (class 1), but who also lived in one of the most deprived 
postcodes (fifth IMD quintile). 
 
4.6.6.  Chronic factors and patient history. 
As data on these factors were not easily available from the electronic records in the 
critical care unit, they were not initially collected by me. However assistance 
became available later from a young medical researcher. She carried out a 
meticulous search through medical and nursing records to identify details of the 
participants’ chronic physical diseases, cancer, alcohol and recreational drug use, 
and prior psychological problems.  
 
4.7 Psychological measures 
 
4.7.1  ICU baseline questionnaire 
This questionnaire was constructed by me to measure mood in the ICU, stress in 
the ICU, illness perceptions, memory and some socio-demographic data (appendix 
12). The sections on mood and illness perceptions were adapted from validated 
questionnaires; the section on ICU stress was created by me for this study and 
based on literature about patient experience in the ICU; and questions in the 
memory section were based on literature about the effects of the ICU on memory, 
with guidance from Professor Chris Brewin, an expert on intrusive memories and 
PTSD at University College London. I wanted to use a questionnaire that would 
cover a range of key psychological responses in intensive care (anxiety, depression, 
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positive emotion, anger, delirium, control, physical stress, support, memory of ICU 
and intrusions about ICU) but that would not be too long or difficult for seriously ill 
patients. No existing questionnaire covered all these areas or was sufficiently brief 
and simple. Variables extracted from the baseline questionnaire were ICU mood, 
ICU stress, amnesia for ICU, intrusive memories of ICU and illness perceptions. I 
used three criteria to construct the baseline questionnaire: 
a) questionnaire items or scales had good construct validity 
b) where possible, questionnaire items or sub-scales had been widely used and 
validated in this patient group or similar patient groups 
c) the questionnaire was short and simple to administer to seriously ill patients 
in the ICU 
4.7.1(i)  Mood states in ICU 
 These were detected using fifteen items from POMS, the Profile of Mood States 
(McNair, 1984). The full POMS has 67 items and six sub-scales. I chose to use 
POMS because of the range of mood states it encompasses and the brevity of its 
one-word items. POMS has achieved wide acceptance as a measure of psychological 
distress in a variety of healthy, physically ill and psychiatric populations (Curran et 
al., 1995). However, physically ill patients may take up to 20 minutes to complete 
the full POMS (Shacham, 1983). Therefore the full POMS would have been too time-
consuming and tiring for ICU patients to complete, along with other items it was 
necessary to include in the questionnaire. Several short forms of POMS have been 
validated for use in patient groups, including breast cancer patients, bone marrow 
transplant patients and renal transplant patients (Cella et al., 1987; Curran et al., 
1995; Shacham, 1983). However the items selected in these versions did not 
exactly fit the purpose of this study. Therefore I adapted the original POMS by 
taking three items (symptoms) each from five of the POMS scales – Tension-
Anxiety, Depression-Dejection, Vigour-Activity, Anger-Hostility and Confusion-
Bewilderment.  The original sub-scales were of varying length, of between seven 
and 15 items each. I intended to use this, not to “diagnose” depressive or anxiety 
disorders, but to give a brief snapshot of a patient’s transient moods during the 
days before their discharge from the ICU. I did not take items from the sixth POMS 
scale of Fatigue-Inertia as I expected that all patients would be very fatigued and 
therefore there would be little variance in this factor. 
 
I selected some POMS items because they had high loadings on the relevant factor 
in the original confirmatory factor analysis (McNair, 1971). Six independent factor 
analytic studies were conducted in the development and validation of the POMS. A 
correlation of 0.30 or higher between item and factor was considered significant. 
For example the item “helplessness” had the following loadings on the Depression 
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scale in six studies: 47, 54, 51, 43, 33, 39. The item “nervous” loaded highly on the 
Anxiety scale: 61, 58, 56, 73, 56, 57 and was therefore used. I also selected some 
items because they reflected symptoms that might be particularly relevant for ICU 
patients, based on previous literature. For example panic is a common state in ICU 
(Granberg et al., 1998) and therefore “panicky” was selected from the POMS 
Anxiety Scale. I included “terrified” and “helpless” from the POMS Depression scale 
as they are important components of a subsequent diagnosis of PTSD: Criterion A2 
for a PTSD diagnosis is that “the person’s response [to a trauma] involved intense 
fear, helplessness or horror” (American Psychiatric Association, 1994). 
 
The scoring for each item was 0-4 for responses ranging from not at all to 
extremely. Scoring was reversed for positively worded items, e.g. “cheerful”.  
Sub-scale scores were obtained by adding the three items together to give a total 
from 0-12. A total mood disturbance score (TMDS) can also be obtained from POMS 
(McNair 1984). TMDS scores for my shortened version ranged from 0-60. 
 
Reliability  Cronbach’s  for the total mood scale used in this study was 0.904 
based on 151 cases (baseline sample) and 0.906 based on 95 cases (follow-up 
sample). Therefore the total scale had very good reliability, and it was reasonable 
to use the total mood disturbance scale as a variable in the analysis. 
 
Factor analysis  When I carried out a confirmatory factor analysis of this version 
of POMS, there were three factors rather than the expected five. Variance explained 
was 63%. One factor was comprised of all the negative mood words (terrified, 
nervous, panicky, tense, unhappy, forgetful, confused, helpless; Cronbach  = 
0.886), one was all the positive terms (alert, cheerful, lively, able to concentrate, 
Cronbach  = 0.812) and one was anger (angry, bad-tempered, resentful, 
Cronbach  = 0.803). It has previously been found in factor analysis of 
psychological questionnaires that negative and positive items may cluster together 
and form two separate factors. These may not reflect true factors but a response 
bias introduced by negative or positive wording (Hankins, 2008). As I was 
interested to find out if there were specific effects related to specific ICU mood 
states I decided to use the original five factor structure for POMS in my analysis. 
Cronbach’s  was 0.809 for Anxiety, 0.722 for Depression, 0.803 for Anger, 0.786 
for Positive Emotion and 0.684 for Mental Confusion. As Cronbach’s  over 0.7 is 
regarded as acceptable, I decided it was reasonable to use these sub-scales in the 
analysis, although mental confusion was clearly less reliable than other sub-scales. 
(In fact as part of the data reduction process, most statistical analyses were 
calculated using total mood disturbance scores rather than subscale scores. 
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However I carried out sub-group analysis to look at the effects of specific ICU mood 
states as predictors of outcome).  
 
4.7.1(ii)  Perceived stress in ICU 
I created the 18-item ICU Stress scale (ICUSS) specifically for this study to detect 
which stressful ICU experiences a participant had experienced and how stressful 
they perceived them to be. The ICUSS also included positive, protective factors 
reported in the psychological literature on intensive care, such as feeling in control 
and receiving emotional support. Other published questionnaires on ICU stress (e.g. 
Granja et al., 2005; Novaes et al., 1997; Rattray, 2005) were either too long for 
participants to complete in this context, or did not encompass the primary stressful  
ICU experiences highlighted in the literature. However I noted their content and 
used it to inform the selection of items for the ICUSS. When designing the scale I 
envisaged four sub-scales – one for physical stress with items on pain, discomfort 
from tubes, difficulty breathing and being unable to sleep; one for disorientation 
with items on hallucinations, nightmares, disorientation, isolation, agitation and 
feeling unreal; one for self-efficacy with items on feeling in control, confidence in 
getting better and ability to communicate and one for emotional support in the 
ICU, including support from staff and family and respect for one’s dignity.  
 
Response options for each item ranged from not at all to extremely (0-4) and 
scores were summed for each sub-scale.  A total ICU stress score was obtained by 
reverse-scoring the positive items and summing all items to produce a score 
ranging from 0 to 72, with 72 as the worst possible stress. Cronbach’s  was 0.818 
based on 145 cases (whole sample), and 0.831 based on 94 cases (follow-up 
sample). As reliability of the total scale was acceptable, total ICU stress was used 
as a variable in the analysis. As this was a new scale, as well as piloting it with ICU 
patients (see 4.7.1 (vi)), it was important to carry out factor analysis, to check if 
the original envisaged structure was evident. Using the Promax method of principal 
components analysis, four factors were detected; Physical stress (dyspnea, anxiety 
about breathing, pain, discomfort from tubes), “Delirium” (disorientation, 
nightmares, hallucinations, isolation, agitation), control (communication, control, 
confidence, information and sense of unreality) and support (dignity, staff support, 
family and friends support, sleep). The sleep item had a much lower loading of 
0.393 on the “support” factor than other items. The structure matrix of the four 
factors of ICUSS can be seen in Table 4.2. Cronbach’s  alpha was acceptable for 
three of four scales; 0.777 for Control; 0.751 for Physical Stress; 0.741 for 
Disorientation. Cronbach’s  for the support scale was 0.493 and was therefore not 
acceptable. When the sleep item was dropped from the support scale there was no 
improvement as   was reduced to 0.453. It will be necessary to work on the 
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support sub-scale to improve reliability if it is to be retained in future studies. The 
“delirium” sub-scale was not intended to represent the DSM-IV (American 
Psychiatric Association, 1994) diagnosis of delirium, but consisted of features 
frequently detected in ICU patients who are delirious or sub-delirious, such as 
hallucinations, disorientation and agitation. 
 
Table 4.3  Factor Analysis of the ICUSS showing four factors 
Kaiser-Meyer-Olkin Measure of Sampling 
Adequacy. .792 
Bartlett's Test of 
Sphericity 
Approx. Chi-Square 813.841 
df 153 
Sig. .000 
  
 
Component 
1 2 3 4 
Control (r) .777 .285 .222 .141 
Communication(r) .728 -.040 .269 .336 
Confidence (r) .673 .296 .232 .306 
Information (r) .649 -.062 .359 .596 
Feeling unreal .623 .314 .575 .038 
dyspnea .259 .836 .272 .003 
Anxiety breathing .356 .807 .400 -.034 
Pain .048 .647 .113 .038 
Discomfort –
tubes 
.131 .630 .440 -.009 
Disorientation .559 .366 .780 .172 
Nightmares .031 .242 .730 .132 
Hallucinations .262 .163 .686 -.113 
Isolation .409 .290 .590 .534 
Agitation .466 .485 .582 .155 
Dignity (r) .275 -.023 .202 .722 
Emotional 
support-staff (r) 
.374 .013 -.032 .623 
Emotional 
support-family (r) 
-.012 -.048 -.080 .570 
Sleep (r) .377 .332 .220 .393 
 Rotation Method: Promax with Kaiser Normalization.  (r) = reversed scoring 
 
4.7.1(iii)  Patients’ illness perceptions 
The eight items of The Illness Perceptions Questionnaire-Brief (Broadbent et al., 
2006; Broadbent et al., 2006) were included in the questionnaire to tap into 
patients’ subjective cognitions about the nature of their medical condition. These 
cognitions have been shown to be predictive of many health outcomes (Weinman & 
Petrie, 1997; Weinman et al., 1996). After the piloting of the ICU baseline 
questionnaire, three items were dropped to shorten the questionnaire. Items 
included in the final version were 
    1. Timeline (how long does patient thinks their condition will last?) 
    2. Control  (how much control does patient feel they have over the condition?)  
    3. Concern (how concerned is the patient about the condition?) 
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    4. Understanding (does the patient understand their condition?) 
    5. Emotional representation (does the condition affect patient emotionally?).  
 
Each item was scored separately on a Likert scale of 0-10. Scales were anchored at 
both ends with phrases such as not at all concerned (0) or extremely concerned 
(10). 
 
4.7.1(iv)  ICU memories 
Six items on ICU memory were included in the questionnaire. Existing ICU memory 
scales were too long and did not include a key factor in my study, early intrusive 
memories of ICU. The memory items used in the questionnaire were based on the 
literature concerning the effects on memory of being in ICU (e.g. Jones et al., 
2001) and on discussions with Professor Chris Brewin, a clinical psychologist and 
expert on intrusive memories. The items were designed to detect how much 
patients could remember of their ICU experience, and the presence and nature of 
early intrusive memories about the ICU (before discharge from the ICU). If 
intrusive thoughts were present they could be categorised as factual or unreal. 
Previous studies referred to “delusional” memories but I preferred the term “unreal” 
as a more accurate reflection of ICU memory content (see chapter 7). 
Memory items were: 
          
a)   Memory of admission to ICU. 
      Scores: 0 (no) 1 (yes) 
b)   Memory of ICU stay. 
      Scores: 0 (very little) 1 (some) 2 (most) 
c)   Intrusive memories of ICU? - if yes, content described. 
      Scores: 0 (none) 1 (yes, factual) 2 (yes, unreal)  
d)   Frequency of intrusive memories  
      Scores: 1 (less than once a day) to 3 (many times a day) 
e)   How distressing are ICU memories? 
      Scores on Likert scale from 0 not at all distressing 
                                            to 7 extremely distressing. 
       
4.7.1(v)  Cognitive function 
At the beginning of the study, the baseline questionnaire included the Mini Mental 
State Exam (MMSE; Folstein et al., 1975) as I hoped to get a baseline 
measurement of patient’s cognitive state. However after the pilot stage, I dropped 
the MMSE from the questionnaire for reasons to be explained in the next section. 
 
4.7.1(vi)  Piloting the ICU baseline questionnaire  
The questionnaires used at both time points were piloted among ICU patients. As 
the ICUSS was a new measure designed specifically for this study it was particularly 
important to pilot it for acceptability and face validity. Although most other 
measures had been widely used and validated, they had been shortened by me and 
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it was also important to find out if the package of measures was acceptable to 
respondents.  
 
The ICU baseline questionnaire was piloted among the first ten participants in the  
study (pilot questionnaire in appendix 4). Piloting was not carried out in a separate 
group of patients because of the difficulty in enrolling sufficient ICU patients for a 
fully powered study within the allotted time period. All ten patients said they found 
the questionnaire acceptable, clear and not too burdensome. They did not object to 
answering any of the questions. The average time taken to complete the 
questionnaire was 25 minutes, including the time taken to complete the MMSE. 
However two among the next ten patients I assessed had problems with the 
questionnaire. One patient found two of the questions upsetting, and another found 
it too tiring to complete the questionnaire. My own instinct when helping patients 
complete the questionnaire was that it was somewhat long and that patients were 
becoming tired during the last part of the questionnaire. 
 
I therefore amended the questionnaire with guidance from my supervisor John 
Weinman, professor of health psychology at Kings College, London. I removed two 
items from the ICU Stress Scale (ICUSS), three mood items, and three illness 
perception items. I had noticed that some very fatigued patients found it difficult to 
understand and answer the IPQ questions. The removal of these items and other 
minor changes did not jeopardize the measurement of the mood and stress 
constructs, as there remained sufficient items to generate reliable measures and 
assess scale reliability. However there was an unfortunate loss of information about 
patients’ illness perceptions. The items that caused potential upset (to a very young 
patient) were Q14 from the ICU Stress scale (Have you felt frightened of dying?) 
and Q2 from the IPQ: 
Q: How long do you think your medical condition will continue? 
A: A very short time 0     1     2    3    4    5    6    7    8    9    10 forever 
 
I removed ICUSS 14, and amended IPQ2 from “forever” to “a very long time”. 
 
I also decided during the pilot stage that administering the mini mental state 
exam (MMSE) was not worth the extra time it was taking. Some elderly patients 
were unable to complete it because of current difficulties with reading or writing, 
or physical weakness (the MMSE involves writing, spelling and drawing). Those 
patients who were able to complete it all gained very similar scores (in the normal 
range). Leaving out the MMSE reduced the time taken to complete the 
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questionnaire to 15 minutes on average. The ten patients who participated in the 
pilot of the baseline questionnaire remained in the study cohort. 
4.7.2  ICU follow-up questionnaire 
The questionnaire that was posted to patients three months after discharge from 
the ICU comprised scales to detect PTSD, anxiety and depression, a brief quality of 
life measure, questions about pre-ICU mental health and questions about socio-
economic circumstances. Each section of the questionnaire is described in greater 
depth below. For full questionnaire, see appendix 13. 
 
4.7.2(i)  PTSD measure 
As the primary outcome of this study was PTSD, I chose to use a questionnaire that 
could be used to diagnose PTSD according to DSM-IV criteria (American Psychiatric 
Association, 1994).The PDS, Posttraumatic diagnostic scale, (Foa et al., 1997) is 
regarded as the gold-standard for questionnaires that detect symptoms of post-
traumatic stress disorder. It is a validated questionnaire that provides both formal 
diagnosis of PTSD and a 17-item measure of symptom severity. The PDS has been 
shown to have high internal consistency and test-retest reliability, high diagnostic 
agreement with the PTSD module of the Structured Clinical Interview (SCID; First 
et al., 1998), and good sensitivity and specificity. I adapted the symptom severity 
items to detect responses specifically related to the ICU, as recommended by the 
authors (Foa et al. 1997) and as advised by Professor Brewin (personal 
communication).  
 
The symptom severity scale (Part 3 of the PDS) consists of the cardinal symptoms 
of PTSD, including five re-experiencing or intrusive symptoms; seven avoidance 
symptoms and five hyper-arousal symptoms. Each item was scored from 0-3 with a 
total possible PTSD score of 51. Response options were not at all, once per week or 
less, 2-4 times per week and 5 or more times per week.  Scores of 1-10 are 
considered to be mild, 11-20 are moderate; 21-35 are moderate-severe, and >36 
are severe (McCarthy, 2008). Other parts of the PDS used in the study were Part 1, 
a checklist of traumas (scoring was 1= life-threatening illness only, 2= illness plus 
one other trauma, 3=illness plus two other traumas, 4= illness plus three or more 
traumas) and Part 4, the level of impairment caused by symptoms across nine 
areas of life functioning. Part 2 was not used. Part 2 was designed to cover DSM 
IV’s Criterion A1 – ‘the person experienced, witnessed or was confronted with an 
event or events that involved actual or threatened death or serious injury, or a 
threat to the physical integrity of self or others’ – and A2 – ‘the person’s response 
involved intense, fear, helplessness or horror’.  I assumed that all level 3 ICU 
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patients fulfilled A1, and questions on helplessness and terror had been included in 
the Mood questionnaire at baseline. 
 
PDS scoring 
 
To qualify as having PTSD according to Foa (1997) there should be  
1.  A trauma to be identified (Part 1) 
2.  Fulfilment of Criterion A1 and A2 (Part 2) 
3.  One or more positive re-experiencing symptoms; positive score=1,2 or 3 
     Three or more positive avoidance symptoms  
     Two or more positive hyper-arousal symptoms 
4.  One or more positive responses in Part 4 (level of impairment) 
 
However as Brewin et al. (1999) pointed out, this method could lead to an 
over-diagnosis of PTSD as people with scores as low as nine, or who had no 
individual item scores higher than one would receive a diagnosis. I decided to 
use a method based on a study (Ehring et al., 2007) in which 18 scoring rules 
for the detection of current chronic PTSD were tested. Three of these were 
found to lead to overall diagnostic efficiency of 80% and sensitivity and 
specificity of at least 0.75. Two of the three methods were a) using a PDS 
total scale cut-point of 18 and b) symptom cluster scoring (described above) 
plus a total scale cut-point of 18. As both methods were rated as highly 
efficient, I opted to use the total PDS scale cut-point of 18. Therefore 
everyone who scored more than 18 on the PDS scale was considered to have 
PTSD and everyone who scored 18 or under was not.  
 
Reliability and factor analysis 
Cronbach’s alpha for the PDS in this study was 0.934, which is acceptable. When 
the PDS was factor analysed, the Kaiser-Meyer-Olkin measure of sampling 
adequacy (KMO) was 0.885 and three factors were identified, explaining 67% of 
variance. However the factor structure reported by Foa et al. (1997) was not 
replicated. In this study one factor was most of the re-experiencing symptoms, one 
factor included most of the avoidance and hyperarousal symptoms together, and a 
third factor consisted of a single item about not being able to remember time in the 
ICU. This third factor was probably related more to loss of memory due to sedation 
or coma in the ICU than to PTSD. The factor structure of PDS was not highly 
relevant in this study as my intention was to use the total PDS score in analysis, 
and not sub-scale scores. 
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4.7.2(ii)  Depression measure 
Clinical depression at three months was assessed using the 20-item Center for 
Epidemiologic Studies Depression Scale (CES-D; Radloff, 1977). The CES-D is the 
most widely used measure of depression in epidemiological and community studies 
and has been validated for both general and psychiatric populations. Responses are 
scored 0 to 3, with higher scores indicating higher frequency giving a possible 
range of total scores from 0 to 60. Scores above 16 are considered high by the 
authors and an indication that the patient is likely to be clinically depressed 
(Radloff, 1977). Severity categories are mild (10-15), moderate (16-24) and severe 
(>24). 
 
In validation studies internal consistency has been found to be high for both 
general (Cronbach’s alpha =0.85) and psychiatric patients (Cronbach’s alpha= 
0.90). The CES-D showed criterion group validity, discriminating between general 
population and psychiatric patients; 70% of patients and only 21% of the general 
population scored above the suggested cut-point of 16. Subsequent studies (Radloff 
& Locke, 1986) confirmed the screening value of the CES-D in detecting depressive 
disorder.  
 
Other authors have suggested that the recommended cut-point of 16 is too low. For 
example a cut-point of 19 was suggested for rheumatoid arthritis patients because 
of the effect of somatic symptoms (Covic et al., 2007). For example a positive 
response to “I felt everything I did was an effort” could be due to disease rather 
than depression. A similar argument could apply to recovering ICU patients who 
may be suffering from physical weakness rather than depression. Other studies 
suggested that the cut-point should be raised to 24 or higher to achieve 
appropriate diagnostic characteristics (Gotlib et al., 1995; Roberts et al., 1991). 
However Cheung et al. (2007) found that sensitivity and NPV were compromised by 
increasing the cut-point from 16. It was concluded there was no optimal cut-point 
but researchers should choose one that was fit for their purpose. I decided not to 
depart too much from the scale authors’ recommendation, but to take into account 
the effect of somatic symptoms and use the cut-point of 19 recommended by Covic 
et al. (2007). 
 
Reliability and factor analysis 
In my cohort study, Cronbach’s alpha for the CES-D was 0.911. In a confirmatory 
factor analysis, four factors were found explaining 68% of the variance. A four-
factor structure was also found by the original factor analytic validation among 
three different population samples. The factors were depressed affect, positive 
124 
 
affect, somatic and retarded activity, and interpersonal. However in my study 
analysis was carried out using the total depression score. 
 
4.7.2(iii)  Anxiety 
Clinical anxiety at three months was measured using a short version of the State 
Trait Anxiety Inventory (Spielberger et al., 1983), a widely used questionnaire that 
has been used with many different populations and different health conditions. It 
has well-established criteria and construct validity and internal consistency 
reliability coefficients. In this study Cronbach’s alpha was 0.878.  After factor 
analysis KMO was 0.820, and one factor was found, as expected, explaining 63% of 
variance. 
 
The full version of STAI includes 20 items to detect state anxiety and 20 items to 
detect trait anxiety. The short form of STAI used in this study consisted of six items 
(calm, secure, tense, at ease, upset, worried) to measure state anxiety only. 
Responses were “not at all, somewhat, moderately, and very much”. Scores per 
item were from 1-4. The total score was divided by six and multiplied by 20 to give 
a range of scores that was consistent with the full STAI of 0-80. 
 
No definitive cut-point has been established for the STAI to determine clinical levels 
of anxiety.  The authors, Spielberger et al. (1983) suggested a cut-point of 32. Cut-
points of 37 and 39 (Addolorato et al., 1999) have also been used. In surgical 
patients the cut-point was set at 44/45 (Kindler et al., 2000). Finally 54/55 was 
recommended as a cut-point for geriatric patients in their 80s with chronic ill health 
(Kvaal et al., 2005). I chose to use the cut-point of 44/45 as ICU patients probably 
have more similarities with surgical patients than other populations assessed with 
STAI, and I wanted a conservative cut-point that would not yield an unrealistically 
high prevalence rate. 
 
4.7.2(iv)  Quality of life  
The SF-36 (Ware, Jr. & Sherbourne, 1992) is a generic, multipurpose health survey 
that produces a profile of function and well-being in eight domains, as well as two 
summary measures for physical and mental health. Extensive evaluation has taken 
place to establish its reliability and validity, and it has been used in articles 
describing more than 200 diseases and conditions. In this study I used its short 
version, the SF-12 health survey (Ware, Jr. et al., 1996). Its 12 questions cover 
four physical domains – physical functioning, role-physical, bodily pain, general 
health and four mental domains – vitality, social functioning, role-emotional, and 
mental health. The four physical domains are summed into a physical health 
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summary measure (PCS) and the mental domains in a mental health summary 
measure (MCS).  
 
I obtained the PCS and MCS results for each patient by using the SF-12 algorithm 
recommended by the SF-12 manual (Ware, Jr et al., 1996).They are scored using 
norm-based methods based on the general US population. Both the PCS-12 and 
MCS-12 scales are transformed to have a mean of 50 and a standard deviation of 
10 in the general U.S. population. A one-point difference is one-tenth of a standard 
deviation. Therefore results can be meaningfully compared with one another. 
Although no cut-points are recommended for poor HRQL by the SF-12 manual, a 
number of recent studies defined poor PCS or MCS by scores lower than or equal to 
40 (e.g. Casso et al., 2004; Myint et al., 2005). Poor PCS has been defined as 
substantial limitations in self-care, physical, social, and role activities; severe bodily 
pain; or frequent tiredness. Poor MCS was defined as frequent psychological 
distress and substantial social and role disability due to emotional problems 
(Rumsfeld et al., 2004). 
 
4.7.2(v)  Past psychological history 
There was a short section in the follow-up questionnaire about past mental health 
problems. Patients were asked if they had ever been to see a GP, therapist, 
counsellor or psychiatrist for a mental health problem. If yes, they were asked what 
the problem was, what treatment they received for it, and if it occurred before 
intensive care, since intensive care or both. Finally they were asked if they were 
currently taking medication for depression or another mental health problem. 
However few patients answered this section (and some answered incorrectly) so 
the data were not used. Subsequently a medical researcher collected data on prior 
mental health problems from the electronic records at the UCH CCU. She noted any 
current or previous mental health diagnoses or current medications prescribed for 
psychological problems that were recorded by ICU staff. 
 
4.7.2(vi)  Social support 
A nine-item social support scale about “support you get from other people” was 
also used in the follow-up questionnaire. It included six items about emotional 
support, and three about instrumental support (support for health behaviours 
including taking medication, having a healthy diet and taking exercise). There were 
five responses ranging from not at all (0) to all of the time (4) resulting in a 
possible range of scores from 0 to 36. The six emotional support items came from 
the ENRICHD Social Support Inventory created for a study of patients recovering 
from myocardial infarction (Mitchell et al., 2003). It was found to have concurrent 
and predictive validity, and acceptable reliability when used with cardiac patients 
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(Vaglio, Jr. et al., 2004). The three items on instrumental support were added to 
the original six items for the TRACE study on tracking recovery after coronary 
events (Wikman et al, in press). 
 
4.7.2(vii)  Socio-economic circumstances 
Finally the follow-up questionnaire included questions pertaining to the NS-SEC 
(Office for National Statistics, 2010). This classification, that is now used in all 
official statistics and surveys in the UK, was used to derive patient SEC. Further 
details were given in Section 4.6.5. 
 
4.7.2(viii)  Piloting the follow-up questionnaire 
I piloted the follow-up questionnaire by sending out questionnaires to patients who 
had been discharged from the ICU three months previously and had been invited to 
attend the ICU follow-up clinic. I sent out 17 questionnaires and 11 were returned 
(response rate: 65%). Of the six non-responses, two patients had been readmitted 
to the ICU, one was going in for new surgery, and three did not respond, for 
unknown reasons. The piloted follow-up questionnaires were not used in the final 
study as these patients had not taken part in the baseline assessment. 
 
Mean time taken to complete the follow-up questionnaire was 21 minutes. Eight of 
the eleven patients completed it in 15 minutes or less. Seven patients had no 
problems with the questionnaire. One patient objected to some questions, “I 
thought the questions were meaningless. My answers relate to other problems in 
my life, not ICU”. (This patient scored highly on the CES-D, a validated depression 
questionnaire (Radloff, 1977). The study did not make the assumption that 
depression was caused by the ICU as confounding variables were considered, so I 
did not alter the questionnaire). Two patients found some of the response options 
to the validated questionnaires confusing. One patient found the layout was 
unclear. None found any questions unclear or ambiguous. The “results” were that 
six patients had no psychological symptoms, and five patients had high levels of 
depression or ICU-related PTSD. In response to patient comments I amended the 
layout of the questionnaire to make it as clear and easy to complete as possible. It 
was not necessary to shorten the questionnaire or make any major changes to it. 
4.8  Power and statistical analysis 
4.8.1 A priori power calculation 
The primary outcome was PTSD symptomatology measured on a continuous scale 
on the PDS which has a range of 0-51 and a standard deviation of 14.68 (Foa et al., 
1997). It was determined that a clinically significant difference in PTSD between 
two groups (as defined by a median split on the ICUSS or any other risk factor) 
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would be ten points on the PDS (personal communication with Professor Brewin), 
approximately two thirds of a standard deviation (Foa et al., 1997). For this effect 
size, 80% power and 5% significance, 34 patients were required in each group. 
With this sample size, the detection of a correlation coefficient of 0.3 between a 
continuous risk factor and outcome would be possible. In order to carry out multiple 
linear regression, the sample size should be inflated. In order to detect the same 
correlation coefficient (0.3) between a risk factor and outcome in a multiple 
regression model where all other variables in the model explained 30% of the total 
variation in outcome, the sample size needed to be inflated by 40%. This yielded a 
total sample size of 95 patients. Based on previous studies I estimated that the 
drop-out rate would be around 30% by the time of follow-up. Therefore I aimed to 
recruit a minimum of 140 patients at baseline. As the study progressed it became 
clear that the drop-out rate was around 35% rather than 30% so I carried on 
recruiting until I had 157 patients at baseline. When I closed the study 100 patients 
(64%) had completed both baseline and follow-up assessment. Therefore the study 
was fully powered according to the a priori calculation. 
4.8.2  Preparation of data for statistical analysis 
All data was double-checked as data entry proceeded, to achieve a high level of 
accuracy. Before data analysis, the steps involved in data cleaning were conducted 
as recommended by a standard text book (Kirkwood & Sterne, 2003). The accuracy 
of data entry was assessed by conducting range checks and inspecting histograms 
of continuous variables to identify out of range values and outliers. For categorical 
variables I checked that all observations related to allowed categories and that the 
frequencies in each category made sense. Any errors were corrected by referring 
back to original questionnaires and data record forms. Outliers that were not errors 
were not removed from the dataset as is sometimes recommended, because high 
scores, for example on one of the psychological questionnaires, were highly 
relevant data to inform one of the main aims of this study, to assess the extent and 
prevalence of psychological morbidity after ICU. The level and location of missing 
data were assessed, followed by an assessment of the extent to which continuous 
data met the assumptions required by statistical tests.  
 
4.8.3  Missing data  
There are no accepted guidelines indicating the amount of missing data which can 
be “allowed” in a sample (Tabachnick & Fidell, 2007) nor are there accepted 
strategies for how to ameliorate the problem (Graham, 2009). In this study there 
were no missing clinical or health-care data, as they were collected directly from 
the electronic records of the patient’s stay in the ICU. Data on age and sex were 
also collected from patient records and were complete, but there were missing data 
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on NS-SEC classification as they were collected via a self-report questionnaire. 
Therefore some cases had to be excluded from analyses using the SEC variable. 
There were missing data from the psychological questionnaires, but only to a 
limited extent, although the amount of missing data from the follow-up 
questionnaires was greater than from the baseline questionnaires. For example, the 
range of missing data for items in the ICU stress scale was 0-2% but for PDS items 
the range of missing data was 2-8%. 
 
I decided that for most of the individual scales used in the questionnaires, cases 
with over 20% of items missing would be excluded. However the manual for the 
SF-12 (Ware et al., 1996) specifies that that all cases with even a single missing 
value should be excluded, and this was adhered to. For the remaining scales it was 
decided to replace missing values in questionnaires by individual means (the 
participant’s mean score for that scale or sub-scale). An article comparing 
imputation methods for dealing with missing data in a depression scale concluded 
that while multiple imputation was the most accurate method for dealing with 
missing data, imputing the mean of an individual’s complete responses to other 
questions, was also an appropriate method that would be interpretable to the 
majority of medical readers (Shrive et al., 2006). 
4.8.4  Distribution of data 
The distribution of continuous variables was assessed by examining frequency 
histograms and using a statistical test for normality, the KS Lilliefors test. When 
data were identified by this method as having a skewed distribution, further 
investigation of the level of skew was carried out, by standardising scores and 
dividing by standard error (Field, 2005). For data to be treated as normally 
distributed, skew should be within +2 and -2. If distribution was outside the 
recommended skewness levels, transformation options were considered. If 
tranformation did not result in the variable being normally distributed, non-
parametric statistical tests were used. 
   
4.8.5  Descriptive Statistics 
Means, standard deviations and ranges or medians and ranges were calculated for   
all continuous variables. Prevalence rates of psychological outcomes were 
calculated as percentages with confidence intervals. Numbers and percentages of 
cases in each category were calculated for binary and categorical variables. 
 
4.8.6  Re-coding categorical variables  
After examining the descriptive statistics some categorical variables were re-coded. 
In some cases this was because there were very few cases in some of the 
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categories. For example variables representing drug groups such as 
“benzodiazepines” had several categories for each specific drug or combination of 
drugs e.g. midazolam, diazepam etc. However this led to so many possible 
categories that analysis was not possible in a sample of this size (100 patients). 
Therefore drug group variables were re-coded so that 1= yes, received a drug from 
this group and 0= no, did not receive a drug from this group. Other categorical 
variables were re-coded for entry into multivariable regression, after univariable 
analysis showed that there were no differences between certain categories. For 
example, intrusive memories was originally coded to have three categories: no, 
yes/factual and yes/delusional. This was because the literature suggests that 
delusional memories of ICU were a predictor of psychological outcome, but factual 
memories were not (e.g. Jones et al. 2001). However as there were no significant 
differences between the factual memory and delusional memory groups at the 
univariable stage, the variable was re-coded as 0=no intrusive memories, and 1= 
yes, intrusive memories present. Similarly memory of ICU was re-coded from three 
categories (little or some or most) to two categories (very little or some/most). 
 
4.8.7  Outline of statistical analysis 
All statistical analyses were conducted using SPSS for Windows (version 14). 
Normal regression models were used with the primary outcome (PTSD) treated as a 
continuous variable.  
(i) Each risk factor was related to the outcome in a univariable model to estimate 
the unadjusted associations. Correlations, T-tests and one-way analysis of variance 
(Anovas) were used with, respectively, continuous, binary and categorical predictor 
variables.  
(ii) The strongest independent predictor variable or variables within each of the four 
pre-defined risk factor groups (1. clinical 2. socio-demographic 3. psychological and 
4. chronic) were then identified using a series of multivariable regression models.  
(iii) A final regression model was developed to assess whether identified risk factors 
were independent of each other. Each step is described in more detail below. The 
same procedure was carried out with all other outcomes. Appropriate tests for 
multivariable model assumptions were carried out (see 4.8.8).  
 
4.8.7(i)  Univariable analysis 
Correlations, T-tests and Anovas were carried out to look for associations between 
clinical, socio-demographic, psychological and chronic risk factors and psycho-social 
outcomes. Associations between risk factors were also examined, e.g. between 
clinical and psychological factors, as this would suggest a potential role of some risk 
factors as mediators or confounders (definitions were given earlier in the chapter). 
Many tests were carried out as part of the univariable analysis, increasing the risk 
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of type 1 errors. This approach was justified as the study was an exploratory one to 
identify risk factors that should be investigated further, in an area in which few risk 
factors have been identified to date. Furthermore in assessing the most important 
risk factors I considered effect sizes, direction of results and patterns of results that 
pointed to similar conclusions rather than relying on significance alone. This 
approach makes it less likely that results were mere statistical artefacts. 
 
4.8.7(ii)  Separate multivariable models  
In recognition of the number of potential variables being tested in these analyses 
and the associated implications for sample size, a two-stage analysis process was 
implemented. If several predictors within each of the 4 risk factor groups were 
identified during the univariable analysis, all statistically significant (p<0.05) 
predictors were entered into a multiple regression. (However, in the case of PTSD, 
there were too many statistically significant clinical predictors to enter into a 
regression, so I selected the variables with largest effect sizes and dropped some 
variables that overlapped with others.) The strongest predictors from these 
regressions, based on effect size and an adjusted significance level (p<0.1), would 
then be entered into the final multivariable model. If only one or two statistically 
significant clinical predictors were identified in univariable analysis, the second 
stage was missed out and predictors were directly entered into a final multivariable 
model.  
4.8.7(iii)  Final multivariable model 
The strongest predictors, based on effect size and significance, from each group of 
risk factors (clinical, socio-demographic, psychological and chronic) were entered in 
separate blocks into final regression analyses for each outcome, to enable the 
variance in outcomes explained by each group of variables (socio-demographic, 
clinical, psychological risk factors, chronic) to be assessed. Socio-demographic 
variables were entered first, clinical variables and chronic health second, 
psychological variables third and psychological history last. Thus the effects of 
clinical variables on outcomes were adjusted for socio-demographic variables, and 
the effects of adding acute and chronic psychological factors to the model could be 
seen. The final regression models were carefully examined to detect which were the 
strongest risk factors (largest effect sizes and smallest p-values, which were 
independent risk factors (not confounded by other variables) and which risk factors 
were confounded or mediated by others. 
4.8.8  Tests of multivariable assumptions 
4.8.8.(i)  Linearity, normality and homoscedasticity 
In order to have confidence in the results of the multiple regressions, it is important 
to check that they do not violate multivariable assumptions (Tabachnick & Fidell, 
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2007). These assumptions include a) a straight line relationship between residuals 
and predicted scores b) that residuals are normally distributed c) that error is 
random and d) that there is homoscedasticity (constant variance of residuals at 
each level of the predictor variable), (Field, 2005). If these assumptions are met 
there is more likelihood that the model that we get for a sample can be applied to 
the population of interest. For each of the final regressions for each outcome, I 
examined histograms of residuals, normal probability plots and scatterplots of 
residuals and predicted values for evidence of linearity, normality and 
homoscedasticity. 
4.8.8(ii) No perfect multicollinearity 
Multicollinearity poses a number of problems in multiple regression. If there is 
perfect collinearity between predictors it is impossible to obtain unique estimates of 
the regression coefficients. As collinearity increases, so do the standard errors of 
the regression coefficients, increasing the risk of type II errors. Collinearity also 
makes it difficult to assess the individual importance of predictors. For all multiple 
regressions I looked at collinearity diagnostics produced by SPSS such as variance 
inflation factors (VIFs indicate if a predictor has a strong linear relationship with 
another) and tolerance factors.  It has been argued that if the average variance 
inflation factor is greater than one, multicollinearity may be biasing the model 
(Bowerman & O'Connell, 1990). The reciprocal of the VIF (1/VIF), the tolerance 
statistic, is another useful diagnostic. It has been suggested that tolerance values 
lower than <0.2 (Menard, 1995) are of concern. If there had been multicollinearity 
I would have deleted one of the variables based on reliability or tolerance value. 
4.8.9 Mediational analysis 
Finally, if associations between risk factors from different groups were found at the 
univariable stage of analysis, for example between ICU clinical factors and 
psychological factors, and assumptions for a mediational relationship were met, 
then a mediational relationship was tested in a further stage of analysis (Baron & 
Kenny, 1986). This analysis was designed to test whether acute psychological 
factors partially accounted for the relationship between clinical predictors and 
psycho-social outcomes and if those factors might be on the causal pathway 
between clinical effects and outcomes (as predicted by hypothesis four).  
 
This method involves first regressing the “mediating variable” on the predictor 
variable; second, regressing the outcome on the predictor variable; and third, 
regressing the outcome on both the predictor variable and the mediating variable. 
The assumptions of mediation are that the predictor must affect the mediator in the 
first equation, the predictor must affect the outcome in the second equation and 
the mediator must affect the outcome in the third equation. If these conditions all 
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hold, then the effect of the predictor on the outcome must be less in the third 
equation than in the second. Perfect mediation would occur if the predictor had no 
effect on the outcome when the mediator was controlled. However when treating 
phenomena that have multiple causes, it is more realistic to seek mediators that 
significantly decrease the predictor-outcome relationship rather than eliminate it 
(Baron & Kenny, 1986).  
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Chapter 5 Results of cohort study  
 
In this chapter I have reported the results from the prospective cohort study of 157 
level 3 intensive care patients that I carried out at UCLH in 2008-2009. The results 
include the prevalence of psychological morbidity after intensive care, specifically 
PTSD, anxiety and depression, and the extent of poor mental and physical HRQL. 
The results of univariable and multivariable statistical analyses to detect strong 
indendependent risk factors for post-ICU psycho-social outcomes, and mediational 
analysis to identify possible mediating variables, are also reported. 
 
5.1  Recruitment of sample 
5.1.1  Baseline recruitment 
A total of 157 “Level 3” intensive care patients were recruited for this study in the 
UCH critical care unit during a period of approximately 10 months from November 
19, 2008 to September 30, 2009, excluding times when I was on annual leave (see 
figure 5.1). The total number of level 3 patients admitted to the Unit during that 
time was 375. Of these, 104 (28%) died in the CCU, 22 were transferred to other 
hospitals from the CCU, four discharged themselves and 62 were excluded 
according to study criteria.  This left 183 patients who were eligible to participate. 
Of these, nine were unable to complete the assessment for miscellaneous reasons, 
and 17 declined to participate. Overall 86% of level 3 patients who were eligible to 
participate in the study were recruited and took part in the baseline assessment at 
time of discharge from the ICU. There were no significant differences in age, sex or 
illness severity between recruits and non-recruits. However it can be seen from 
Table 5.1 below that non-recruits were more likely to be men, were a little younger 
than recruits and a little less sick on admission to the ICU.  
Table  5.1   Comparison of baseline characteristics, recruits and non-recruits  
 
 
5.1.2   Follow up sample 
A total of 57 patients were lost to follow-up.  Of these, 46 could not be contacted 
or were unable to complete an assessment for the following reasons: 17 had died  
after leaving  intensive care, nine were homeless, eight were still seriously ill in 
hospital, three were mentally ill or had learning disabilities, five were confused,  
 
   N Age 
Mean (SD) 
Sex 
% men/women 
Illness severity 
Mean (SD) 
Recruits  157 57.24 (16.83) 57.3%  vs 42.7% 22.17 
Non-recruits  17 55.53 (13.46) 64.7%  vs 35.3% 20.41 
Mean difference, 
95% CIs, 
 p-value 
 1.71  
(-6.63, 10.04) 
p=0.687 
 
p=0.558 
1.75  
(-0.71,4.22) 
p=0.157 
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Figure 5.1  Recruitment, participation and follow-up of patients 
 
 
 
 
 
 
 
Time one  
recruitment 
 
 
 
 
 
 
 
Time two  
assessment 
 
 
 
 
375 level 3 patients admitted 
to ICU (Nov 08 – Sept 09) 
245 level 3 patients identified for 
possible  recruitment to cohort 
study before  ICU discharge 
 183 patients eligible for 
recruitment to cohort study 
 157 level 3 patients recruited  
        and completed baseline   
        assessment 
17 declined to participate 
  9 agreed to participate but were     
     unable to complete assessment  
     before leaving hospital 
62 excluded (exclusion criteria): 
No English/no translator 
Chronic or acute confusion  
Communication problems   
Sensory impairment  
Palliative or terminal care. 
Reduced consciousness, GCS<15  
Less than 18 years of age. 
  104 died 
    22 transferred from ICU to other  
         hospitals 
      4 self-discharged 
 
100 patients remained in the study 
at three-month follow-up and were 
fully assessed for outcomes 
17 died  
  8 were homeless  
  9 still seriously ill in hospital 
  3 serious mental illness or LDs 
  5 confusion 
  2 language difficulties 
  2 blind 
11 did not respond/dropped out 
 
 
two had language difficulties and two were blind. Eleven further patients declined to 
take part or did not respond to successive efforts to contact them. This left 100 
patients who took part in both baseline (time one) and follow-up (time two) 
assessments. Overall follow-up rate was 64%. However 90% of patients who were 
alive, contactable and capable, participated in the follow-up assessment. 
 
5.2  Characteristics of the sample 
5.2.1  Socio-demographic characteristics 
Table 5.2 contains socio-demographic data about the full sample of participants at 
time one, the 100 participants who were followed up at time two and the 57 who 
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were not. The mean age of participants was approximately 57 years old. There 
were more men than women at time one (57.3%/42.7%) but the final sex balance 
(52% men /48% women) was an almost even split. Most participants at both time 
points (85.5%) were white.  Participants were predominantly from the most 
deprived areas (4th and 5th quintiles). At time one 43.4% of participants were from 
the most deprived areas (5th) while 8.6% lived in the least deprived areas (1). At 
time two 37.1% of participants were from the most deprived (5th) and 12.4% from 
the least deprived (1st).  However a somewhat different picture of the socio-
economic circumstances of the follow-up group emerged from the classification by 
occupational groups using NS-SEC (see Figure 5.2). This measure, which was 
completed at time two, indicated that 33% of the sample belonged to class 1 
(professional, managerial classes) while 20% belonged to class 5 (routine and 
semi-routine occupations).  For reasons explained in chapter four (methods) I 
decided that NS-SEC (Office of National Statistics, 2010)  was a better indicator of  
SEC in this cohort, and so used NS-SEC rather than IMD 2007 (Communities and 
Local Government, 2010) in the statistical analyses.  
 
Table 5.2  Patients’ socio-demographic characteristics 
                                 Means, SDs for continuous variables;  N (%) for categorical variables 
  Total 
 Sample 
 (n=157)                  
Not followed 
up (group 1) 
(n=57) 
Followed up 
 (group 2)   
(n=100)                            
Difference 
between groups  
1 and 2 
Age                    
(years) 
  57.24 (16.8) 
  median 59 (79) 
 min 18y max 97y 
57.19 (15.62) 57.26 (17.40)   p=0.981 
Sex     men                     
            women 
    90 (57.3%)  
   67 (42.7%)  
38 (66.7%) 
19 (33.3%) 
52 (52%) 
48 (48%)  
 
  p=0.074 
Education                                    
            Degree 
            College           
            A’level  
            GCSE                           
No qualification 
   
  39 (26.5%) 
  20 (13.6%)                                              
  19 (12.9%) 
  25 (17.0%) 
  44 (29.9%) 
 
12 (22.2%)  
8 (14.8%)
  5 (9.3%) 
  7 (13.0%)  
22 (40.7%) 
 
27 (29%) 
12 (12.6%) 
14 (14.7%) 
18 (18.9%) 
22 (23.2%) 
 
 
  p=0.220 
Ethnicity   
              white                 
other ethnicity 
   
  132 (85.5%) 
   22  (14.5%) 
  
49 (86%) 
  8 (14%) 
 
 83 (85.6%) 
 14 (14.4%) 
 
  p=0.625 
Deprivation*           
            1.Least 
            2. 
            3. 
            4. 
            5. Most           
    
   13 (8.6%) 
   13 (8.6%) 
   25 (16.4%) 
   35 (23%) 
   66 (43.4%) 
 
 1 (1.8%) 
 3 (5.5%) 
 3 (5.5%) 
18 (32.7%) 
30 (54.5%) 
 
12 (12.4%) 
10 (10.3%) 
22 (22.7%) 
17 (17.5%) 
36 (37.1%) 
 
 
  p=0.001 
Occupation **  
1. Professional 
2. Intermediate 
3. Own account 
4. Technical 
5. Routine 
6. Unclassified                      
 
  No data – data  
collected at time  
two (follow up) 
 
  
33 (33%) 
10 (10%) 
21 (21%) 
  7 (7%) 
20 (20%) 
  9 (9%) 
 
*IMD 2007 (Communities and Local Government, 2010)** NS-SEC (Office of National Statistics, 2010) 
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Figure 5.2  Bar charts showing socio-economic circumstances 
                    (follow-up sample, with a)IMD 2007 and b)NS-SEC)          
 
                a) Percent of sample in Index of Multiple Deprivation 2007 quintiles 
 
                                      
5.2.2  Comparison of followed up/not followed up groups 
Participants in the follow-up group did not significantly differ from the non-follow-up 
group in terms of age, education or ethnicity. There was however a difference in 
the sex composition of the two groups which approached significance, caused by 
more men (42%) than women (28%) “dropping out” between times one and two. 
There was a significant difference in level of deprivation between the follow-up and 
non-follow-up groups, as a smaller percentage of participants from 4th and 5th IMD 
 6    Routine 
Semi-routine 
 
4   3                 2 Professional 
 Managerial  
50.0%
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30.0%
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0.0% 
 
           b) Percent of sample in NS-SEC  categories 
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10.0%
0.0%
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quintiles (most deprived) took part in the follow-up compared to  participants from 
less deprived quintiles. From table 5.2, it can be seen that 44 out of 51 (85%) 
participants from the three least deprived quintiles responded at time two, whereas 
only 53 out of 101 participants (52%) from the two most deprived quintiles took 
part in the follow-up assessment. Although there was no significant difference in 
Education, it was noticeable that people with no qualifications were almost twice as 
likely to be in the not followed up group (40.7% vs 23.2%). Those with a degree 
were more highly represented in the follow up group (29% vs 22.2%).  
 
5.2.3  Clinical indicators and interventions received 
To summarise the main points emerging from the large amount of acute clinical and 
healthcare data that was collected for patients (see table 5.3), I have mainly 
referred to the statistics for the follow-up sample of 100 patients. I will report first 
on admission and healthcare pathways.  Most patients were admitted to the CCU 
from theatre/recovery (34.7%) or from a UCH ward (28.6%), with the rest coming 
from A&E, or other hospitals’ ICUs or wards. Patients in this study spent 13.55 days 
on average in the CCU, including a mean 8.53 days receiving “level 3”  intensive 
care. After discharge from the CCU, most patients went to UCH wards (93%). After 
an average stay in hospital of 39.67 days, 69% of patients went home and were 
still there at three months. Of the rest, six per cent went to residential care or 
rehabilitation, and 11% had one or more re-admissions to hospital. Four were still 
in hospital at three months. However 18 (11.5%) of the original sample died – 17 
died before time two and one died after time two. Illness severity scores were high, 
with a mean Apache II score (Knaus et al., 1981) of 22.  
 
The primary body system most commonly affected was the respiratory system 
(30% of patients), followed by the gastro-intestinal (GI) system (29%) and the 
cardiovascular (CV) system (17%). Most patients were non-surgical patients 
(63%), with emergency surgical patients forming the smallest group (14%). A total 
of 81 (81%) of patients had sepsis (based on C-reactive protein scores, white cell 
count and lactate levels). The level of intervention received was measured by the 
TISS (therapeutic intervention scoring system) score (Keene et al., 1983).  Mean 
score was 24.61. Patients received up to nine types of organ support, with mean 
4.40 (1.70) types of organ support received. The most common forms of organ 
support received were GI support (mean 9.38 days, 73% of participants), advanced 
respiratory support (mean 7.92 days, 79% participants) and advanced CV support 
(mean 2.13 days, 52% of patients). The most common combination of organ 
support received was respiratory, CV and GI support (29.9% of patients). The 
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second most common combination was respiratory, CV, GI and dermatological 
support (11.5%). 
Table 5.3  Clinical data (excluding drugs received) 
 
Level 3 patients are often administered a number of drugs with potential  
  psycho-active effects during the ICU stay. Patients were sedated for an average  
3.13 days, up to 24 days; with 60% of patients receiving benzodiazepines (e.g.  
D         Means (SD) continuous variables (+median if skewed) or N(%) for categorical  variables 
                                        Total sample       Not followed            Followed  up                   p-value   
                                                                     up group                    group                         of differ- 
                                            (n=157)            (n=57)                     (n=100)                        ence                                                                                               
Type Admission 
      Elective surgical 
 Emergency surgical 
           Non-surgical 
                
   37 (23.6%) 
   19 (12.1%) 
 101 (64.3%) 
 
14 (24.6%) 
   5 (8.8%) 
38 (66.7%) 
         
23 (23%)                                                   
14 (14%)                              
63 (63 %)  
 
p=0.627
Admitted from 
      Theatre                            
       Ward 
       A&E 
       Other 
    
50 (32.1%) 
   45 (28.8%) 
   31 (19.7%) 
   32 (19.2%) 
 
16(28.1%) 
16(28.1%) 
14(24.6%) 
11(19.4%) 
                           
 34 (34.7%)   
 28 (28.6%)   
 17 (17.3%) 
 19 (19.4%)                         
 
 
p=0.725 
Post-hospital to: 
     Home                 
     Other hospital 
     Care/rehab 
     Died* 
     Readmission/s 
     Still in hospital 
 
   96 (61.1%) 
   17 (10.8%) 
     8  (5.1%) 
   18 (11.5%) 
   13 (8.3%) 
     5 (3.2%)    
 
27(47.4%) 
 8 (14%) 
 2 (3.5%) 
17 (30.1%) 
 2(3.5%) 
 1(1.8%) 
 
 69 (69%) 
   9 (9%) 
   6 (6%) 
   1 (1 %)   
  11(11%)    
    4(4%) 
 
p=0.000 
Illness severity 
on admission 
 22.17 (7.90) 
Range (7-48) 
22.44 (9.07)  22.01(7.19)  
p=0.760 
Primary system 
   Respiratory  
   CV 
   GI 
   Neuro   
     
48 (30.6%) 
28 (17.8%) 
43 (27.4%) 
11 (7%) 
 
18(31.6%) 
11(19.3%) 
14(24.6%) 
5 (8.8%) 
                      
30 (30%) 
17 (17%) 
29 (29%) 
  6 (6%)   
 
 
 
p=0.625 
Hospital LoS 
(days) 
 40.32  (39.15) 
 median 27(239) 
41.44 (41.06)  39.67(38.18) 
 median 27(239) 
p=0.788 
ICU LoS 13.10(13.24) 
median 9 (85) 
12.31(9.25)  13.55(15.10) 
 median 8(85) 
p=0.575 
Level 3 days  8.07(12.11) 
 median 4 (80) 
7.26(7.775)   8.53(14.02) 
  median 3 (80) 
p=0.530 
TISS score  24.52(5.34) 
Range (0-36) 
24.37 (5.86)  24.61(5.05)                        p=0.786 
Number of organs 
supported 
4.6 (1.69) 
Range (1-8) 
4.97(1.61)   4.40(1.70) 
   
p=0.040 
Advanced  
respiratory  
support  
7.41(11.95)days 
median 3 (80) 
N:128 (81.5%) 
6.53(7.41) 7.92(13.89)  
median 3 (80) 
N: 79 (79%)             
p=0.484 
Advanced 
cardiovascular 
support  
 2.29(3.53) days 
median 1(20)  
N: 88 (56.05%)  
2.58(3.81) 2.13(3.37)        
median 1(16) 
N: 52 (52%) 
p=0.446 
Renal 
support  
1.69 (4.99) days 
 median 0 (40): 37 
(23.57%)  
1.72(1.67)  1.67(5.56))  
 median 0(40) 
N: 21 (21%)  
p=0.953 
Neuro 
support  
0.48(1.04) days 
median 0 (5) 
N: 38 (24.20%) 
 0.54(1.09)  0.44(1.02)  
 median 0(5) 
 N:  22 (22%) 
p=0.550 
Gastro-intestinal 
support 
8.93(13.09)days 
median 4 (89) 
 N: 73 (89%) 
8.14(9.54) 9.38(14.76) 
median 4(89) 
N: 73 (73%)              
p=0.570 
Dermatological   
support  
1.43(4.48) days 
median 0 (39) 
N: 46 (29.3%) 
1.35(2.82)  1.48(5.21))  
 median 0(39) 
 N: 24 (24%) 
p=0.863 
Liver 
support  
0.05(0.464) days 
median 0 (5) 
N: 2 (1.3%) 
0.09(0.662)   0.03(0.300) 
 median 0 (3) 
N: 1 (1%)  
p=0.455 
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midazolam) and 66% receiving anaesthetics agents (mainly propofol) for sedation. 
Other drugs received were opioids such as morphine sulphate or fentanyl (93%), 
inotropes and vasopressors, including adrenaline and noradrenaline (47%), 
antipsychotics, primarily haloperidol for delirium (39%), hypnotics, mainly 
zopiclone, for insomnia (31%), and steroids such as hydrocortisone or 
dexamethazone (33%). The mean number of “psychoactive” drug groups received 
was 3.67(1.68) of a possible seven. 
 
Table 5.4  Drugs received by the cohort  
                
  
It can be seen from table 5.3 above that there were few significant differences in 
clinical (illness and treatment) factors between the followed-up and not followed-up 
groups. This suggests that the follow-up sample was representative of the total 
sample in terms of illness and healthcare received. There was a significant 
difference for the post-hospital variable, but this was accounted for by the fact the 
non-follow-up group included the 17 patients who died before time two. There was 
a genuine difference for “numbers of organ supported”; with a lower score in the 
follow-up group (4.97 vs 4.40, p=0.040). Although not significant findings, there 
appeared to be real differences in the amounts of drugs received between the two 
groups (table 5.4). The group who were not followed up were more likely to have 
had benzodiazepines (70.2% vs 60%, p=0.186) for sedation, or inotropes or 
vasopressors (61.4% vs 47%, p=0.082). They also had more days of sedation 
(4.12 vs 3.13) and more time in intensive care (13.55 vs 12.1 days) than the 
follow-up group. Follow-up patients were more likely to have come from theatre 
(34.7% vs 28% of sample) than non follow-up patients whereas non-follow-up 
patients were more likely to come from Accident & Emergency (24.6% vs 17.3%) 
than follow-up patients. It would not be surprising if the non-follow-up group had 
more organ failure and intensive care, as it included those who died or were too ill 
to take part in follow-up. However as these differences were non-significant, they 
are not of great concern. 
Variable  Total sample 
n=157 
Not followed up 
group n=57 
Followed up 
group 
n=100 
p-value for 
difference 
Days of Sedation  3.48 (4.41) days 
median 2 (24) 
4.12 (4.66)   3.13(4.24) 
median 2(24) 
p=0.184 
Number drug 
groups received 
Not calculated 
for total sample 
  3.67 (1.68) 
 Range 0-7 
 
Hypnotics 47 (29.9%)                                  16 (28.1%)   31 (31%)  0.700 
Benzodiazepines 100 (63.7%)  40(70.2%)   60 (60%)  0.186 
Anaesthetics 105 (66.9%) 39 (68.4%)   66 (66%) 0.757 
Antipsychotics  66 (42%) 27 (47.4%)   39 (39%) 0.700 
Inotropes and 
vasopressors 
82 (52.2%) 35 (61.4%)   47 (47%)  0.082 
Steroids  53 (33.8%) 20 (35.1%)   33 (33%) 0.790 
Opioids 146 (93%) 53(93%)   93 (93%)  0.997 
Sepsis  not calculated 
for total sample 
   81 (81%)  
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5.2.4  Psychological response of ICU patients 
 
Table 5.5  Acute psychological responses in the ICU 
   Means(SD) for continuous variables or Ns( % )for categorical variables 
                                                     Total sample 
 n=157 
Group1 –
not 
followed up  
n=57 
Group 2 – 
followed up 
 n=100 
 difference 
between 
groups 1+2 
(i)Total mood 
disturbance 
 28.34 (13.57) 
Range 3-59 
Poss Range 0-60                   
27.18(13.58) 29.00 (13.60) 
Range 3-59 
p=0.421 
        Anxiety   5.10 (3.69) 
Range 0-12 
Possible 0-12 
4.90(3.84) 5.18 (3.610) 
Range 0-12 
 
p=0.606 
    Depression   5.46 (3.38) 
Range 0-12 
5.28(3.39) 5.51 (3.410) 
Range 0-12 
p=0.613 
        Positive 
       emotion 
 3.49 (3.04) 
Range 0-11 
Possible 0-12 
3.73(3.10) 3.36(3.02) 
Range 1-12 
p=0.464 
           Anger  2.91 (3.39) 
Range 0-12 
2.63(3.03) 3.08 (3.58) 
Range 0-12 
p=0.427 
         Mental  
     confusion 
 6.45 (3.47) 
Range 0-12 
6.21(3.62) 6.58 (3.368) 
Range 0-12 
p=0. 511 
ii) ICU Stress  
Total 
 32.42 (12.49) 
Range 3-61 
Possible 0-72 
31.62(11.98) 32.89 (12.81) 
Range 3-61 
 
p=0.541 
  Physical stress  8.22 (4.43) 
Range 0-16 
Possible 0-16           
7.57(4.34) 8.61 (4.46) 
Range 0-16 
 
p=0.721 
      Delirium  8.06 (5.19) 
Range 0-20 
Possible 0-20 
7.86(5.49) 8.17 (5.04) 
Range 0-18 
p=0.162 
 Sense of  
personal control 
 
 9.57 (4.86) 
Range 0-19 
Possible 0-20 
9.51(4.59) 9.61 (5.03) 
Range 0-19 
 
p=0.902 
  Emotional   
  Support  in ICU 
 10.31 (2.95) 
Range 2-16 
Possible 0-16 
10.36(2.65) 10.28 (3.13) 
Range 2-16 
p=0.874 
iii) Illness 
perceptions 
    Timeline  
  of condition 
  
 
6.56 (2.82) 
Range 0-10 
 
 
6.44(2.93) 
 
 
6.64 (2.77) 
Range 0-10 
 
 
 
p=0.692 
     Control 
    over condition 
 4.22 (3.09) 
Range 0-10 
4.62(3.31) 4.00 (2.97) 
0-10 
p=0.248 
    Concern about 
    condition 
 7.25 (2.94) 
Range 0-10 
7.09(3.20) 7.34 (2.80) 
Range 0-10 
p=0.612 
   Understanding 
    of condition 
 7.19 (3.06) 
Range 0-10 
7.41(3.23) 7.06 (2.97) 
Range 0-10 
p=0.498 
  Emotional effect 
    of condition 
  6.04 (3.40) 
Range 0-10 
6.24(3.75) Mean 5.92 
(3.40) 
Range 0-10 
p=0.592 
iv) Memory 
      Memory of  
  admission to ICU 
 
Yes  
No 
 
 55 (35.5%) 
 100 (64.5%) 
 
21 (37.5%) 
35(62.5%) 
 
34  (34.3%) 
65  (65.7%) 
 
 
p=0.693 
     Memory for 
     whole ICU stay 
 
Little  
Some 
Most 
 
 66 (43%) 
42 (27%) 
47  (30%) 
21(37.5%) 
13 (23.2%) 
22(39.3%) 
45 (45.5%) 
29 (29.3%) 
25 (25.3%) 
p=0.188 
     Early intrusive 
  memories re-ICU 
Yes 
No 
 73  (47.1%) 
 82  (52.9%) 
24(42.8%) 
32(57.1%) 
49 (49.5%) 
50 (50.5%) 
p=0.727 
 (i) based on POMS items (ii) ICUSS items (iii) Brief IPQ (iv) memory items 
 
5.2.4 (i) Mood and stress (mean scores) 
I have also mainly referred to the scores of the 100 follow-up participants in this 
section on psychological response (see table 5.5). Patients’ mean total mood 
disturbance score was 29.00 (on a scale of 0 to 60). Sub-scale scores were 5.18 for 
anxiety (0-12), 5.51 for depression (0 to 12), 3.08 for anger (0-12), 3.49 for 
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positive mood (0-12)  and 6.58 for mental confusion (0-12). The mean score for 
total ICU stress was 32.89 (0-72). Mean ICUSS sub-scale scores were 8.61 for 
perceived physical stress (0-16), and 8.17 for “delirium” (0-20). Mean score for 
sense of control was 9.61 (0-20) and for emotional support from family and staff 
was 10.28 (0-16).  
5.2.4 (ii)  Mood and stress (severity levels)   
In table 5.6 it can be seen that 78% of patients had mood disturbance (with 47%   
of scores at the higher levels). Furthermore 35% were in the two higher ranges 
for anxiety, 37% for depression, 51% for “mental confusion” and 21% for anger.   
ICU stress was experienced by 88% of patients, with 36% of patients at the  
higher levels. As many as 77% had physical stress (pain, dyspnea, discomfort  
from tubes) with 56% at higher levels, and 66% had “delirium” with 34% at  
higher levels. Within positive factors, 77% had high scores for emotional support  
received from staff and family but positive emotion was lacking, with 81% of  
scores in the lower ranges. A low sense of personal control while in the ICU was   
prevalent in 58% of participants. As no severity cut-points have been set for POMS  
(McNair, 1984), I set low-mild scores for total mood disturbance as 0-15, 
 mild-moderate were 16-30, moderate-high were 31-45 and high-very high  
were 46-60. This was based on the meaning of response options. I carried out a 
similar process for ICU stress. These ranges should be validated in further studies. 
 
Table 5.6  Levels of mood disturbance and stress in ICU 
                          (based on follow-up sample; n=100) 
  Low-mild Mild-moderate Moderate-high High- v. high 
Total mood 
disturbance 
22% 31% 36% 11% 
Total ICU Stress 12% 52% 32% 4% 
Negative factors     
   Anxiety 38% 27% 21% 14% 
   Depression 34% 29% 22% 15% 
   Anger 67% 12% 13% 8% 
   Mental   
   Confusion 
23% 26% 28% 23% 
   Delirium 34% 32% 25% 9% 
   Physical Stress 23% 21% 36% 20% 
Positive factors     
Sense of Control 24% 34% 28% 14% 
Support  6% 17% 54% 23% 
Positive Emotion 51% 30% 16% 3% 
     
Looking in more detail at the ICU stress questionnaire, delirium results showed that 
64.6% of patients had hallucinations (43.4% at highest levels); 47.5% had 
nightmares; 73.7% were disorientated (43.4% at highest levels); 68% had 
confusion (42% highest) and 75% were agitated (37% at highest levels).  In terms 
of physical stress, it was found that pain affected 73% of patients (43.4% at 
highest levels) while 75.8% endured difficult breathing (46.5% highest levels) and 
79.8% were sleep deprived (55.6% highest levels). Socially, 52% felt isolated 
(31% very much so); 56.8% had problems communicating in the ICU (40% very 
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much so); and 86% felt they had little personal control in the ICU (67.3% very 
much so). 
5.2.4 (iii) Illness perceptions  
Mean scores for illness perceptions (0-10) suggested that patients believed their 
condition would last for a long time (6.64),  that their control over their condition 
was limited (4.00), that they were concerned about their condition (7.34), they 
believed they understood their condition (7.06) and that they were emotionally 
affected by their condition (5.92). 
5.2.4 (iv) Memory 
Two thirds of patients had no memory of their admission to the ICU while a third 
were able to remember being admitted. For the rest of their ICU stay, 45.9% said 
they remembered little; 29.6% remembered a moderate amount of the time and 
24.5% remembered most of the time. Almost half of all patients (49.5%) said they 
had intrusive thoughts or “memories” about the ICU by the time of discharge from 
the ICU. For 22.6% of patients, their intrusive memories were “factual” – 
apparently pertaining to real events and experiences in the ICU.  But for 20% of 
patients, the intrusions were “unreal” memories of dreams, hallucinations or 
delusional states experienced in the ICU. Another five patients described their 
memories as both factual and unreal, and two patients chose not to describe the 
content of the memories.  
5.2.5.  Summary of psychological state of ICU patients 
To summarise the psychological state of a sample of 157 level 3 patients who were 
on the point of discharge from the ICU, there were considerable levels of mood 
disturbance such as anxiety and depression, and of cognitive dysfunction such as 
confusion and delirious symptoms. High levels of physical stress including pain, 
discomfort and difficulty breathing were reported. Personal control and positive 
emotion were low, but emotional support from staff and family was rated as high. 
Memory was distorted, as nearly half of the patients remembered little of their ICU 
stay, and many patients experienced intrusive thoughts about the ICU. 
5.2.6  Comparison of psychological factors: follow-up/non follow-up 
groups 
There were no significant differences of mean scores for mood and stress between 
the follow-up and non-follow-up groups, but it is of interest that all the follow-up 
group’s scores were somewhat more negative than the non-follow-up group’s. 
Although there were also no significant differences between groups for memory 
factors, it can be seen that the patients who remembered least about the ICU and 
patients who had intrusive memories were more likely to have responded to the 
follow-up survey.  
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5.2.7  Chronic health-related factors 
Other background factors that could have an impact of psychological outcomes 
after intensive care were chronic physical illness, psychological history, and history 
of alcohol abuse. Data on these outcomes were collected only for the 100 patients 
who were followed up, due to difficulties in getting access to data, and limitations of 
time (see chapter four). Although these factors could be broken down into more 
detailed categories (see table 5.7), they were used as binary variables in analysis 
because of small numbers within categories. Mean social support at 3 months 
(emotional and practical support from loved ones) was good (26.29 (8.68)).                                                                                                                                                        
Table 5.7  Chronic health-related factors  
 n/% or 
mean(SD) 
Description/detailed coding/frequencies 
chronic physical 
illness                  yes 
                              no 
  49 
  51 
Included respiratory (5 patients), cardiovascular (5), 
endocrine(6), neurological(4), GI/obesity (10), HIV(2), 
renal (1), 2 conditions(9), 3 or more(6) 
cancer                  yes 
                              no 
 24 
 76 
Included lung (2), breast(1), gastrointestinal(3), head 
and neck(7), urological(2), gynaecological(2), 
sarcoma(2), haematological(4), neuroendocrine(2) 
history of             yes 
depression            no 
 16 
 84 
Includes previous or current psychological history. 
Depression (14), depression with psychosis (1) anxiety, 
OCD, depression(1) 
alcohol  use         yes 
                              no           
 12 
88 
Includes previous or current heavy alcohol use. Amounts 
recorded vary from one bottle wine/day to 20 pints a 
day. 
 Social support  
 
26.29 (8.68) 
Range 0-36 
Measure of emotional support and practical support at 
three months 
 
5.3  Prevalence of psycho-social outcomes 
Mean scores, prevalence rates and symptom severity ranges for PTSD, anxiety 
depression, and HRQL at three months follow in table 5.8 below. 
Table 5.8  Outcomes and prevalence of psychological morbidity at three months. 
 PTSD Depression Anxiety Mental HRQL Physical HRQL 
Mean 14.3 (11.81) 20.55 (14.00) 43.71 (14.78) 43.93(10.82) 
(95%CIs: 
32.26, 36.58) 
34.42(10.07) 
(95%CIs: 
41.62, 46.26) 
Range 0-51 0-54 20-80 18.92-64.19 17.44- 55.91 
Possible 
range 
0-51 0-60 20-80 0-100 0-100 
Cut-off  18 19 45   
Prevalence 
95%CIs 
27.1% 
(18.3, 35.9%) 
 46.3% 
(36.5, 56.1%) 
 44.4% 
(34.6, 54.2%) 
  
no 
symptoms 
6% 3% 5%   
mild  
 symptoms         
41% 38% 
 
24%   
 moderate 
symptoms 
32% 
 
24% 17%    
severe 
symptoms 
21% 
 
35% 54%    
Subscale 
mean(SD) 
Intrusion 
3.24 (3.94) 
Max: 15 
    
Subscale 
mean(SD) 
Avoidance 
6.03(5.32) 
Max: 21 
    
Subscale 
mean (SD) 
Arousal 
4.83 (4.26) 
Max: 15 
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5.3.1 Primary outcome: PTSD at 3 months 
 
The mean score on the PDS scale (Foa et al., 1997) was 14.13 (11.81). Mean sub-
scale scores were 3.24 (3.94) for intrusive symptoms (maximum 15), 6.03 (5.32) 
for avoidance symptoms (maximum 21), and 4.83 (4.26) for hyper-arousal 
symptoms (maximum 15). Using a method for diagnosing PTSD recommended by 
the author of the PDS (Foa et al., 1997), the prevalence of cases was 45.8% (95% 
CIs: 35.8%, 55.79%). However a number of different methods have been 
suggested for using the PDS to establish a diagnosis of PTSD (Foa et al., 1997). In 
a study that tested 18 different scoring rules, it was found that using a cut-point of 
18 on the PDS severity scale was a highly efficient method of diagnosing PTSD 
(Ehrings et al., 2007). Using this method, the prevalence of PTSD cases was 
27.1% (95%CIs: 18.3, 35.9%). Only six% of patients had no PTSD symptoms, 
41% had mild symptoms (1-10); 32% had moderate symptoms (11-20), 15% had 
moderate/severe symptoms (21-35) and 6% had most severe symptoms (36-51). 
5.3.2 Outcome: Depression 
The authors of the CES-D (Radloff, 1977) recommend a cut-point of 16 for likely 
clinical depression, but I used a more conservative cut-point of 19 recommended 
for patients with somatic symptoms, as explained in chapter four.  Using the 
original cut-point, prevalence of depression in this sample would be 55.8%, but 
using the more conservative cut-point the prevalence of depression was 46.3% 
(95% CIs: 36.5, 56.1%).  
5.3.3 Outcome: Anxiety  
Cut-points of 32 and 39 have been recommended for the STAI, but 44-45 was 
suggested for hospital patients (see chapter four). The latter seemed more 
appropriate for this sample, and prevalence for anxiety was found to be 44.4% 
(95% CIs: 34.6, 54.2%).  
5.3.4 Outcome: HRQL 
 Results are given for the physical component summary (PCS) and the mental 
component summary (MCS) of the SF-12 (Ware et al., 1996). These two scales 
were transformed to have a mean of 50 and a standard deviation of 10 (in the 
American population). Mean PCS in this sample was 34.42 (95%CIs: 32.26, 
36.58). The minimum score was 17.44 and the maximum was 55.91. Mean MCS 
was 43.93 (95%CIs: 41.62, 46.26). Minimum score for MCS was 18.92 and 
maximum was 64.19. Therefore mean PCS at 3 months was 16 points below 
average in the population and MCS seven points below average. Therefore physical 
health of former ICU patients was 1.6 SDs below the mean of the normal 
population and mental health was 0.6 SDs below. Further examination of the 
frequency of scores showed that 43% of the patients had MCS scores of between 
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18 and 40 and therefore had poor mental HRQL. For PCS 50% of patients had 
scores ranging from 17.5 to 34, suggesting their physical HRQL was extremely 
poor. Up to 75% of patients had scores under 40, the cut-point for poor HRQL 
(Casso et al., 2004).  
5.3.5 Associations between outcomes  
Associations between psycho-social outcomes were measured because of the issue 
of co-morbidity. The correlation between PTSD and depression was 0.796 
(p<0.001); between PTSD and anxiety it was 0.653, (p<0.001) and between 
depression and anxiety it was 0.809 (p< 0.001). Depression was associated with 
worse mental and physical HRQL (with MCS -0.770, p<0.001; with PCS -0.250, 
p=0.022). Post-ICU anxiety was  highly associated with both aspects of HRQL (with 
MCS -0.808, p<0.001; with PCS -0.323, p=0.002). Finally 
PTSD was associated with MCS (0.590, p<0.001) but not with PCS (-0.115, 
p=0.293). The physical and mental aspects of HRQL, PCS and MCS, were not 
significantly associated with each other (r=0.174, p=1.09). 
5.3.6 Prevalence of adverse psycho-social outcomes after ICU 
As the aim of my study was to present the extent of adverse psycho-social 
outcomes affecting ICU patients after 3 months, I am also reporting combined 
rates. Looking first at psychological morbidity alone, 55% of patients had either 
PTSD or depression or anxiety after 3 months. Of these 23% had all three 
syndromes, 17% had two syndromes and 15% had one. If poor mental HRQL 
(MCS<40) is included, then 60% of patients had an adverse psycho-social 
outcome. If poor physical HRQL is included (PCS<40) then 86% of patients had an 
adverse psycho-social outcome. Fifteen percent of patients had all five adverse 
psycho-social outcomes. 
5.4   Statistical Analysis 
To test hypotheses one to four, univariable, multivariable and mediational  analyses 
of data were carried out. 
5.4.1 Distribution of continuous data 
Before testing for associations, distributions were examined and tests carried out to 
check whether continuous variables had normal distributions. Looking first at the 
results of KS Lilliefors normality tests (table 5.9) and histograms for outcomes 
figure 5.3), it was clear that anxiety, physical HRQL and mental HRQL had close to 
normal distribution. However both PTSD and depression scores were skewed to the 
left, with a long right-hand tail. For data to be treated as normally distributed, skew 
should be approximately within +2 and -2 (Field, 2005). Therefore it was 
acceptable to treat depression as a normally distributed variable as the skew was 
<2. As the skew of PTSD was 4.38, I tried log-transforming PTSD data but the skew 
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was still 2.96. However when PTSD was regressed on individual risk factors,  
residuals were normally distributed (see Figure 5.4 for scatterplot and normal 
probability plot for PTSD and one risk factor, TISS). As PTSD was an outcome 
variable, I decided it was acceptable to treat it as a normally distributed variable for 
carrying out regressions. Therefore parametric tests were used for associations 
between normally distributed risk factors and all outcomes including PTSD. 
Table 5.9  Tests of normality and skewness statistics for outcomes 
   
 
Figure 5.3 Histograms for outcomes 
 
 
 
 
 KS-Lilliefors Test of 
Normality 
Skewness SE of 
skewness 
Skewness÷ 
SE  
 PTSD scores .121, df=96, p = .001 1.077 .246 4.38 
Depression .105, df=95, p= .012 .473 .247 1.91 
Anxiety .070, df=95, p= .200 .393 .243 1.62 
Phys HRQL .088, df=86, p= .097 .456 .261 1.75 
Mental HRQL .085, df=86, p= .173 -.262 .261 -1.00 
Transformed 
PTSD scores 
 -.722 .244  2.96 
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Figure 5.4  Plots showing distribution of residuals in PTSD regressions. 
 
 
                      
5.4.2 Distribution of continuous variables (“risk” factors) 
Because there were many variables in the study, most histograms of risk factors 
are not shown.  However all continuous variables were examined for normality.   
5.4.3 Clinical continuous variables 
Apache II scores, TISS scores,  number of organs supported and number of drug 
groups received all had a skew of <2 and were treated as normally distributed 
variables.  However hospital, ICU and Level 3 days, sedation days and all days of 
organ support variables were skewed to the left, with a long right-hand tail, 
reflecting the fact that most patients were admitted and treated for a few days 
                                         
                           Scatterplot (TISS and PTSD) 
            (Y-axis=Regression Standardised Predicted Values  
              X-axis =Regression Standardized Residual?) 
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while a few patients stayed for many days. Figure 5.5 shows the histograms for 
TISS (nearly normally distributed) and days of advanced cardiac support (very 
skewed to the left) to illustrate the difference. I decided to use parametric tests for 
associations of outcomes with normally distributed clinical variables, and non-
parametric tests for associations of outcomes with very skewed variables such as 
days of sedation or days in ICU. 
 
Figure 5.5 Distribution of predictors 
 
 
5.4.4 Distribution of psychological and socio-demographic variables 
The variable for age was slightly skewed to the right, due to the older age of 
patients in the ICU, but the skew was <2, so age was treated as a normally 
distributed variable. Total ICU stress score and total mood disturbance score were 
normally distributed variables. All ICU stress sub-scales (delirium, physical stress, 
control and support) and almost all POMS subscales (depression, anxiety, 
confusion, positive mood) were normally distributed. Some IPQ variables were 
15 10 50
Days advanced cardiac support 
 
50
40
30
20
10
0 
 
 
35 30 2520 15 10
Highest TISS scores
25
20
15
10
5 
0 
 
 
150 
 
skewed. I used parametric tests for associations with most psychological and socio-
demographic variables, and non-parametric tests with IPQ variables. 
5.5 Univariable associations 
   In the tables in this section I have presented associations between all groups of    
   explanatory factors and each outcome. I have then reported on associations   
   between the four groups of  risk factors.  
 
5.5.1 Socio-demographic risk factors of psycho-social outcomes 
As shown in table 5.10 age and sex did not have statistically significant associations 
with any of the outcomes, but there were trends for those with higher PTSD scores 
to be younger (r=0.184, p=0.073) and female (p=0.075).The effect of sex was a 
difference in mean PTSD scores of 4.3 points. Ethnicity was a significant predictor 
of depression but no other outcome; Mean depression score for “other ethnic 
groups” was 6.41 points higher than the score for “white” ethnic groups. Socio-
economic circumstances were significant predictors of depression, anxiety and 
mental HRQL (MCS), but not of PTSD or physical HRQL (PCS). Education was not a 
significant risk factor for any outcome.  
 
Table 5.10  Associations between socio-demographic variables and outcomes. 
 
 PTSD Depression Anxiety Mental 
HRQL 
Physical 
HRQL 
Age -0.184 
p=0.073 
0.166 
p=0.107 
-0.027 
p=0.789 
0.096 
p=0.381 
   -0.095 
p=0.382 
Sex         
 
4.30 
(-9.04,0.44) 
p=0.075 
4.01 
(-9.69,1.68) 
p=0.165 
-3.39 
(-9.69,1.68) 
p=0.257 
4.20 
(-0.39,8.79) 
p=0.072 
-0.81(-
5.16,3.54) 
p=0.712 
Ethnicity  white                   
other  
p=0.604 -6.41 
(-12.69,-0.13) 
p=0.046 
p=0.493 p=0.200 p=0.153 
NS-SEC 
1. professional 
2. intermediate 
3.own account 
4. technical/ 
5. routine/semi 
6. unclassified 
p=0.246 
11.77(9.10) 
15.61(7.25) 
13.12(12.46) 
  8.04(4.79) 
18.19(13.77) 
18.56(18.66) 
p=0.008 
14.46(10.68) 
30.33(12.51) 
22.71(14.21) 
13.64(8.59) 
24.75(15.65) 
24.98(21.30) 
p=0.041 
39.27(11.69) 
53.00(13.19) 
43.33(13.89) 
36.19(11.45) 
46.33(16.11) 
50.52(21.30) 
p=0.016 
48.47 (9.53) 
39.58(10.73) 
45.55(10.79) 
43.53(8.75) 
38.43 (9.48) 
37.98(12.97) 
p=0.691 
35.86(9.66) 
31.16(6.95) 
34.13(10.81) 
38.21(10.77) 
35.40(11.32) 
34.57(11.45) 
Education p=0.261 p=0.585 p=0.735 p=0.921 p=0.184 
       †There were significant differences in depression scores between NS-SEC classes 1 and 2. There were 
no significant differences in anxiety between classes. There was a significant difference of mean MCS 
between NS-SEC classes 1 and 5. 
 
 
For NS-SEC, a significant mean difference of 15.88 points (95%CIs: 0.67,31.08) 
was found for depression between class 1 (professional/managerial) and class 2 
(intermediate  professions). Class 2 was more depressed. A significant mean 
difference of 10.04 points (95% CIs: 0.79, 19.29) was found for mental HRQL  
between class 1(professional/managerial) and class 5(routine/semi-routine 
occupations). The latter had worse mental HRQL. There were no  
  significant differences in anxiety scores between NS-SEC groups. Although  
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  relationships between SEC and PTSD were non-significant in this analysis,  
  differences  between groups could be seen. For example there was a seven point    
  difference between NSSEC classes 1 (professional) and 5 (routine).  
 
5.5.2 Clinical risk factors and 3-month outcomes 
 Looking first at illness-related factors, it can be seen from Table 5.11 that there 
were no associations between illness severity on admission (Apache II scores) 
and any of the outcomes, although there was an association of 0.179 with three-
month anxiety that approached significance (p=0.077). There were also no 
associations between primary body system involved at ICU admission and PTSD, 
anxiety and HRQL.  
 
 Figure 5.6   Depression scores at 3 months for different diagnostic groups 
 
 R=respiratory, C=cardiovascular G=gastrointestinal, N=neuro, P=poison, g=genitourinary, 
H=haematological 
 
However there was a significant relationship between primary body system and 
depression at three months (see Figure 5.6). Specifically there was a significant 
difference of 13 points between respiratory and CV for depression, as well as large 
non-significant differences between other groups. There were few significant 
relationships between outcomes and factors representing health care pathways. 
However three-month depression was predicted by hospital length of stay and 
destination after hospital discharge. Otherwise, psychosocial outcomes were not 
associated with type of admission (non-surgical, elective or emergency surgical), 
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source of admission, ICU length of stay or days as level 3 patient in ICU. Many 
significant relationships were found between intervention and treatment-related  
 
Table 5.11  Associations between clinical factors and outcomes   
              (Effect sizes: “r” for normally distributed continuous variables, rho for skewed variables, mean  
            difference with 95%CIs for binary variables. P-values only are reported for categorical variables)    
                     
                             PTSD           Depression           Anxiety           Mental              Physical  
                                                                                                         HRQL                  HRQL 
Illness severity 
score 
  0.059 
 p=0.569 
  0.123 
p=0.236 
  0.179 
p=0.077 
-0.143 
p=0.190 
-0.040 
p=0.712 
Primary body 
system    
    
p=0.201 
 
p=0.028 
   
0.139 
   
p=0.304 
 
p=0.169 
TISS score   0.253 
  p=0.013 
0.080 
p=0.438 
0.066 
p=0.517 
-0.055 
p=0.618 
0.036 
p=0.742 
No. of organs  0.264 
p=0.009 
0.124 
p=0.232 
0.058 
p=0.571 
-0.079 
p=0.467 
0.075 
p=0.491 
Days 
respiratory  
0.204 
p=0.046 
0.089 
p=0.390 
0.058 
p=0.568 
-.013 
p=0.909 
-.014 
p=0.899 
Days adv 
Circulatory 
0.246 
p=0.016 
0.142 
p=0.169 
0.125 
p=0.218 
-0.201 
p=0.063 
-0.030 
p=0.787 
Days gastro- 
Intestinal 
0.221 
p=0.031 
0.122 
p=0.238 
0.007 
p=0.948 
-0.072 
p=0.509 
0.000 
p=0.999 
Days of 
sedation 
0.268 
p=0.008 
0.189 
p=0.066 
0.171 
p=0.090 
-0.203 
p=0.061 
0.025 
p=0.820 
No. of drug 
Groups  
0.280 
p=0.006    
0.102 
p=0.323 
0.103 
p=0.311 
-0.099 
p=0.467 
-0.197 
p=0.070 
Hypnotics *      
 
-4.11 
(-9.13,0.91) 
p=0.108 
-2.24 
(-8.39,3.91) 
p=0.471 
-0.67 
(-7.06,5.71) 
p=0.835 
0.23 
(-4.67,5.12) 
p=0.927 
 -1.38 
(-5.93,3.16) 
p=0.546 
Benzo-
diazepines  
 
-6.96 (-
11.57,-2.36) 
p=0.002 
-7.44 
(-13.07,-1.81) 
p=0.010 
-5.95(-
11.87,-0.03) 
p=0.049 
4.08 
(-0.56,8.73) 
p=0.084 
0.27 
(-4.12,4.67) 
p=0.902 
Anaesthestics  
 
-1.64 
 (-6.65,3.35) 
p=0.514 
2.35    
(-3.80,8.50) 
p=0.449 
2.61 
(-3.65,8.88) 
p=0.409 
-2.02 
(-6.93,2.9) 
p=0.416 
-4.45(-
8.94,0.04) 
p=0.052 
      Inotropes   
       and 
vasopressors  
-4.84 (-
9.57,-0.1) 
p=0.046 
-3.70 
(-9.40,1.99) 
p=0.200 
-7.63(-
13.37,-1.89) 
p=0.010 
4.51 
(-.06,9.08) 
p=0.053 
-0.06 
(-4.41,4.29) 
p=0.978 
Antipsychotics  
 
-5.81(-
10.81,-0.8) 
p=0.024 
-1.59 
(-7.39,4.31) 
p=0.594 
-1.18 
(-7.25,4.87) 
p=0.699 
1.58(-
3.12,6.28) 
p=0.507 
-4.14 
(-8.43,0.15) 
p=0.059 
Opioids       
 
0.55(-
9.32,10.42) 
p=0.912 
7.12 
(-3.77,18) 
p=0.197 
7.79(-
3.66,19.25) 
p=0.180 
-7.42(-
15,80,0.96) 
p=0.082 
-0.29 
-8.23,7.65 
p=0.943 
Steroids     
 
0.28 
(-4.77,5.33) 
p=0.913 
1.08 
(-5.08,7.25) 
p=0.728 
1.57 
(-4.71,7.85) 
p=0.622 
0.59 
(-4.31,5.48) 
p=0.813 
-5.57 
(-9.96,-1.18 
p=0.029 
Type admission    p=0.806 p=0.502    p=0.232 0.812 0.531 
Source of 
Admission       
 
p=0.828 
 
p=0.531 
 
p=0.975 
 
p=0.217 
 
p=0.507 
Days as level 3 
patient in ICU 
  0.163 
p=0.114 
0.083 
p=0.425 
  0.043 
p=0.670 
-0.075 
p=0.493 
0.041 
p=0.710 
Days in ICU   0.109 
p=0.292 
-0.046 
p=0.656 
-0.056 
p=0.581 
-0.018 
p=0.869 
0.018 
p=0.868 
Days in hospital   0.149 
p=0.152 
0.206 
p=0.049 
0.089 
p=0.388 
-.179 
p=0.105 
-0.065 
p=0.561 
Post-hospital 
destination 
p=0.377 p=0.048 p=0.249 p=0.220 p=0.903 
C-reactive 
protein on 
admission** 
0.248 
p=0.014 
0.163 
p=0.114 
0.098 
p=0.336 
  
C-reactive 
protein 
(highest) 
0.219 
p=0.030 
0.104 
p=0.315 
0.079 
p=0.439 
  
*For all drug groups, the mean for patients who had the drug was subtracted from the mean of patients 
who did not have the drug. Therefore negative mean differences indicated higher outcome scores for 
those who the drug (meaning worse psychological morbidity or better HRQL).  
**C-reactive protein is a sepsis diagnostic marker ***Significant p-values are in bold, almost significant 
p-values (trend) are in bold italic. 
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    variables (including drugs) and PTSD. The variables that predicted PTSD  were TISS 
(Keene et al., 1983), a sepsis marker (CRP), number of organs supported, number 
of drug groups given, days of sedation, days of respiratory support, days advanced 
CV support, days of GI support, benzodiazepines, inotropes and antipsychotics. Use 
of benzodiazepines predicted depression at three months in addition to the 
healthcare factors mentioned above. Anxiety at three months was predicted by the 
the use of benzodiazepines and inotropes. The administration of inotropes predicted 
mental HRQL, and steroids and anaesthetics predicted better physical HRQL. Other 
trends seen in table 5.11 are of interest. The associations between days of sedation 
and depression, anxiety and mental HRQL at three months were all approaching 
significance at the 0.05 level. Although not significant, participants who received 
opiates had substantially better depression, anxiety and mental HRQL scores 
(around seven points lower) than participants who did not. This was in contrast to 
those receiving benzodiazepines, hypnotics and inotropes who generally had worse 
psychological outcomes than patients who did not receive these drugs. 
 
5.5.2  Acute psychological factors and outcomes 
Mood and Stress in the ICU 
  It is clear from table 5.12 that there were many highly significant relationships 
between acute psychological responses, both emotional and cognitive, in the ICU, 
and psycho-social outcomes at three months. Total ICU mood disturbance and total 
ICU stress were both significantly correlated with all outcomes except physical 
HRQL. All ICU mood subscales (symptoms of anxiety and depression, positive 
emotion, anger and mental confusion) were associated with most outcomes. Three 
of the four ICU Stress sub-scales – physical stress, delirium and ICU control were 
associated with all outcomes except physical HRQL. However the fourth sub-scale, 
ICU support, was not related to any outcomes. This may be explained because 
most patients rated support received from staff and family in the ICU highly and 
there was little variation in this factor. Most effect sizes between ICU mood and 
stress and outcomes were medium and large. 
 
Cognitive factors  
It was seen in the previous section that the cognitive factors – mental confusion 
and “delirium” from the ICU mood and ICU stress scales were associated with 
PTSD, depression, and to a lesser extent, with anxiety at three months. A similar 
pattern was found with two further cognitive variables, memory for ICU and early 
intrusive memories of ICU. Patients with very little memory of their ICU experience 
had significantly higher levels of PTSD and depression at three months  
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Table 5.12  Associations between ICU psychological factors and  outcomes          
 PTSD Depression Anxiety Mental 
HRQL 
Physical 
HRQL 
Total ICU mood 
disturbance 
0.495 
p=0.000 
0.420 
p=0.000 
0.376 
p=0.000 
-0.473 
p=0.000 
-0.011 
p=0.923 
     Anxiety 0.421 
p=0.000 
0.344 
p=0.001 
0.377 
p=0.000 
-.399 
p=0.000 
-0.007 
p=0.950 
     Depression 0.380 
p=0.000 
0.340 
p=0.001 
0.369 
p=0.000 
-0.421 
p=0.000 
-0.113 
p=0.301 
     Positive -0.386 
p=0.000 
-0.298 
p=0.003 
-0.238 
p=0.018 
 0.334 
p=0.002 
0.128 
p=0.241 
     Anger 0.362 
p=0.000 
0.356 
p=0.000 
0.280 
p=0.005 
-0.402 
p=0.000 
0.100 
p=0.359 
     Mental 
     confusion 
0.377 
p=0.000 
0.287 
p=0.005 
0.196 
p=0.052 
-0.296 
p=0.006 
0.079 
p=0.471 
ICU stress  
Total 
0.463 
p=0.000 
0.361 
p=0.000 
0.316 
p=0.002 
-0.373 
p=0.000 
-0.90 
p=0.413 
    Physical    
    stress 
0.394 
p=0.000 
0.357 
p=0.000 
0.316 
p=0.002 
-0.329 
p=0.002 
-0.034 
p=0.759 
    “Delirium” 0.402 
p=0.000 
0.252 
p=0.014 
0.196 
p=0.052 
-0.270 
p=0.012 
0.002 
p=0.987 
     Personal  
     control 
-0.360 
p=0.000 
-0.285 
p=0.005 
-0.262 
p=0.009 
0.304 
p=0.005 
0.122 
p=0.265 
     Support in ICU  -0.050 
p=0.634 
-0.023 
p=0.823 
-0.004 
p=0.965 
0.048 
p=0.659 
0.068 
p=0.537 
Illness Perceptions 
      Timeline  
0.275 
p=0.008 
.217 
p=0.038 
0.228 
p=0.027 
-0.157 
p=0.157 
-0.393 
p=0.000 
      Control of    
      condition 
-0.038 
p=0.716 
-0.066 
p=0.531 
-0.049 
p=0.635 
-0.056 
p=0.613 
0.129 
p=0.242 
       Concern 0.277 
p=0.007 
0.323 
p=0.002 
0.219 
p=0.032 
-0.197 
p=0.073 
-0.264 
p=0.015 
      Under-  
      standing 
-0.083 
p=0.426 
0.040 
p=0.702 
-0.006 
p=0.955 
0.019 
p=0.861 
-0.074 
p=0.499 
      Emotional 
      Representation 
0.289 
p=0.005 
0.315 
p=0.002 
0.290 
p=0.004 
-0.281 
p=0.009 
-0.175 
p=0.109 
Memory   admission 1.72 
(-3.34,6.78) 
p=0.501 
-0.33 
(-5.84,6.50) 
p=0.917 
0.57 
(-5.72,6.85) 
p=0.858 
-3.00(-
7.88,1.88) 
p=0.225 
0.66(-
3.93,5.26) 
p=0.774 
            ICU memory 
 
-6.30 
(-10.98,-1.56) 
p=0.010 
-6.05  
(-11.73,-0.37) 
p=0.037 
-3.06 
(-9.-4,2.91) 
p=0.311 
2.01 (-
2.68,6.71) 
p=0.396 
-0.54(-
4.95,3.85) 
p=0.806 
         ICU Intrusions 
 
-9.39 
(-13.85,-4.92) 
p=0.000 
-7.10 
(-12.71, -1.47) 
p=0.014 
-5.85 
(-11.72,0.02 
p=0.051 
3.38 (-
1.27,8.03) 
p=0.152 
-1.86 (-
6.23,2.52) 
p=0.401 
       (Effect sizes: ’r’ or ‘rho’ for continuous variables; mean differences+ 95%CIs for categorical) 
        Significant p-values are in bold. 
 
than patients who  could remember what happened to them in the ICU, but there 
was no significant association with anxiety at three months. Patients who had 
intrusive memories about ICU experiences at the point of ICU discharge had 
significantly higher levels of PTSD, depression and, to a lesser extent, anxiety at 
three months.  Memory of ICU and ICU Intrusions were associated with each other 
(χ²=5.346, df=1, p=0.021). The association was that patients with very little 
memory of ICU were more likely to have early intrusive ICU memories than 
patients who remembered the ICU (62.2% vs 38.8%). The finding that cognitive 
and memory disturbances in the ICU had strongest associations with PTSD and 
depression at three months will be discussed in chapter six. 
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   Illness perceptions (patients’ beliefs about their medical condition while in ICU) 
were associated with all outcomes including physical HRQL. Timeline and concern 
predicted PTSD, Depression, Anxiety and PCS, while emotional representation 
predicted psychological morbidity and MCS. Timeline and concern were the only 
psychological factors that predicted PCS.  
5.5.3 Chronic health-related factors and outcomes 
Several chronic health-related factors were associated with outcomes. Chronic   
disease was associated with depression, anxiety and health-related HRQL.   
Cancer patients had better psychological outcomes than non-cancer patients but 
the differences were not significant.  Psychological history was a significant 
predictor of all outcomes except PCS.  Alcohol use predicted only PTSD. The 
existence of past traumas (prior to having a life-threatening illness or condition) 
had no significant effect on psychological morbidity at 3 months but there was a  
trend that it predicted PTSD (p=0.080). Social support at three months was not 
associated with any outcomes (see table 5.12).  
 
Table 5.13  Chronic and previous illness and outcomes 
       (Effect sizes: ’r’ or ‘rho’ for continuous variables; mean differences+ CIs for categorical 
   
5.5.4 Relationship of clinical factors and ICU psychological response  
In table 5.12 we saw that there were large correlations between acute 
psychological responses in ICU and psycho-social outcomes at three months. As the 
first step in testing hypothesis H4, that acute psychological risk factors could be 
mediators between acute clinical factors and outcomes, I looked at correlations 
between acute clinical risk factors and acute psychological responses in the ICU The 
overall pattern (see table 5.13) was that increased numbers of interventions or 
drugs were associated with worse psychological responses, i.e. more negative 
mood, more stress, more intrusive thoughts and less memory for the ICU. 
      
 
 PTSD Depression Anxiety MCS PCS 
Chronic 
illness 
3.55 
(1.14, 8.23) 
p=0.136 
5.94 
(0.33,11.54) 
 p=0.038 
7.31  
(1.57,13.05) 
p=0.013 
7.25 
(2.86,11.65) 
p=0.001 
4.41 
(0.17,8.64)   
p=.042 
Cancer -1.38 
(-4.12, 6.88) 
p=0.620 
-2.80 
(-3.88, 9.46) 
p=0.407 
-0.48  
(-6.42, 7.41) 
p=0.887 
1.01 
(-6.28,4.26) 
P=0.704 
1.47 
(-6.37,3.43) 
P=0.552 
Psychological 
history 
 10.48 
(16.52,4.43) 
 p=0.001 
11.42 
(4.12,18.71) 
p=0.002 
12.92 
(5.30,20.54) 
p=0.001 
7.25 
(1.47,13.03) 
p=0.015 
3.12 
(-2.42,8.66) 
p=0.119 
Alcohol use 9.17 
(2.20,16.15) 
 p=0.011 
6.36 
(2.17,14.89) 
  p=0.142 
3.62 
(5.44,12.67) 
 p=0.430 
0.38 
(-6.35,7.11) 
P=0.911 
-0.19 
(-6.45-6.10) 
P=0.953 
Social 
support 
-0.050 
p=0.658 
0.004 
p=0.970 
0.025 
p=0.820 
0.013 
p=0.913 
-0.063 
p=0.586 
Past trauma 4.41 
(-9.36,0.53) 
p=0.080 
3.52 
(-9.5,2.46) 
p=0.286 
2.07 
(-8.26,4.12) 
p=0.509 
-0.71 
(-5.26,3.85) 
p=0.758 
-0.61 
(-5.50,4.28) 
p=0.805 
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Table 5.14 Clinical factors and ICU psychological responses  
       (Effect sizes: ’r’ or ‘rho’ for continuous variables; mean differences+ 95%CIs for categorical) 
 
Factors that indicated increased amount of intensive care (e.g. TISS) were 
associated with ICU amnesia. Intrusive memories of ICU were mainly related with 
drug variables. Other relationships between clinical factors and acute psychological 
response were approaching significance. 
 
5.5.5 Relationship between clinical and socio-demographic factors 
   As can be seen in table 5.15 there were very few associations between clinical 
factors and socio-demographic factors.  Interventions and drugs received did not 
appear to vary according to age, sex, or socio-economic circumstances. The only 
 Total mood  Total ICU 
stress 
ICU 
Intrusions 
Memory of 
ICU 
Illness  
reps1-5 
TISS 0.339 
 
p=0.001 
0.315 
 
p=0.002 
-1.427 
(-3.44,0.59) 
p=0.163 
-2.76  
(-4.73, -.8) 
p=0.006 
0.214 
timeline 
p=0.037 
Number  
organs 
0.270 
 
p=0.007 
0.290 
 
p=0.004 
-0.55 
(-1.23,0.12) 
p=0.107 
 -0.99 
(-1.65,-.33) 
p=0.004 
all n.s. 
Number  
drugs 
0.278 
 
p=0.005 
0.294 
 
p=0.003 
-0.76  
(-1.41, -.10) 
p=0.024 
-0.76 
(-1.41, -0.10) 
p=0.025 
0.174 
timeline 
p=0.091 
Days  
sedation 
0=.305 
 
p=0.005 
 0.299 
 
p=0.003 
-2.13 
(-3.80,-.46) 
p=0.013 
-2.78  
(-4.51,1.04) 
p=0.002 
0.230 
timeline 
p=0.024 
Days  
respira-
tory 
support 
0.143 
 
p=0.156 
0.300 
 
p=0.003 
-5.40 
(-11.85,1.05) 
p=0.099 
-1.46 
(-7.81,4.89) 
p=0.656 
0 .184 
timeline 
p=0.073 
Days 
Advanced 
CV 
support 
0 .287 
 
p=0.004 
0.308 
 
p=0.002 
-1.05 
(-2.40,0.30) 
p=0.125 
-1.33 
(-2.67,0.014) 
p=0.052 
0 .228 
timeline 
p=0.025 
Days 
GI 
support 
0.158 
 
p=0.116 
0.284 
 
p=0.004 
-3.75 
(-9.64,2,15) 
p=0.210 
-1.00 
(-6.96,4.96) 
p=0.740 
all n.s. 
Primary  
body 
system 
 
p=0.483 
 
p=0.378 
 
p=0.751 
 
p=0.132 
emotional 
rep 
p=0.012 
Hospital 
days 
0.174 
 
p=0.089 
0.147 
 
p=0.154 
 
 
p=0.187 
-3.88 
(-19.58,11.82) 
p=0.625 
all n.s. 
 
Post 
hospital 
 
p=0.399 
 
p=0.396 
 
p=0.097 
 
p=0.661 
all n.s. 
Benzodi-
azepines        
 -5.10 
(-0.50,0.27) 
 p=0.063 
 -7.19 
(-12.2,-2.18) 
p=0.005 
benzodiazepines 
=more IMs  
p=.018  
benzodiazepines 
=less memory 
p=.003  
concern 
 
p=0.054 
Antipsy-
chotics 
-5.25 
(-0.68,0.18) 
p=0.058 
-4.50 
(-9.70,0.71) 
p=0.089 
antipsychotics-
more IMs 
p=0.053 
antipsychotics 
=less memory 
p=.029 
all n.s. 
Iono- 
tropes        
                
-5.78 
(-11.11,-0.44)  
p=0.035 
-5.21 
(-10.24,-0.17) 
p=0.043 
 
 
p=0.368 
 
 
p=0.659 
timeline 
p=0.016 
 
Anaes- 
thetics 
 
 
p=0.446 
 
 
p=0.235 
 
 
p=0.320 
 
anaesthetics 
=less memory 
p=0.010 
 
all n.s. 
Steroids  
 
 
 
p=0.414 
 
 
 
 
p=0.645 
 
 
 
 
p=0.069 
 
 
 
 
p=0.477 
control 
p=0.041 
under-
standing 
p=0.084 
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significant results obtained were that illness severity increased with age, and 
women had an average 1.43 days more of advanced CV support than men.  
Table 5.15 Clinical and Socio-Demographic factors 
 age sex NS-SEC 
TISS p=0.292 p=0.791 p=0.709 
Number organs p=0.734 p=0.933 p=0.631 
Number drugs p=0.670 p=0.566 p=0.733 
Days sedation p=0.293 p=0.519 p=0.302 
Days Respiratory p=0.245 p=0.192 p=0.597 
Days advanced CV p=0.399  1.43 (2.79, -0.08) 
p=0.039 more women 
p=0.992 
Days GIS p=0.172 p=0.460 p=0.713 
Primary system p=0.099 p=0.132 p=0.419 
Hospital 
days 
0.193 
p=0.058 
p=0.230 p=0.750 
hypnotics -6.45 
(-13.84,0.94) 
p=0.086 
older more 
p=0.359 p=0.340 
Benzodiazepines              p=0.841 p=0.896 p=0.598 
Antipsychotics p=0.127 p=0.264 p=0.458 
Inotropes               p=0.253 p=0.075 more women p=0.527 
steroids p=0.512 p=0.621 p=0.867 
Illness severity 
score 
0.221 
p=0.027 
p=0.967 p=0.876 
 
  
5.5.6 Socio-demographic and psychological factors 
Patients with intrusive thoughts about the ICU were on average 6.73 years  
younger than patients who had no intrusions (p=0.054). There was also a trend   
that patients with amnesia about ICU were younger (see table 5.15).  Women had 
more negative mood than men (mean difference = 5.35 points) and were  
Table 5.16 Psychological and socio-demographic factors 
 
               
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
       *Differences between NS-SEC classes 2 and 1, and classes 2 and 5 
  more likely to have intrusions (62% women vs 38% men). There was a significant 
association between NS-SEC and ICU total mood score. NS-SEC class 2 
(intermediate occupations) had worse average total mood scores than both classes 
1 (professional/managerial occupations) and 5 (semi-routine/routine occupations).  
 age sex NS-SEC 
ICU  
mood total 
p=0.261 -5.35 
(-10.65,-.06) 
p=0.047 
Women have 
 worse mood 
1. 27.89 (14.83) 
2. 41.61 (8.16) 
3. 28.23 (11.98) 
4. 29.00 (18.35) 
5. 24.80 (12.53) 
6. 30.44 (8.53) 
p=0.046* 
ICU stress 
total 
 
p=0.998 
 
p=0.234 
 
p=0.325 
Intrusions 
in ICU 
6.73 
(-0.12,13.57) 
p=0.054  
Intrusions group 
younger 
 
  
p=0.021  
Intrusions group 
more women 
p=0.966 
Amnesia 
in ICU 
5.83  
(-1.08,12.74) 
p=0.097 
Amnesia group 
younger 
p=0.508 p=0.265 
Illness  
perceptions 
p=0.622 
timeline 
p=0.052 
Women timeline 
p=0.080 
timeline 
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5.5.7 Relationships between chronic factors and others 
Finally I examined relationships between chronic factors – psychological history, 
chronic physical illness and alcohol use – and the socio-demographic, clinical and 
acute psychological factors. Table 5.17 shows that psychological history was 
associated mainly with clinical factors while chronic physical illness was associated 
mainly with psychological and social factors. Psychological history was associated 
with TISS (trend), number of organs supported in ICU, and benzodiazepines and 
inotropes (trend). It was also associated with acute psychological factors mood in 
ICU and timeline. Chronic physical illness was associated with deprivation and with 
ICU mood, ICU stress, ICU amnesia and timeline. It was also associated with 
steroids. Alcohol use was associated with more days of sedation, benzodiazepines 
(a trend) and ICU amnesia.  
 
Table 5.17  Associations between chronic factors and other groups of  factors 
 Psychological 
history (PH) 
chronic physical 
illness (CPI) 
alcohol use (AU) 
i) S.D.         age p=0.688 p=0.115 p=0.306 
                  sex p=0.205 p=0.313 p=0.278 
                  SEC p=0.724 p=0.532 p=0.365 
ii) Clinical    
                    TISS 
                   score 
-2.55 (-5.25,0.151) 
(PH higher score) 
p=0.064 
 
 
p=0.691 
 
 
p=0.342 
               Apache p=0.311 p=0.368 p=0.836 
          Number of   
               organs 
-0.95 (-1.85,-0.05) 
(PH higher score) 
p=0.040 
p=0.917 p=0.133 
               Days of  
              sedation 
p=0.485 p=0.247 -2.88 (-5.42,-0.34) 
(AU more days) 
p=0.026 
               Number  
               of drugs 
p=0.132 p=0.922 p=0.203 
           Benzodia-        
               zepines 
81.8% HoD  vs 
53.6% no HoD 
p=0.040 
 
 
p=0.814 
83.3% AU vs 
54.5% no AU 
p=0.058 
               Antipsy- 
                 chotics 
 
p=0.123 
 
p=0.111 
 
p=0.143 
          Inotropes 68.6% HoD vs 
42.9% no HoD 
p=0.057 
 
 
p=0.430 
p=0.693 
       Anaesthetics p=0.747 p=0.571 p=0.177 
              Steroids p=0.186 22% CPI vs 
43.1% no CPI 
p=0.028 
 
 
p=0.979 
iii) Acute 
     psychological 
           ICU mood 
                  total 
-8.89 (-16.03,-1.75) (PH 
higher score) 
p=0.004 
-6.23 (-11.48,-0.98) 
(CPI higher score) 
p=0.020 
 
 
p=0.154 
         ICU stress  
                  total 
p=0.253 -7.87 (-12.76,-2.98) 
(CD higher score) 
p=0.002 
 
p=0.145 
                    ICU 
            amnesia 
p=0.344 54.2% CPI v little memory 
vs 37.3% no CPI 
p=0.091 
83.3% AU vs 
40.2% no AU 
p=0.005 
                    ICU   
         Intrusions 
p=0.965 p=0.267 p=0.204 
            Timeline -1.41(-2.90,0.08) 
(PH  higher score) 
p=0.062 
-1.13 (-2.37,-0.03) 
(CPI higher score) 
p=0.045 
p=0.629 
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5.5.8 Summary of univariable analysis 
Most clinical factors relating to interventions, sedation and administration of 
psychoactive drugs in the ICU were associated with PTSD at three months. Some 
clinical factors, notably administration of benzodiazepines and inotropes, were 
associated with depression and anxiety at three months. Almost no healthcare 
factors such as type of admission or LoS were associated with outcomes (except 
hospital days and hospital destination with depression). Acute psychological factors 
such as ICU mood, ICU stress and memory of ICU were associated with all 
outcomes at three months except PCS. Of the socio-demographic factors measured, 
ethnicity was associated with depression, and socio-economic circumstances were 
associated with anxiety, depression and MCS. Other notable results were that most 
clinical factors were associated with most ICU psychological responses. There were 
few associations between socio-demographic factors and clinical factors, but some 
findings related to socio-demographic factors and acute psychological response. 
Psychological history was related to several clinical factors while chronic physical 
illness was mainly related to psychological factors and deprivation. Alcohol use was 
related to days of sedation and benzodiazepines. 
   
 5.6 Multivariable analysis 
   In this section I have presented the analysis carried out to identify independent 
risk factors of post-ICU psychosocial outcomes as well as possible mediating 
variables. This was done as a two-stage process in order to reduce the number of 
predictors that would be entered in the final multiple regressions for each outcome. 
First if there were many statistically significant predictors (p<0.05) in a category 
(socio-demographic, clinical, psychological or chronic) I identified the strongest 
predictors by entering them in a multiple regression. I then entered only the 
strongest predictors (based on effect size and significance level p<0.1) from each 
group in a final regression for each outcome. 
 5.6.1 Risk factors for post-ICU PTSD 
  Figure 5.7 is a model showing all factors that had significant associations with PTSD 
(p<0.05) in the univariable analysis. All listed clinical factors were associated with 
PTSD, and most of them were associated with most factors in the psychological 
response box.  
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Figure 5.7   Predictors of PTSD and possible relationships  
     
 
                       
                                                                  
 
                                                                          
 
 
                   
 
 
 
 
 
 
 
 
 
 
 
 
 
  
   Data patterns in the above model would suggest that relationships between ICU 
clinical factors and PTSD were mediated by acute psychological responses. However 
before proceeding to test for mediational relationships, I decided it was necessary 
to carry out further data reduction on the clinical and psychological factors, to find 
out which were the strongest predictors and most important relationships.  
   
 5.6.2 Analysis of clinical factors 
  I tried several approaches to identifying the variables that captured the most 
important clinical information. As a number of ICU interventions, practices and 
drugs were predictors of PTSD, one approach would be to use the TISS variable 
(Keene et al., 1983) as it is a global indicator that summarises the amount or 
intensity of intervention that a patient received in the ICU. This is in line with the 
advice of Kraemer, Stice, Kadzin et al. (2001) that where there are multiple risk 
factors of an outcome, all may be proxy risk factors for one global factor and may 
be aggregated to gain clearer understanding of what the causal processes might be. 
Other arguments in favour of this approach included the finding that TISS was 
highly correlated with a number of other clinical variables (see table 5.16). 
    
  Table 5.18 Correlations between TISS and other clinical variables 
 
 
 
   When TISS was entered into a regression and adjusted for socio-demographic 
factors and the Apache II illness severity score (as it is common practice in ICU 
research to adjust for these variables), the model was significant (p=0.018) and 
 Number of organs 
supported 
Number of drug 
groups given 
Days of 
Sedation 
TISS r=.748** r=.552** r=.632** 
Clinical factors              
TISS score 
Organ support score 
Drug group score 
Days Sedation 
Benzodiazepines 
Antipsychotics 
Ionotropes 
Days Resp support 
Days GI support 
Days CV support 
Sepsis markers 
 
 
Psychological 
response in ICU 
ICU stress 
ICU mood 
Memory 
Intrusions 
Illness perceptions  
 
 
 
PTSD 
at  three 
months 
Chronic/history 
Psychological history 
Alcohol abuse 
 
 
161 
 
explained 12.2% of variance. It can be seen in table 5.19 that TISS had a 
significant medium-size effect on PTSD (β =0.261, p=0.012) when adjusted for 
age, sex, and illness severity.  
 
Table 5.19  Multiple regression of PTSD on TISS and other factors  
 
Model   Unstandardized 
Coefficients 
Standardized 
Coefficients 
p-value 
                              B Beta   
1 (Constant) 3.335   .641 
  Highest TISS 
score in ICU 
.603 .261 .012 
  Apache II score .058 .036 .731 
  Age -.116 -.173 .115 
  Sex 2.831 .120 .259 
 
Similarly the variable “number of types of organ support received” could be argued 
to capture the totality of ICU interventions experienced by a patient. Identified 
predictors such as “days of cardiovascular support” were probably proxy risk factors 
for this more global variable (Kraemer et al., 2001). When “number of organs” was 
entered into a regression with socio-demographic factors and illness severity, a 
similar result was obtained as for TISS (table 5.20). The model explained 12.5% of 
variance and was significant, (p=0.015). “Number of organs” had a significant 
medium size effect on PTSD (β=0.270, p=0.010) after adjusting for age, sex and 
illness severity.  
Table 5.20 Multiple regression of PTSD on “number of organs” and other factors  
 
 
 
5.6.3 Multiple regression: clinical factors and PTSD  
To examine further the relationship between global risk factors such as TISS, 
number of organs supported and their possible proxies, another approach was to 
enter significant clinical predictors (p<0.05) into a regression to identify the 
strongest predictors of PTSD. In this case all significant predictors were not entered 
because of the large number of variables and the fact that many were overlapping. 
I did not include days of respiratory support, CV support or GI support on the 
grounds that they were most likely covered by the organ support variable and they 
had smaller effect sizes than other variables. Only one sepsis indicator was 
included, highest C-reactive protein during admission. In table 5.21, it can be seen 
Model   Unstandardized 
Coefficients 
Standardized 
Coefficients 
p-value 
    B Beta   
1 (Constant) 9.058   .126 
  Age -.095 -.142 .194 
  Sex 3.389 .144 .177 
  Number of organs 1.897 .270 .010 
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that the model was highly significant (p=0.005) and explained 21.6% of variance 
in the sample.  
 
Table 5.21  Multiple regression of PTSD on all clinical variables   
 
Model   Unstandardized 
Coefficients 
Standardized 
Coefficients 
p-value 
    B Std. Error Beta   
1 (Constant) 10.062 6.337   .116 
  Highest TISS score  .027 .347 .011 .939 
  Number of types of 
organ support received 
-.640 1.303 -.091 .624 
  Days of sedation .703 .340 .256 .042 
  Benzodiazepines 7.348 3.027 .308 .017 
  Inotropes  5.904 3.168 .251 .066 
  Antipsychotics 6.074 3.145 .254 .057 
  Number of drug groups  -2.223 1.553 -.316 .156 
  Sepsis .013 .010 .144 .197 
 
The most important clinical predictors of PTSD in this regression based on the size 
of standardised coefficients  and p-values were “days of sedation” (β =0.256, 
p=0.042), inotropes (β =0.251, p=0.066),  benzodiazepines (β=.308, p=0.017) 
and antipsychotics (β =0.254, p=0.057).  It can be seen that the effect size 
(standardized coefficient) of TISS/PTSD had reduced from 0.253 (p=0.013) in the 
univariable analysis to 0.011 (p=0.939) in this multiple regression with other 
clinical factors. This analysis suggested it was likely that TISS was a significant 
predictor for PTSD in large part because it was a global score that included the 
effects of days of sedation and drugs such as benzodiazepines, inotropes and 
antipsychotics. Kraemer et al. (2001) argue that sometimes a complex global 
measure such as TISS needs to be disaggregated to improve understanding of the 
causal process. I decided that days of sedation, benzodiazepines, and 
antipsychotics would be the best clinical variables to include in a final model for 
PTSD as they had the largest standardised coefficients and lowest p-values.  
      
 5.6.4 Acute psychological response and PTSD 
   To reduce the number of psychological variables in the final analysis, first I decided 
to use total mood scores and total ICU stress scores rather than all sub-scale 
scores. This was acceptable from a psychometric point of view as Cronbach  was 
0.818 for the ICU stress scale and 0.904 for the mood scale. When all psychological 
response factors  that were significant in the univariable analysis (ICU stress, 
mood, memory, intrusions and three illness perceptions) were entered into a 
multiple regression on PTSD (table 5.22) they explained 37.6% of  variance in the 
sample, and the model was highly significant, ( p<.001). Most important 
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psychological predictors of PTSD were mood (=.252, p=.083), intrusions 
(=.228, p=.018) and timeline (=.185, p=.042). 
 
Table 5.22   Regression  of PTSD on ICU psychological factors  
 
Model   Unstandardized 
Coefficients 
Standardized 
Coefficients 
p-value 
    B Std. Error Beta   
1 (Constant) -8.676 4.060   .036 
  Mood total .220 .125 .252 .083 
  ICU stress total .117 .128 .127 .361 
  ICU amnesia 1.130 2.219 .048 .612 
  ICU Intrusions  5.361 2.216 .228 .018 
  IPQ Timeline .789 .382 .185 .042 
  IPQ concern .482 .410 .114 .243 
  IPQ emotional rep .104 .396 .028 .793 
 
It looked from this analysis as if ICU stress and ICU mood were “overlapping” risk 
factors, that were tapping into the same construct (Kraemer et al., 2001). 
Univariable analysis showed that the two factors were highly correlated (r=.729**). 
Although mood, intrusions and IPQ timeline were all entered in the final regression 
model for PTSD, I also carried out parallel regressions on PTSD using ICU stress as 
a variable because ICU stress encompassed elements of interest such as physical 
stress and delirious phenomena, that were not aspects of the “mood” variable. 
When mood was not entered, ICU stress was a strong significant risk factor for 
PTSD (β=.322, p=.002) along with ICU intrusions and IPQ timeline, and variance 
explained was 35.5%. When stress was not entered, mood was a significant 
predictor of PTSD (β=0.344, p=0.001) and variance explained was 36.9%.  I 
carried out all multiple regressions in different versions with both ICU stress and 
ICU mood (although I have not presented the ICU stress versions as tables here) 
and found that results were almost always the same. 
  
5.6.5  Chronic health factors and PTSD 
Finally psychological history, alcohol use, and past traumas were entered into a 
regression model for PTSD. Variance explained was 17.3% in a highly significant 
model (p<0.001) in which psychological history and alcohol use were more 
important predictors than past trauma. 
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Table 5.23  Regression of PTSD on chronic health factors  
 
 
 
 
 
 
 
 
 
 
 
5.6.6  Multiple regression model with strongest predictors of  PTSD 
   I carried out a final regression using the most important clinical, acute 
psychological and chronic health predictors identified in the first round of 
regressions. Factors were entered using the hierarchical method with clinical factors 
in block one, psychological factors in block two and chronic factors in block three.  I 
found that: 
   Model 1(clinical factors) was significant, p=0.001, accounting for 17.5% variance 
   Model 2(clin/psych) was significant, p<0.001, accounting for 39.1% of variance 
   Model 3(clin/psych/chronic) was significant, p<0.001, accounting for 44.7% of  
   variance.  
  
   In table 5.24 model one showed that days of sedation was the strongest clinical 
predictor of PTSD with a medium effect size (r=0.256, p=0.019). The PTSD score 
increased by 0.692 points with each extra day of sedation.  When acute 
psychological factors were entered into the model, mood, intrusions and IPQ 
timeline were all shown to be significant and independent predictors of PTSD.  
Days of sedation was not a significant risk factor in model two and its effect size 
was halved by the introduction of the acute psychological factors (the 
unstandardised coefficient was reduced from 0.692 to 0.349). The effect sizes of 
benzodiazepines and antipsychotics were also greatly reduced. This suggested that 
acute psychological responses acted as partial mediators of the relationships 
between clinical variables such as days of sedation and PTSD.  When I entered 
psychological history and alcohol use into model 3, psychological  history was 
shown to be an independent predictor of PTSD. The acute psychological factors 
mood total and intrusions were also independent predictors of PTSD in this 
model. Therefore the strongest independent predictors of PTSD found in this model 
were total mood (0.284, p=0.000), intrusions (0.248, p=0.007) and 
psychological history (0.207, p=0.021) after controlling for clinical factors.   
 
 
 
 
 
Model   Unstandardized 
Coefficients 
Standardized 
Coefficients 
p-value 
    B Std. Error Beta   
1 (Constant) 10.598 1.471   .000 
  Psychological 
history 
9.415 3.100 .291 .003 
  Alcohol use 7.755 3.526 .210 .030 
  Any past traumas 3.300 2.344 .134 .163 
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Table 5.24 “Final” regression for post-ICU PTSD  
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 5.6.7  Independent risk factors for post-ICU depression 
  It was seen in the univariable analysis that there were fewer clinical risk factors for 
depression at three months than for PTSD. All acute psychological factors were 
associated with depression at three months.  Socio-economic circumstances (NS-
SEC), and ethnicity were also associated with depression. Chronic physical illness  
and psychological history were also associated with depression at three months. 
Figure 5.8 depicts how these factors might be inter-related.  
   Figure 5.8  Possible relationships between predictors and depression 
 
 
                       
                                                                  
 
                                                                          
 
 
                   
 
 
 
 
 
 
 
 
 
 
 
 
Mode
l 
  Unstandardized 
Coefficients 
Standardized 
Coefficients 
p-value 
    B Std. Error Beta   
1 (Constant) 8.292 1.926   .000 
  Days of sedation .692 .288 .256 .019 
  Benzodiazepines 3.980 2.508 .166 .116 
  Antipsychotics 3.315 2.477 .139 .184 
2 (Constant) -4.845 3.248   .140 
  Days of sedation .349 .260 .129 .184 
  Benzodiazepines 1.259 2.250 .053 .577 
  Antipsychotics 1.883 2.189 .079 .392 
  Mood total .306 .083 .343 .000 
  IPQ timeline .786 .369 .187 .036 
  Intrusions 5.208 2.161 .221 .018 
3 (Constant) -3.884 3.166   .223 
  Days of sedation .332 .255 .123 .197 
  Benzodiazepines .352 2.193 .015 .873 
  Antipsychotics  1.055 2.131 .044 .622 
  Mood total .254 .083 .284 .003 
 IPQ timeline .711 .359 .169 .051 
  Intrusions 5.833 2.104 .248 .007 
  Psychological 
history 
6.549 2.790 .207 .021 
  Alcohol use 4.629 3.088 .128 .138 
Clinical 
factors                       
Body system 
Benzodiazepines 
Days in hospital 
Post-hospital 
destination 
 
Psychological 
response in ICU 
ICU stress 
ICU mood 
Memory 
Intrusions 
Illness perceptions 
Socio-demographic  
Ethnicity  
Socio-economic circumstances 
Chronic/history 
Chronic illness 
Psychological history 
 
 
 
Depression 
at 3 
months 
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5.6.8  Regression of clinical factors and depression 
When I entered significant clinical factors into a regression on depression (table 
5.25 below), 10.5% of variance was accounted for and the model was significant, 
(p=0.044). The strongest clinical predictor was benzodiazepines (B=5.685, 
β=.201, p=0.065).  Patients given benzodiazepines for sedation in the ICU were 
nearly six points higher on the depression scale than patients who were not given 
benzodiazepines, after adjusting for other important clinical factors for depression. 
 
Table 5.25  Regressing depression on clinical factors   
 
Model   Unstandardized 
Coefficients 
Standardized 
Coefficients 
p-value 
    B Std. Error Beta   
1 (Constant) 17.381 3.358   .000 
  Primary body system 
(ICNARC) 
-.558 .595 -.099 .351 
  Length of stay in 
hospital 
.066 .042 .180 .120 
  Hospital discharge to.. -.573 1.227 -.053 .642 
  Benzodiazepines 5.685 3.044 .201 .065 
 
5.6.9  Regression of psychological factors on depression 
Next I entered the psychological predictors into a regression for depression (table 
5.26). The model was highly significant (p<0.001) and accounted for 24.6% of 
variance. The strongest predictor was ICU mood score (β =0.292, p=0.011). 
 
Table 5.26  Regression of depression on acute psychological factors 
  
Model   Unstandardized 
Coefficients 
Standardized 
Coefficients 
p-value 
    B Std. Error Beta  
1 (Constant) -1.223 4.924   .804 
  IPQ Timeline .552 .494 .109 .267 
  IPQ Concern .668 .529 .133 .210 
  IPQ Emotional rep .370 .499 .084 .461 
  Mood total .302 .117 .292 .011 
  Intrusions  3.105 2.826 .111 .275 
  ICU Amnesia 1.572 2.816 .056 .578 
 
 
5.6.10 Final regression model with strongest predictors of depression 
Finally I built a model for post-ICU depression including SEC, ethnicity, 
benzodiazepines, chronic physical illness, ICU mood, and psychological history 
(table 5.27). As a discrete categorical variable, NS-SEC had to be entered into the 
model as dummy variables NSSEC 2,3,4,5, 6. These compared the numbered group 
with all other groups. As there were six groups in NS-SEC, five dummy variables 
were needed. The three models were highly significant and accounted for 18%, 
27% and 39% respectively of variance in the sample. SEC was found to be a risk 
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factor for depression with significantly higher depression among groups 2 
(intermediate professions), 3 (self-employed) and 5 (routine/semi-routine jobs) 
than the other groups. Ethnicity was no longer significant when adjusted for SEC. 
When adjusted for socio-demographic variables, benzodiazepines was an 
independent predictor of three-month depression accounting for a difference of 
6.73 depression points (p=0.014). Chronic physical illness accounted for 5.1 
depression points (p=0.059). When ICU mood and psychological history were 
added to the model, mood, psychological history and SEC variables were the 
only significant factors.  Therefore the strongest independent predictors of post-ICU 
depression in this model were SEC, ICU mood (0.268, p=0.01) and 
psychological history (0.206, p=0.030). Total mood score appeared to mediate 
the effect of benzodiazepines on depression as B (the unstandardised coefficient for 
benzodiazepines) was reduced from 6.73 (p=0.014) to 4.54 (p=0.085) when mood 
was entered into the model.  
 
Table 5.27  Final regression model for post-ICU Depression   
 
 
Model 
  Unstandardized 
Coefficients 
Standardized 
Coefficients 
p-values 
    B Std. Error Beta   
1 (Constant) 8.116 4.710   .088 
  Ethnicity 5.485 3.547 .151 .126 
  NSSEC2 15.362 5.191 .306 .004 
  NSSEC3 8.241 3.796 .237 .033 
  NSSEC4 -.745 5.469 -.014 .892 
  NSSEC5 10.331 3.736 .302 .007 
  NSSEC6 9.548 4.985 .201 .059 
2 (Constant) 2.553 4.805   .597 
  Ethnicity  5.336 3.388 .147 .119 
  NSSEC2 14.587 4.968 .291 .004 
  NSSEC 3 7.862 3.650 .226 .034 
  NSSEC4 -1.747 5.227 -.033 .739 
  NSSEC5 9.078 3.597 .266 .013 
  NSSEC6 7.639 4.890 .161 .122 
  Benzodiazepines 6.734 2.674 .239 .014 
  Chronic physical 
illness 
5.052 2.643 .181 .059 
3 (Constant) -3.878 4.760   .417 
  Ethnicity  5.153 3.226 .142 .114 
  NSSEC2 11.394 4.772 .227 .019 
  NSSEC3 7.609 3.396 .218 .028 
  NSSEC4 -.381 4.868 -.007 .938 
  NSSEC5 10.553 3.361 .309 .002 
  NSSEC6 7.399 4.522 .156 .106 
  Benzodiazepines 3.803 2.575 .135 .143 
  Chronic physical 
illness 
3.100 2.531 .111 .224 
  Mood total .278 .105 .268 .010 
  Psychological 
history 
7.671 3.475 .206 .030 
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5.6.11  Independent risk factors for anxiety 
 
In the univariable analysis, the factors depicted in figure 5.9 were found to be 
significant predictors of post-ICU anxiety. 
Figure 5.9   Possible relationships between risk factors and anxiety 
 
 
                       
                                                                  
 
                                                                          
 
 
                   
 
 
 
 
 
 
 
 
 
 
 
 
  
  5.6.12 Regression: psychological responses and anxiety 
  When acute psychological predictors were entered in a regression with anxiety 
(table 5.28), the model was significant and variance accounted for was 20.2%. The 
most important psychological predictors were ICU mood and IPQ timeline. 
 
 Table 5.28: Psychological factors and anxiety outcome  
  
Mode
l   
Unstandardized 
Coefficients 
Standardized 
Coefficients p-value 
    B Std. Error Beta   
1 (Constant) 22.664 5.289   .000 
  Total mood .287 .122 .261 .021 
  Intrusions  2.025 2.990 .068 .500 
  IPQ timeline .961 .529 .181 .073 
  IPQ concern .084 .570 .016 .883 
  IPQ emotional reps .719 .558 .151 .201 
 
In a final regression containing all the strongest risk factors for anxiety, the five 
models were all significant and variance accounted for was 12%, 21%, 26%, 31% 
and 34% respectively. Inotropes was the strongest clinical risk factor when 
entered with SEC (β=7.06, p=0.023). When chronic illness was entered it was 
significant (6.573, p=0.023) and inotropes remained significant.  
 
 
Clinical 
Benzodiazepines 
Ionotropes 
Psychological 
response in ICU 
ICU stress 
ICU mood 
Intrusions 
Illness perceptions 
Sociodemographic  
Socio-economic 
circumstances 
 
 
Anxiety 
at three 
months 
Chronic/history 
Chronic physical 
illness
Psychological history 
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Table 5.29  “Final” regression model for post-ICU anxiety 
 
  
Model   Unstandardized Coefficients Standardized coeff.s p-values 
    B Std. Error Beta   
1 (Constant) 39.273 2.495   .000 
  NSSEC2 12.949 5.389 .257 .018 
  NSSEC3 3.710 4.127 .101 .371 
  NSSEC4 -3.082 5.963 -.055 .607 
  NSSEC5 8.505 4.199 .226 .046 
  NSSEC6 11.246 5.389 .223 .040 
2 (Constant) 33.098 3.074   .000 
  NSSEC2 11.912 5.166 .236 .023 
  NSSEC3 5.176 4.076 .140 .208 
  NSSEC4 -1.503 5.767 -.027 .795 
  NSSEC5 9.036 4.032 .240 .028 
  NSSEC6 9.488 5.277 .188 .076 
  Benzodiazepines 4.513 3.051 .150 .143 
  Inotropes 7.057 3.049 .238 .023 
3 (Constant) 30.394 3.217   .000 
  NSSEC2 11.521 5.043 .229 .025 
  NSSEC3 5.865 3.988 .159 .145 
  NSSEC4 -2.166 5.634 -.038 .702 
  NSSEC5 7.812 3.969 .207 .052 
  NSSEC6 10.657 5.173 .211 .042 
  Benzodiazepines 4.061 2.983 .135 .177 
  Inotropes 6.600 2.981 .223 .029 
  Chronic physical 
illness 
6.573 2.830 .223 .023 
4 (Constant) 23.158 4.705   .000 
  NSSEC2 7.818 5.171 .155 .134 
  NSSEC3 5.923 3.901 .161 .133 
  NSSEC4 -2.453 5.512 -.043 .657 
  NSSEC5 8.138 3.980 .216 .044 
  NSSEC6 9.568 5.156 .190 .067 
  Benzodiazepines 2.589 2.981 .086 .387 
  Inotropes 5.478 2.987 .185 .070 
  Chronic physical 
illness 
4.616 2.893 .156 .114 
  ICU mood .263 .113 .238 .023 
  IPQ timeline .363 .535 .068 .499 
5 (Constant) 25.208 4.702   .000 
  NSSEC2 9.352 5.111 .186 .071 
  NSSEC3 4.734 3.858 .128 .223 
  NSSEC4 -1.373 5.418 -.024 .801 
  NSSEC5 7.985 3.896 .212 .044 
  NSSEC6 9.756 5.048 .194 .057 
  Benzodiazepines 2.080 2.927 .069 .479 
  Inotropes 4.635 2.950 .157 .120 
  Chronic  physical 
illness 
5.159 2.843 .175 .073 
  ICU mood .200 .115 .181 .085 
  IPQ timeline .184 .530 .034 .730 
  Psychological 
history 
8.373 3.874 .212 .034 
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Inotropes also remained significant when ICU mood (0.263, p=0.023) was 
entered. In the final model the independent risk factors for Anxiety were SEC 
(groups 2 (intermediate), 5(routine) and 6 (unclassified) had higher anxiety than 
other groups), chronic physical illness, ICU mood and psychological history. 
Inotropes appeared to be partially mediated by ICU mood. 
 
 5.6.13  Risk factors for mental HRQL after intensive care 
In univariable analysis, associations were found  between psychological factors 
(stress, mood, illness perceptions: emotional representations), socio-demographic 
factors (SEC) and one clinical factor (inotropes) and MCS (mental HRQL). MCS was 
also associated with chronic physical illness and psychological history (figure 5.10) 
Figure 5.10  Relationships between predictors and mental HRQL 
 
 
 
                       
                                                                  
 
                                                                          
 
 
                   
 
 
 
 
 
 
 
 
 
 
 
 
5.6.14  Final multiple regression of risk factors for mental HRQL 
When all predictors were entered into a regression for Mental HRQL (table 5.30), 
42.8% of variance was accounted for in a significant model, (p<0.001). Inotropes 
(-0.194, p=0.05) and chronic physical illness (-0.301, p=0.003) were both 
independent risk factors after adjusting for SEC. In the final model, ICU mood and 
socio-economic circumstances (with group 5 (routine) and group 6 (unclassified) 
having worse MCS (9-10 points lower) than other groups) were the strongest 
independent predictors of Mental HRQL score at three months. 
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Table 5.30   Risk factors for mental HRQL after ICU  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5.6.15   Possible relationships between risk factors and physical health 
As depicted in figure 5.11 steroids, anaesthetics, illness perceptions and chronic 
physical illness were the only risk factors for Physical HRQL identified by the 
univariable analysis.  
 
 
Model   Unstandardized 
Coefficients 
Standardized 
Coefficients 
p-values 
    B Std. Error Beta   
1 (Constant) 48.470 1.879   .000 
  NSSEC2 -8.888 4.321 -.226 .043 
  NSSEC3 -2.875 3.018 -.111 .344 
  NSSEC4 -4.937 4.973 -.107 .324 
  NSSEC5 -10.039 3.187 -.363 .002 
  NSSEC6 -10.487 4.096 -.283 .012 
2 (Constant) 53.755 2.306   .000 
  NSSEC2 -7.444 4.060 -.189 .071 
  NSSEC3 -4.430 2.865 -.171 .126 
  NSSEC4 -5.471 4.711 -.119 .249 
  NSSEC5 -8.740 3.016 -.316 .005 
  NSSEC6 -11.225 3.832 -.303 .004 
  Inotropes -4.208 2.163 -.194 .055 
  Chronic 
physical illness 
-6.516 2.146 -.301 .003 
3 (Constant) 60.828 2.891   .000 
  NSSEC2 -3.453 3.849 -.088 .373 
  nssec3 -3.310 2.642 -.127 .214 
  NSSEC4 -3.451 4.715 -.075 .467 
  NSSEC5 -10.179 2.816 -.368 .001 
  NSSEC6 -9.819 3.561 -.265 .007 
  Inotropes -2.281 2.038 -.105 .267 
  Chronic physical 
illness 
-3.480 2.103 -.161 .102 
  ICU mood -.324 .091 -.405 .001 
  IPQ emotional 
reps 
-.094 .379 -.027 .805 
4 (Constant) 60.269 2.907   .000 
  NSSEC2 -4.110 3.862 -.104 .291 
  NSSEC3 -3.129 2.633 -.121 .238 
  NSSEC4 -3.986 4.708 -.087 .400 
  NSSEC5 -9.915 2.809 -.358 .001 
  NSSEC6 -9.640 3.546 -.260 .008 
  Inotropes -1.783 2.062 -.082 .390 
  Chronic 
physical illness 
-3.84 2.115 -.180 .070 
  ICU mood -.289 .095 -.361 .003 
  IPQ emotional 
reps 
-.073 .378 -.021 .848 
  Psychological 
history 
-3.650 2.753 -.129 .189 
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 Figure 5.11: Risk factors for physical HRQL 
         
                       
                                                                  
 
                                                                          
 
 
                   
 
 
 
 
 
 
 
 
 
 
 
When a regression model was built for physical HRQL using these predictors, it 
explained 27.5% of variance in physical HRQL and was significant, p<0.001 (table 
5.31). Anaesthetics and steroids in the ICU predicted physical HRQL more 
strongly than chronic physical illness. The illness perception “IPQ timeline” was also 
a highly significant predictor of physical HRQL. 
 
   Table 5.31  Risk factors for physical HRQL after ICU  
 
 
 
 
 
 
 
 
 
 
 
 
 
To summarise all the models described in this section, Table 5.32 contains the 
variables that could be considered strong independent risk factors for psycho-social 
outcomes after ICU. All the clinical risk factors were drug-related: number of days 
during which a patient was sedated; and the administration or not of 
benzodiazepines, inotropes or steroids. The over-riding acute psychological risk 
factors for worse psycho-social outcomes were total mood disturbance in the ICU 
and ICU stress (physical stress, delirium and loss of control). Additionally 
“intrusions” (early intrusive memories of ICU) was an independent risk factor for 
PTSD, and IPQ timeline (a patient’s belief about how long their condition would last) 
Model   Unstandardized 
Coefficients 
Standardized 
Coefficients 
p-value 
    B Std. Error Beta   
1 (Constant) 31.440 2.344   .000 
  Anesthetics 4.373 2.243 .206 .055 
  Steroids  4.809 2.278 .227 .038 
  Chronic physical 
illness 
-2.678 2.165 -.133 .220 
2 (Constant) 42.063 3.829   .000 
  Anesthetics  4.345 2.082 .205 .040 
  Steroids  4.690 2.165 .221 .033 
  Chronic physical 
illness 
-.339 2.100 -.017 .872 
  IPQ timeline -1.282 .362 -.360 .001 
  IPQ concern -.446 .379 -.123 .243 
 
Clinical 
Anaesthetics 
Steroids 
Psychological 
response in ICU 
IPQ Timeline 
 
 
HRQL at 3 
months 
(physical) 
 
Chronic/history 
Chronic physical 
illness 
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was an independent risk factor for physical HRQL. Socio-economic circumstances 
were strong risk factors for worse depression, anxiety and mental health. Groups 2 
(intermediate), 5 (routine jobs) 6 (unclassified, retired, unemployed etc) were 
worse off for at least two outcomes each.  Chronic physical illness was an 
independent risk factor for depression, anxiety and MCS. Psychological history was 
an independent risk factor for PTSD, depression and anxiety. Acute psychological 
responses were independent of psychological history.  
 
Table 5.32  Summary of strongest risk factors  
 
Risk 
factors 
PTSD Depression Anxiety Mental 
HRQL 
Physical 
HRQL 
Acute 
clinical  
Days of 
sedation 
Benzodiazepines Inotropes Inotropes Steroids 
Anaesthetics 
Acute 
psychological 
response 
ICU mood 
ICU stress 
ICU Intrusions 
ICU mood 
ICU stress 
 
ICU mood 
ICU stress 
ICU mood 
ICU stress 
IPQTimeline 
Socio- 
demog 
 NS-SEC (groups 
2,3,5 worse) 
NS-SEC (groups 
2,5,6 worse)  
NS-SEC 
(groups 5,6) 
 
Chronic  
health 
psychological 
history 
Chronic illness 
Psych history 
Chronic illness 
Psych history 
Chronic 
illness 
 
 
5.6.16  Assumptions of the models 
It is recommended to check that multiple regressions do not violate multivariable 
assumptions (Field, 2005; Tabachnick & Fidell 2007). For each of the final 
regressions for each outcome, I examined histograms of residuals, normal 
probability plots and scatterplots of residuals and predicted values. In each case the 
histogram suggested that residuals were normally distributed, as did the normal 
probability plots of expected and observed values. The shape of the scatterplots (a 
random array of dots evenly dispersed around zero) suggested that errors were 
random and that there was homoscedasticity (that the variance of residuals was 
constant at each level of the predictor variable).  
 
I also looked at tolerance values and variance inflation factors to assess 
multicollinearity – when predictors within a multiple regression are too highly 
correlated (Field 2005). As the average variance inflation factor in each case was 
around one (Boweman & Connell, 1990) and tolerance values were not <0.2 
(Menard, 1995), there was no evidence of collinearity. However I also inspected  
the eigenvalues given in the SPSS collinearity diagnostics table and again found no 
evidence of collinearity. 
 
5.7 Mediation  
In the final regression models presented in section 5.6, it was seen that while the 
strongest clinical factors were significant after controlling for socio-demographic 
factors, they became non-significant and weaker when acute psychological factors 
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were added to the models. This suggests that acute psychological factors partially  
mediated relationships between clinical risk factors and adverse psycho-social 
outcomes. Therefore as an alternative approach I decided to carry out further 
mediation analyses as these could lead to a better understanding of possible causal 
pathways than the multiple regressions carried out above.  
 
 To explore further whether psychological factors mediated between clinical factors    
and psychosocial outcomes, I carried out mediation analyses using a method 
recommended by Baron & Kenny (1986). This method involves first regressing the 
“mediating variable” (MV) on the clinical variable (IV); second, regressing the 
outcome (DV) on the IV; and third, regressing the DV on both the IV and the MV. 
To establish mediation, the IV must affect the mediator in the first equation, the IV 
must affect the DV in the second equation and the mediator must affect the DV in 
the third equation. If these conditions all hold, then the effect of the IV on the DV 
must be less in the third equation than in the second. Perfect mediation would 
occur if the IV had no effect on the DV when the mediator was controlled. However 
when treating phenomena that have multiple causes, it is more realistic to seek 
mediators that significantly decrease the IV-DV relationship rather than eliminate it 
(Baron & Kenny, 1986). 
 
5.7.1  Mediators between clinical factors and psychological outcomes 
   I looked at whether psychological responses in the ICU such as stress, mood, 
intrusions and memory mediated the relationships between clinical factors and 
PTSD, depression, anxiety and mental HRQL (figure 5.12). First I looked at 
mediational relationships using the strongest independent risk factors identified in 
the multiple regressions in Section 5.7. However, this approach meant that 
important predictors and mediators could be over-looked. Therefore I subsequently 
looked at other hypothesised predictors that could be involved in mediational 
pathways. Not all mediational processes were reported in full here due to the large 
number of possible combinations. However all results are summarised in table 5.32.    
   Figure 5.12  Potential mediational pathways    
 
     Clinical variables        psychological responses      outcomes at 3 months 
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M1. Did ‘mood in ICU’ mediate the effect of ‘days of sedation’ on PTSD? 
Step 1. Regress MV (Mood) on IV (days of sedation)  =0.785  = 0.246   p=0.014 
Step 2. Regress DV (PTSD) on IV (days of sedation)  =0.926  =0 .338  p=0.001 
Step 3. Regress DV (PTSD) on IV (days of sedation)  =0.596  = 0.217  p=0.019 
                                                 and MV (Mood).      =0.385  =0.435    p=0.000        
Because the MV (Mood) had an effect on the DV (PTSD) in the third equation, and the 
effect of the IV (days of sedation) on the DV was substantially less in the third 
equation, ICU mood can be said to partially mediate the effect of days of Sedation on 
PTSD. The unstandardised coefficient of “days of sedation” was reduced by 35.64% 
when “mood” was added.  
 
M2. Did ‘ICU intrusions’ mediate the effect of ‘days of sedation’ on PTSD? 
Step 1. Regress MV (Intrusions) on IV (days sedation)   =.030   = 0.251    p=0.012 
Step 2. Regress DV (PTSD) on IV (days of sedation)      =0.926   =0.338  p=0.001 
Step 3. Regress DV (PTSD) on   IV (days of sedation)    =0.695   =0.253 p=0.009 
                                              and MV (Intrusions)         = 7.859 =0.333 p=0.001     
The MV (Intrusions) had an effect on the DV (PTSD) in the third equation, and the 
effect of the IV (days of sedation) on the DV was less in the third equation. Therefore 
ICU intrusions partially mediated the effect of days of Sedation on PTSD. The 
unstandardised coefficient of “days of sedation” was reduced by 24.95% when 
“intrusions” was added.   
 
M3. Did ICU stress mediate the effects of TISS on PTSD? 
Step 1. Regress MV (ICU stress) on IV (TISS)   B=0.795  =0 .315   p=0.002 
Step 2. Regress DV (PTSD) on IV (TISS)           =0.575   = 0.248 p=0.014 
Step 3. Regress DV (PTSD) on        IV (TISS)     =0.253   =0.109   p=0259 
                                      and MV (ICU stress)   B=.399  =.428    p=0.000     
           The MV (ICU stress) had an effect on the DV (PTSD) in the third equation, and the   
effect of the IV (TISS) on the DV was less in the third equation and became non-
significant. Therefore the ICU stress variable partially mediated the effect of TISS on 
PTSD. The unstandardised coefficient (B) of TISS was reduced by 56% when ICU 
Stress was added.   
 
M4. Did ICU stress mediate the effects of benzodiazepines on depression? 
 
Step 1. Regress MV (stress) on IV (benzodiazepines)         =7.186   = 0.278   p=0.005 
Step 2. Regress DV (Depression) on IV (benzodiazepines)  =7.439  =0 .263 p=0.010 
Step 3. Regress DV (Depression) on  IV (benzodiazepines)  =5.071   =0.179    p=0.079 
                                                       And MV (stress)       =0.331  =0.306    p=0.003     
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The MV (ICU stress) had an effect on the DV (depression) in the third equation, and 
the effect of the IV (benzodiazepines) on the DV (depression) was less in the third 
equation and became non-significant. Therefore the ICU stress variable mediated the 
effect of benzodiazepines on depression. The unstandardised coefficient of 
benzodiazepines was reduced by 31.85% when stress was added to the equation. 
 
M5. Did ICU mood mediate the effect of inotropes on anxiety?  
Step 1. Regress MV (mood) on IV (inotropes)       =5.686   = 0.211  p=0.035 
Step 2. Regress DV (Anxiety) on IV (inotropes)     =7.634   =0 .259 p=0.010 
Step 3. Regress DV (Anxiety) on IV (inotropes)        =5.553   =0.188  p=0.050 
                                                And MV (mood)  =0.366 =0.336  p=0.001     
The unstandardised coefficient for inotropes was reduced by 27.26% when mood was 
added to the regression for anxiety. Therefore it appears that “mood” partially 
mediated the effect of inotropes on anxiety. 
 
M6. Did ICU mood mediate the effect of inotropes on MCS (mental HRQL)? 
Step 1.   Regress MV (mood) on IV (inotropes)        =5.686   = 0.211  p=0.035 
Step 2.   Regress DV (MCS) on IV (inotropes)       = 4.511   =0 .209 p=0.053 
Step 3.   Regress DV (MCS) on IV (inotropes)            = 2.186  =0.101    p=0.309 
                                             And MV (mood)      = 0.355  =0.448   p=0.000     
The unstandardised coefficient for the effect of inotropes on the outcome mental 
HRQL was more than halved and the effect of inotropes became non-significant. 
Therefore there was clear evidence that “ICU mood”  mediated the relationship 
between inotropes in the ICU and mental health-related HRQL. 
 
To summarise the results of all mediation analyses carried out, it can be seen in table 
5.33 that mood, stress and intrusions in ICU were found to mediate pathways 
between a number of clinical risk factors and psycho-social outcomes. In addition, 
ICU memory was a mediator between TISS and PTSD.  
 
Table 5.33  Mediators of clinical factors and psychological outcome 
 Mediators for PTSD Mediators for 
Depression 
Mediators for 
Anxiety 
Mediators for MCS 
(HRQL) 
Days sedation Mood in ICU 
Intrusions in ICU 
ICU Stress 
   
TISS ICU Stress 
ICU Mood  
ICU Memory 
   
Benzodiazepines Intrusions 
Mood 
Stress 
ICU Stress 
ICU Mood 
  
Inotropes   ICU Mood 
ICU Stress 
ICU Mood 
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5.7.2 Sub-analysis of mediating (psychological) factors 
Three of the four subscales of the ICU stress questionnaire represent variables of 
considerable interest in the ICU literature and in the clinical setting. They are also 
potentially modifiable risk factors. They are a) delirium, symptoms such as 
disorientation and hallucinations in the ICU b) control, the patient’s sense of being in 
control of their situation in the ICU and c) physical Stress – the patient’s perception 
of how much pain and discomfort they have had in intensive care. I decided to look 
at the relationships in which ICU stress was identified as a mediator to explore if any 
of these three factors were particularly important. I also looked at mood subscales – 
depression, anxiety, positive emotion, and mental confusion. It would be important in 
the development of tools to assess whether patients are at risk of poor psychological 
outcomes, and the development of interventions to reduce post-ICU psychological 
distress, to know if specific psychological symptoms that can be detected and 
recorded in the ICU are predictive of psycho-social outcomes.  
 
Unadjusted correlations between the three factors of ICU stress and clinical factors.  
are in table 5.34. Delirium was associated with global indicators of the amount of ICU 
intervention received such as TISS, “number of organs supported” and days of 
sedation. The more intervention received, the higher the rates of delirium. As it was 
not associated with most specific drugs or interventions, “delirium” may be a 
response to some sort of overload of multiple failing organs, drugs and treatments. 
Its association with anti-psychotics was expected as they are a treatment for 
delirium in ICU.  Almost all of the clinical factors, specific or global, were associated 
with Control; the more intervention received, the lower the perception of control. 
Perceived physical stress was associated with days of sedation, but no other clinical 
factors. Of the ICU mood factors (table 5.35), most were associated with most 
clinical factors.  
 
I then carried out an analysis to explore if delirium could be a mediating factor 
between TISS and PTSD. All conditions for mediation held, and the association 
between TISS and PTSD was reduced by 42% and became non-significant when 
delirium was added to the regression. Therefore there is a strong case that delirium 
was a powerful partial mediator between TISS (amount of intervention) and PTSD. 
Control reduced the effects of benzodiazepines on 3-month depression by 27.5%, 
and on PTSD by 36%. It reduced the effect of inotropes on 3-month anxiety by 22%. 
In all cases the effect of the clinical factor on the outcome became non-significant 
when mediated by control. Therefore ICU delirium and ICU control look like variables 
that may lie on the causal pathway between intensive care treatment and adverse 
psychological outcomes at three months. 
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Table 5.34  Correlations of ICU stress sub-scales with clinical factors 
              ACVS=advanced CV support 
 
Table 5.35 Correlations of ICU mood subscales with clinical factors 
 
 
 
 
 
 
 
 
 
 
5.7.3 Summary of multivariable and mediational analysis  
When multiple regressions were carried out, it was found that the strongest clinical 
predictors were days of sedation for PTSD, benzodiazepines for depression, 
inotropes for anxiety and steroids and anaesthetics for physical HRQL.  Strongest 
psychological predictors were ICU mood, ICU stress, ICU intrusions and IPQ 
timeline for PTSD, ICU mood and stress for depression, anxiety and mental HRQL 
and IPQ timeline for physical HRQL. The strongest socio-demographic factor was 
SEC predicting depression, anxiety and mental HRQL. Chronic physical illness was an 
independent risk factor for depression, anxiety and poor mental HRQL but did not 
confound the effects of acute ICU clinical factors (treatment and illness). 
Psychological history was an independent risk factor for PTSD, depression and 
anxiety. However acute ICU psychological response had an independent effect from 
psychological history in all models except anxiety.  
 
The clinical predictors remained significant after controlling for SEC; however when 
ICU psychological factors were entered into the models, effect sizes of clinical 
predictors were greatly reduced. Therefore as psychological factors appeared to be 
mediating the relationship between clinical predictors and psycho-social outcome, 
mediational analysis was carried out.  The factors of ICU mood, stress, intrusions and 
memory were found to be mediators between clinical factors such as TISS, days of 
sedation, benzodiazepines and inotropes, and psychosocial outcomes.  
  
 
 
 TISS Number 
organs 
Days 
Sedation 
Days 
ACVS 
Benzodiaz-
epines 
Antipsy-
chotics 
Inotropes 
Delirium 
 p-value 
0.286 
0.004 
0.268 
0.007 
0.233 
0.020 
0.172 
0.087 
 
0.176 
 
0.008 
 
0.258 
Control 
p-value 
0.393 
0.000 
0.271 
0.007 
0.267 
0.008 
0.279 
0.005 
 
0.000 
 
0.030 
 
0.004 
Physical 
stress 
 p-value 
0.170 
0.093 
0.152 
0.134 
0.197 
0.050 
0.063 
0.533 
 
0.196 
 
0.853 
 
0.252 
 TISS No of 
organs 
supported 
Days 
sedation 
Days of 
advanced CV 
support 
Anxiety in ICU 
             p-value 
0.239 
0.017 
0.196 
0.050 
0.289 
0.004 
0.201 
0.045 
Depression in ICU 
             p-value 
0.327 
0.001 
0.253 
0.011 
0.274 
0.006 
.252 
0.011 
Positive Emotion    
            p-value 
0.364 
0.000 
0.250 
0.012 
0.183 
0.069 
.288 
0.004 
Mental confusion   
            p-value 
0.341 
0.001 
0.318 
0.001 
0.206 
0.039 
.323 
0.001 
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Chapter 6  Discussion: cohort study 
 
In this chapter I will discuss whether the findings of the cohort study answered the 
original research questions and furthered existing knowledge. The first research aim 
was to establish the prevalence and severity of PTSD, depression, anxiety and 
HRQL three months after intensive care. The second aim was to identify key 
clinical, psychological and socio-demographic risk factors driving poor psychosocial 
outcomes. The third was to explore how risk factors worked together, as 
independent predictors or as mediators explaining the effect of other variables. 
Finally I discuss potential biological and psychological mechanisms underlying the 
association between intensive care and psychological morbidity. 
 
6.1 Prevalence of psycho-social outcomes 3 months after ICU  
This is the only fully-powered prospective study to date that has assessed the full 
range of psychosocial outcomes after intensive care including PTSD (using DSM-IV 
criteria), depression, anxiety, and mental and physical health-related HRQL. It is 
debatable whether there can ever be a “true” prevalence rate of psychological 
morbidity as different rates will be obtained depending on methods of assessment 
used and decisions made about thresholds for clinical disorder. Nevertheless I 
believe that the conservative and sensible methods of estimating prevalence used 
in this study lend credibility to the findings.  
 
6.1.1 Prevalence of post-ICU PTSD 
This study found that 27.1% (95% CIs: 18.3%, 35.9%) of patients had PTSD at 
three months using Foa et al.’s PTSD Diagnostic scale (1997). The prevalence rate 
was arrived at using a more conservative method than the method recommended 
by Foa et al. (1997) which yielded a higher rate of 44%. Nevertheless a rate of 
27.1% was higher than the prevalence rates established by the systematic review 
(see chapter two). Initial results of the systematic review were that prevalence of 
post-ICU PTSD ranged from 0 to 62%. When only high quality studies were 
included, a narrower range of estimates was obtained, from 8.4% - 22%. However 
these were based on only three high quality studies (Cuthbertson et al., 2004; 
Jones et al., 2007; Samuelson, 2007). While some of the lower quality studies used 
assessment tools that were not true measures of PTSD, these three studies used 
good instruments – the PDS (Foa et al., 1997), the IES-R (Weiss & Marmar, 1997) 
and the DTS (Davidson et al., 1997). The difference in prevalence rates between 
those and my cohort study is therefore not likely to be due to using different 
questionnaires. Time to follow-up was also around three months in the three other 
studies, so would not account for the differences in prevalence. 
180 
 
 
Perhaps the difference between prevalence rates could be attributed to differences 
in the populations; For example patients in my cohort study had higher illness 
severity scores on admission to ICU (mean Apache II score 22) than the other 
studies (means or medians from 13-19) and spent longer in the ICU (mean 13.55 
days vs means or medians ranging from 5-13). My sample contained a higher 
percentage of non-surgical patients than the other three studies (63% vs 50-54%). 
It should also be noted that one of the other three studies was conducted in 
Sweden and one was a multi-centre European centre. There are undoubtedly 
differences between intensive care in the UK and other countries. However it is 
hard to make good comparisons between the three studies and mine as some 
reported different statistics (e.g. medians instead of means) or different clinical 
details. I would argue that the prevalence rate of 27.1% arrived at in my cohort 
study is credible as I used a gold-standard questionnaire for diagnosis of PTSD. The 
rate also accords with the common finding that 25-30% of people exposed to a 
trauma are likely to develop PTSD (Green, 2003). Furthermore I chose a cut-point 
of 18 for the PDS because in a comparison of 18 scoring rules for detecting PTSD 
(Ehring et al., 2007) it was one of the three rules that had the highest diagnostic 
efficiency, with a sensitivity of 0.88, specificity of  0.87 and overall efficiency of 
0.87. Since the completion of my systematic review, another study (Myhren et al., 
2010) reported the same prevalence rate (27%) for PTSD in ICU patients after one 
year, using the Impact of Events Scale (IES, Horowitz, 1976). 
 
6.1.2 Prevalence of depression three months after ICU 
The prevalence rate for depression estimated in my study, 46% (95%CIs: 36.5, 
56.1) was also somewhat higher than the estimates of studies in the systematic 
review. My estimate was calculated using the CES-D scale (Radloff, 1977), which is 
the most widely used measure of depression in epidemiological and community 
studies and is validated for both psychiatric and general populations. According to 
the author, a cut-point of 16 represents likely clinical depression, but I used a cut-
point of 19. The slightly higher cut-point was previously used in a study of 
rheumatoid arthritis patients (Covic et al., 2007) and recommended as a better 
predictor of depression in patients with somatic symptoms. In the systematic 
review, studies that included depression as a primary or secondary outcome post-
ICU yielded estimates for the prevalence of depression ranged from 2.8% to 47% 
at times between two months and fifteen months. Taking only rates of probable 
depression from high quality studies the range of estimates was still wide, from 
2.8% to 32%. Comparing my study to the four high quality studies with depression 
as an outcome (Chelluri et al., 2004; Eddleston et al., 2000; Samuelson, 2007; 
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Weinert & Meller, 2006), three had a similar follow-up time-point (two-three 
months) and one was carried out at one year. From other study characteristics 
where sufficient information was reported by the other studies, the only aspect that 
stands out is that my cohort had a longer mean LoS in ICU (13.55 days vs 5.57-
11). However LoS does not appear be a risk factor for post-ICU depression. A high 
estimate of prevalence (32%) came from the study by Weinert & Meller (2006) 
using the SCID (First et al., 1998), arguably the most reliable method of diagnosis 
to establish depressive disorders. Therefore a high estimate seems realistic.  
 
6.1.3 Prevalence of anxiety at 3 months 
The prevalence of anxiety found in my cohort study was 44.4% (95%CIs: 34.6%, 
54.2%) based on a cut-point of 44/45 for the Stait Trait Anxiety Inventory (Kindler 
et al., 2000). This compared to prevalence found in the systematic review of up to 
43% possible anxiety and up to 34% probable anxiety. The results of the cohort 
study and systematic review were similar, and suggested that post-ICU patients 
experienced clinically significant levels of anxiety symptoms.  
 
6.1.4 HRQL 
The mean score for the mental health component of the SF-12 (Ware et al., 1996) 
for patients in my cohort study was 43.93 (10.06). This compares to a mean of 50 
and standard deviation of 10 in the general population. Therefore the average 
mental HRQL of former ICU patients was 6.07 points or 0.6 of a standard deviation 
lower than the general population. However the range of scores was 18.92 - 64.19, 
suggesting that some participants had extremely poor mental health. Indeed 
examination of the frequency of scores shows that 43% of the patients had MCS 
scores of between 18 and 40 and therefore had very poor mental HRQL. This 
percentage is in line with the rates of psychological morbidity found in the cohort 
study. In the meta-analysis of previous studies that measured  HRQL in post-ICU 
patients using the SF-36 (see chapter two), mean mental HRQL was found to be 
ten points below the UK population norm (65.75 vs 75.9, based on scores for the 
MH domain rather than MCS aggregate scores, as the latter were not reported in 
most of the reviewed studies).  
 
The mean score for the physical health component of the SF-12 (Ware et al., 1996) 
for patients in the cohort study was 34.43 (10.06) compared to the population 
mean of 50 (10). In fact 50% of patients had scores ranging from as low as 17.5% 
to 34%, suggesting that the physical component of HRQL was extremely poor for 
many patients in the cohort. Up to 75% of patients had scores under 40. In the 
meta-analysis of previous studies from my systematic review, I found that mean 
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scores for the physical functioning domain were 58.82 for ICU patients compared to 
79.4 in the general population. Therefore results from the cohort study and meta-
analysis led to the conclusion that both mental and physical HRQL were greatly 
compromised for many former ICU patients at three months. Physical health scores 
were generally lower than mental health scores. 
 
6.1.5 Prevalence of adverse psycho-social outcomes after ICU 
Part of the first aim of the study was to discover the extent of adverse psycho-
social outcomes. For psychological morbidity alone, 55% of patients had either 
PTSD or depression or anxiety after 3 months. Of these 23% had all three 
syndromes, 17% had two syndromes and 15% had one. If poor mental HRQL 
(MCS<40) is included, then 60% of patients had an adverse psycho-social 
outcome. If poor physical HRQL is included (PCS<40) then 86% of patients had an 
adverse psycho-social outcome. Fifteen percent of patients had all five adverse 
psycho-social outcomes. No previous study has looked at the extent of 
psychological morbidity or HRQL in this way. It is a truly troubling picture. 
 
6.1.6 Prevalence of pre-ICU psychological morbidity   
Before admission to ICU, 16(16%) of the cohort of patients had past psychological 
problems. All 16 patients had a past or current history of depression. One of the 16 
was diagnosed with depression with psychosis and one had been diagnosed with 
depression and OCD since being diagnosed with cancer. No patients were recorded 
as having PTSD or an anxiety disorder before admission to ICU. Since the 
prevalence of psychological problems including PTSD, depression and anxiety post-
ICU was estimated as 55% it can be assumed that around 39% of cases were new 
post-ICU cases.  
6.1.7 Relationship between psychological morbidity and HRQL 
Post-ICU depression was associated with worse mental and physical HRQL (with 
MCS -0.770, p<0.001; with PCS -0.250, p=0.022). Post-ICU anxiety was also 
highly associated with both aspects of HRQL (with MCS -0.808, p<0.001; with PCS 
-0.323, p=0.002). PTSD was associated with MCS (0.590, p<0.001) but not with 
PCS (-0.115, p=0.293). MCS and PCS were not significantly associated with each 
other (r=0.174, p=1.09). This is curious, because depression and anxiety were 
associated with PCS. The associations between outcomes should be regarded 
cautiously as they were measured simultaneously at three months and are 
therefore cross-sectional data. It is unclear whether psychological morbidity affects 
HRQL, or vice versa, or whether both are measures of closely related constructs. 
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6.1.8 Co-morbidity of psychological outcomes 
In this study all three psychological outcomes were highly correlated. The 
correlation between PTSD and depression was 0.796 (p=0.000); between PTSD and 
anxiety it was 0.653 (p=0.000) and between depression and anxiety it was 0.809 
(p= 0.000). For patients, severe distress is severe distress, however it is labelled; 
However from a clinical point of view, it is important to have an accurate idea of the 
nature of post-ICU distress to inform likely interventions. It is well- known that 
depression and anxiety frequently co-exist, and it has been argued that a diagnosis 
of mixed anxiety-depression should be recognised (Gorwood, 2004). The link 
between PTSD and anxiety is clear; PTSD is an anxiety disorder and one of the 
main symptom clusters is of hyperarousal symptoms (DSM-IV, APA, 1994). Indeed 
PTSD is almost always found with other disorders. In one survey, 88% of men and 
79% of women with PTSD were also diagnosed with another psychological disorder 
(Davidson et al., 1991). The most frequent co-diagnoses are depression, general 
anxiety disorder and substance abuse. It has been observed that many depressive 
symptoms also appear in the DSM-IV criteria for PTSD. However Brewin et al. 
(1996) argued that symptom overlap is not the explanation for co-morbidity and 
that distinctive features of PTSD are the exaggerated startle, the re-experiencing 
symptoms and physiological reactivity to trauma-related cues.  In this study it was 
found that different outcomes were most strongly predicted by different risk 
factors, suggesting that distinct syndromes had occurred. 
 
6.2 Risk factors for psychological morbidity after ICU 
After establishing the likely prevalence of psychological morbidity three months 
after ICU, the second aim of the PhD was to identify consistent risk factors for 
psychological morbidity and poor HRQL. The systematic review (chapter two) 
showed that few risk factors had been investigated and identified in a systematic 
way in previous studies. As so little was known, I decided to explore a 
comprehensive set of risk factors divided into three groups; 
1.  Clinical factors (illness and healthcare)  
2.  Psychological factors (emotional and cognitive reactions in the ICU)  
3.  Socio-demographic factors (age, sex, SEC, ethnicity) 
Chronic physical illness, previous psychological history and alcohol use were 
investigated as possible confounding variables. 
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6.2.1 Psychological risk factors: Prevalence of distress, delirium and 
memory problems in ICU 
 
The study showed that there was a high prevalence of emotional distress, and 
cognitive problems such as delirium and memory distortions, while patients were in 
the ICU. The severe nature of the emotional, physical and social stress experienced 
by patients in ICU may help to explain how psychological morbidity could develop 
as a consequence. Of the 100 follow-up patients (results for the 157 baseline 
sample were very similar), 78% had mood disturbance (anxiety, depression, 
confusion, anger) with 47% at the highest levels; while 88% experienced ICU 
stress (delirium, physical stress, loss of control, emotional support) with 36% at 
highest levels.  
 
Delirium results showed that 64.6% of patients had hallucinations (43.4% at 
highest levels); 47.5% had nightmares; 73.7% were disorientated (43.4% at 
highest levels); 68% had confusion (42% highest) and 75% were agitated (37% at 
highest levels). The fact that results were so similar for hallucinations, 
disorientation, confusion and agitation suggests that it is correct to see them as a 
delirium syndrome, with about 43% experiencing severe delirium and a further 
25-30% moderate delirium. This was also consistent with memory results as 
45.5% of patients remembered very little of their ICU stay and 49.5% had 
experienced intrusive memories of ICU by the time of discharge. 
 
Physical stress results showed that pain affected 73% of patients (43.4% at highest 
levels) while 75.8% endured difficult breathing (46.5% at highest levels) and 
79.8% were sleep deprived (55.6% at highest levels). Socially, 52% felt isolated 
(31% very much) and 57% had communication problems (40% very much); 
However 83% gave high ratings for emotional support from family and 65% for 
emotional support from staff. Respect for dignity was highly rated by 73% and 
provision of information by 59%. Less positively, 86% felt they had no personal 
control in the ICU (67.3% felt this very much). 
 
6.2.2 Prevalence of ICU distress in other studies 
These results suggest that 70-80% of patients had a difficult time in the ICU and 
that 40-45% of patients were particularly badly affected by their experiences. 
There is little previous research to provide a comparison with these rates. Much 
research about the psychological condition of patients in ICU was based on a few 
case histories (Tomlin, 1977) or interviews (Laitinen, 1996). Interviews often took 
place several months after ICU (Stein-Parbury & McKinley, 2000) and therefore 
depended on memories that may not have been reliable. Much of the research is 
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now more than twenty years old and cannot be assumed to represent the 
experiences of ICU patients today. However a few studies (Bohrer et al., 2002; 
Brullmann et al., 1997; Nelson et al., 2001; Nelson, 2004; Pochard, 1995; Simini, 
1999) reported quantitative data about psychological symptoms and stressors 
assessed within a few days of weaning (coming off a mechanical ventilator) or at 
discharge from the ICU. The most common issues were insomnia (62-68% 
prevalence), pain (43-56%), discomfort from tubes (75%), anxiety (51-69%) and 
depression (29-60%). Hunger, unsatisfied thirst and distress at inability to 
communicate were also common. The growing literature on ICU delirium  (e.g. 
Pandharipande et al., 2005) suggests that the prevalence of delirium in the ICU is 
up to 80%. Prevalence rates of ICU psychological distress may vary according to 
methods of measurement, but this cohort study and others suggest there is clear 
evidence that pain, insomnia, discomfort from tubes, anxiety, depression and  
delirium are serious problems in intensive care for the majority of patients.  
 
It is striking that the prevalence of most severe distress in the ICU (mood and 
delirium) was 40-45%, and prevalence of anxiety and distress at three months 
post-ICU was 44-46%. Prevalence of PTSD was 27.1% but there were many more 
patients with significant levels of PTSD symptoms; and prevalence would have been 
44-45% using the Foa et al. (1997) scoring method. It may be that distress in the 
ICU persisted after discharge, and had developed into clinical disorders at three 
months, although the truth of this is not known. The proportion of patients who had 
suffered psychological problems (mainly depression) at any time before admission 
to the ICU was 16%. Therefore it appears that many people developed acute 
emotional and cognitive problems for the first time in ICU, and that this might have 
triggered processes leading to psychological morbidity at three months. Therefore it 
should not be assumed (as currently it often is) that psychological reactions 
commonly seen in the ICU are transient and do not require intervention. 
 
6.2.3 Psychological predictors of post-ICU psychological morbidity 
The cohort study showed that total mood disturbance in the ICU strongly predicted 
all psychological outcomes at three months (e.g. correlation with PTSD; r= 0.495, 
p<0.001).  “ICU stress”, (physical stress, delirium, control and support) was also a 
potent risk factor (e.g correlation with PTSD; r=0.463, p<0.001). Within these 
broader categories of mood and stress, it is of particular interest that delirium, 
physical stress such as pain and loss of control predicted all psychological 
outcomes. The association of delirium with PTSD (r=0.402, p<0.001) and 
depression (r=0.252, p=0.014) was much larger than with anxiety (r=0.196, 
p=0.05). The same pattern was seen with the predictor confusion. This might 
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suggest that PTSD and depression are more strongly predicted by more cognitive 
ICU factors while anxiety is more strongly predicted by emotional ICU factors. This 
fits with increasing evidence that PTSD and depression are accompanied by 
structural changes in the brain as well as emotional reactions (Bremner, 1999; 
Marazziti et al., 2010) 
 
Two memory variables were strongly correlated with three month psychological 
outcomes. Amnesia for the ICU was correlated with PTSD (mean difference=-6.30, 
95%CIs: -10.998,-1.56, p=0.01) and with depression (mean difference=-6.05, 
95%CIs:-11.73, -0.37; p=0.037). Again amnesia is a cognitive risk factor, while 
PTSD and depression involve cognitive as well as emotional changes (Brewin, 2001; 
Kizilbash et al., 2002).  Early intrusive thoughts about ICU (at discharge from ICU) 
strongly predicted later PTSD (mean difference= -9.39, 95% CIs: -13.85,-4.92, 
p<0.001), depression (-7.10, 95% CIs: -12.71, -1.47, p=0.014) and anxiety (-
5.85, 95%CIs: -11.72, 0.02, p=0.05). Patients’ beliefs about their condition 
(particularly IPQ timeline, the belief that their condition would continue for a very 
long time; Broadbent et al., 2006) were also associated with psychological 
outcomes and physical HRQL.  
 
These results are consistent with the hypothesis that critical illness and intensive 
care give rise to extreme acute stress reactions which if untreated or unmodified, 
may trigger longer term psychological morbidity. Furthermore they suggest that the 
effects of ICU on memory systems may be important processes in the development 
of psychological morbidity, particularly PTSD and depression. Memory deficits are 
known to be associated with clinical depression (Bremner et al., 2000) as well as 
PTSD (Brewin et al., 2010). The combination of amnesia for real ICU events and 
early intrusive memories either of fragments of reality (such as pain) or of 
hallucinations and delusions, may be fertile ground for the development of post-ICU 
PTSD.  
 
6.2.4 Psychological risk factors from other studies 
Previous studies had identified a number of psychological risk factors for post-ICU 
psychological morbidity. A study by Samuelson (2007) identified extreme fear of 
ICU (OR: 6.95, 95%CIs: 2.22-21.7, p=0.002), number of stressful events in 
ICU (OR: 1.13, 95%CIs:1.03-1.24), p=0.008) and agitation in ICU (OR:1.77 CIs: 
1.21-2.59, p=0.005) as predictors of PTSD at two months. Satisfaction with care 
was a risk factor for anxiety (standardised β= -0.188, p=0.046) at 12 months 
(Rattray, 2005). Depression at ICU discharge was a predictor of cognitive 
impairment at six months (Jackson  et al., 2003). These factors are similar to the 
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emotional reactions measured in my study (total ICU mood disturbance and ICU 
stress). 
 
 A number of studies (Jones et al., 2001; Jones et al.; 2003, Jones et al., 2007) 
identified unreal (delusional) memories as a risk factor for PTSD. In my study 
intrusive memories (IMs), both factual and unreal, at discharge from ICU predicted 
post-ICU psychological morbidity but there were no significant differences between 
factual or unreal IMs. My study suggested that it was the intrusiveness of memories 
(breaking into consciousness when unwanted) that predicted outcome rather than 
the content (factual vs unreal) of memories. However the qualitative memory study 
I carried out (see chapter seven) did suggest that unreal intrusive memories at 
three months were more prevalent in post-ICU PTSD than factual memories. Other 
studies investigated different  types of memory variables such as “traumatic” 
memories (Schelling, 1998) or just ICU recall (Rattray, 2005) at various times. A 
lack of clarity about the type of memory investigated and the appropriate time to 
assess memory has hampered investigation of this risk factor. 
 
When psychological factors were entered into multiple regressions with other types 
of factor in my cohort study the strongest risk factors for all psychological outcomes 
were ICU mood and ICU stress. However when they were entered together, ICU 
mood suppressed the effect of ICU stress. There was some overlap between mood 
items (anxiety, depression, anger, positive emotion and confusion) and stress 
(physical stress, delirium, control, support) and this could have been improved in 
the design phase of the study. However I reported some results for ICU stress as it 
included items such as pain and delirium that are of great interest in the ICU. 
Additionally “ICU intrusions at time one (ICU discharge)” was a strong independent 
predictor of PTSD at three months after controlling for other risk factors.  This is in 
line with PTSD studies that found that high levels of intrusion immediately after a 
trauma were predictive of a worse outcome (McFarlane, 1989). However others 
such as Creamer et al. (1992) found that initial intrusions were a predictor of 
successful recovery. ICU amnesia was not an independent risk factor and was 
confounded by ICU mood and ICU stress. This was possibly due to ICU mood and 
stress including sub-scales for delirium and confusion that helped to explain the 
presence of ICU amnesia. Finally IPQ timeline was the strongest psychological 
predictor for physical HRQL; Patients who believed at ICU discharge that their 
condition would continue for a long time, had worse physical HRQL at three 
months. 
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6.3 Clinical risk factors 
This cohort of level 3 ICU patients consisted of 36% surgical and 64% non-surgical 
patients with mixed diagnoses. The respiratory system was the primary system 
involved for 30% of patients, the gastro-intestinal system for 27% and the 
cardiovascular for 18%. On average each patient received more than four types of 
organ support. Up to 79% received advanced respiratory support, 73% GI support, 
52% CV support, 24% dermatological support and 24% renal support. They spent 
an average of 13.5 days in the ICU and 40 days in the hospital. The prevalence of 
sepsis was 81%. Mean number of drug groups of interest administered was 3.67 
per patient; Opioids were administered to 93% of the cohort, 64% received 
benzodiazepines, 52% inotropes, 42% anti-psychotics and 34% steroids.  
 
Many clinical risk factors were found to predict PTSD in this study. They included 
TISS (Therapeutic Intervention Scoring System, Keene et al., 1983), number of 
organs supported, days of respiratory, GI and CV support, sepsis biomarkers, days 
of sedation, benzodiazepines, inotropes, antipsychotics and number of drug groups 
administered. Many of these factors had not been investigated before. Of those that 
had been investigated in other studies, duration of respiratory support was 
found to have an association with PTSD in one study (Cuthbertson et al., 2004) but 
not in two others. However these two studies (Richter et al., 2006; Girard et al., 
2007), had only 37 and 43 participants respectively and may not have been 
powered to detect an association between duration of respiratory support and 
PTSD.  
 
The only other clinical predictor of PTSD to receive much previous attention was 
sedation. Jones et al. (2007) found that duration of sedative and opiate 
medication was a predictor of PTSD, while Girard et al. (2007) reported that total 
lorazepam dose (in 10mg intervals) predicted PTSD symptoms (rho=0.300, 
p=0.05). In Samuelson (2007) patients with high level PTSD symptoms at 2 
months were more likely to have received midazolam (p=0.020). A study by Kress 
et al. (2003), that was not included in my systematic review because of small 
numbers, found that patients whose sedation was interrupted on a daily basis had a 
lower number of PTSD-type symptoms (using the Impact of Events Scale, Horowitz, 
1979) than a control group (11.2 vs 27.3, p=0.02). Richter et al. (2006) found that 
sedation did not predict PTSD, but this was tested in a sub-group of only sixteen 
patients. 
 
Sedation and the administration of particular drug groups proved to be the most 
important clinical predictors of PTSD in my cohort study. When all clinical factors 
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were entered into a multiple regression for PTSD, the strongest predictor was 
duration of sedation (days) (β=0.294, p=0.062). Other important predictors of 
PTSD were benzodiazepines (β=0.277, p=0.036), inotropes (β=0.292, 
p=0.059) and antipsychotics (β=0.248, p=0.072). 
 
In my systematic review no clinical risk factors were reported for anxiety and 
depression. In the cohort study clinical risk factors for depression included primary 
body system involved (respiratory patients had higher depression scores than 
cardiovascular patients), longer stay in hospital and post-hospital destination, but 
the strongest risk factor was benzodiazepines. Those who received 
benzodiazepines in the ICU had higher three-month depression scores than those 
who did not receive benzodiazepines (mean difference 7.44 points, 95% CIs: 
1.81,13.07, p=0.01). Duration of sedation was also approaching significance 
(rho=0.189, p=0.066). Benzodiazepines (mean daily ICU dose of ≥75mg of 
midazolam-equivalent) were also found to predict depression (RR:2.1, 95%CIs: 
1.1-3.5) in a study of  acute lung injury (ALI) patients 6 months after ICU (Dowdy 
et al., 2009). Other risk factors identified in this study were surgical admission (RR 
2.2, CIs: 1.1,4.2) and maximum daily SOFA  (Vincent et al., 1996) score >10 (RR 
2.1, 95% CIs: 1.1,3.5). Hypoglycemia in the ICU was associated with increased 
depression at three months (mean difference = 2 points, 95%CIs: 0.5,3.5) in a 
study of ALI patients by Dowdy et al. (2008). These studies were not considered for 
inclusion in my systematic review because they appeared after the review was 
completed, but would not have been eligible as the cohorts consisted of an ICU 
sub-group (ALI patients) and not general patients.  
 
Clinical predictors of three-month anxiety in my cohort study were inotrope usage 
(-7.63, 95% CIs:-13.37,-1.89, p=0.01) and benzodiazepines (-5.95, 95%CIs: -
11.87,-0.03, p=0.049). Days of sedation was also approaching significance as a 
predictor of anxiety.  Mental HRQL was predicted by inotropes (4.51, 95% CIs: -
.06, 9.08, p=0.05). Other factors that also approached significance as predictors of 
mental HRQL were days of sedation, benzodiazepines and days of CV support. 
There was a big effect size for opioids (7.42, 95%CIs:-15.80, 0.96, p=0.08) as a 
predictor of better mental HRQL. A similar effect in the same direction was found 
for opioids and depression (7.12 points) and anxiety (7.79 points), although the 
results were not significant. Finally physical HRQL (PCS) at three months was 
predicted by steroids (-5.57, 95%CIs: -9.96,-1.18, p=0.029) and anaesthetics (-
4.45, 95%CIs:-8.94, 0.04, p=0.05). The association between antipsychotic drugs 
and physical HRQL (-4.14, 95% CIs: -8.43, 0.15) was nearing significance 
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(p=0.059). Those administered steroids, anaesthetics or antipsychotics had better 
physical HRQL than those who were not. 
 
A different set of clinical predictors was identified for HRQL in my systematic 
review.  Illness severity, assessed by Apache II score (Knaus et al., 1981), SOFA 
score (Vincent & Moreno, 1996) or presence of MOD (multiple organ dysfunction) 
was a predictor in seven out of eleven studies that investigated it (see chapter 
two). However in my cohort study Apache II score had no association with HRQL. 
Length of stay (LoS) in the ICU predicted HRQL in five out of eight studies in the 
systematic review. But LoS in ICU was not a risk factor for HRQL in my cohort 
study. Finally HRQL was predicted by diagnostic group or admission type in five 
studies reviewed, but not in my cohort study. Trauma or multiple trauma patients 
had worse HRQL than other groups in four studies (Badia et al., 2001; Garcia-
Lizana, 2003; Granja et al.  2002; Niskanen, 1999). Others found to be at risk of 
poor HRQL were neurological patients (Garcia-Lizana, 2003), emergency surgical 
patients (Granja et al., 2002), respiratory patients (Niskanen, 1999; Wehler et al., 
2003) and acute renal failure patients (Wehler et al., 2003). The reasons for the 
differences between results of my cohort study and other studies regarding clinical 
risk factors were not clear. Studies used different measures of HRQL at different 
time-points and reported different domains. Furthermore studies took place in 
different countries in a variety of types of ICU. Additionally my cohort study 
measured several clinical factors that were not measured by other studies and 
therefore cannot be compared. 
 
The results of the cohort study suggest two distinct types of relationship between 
clinical risk factors and psychological outcomes. First there is a clear message that 
PTSD is associated with an accumulation of clinical factors. PTSD score increased 
with a higher TISS score (Keene et al., 1983), a greater number of organs 
supported and a greater number of drug groups given as well as with specific 
interventions such as advanced respiratory support. In other words, the more  
intensive care a patient received the greater their risk of PTSD at three months. 
However these aggregated risk factors did not put them at greater risk of 
depression, anxiety or poor HRQL at three months. Secondly there were quite 
specific risk factors for each psychological outcome. These were all related to 
sedation or other types of drugs given in the ICU, highlighting a possible central 
role for drugs in the development of psychological morbidity after intensive care. 
Thus the strongest clinical risk factor for PTSD was duration of sedation 
(rho=0.268, p=0.008), for depression it was benzodiazepines (7.44 depression 
points, p=0.01), and for anxiety it was inotropes (7.63 anxiety points, p=0.01). 
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Inotropes also predicted worse mental HRQL, and steroids and anaesthetics 
predicted better physical HRQL. 
 
6.3.1 Possible psychological mechanisms explaining the effect of clinical 
risk factors 
I would argue that there are different biological and psychological mechanisms 
underlying these two types of relationship. First it could be argued that one of the 
underlying causes of post-ICU PTSD is an accumulation of factors (captured by 
variables such as TISS score and number of organs) putting the patient under 
significant levels of physiological, psychological and social stress. The TISS score 
(Keene et al., 1983) encompasses all interventions received by an ICU patient 
including drugs, treatments and invasive monitoring. Similarly an increasing 
“number of organs supported” entails a greater number of potentially stressful 
treatments and procedures such as oxygen delivered by tight-fitting face mask, 
mechanical ventilation, endo-tracheal tubes, naso-gastric tubes, dialysis and 
haemofiltration, open abdomen procedures, and cardiac, abdominal, neurological 
and pulmonary monitoring.  
As level 3 ICU patients undergo multiple treatments, generally know that their life 
is threatened and stay in an environment that is thought to be extremely 
frightening (Dyer, 1995), it is not surprising that they exhibit severe stress 
responses as described earlier in the thesis. Theories of psychological stress 
suggest that repeated acute stress responses may become chronic and lead to 
outcomes such as a mental or physical illness (Steptoe & Ayers, 2004). PTSD is 
defined as an anxiety disorder that often follows exposure to an extreme stressor 
that causes injury, threatens life or physical integrity (American Psychiatric 
Association, 1994). To meet diagnostic criteria for PTSD, the person’s response to 
the event or series of events must involve intense fear, helplessness or horror at 
the time of the trauma. Critical illness was added as an example of a traumatic 
stressor that could cause PTSD in the last version of the DSM (APA, 1994) and 
section 6.2.1 quantified the high levels of fear, helplessness and horror suffered by 
many patients in intensive care.  
 
The appraisal of continued threat is thought to be central to the development of 
post-traumatic stress disorder. Patients with PTSD continue to detect and react to 
threats in the environment even when a traumatic event is over (Ehlers & Clark, 
2000).  ICU patients are subject not just to one stressor but to repeated or even 
continuous stressors and emotional and physical shocks over a period of days or 
weeks. Furthermore ICU experiences are unpredictable, uncontrollable by patients 
and may be of long duration, which are characteristic of stressors that produce 
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pronounced physiological stress responses (Steptoe & Ayers, 2004). All this, along 
with a state of heightened arousal, confusion and cognitive dysfunction, might 
trigger in patients a tendency to react strongly to real or imagined threats to their 
well-being after leaving intensive care.  
 
In support of this argument, mediational analysis carried out in the cohort study 
showed that emotional and cognitive risk factors partially mediated the 
relationships between clinical risk factors and psychological outcomes. A mediator is 
a variable (B) that explains how or why another variable (A), which must precede 
(B) affects the outcome (O), and may be on the causal pathway between predictor 
(A) and outcome (Baron & Kenny, 1986; Rothman & Greenland, 1998). Of course 
causality cannot be inferred from non-experimental data; the most that can be said 
is that what is observed would be expected if there were a causal path leading from 
A to B to O (Kraemer et al., 2001).  
 
When acute psychological risk factors such as mood, stress or intrusions were 
entered into regressions with clinical risk factors, the effect size of clinical risk 
factors was greatly reduced and often became non-significant. So for example, the 
effect size of the TISS score on PTSD (B=.575, p=0.014) was more than halved 
(B=0.253, p=0.259) when ICU stress was entered into the regression. This 
suggests that the relationship between TISS and PTSD at three months was partly 
explained by the stress experienced in ICU. The remaining effect of TISS may be 
due to other psychological mediators or to physiological mechanisms involved in 
PTSD (to be discussed in 6.3.3 below).  
 
As depicted in the possible mediation model from chapter five (figure 6.1), the 
hypothesised causal pathways were that interventions, sedation and drugs 
administered might trigger mood and stress responses and memory changes in ICU 
which might in turn lead to adverse psychological outcomes at three months. More 
specifically, intrusive memories at T1 (ICU discharge) partially mediated the 
pathway between benzodiazepines and PTSD, and ICU amnesia partially mediated 
the pathway between TISS and PTSD. Mood and stress mediated pathways 
between several clinical factors and outcomes (see Table 6.1) 
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Figure 6.1 Potential causal pathways 
           
ICU clinical factors                   Psychological                      Outcomes (3m) 
                                                   reactions in ICU                     
                                              
 
 
 
     
     Table 6.1 Mediators identified in analysis 
 
  Mediators 
 (PTSD) 
Mediators  
(Depression) 
Mediators 
(Anxiety) 
Mediators   
(mental HRQL) 
Days sedation ICU Mood  
ICU Stress 
ICU Intrusions  
 
   
TISS ICU Mood  
ICU Stress 
ICU Amnesia 
   
Benzodiazepines ICU Mood  
ICU Stress 
ICU Intrusions 
ICU Mood 
ICU Stress 
 
  
Ionotropes   ICU Mood 
ICU Stress 
ICU Mood 
    
 6.3.2 Possible psychobiological mechanisms explaining the effect of 
   clinical risk factors 
As well as psychological explanations for the way stress leads to outcomes such as 
PTSD, other theories centre on biological aspects of the stress response and their 
long-term effect. It is thought that extreme fear activates the amygdala, part of the 
brain that initiates autonomic responses to stress including the release of stress 
hormones such as adrenaline, noradrenaline, and cortisol (LeDoux, 1996). 
Prolonged, intense stress may lead to over-production of cortisol, which is thought 
to impair hippocampal function and to enhance functioning of the amygdala. The 
hippocampus has been shown to be smaller in PTSD sufferers in a number of 
studies (Bremner et al., 1995). As the hippocampal formation is necessary for 
establishing long-term explicit or declarative memory (Zola et al., 2000), intense 
stress can be expected to have a profound effect on memory processes. A similar 
pattern of high levels of cortisol, reduced hippocampal volume and declarative 
memory deficits has also been found in depression (Bremner et al., 2000). Thus 
prolonged intense fear, which is frequently experienced in the ICU, could in 
principle trigger a series of events leading to PTSD or depression. This theory would 
also suggest that extreme ICU stress could also be associated with physical 
outcomes such as heart disease but this was not investigated in the study. 
 
 
Interventions to 
support organs 
Provision of drugs 
Length of sedation 
 
Mood  
Stress 
Intrusions 
Memory 
PTSD 
Depression 
Anxiety 
MCS 
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6.3.3 Possible physiological mechanisms explaining the effect of clinical 
risk factors 
Mechanisms relating PTSD (and depression) to psychological stress caused by 
multiple stressors in the intensive care environment have been outlined. However 
there are also plausible mechanisms that could link the physiological stress of 
critical illness and intensive care to damaging effects on the brain and subsequent 
psychological morbidity. The exact mechanisms are unknown but might be related 
to characteristics of critical illness such as sepsis, hypoxia, hypoperfusion, 
hypotension, cytokine-mediated inflammation and microvascular thrombosis, as 
well as abnormalities in neurotransmitter systems involving acetylcholine, 
dopamine, GABA, serotonin, glutamate and noradrenaline (Milbrandt & Angus, 
2005). The cohort study showed that a number of sepsis markers (C-reactive 
protein, white cell count, lactate and noradrenaline administration) were related to 
PTSD and anxiety, though not to depression. This is the first study to show this 
link, which merits further research.  
C-reactive protein is a marker of acute inflammation and it has been hypothesised 
that acute inflammation may lead to diffuse brain damage and thus to the 
development of delirium (Sharshar et al., 2005). It is well known that sepsis 
commonly induces secondary encephalopathy, often in the form of delirium. 
Although the pathophysiology behind septic encephalopathy is not well understood 
(Flierl et al., 2010), it is thought that the blood-brain barrier is broken down by 
cytokines, activation of the complement cascade and bacterial products. An 
inflammatory response is then triggered in the subarachnoid space. A study by 
Sharshar et al. (2002), which found white matter lesions in the brains of sepsis 
patients, suggested that diffuse occult brain injury was associated with high levels 
of pro-inflammatory cytokines. It is not known if these patients had delirium, but 
acute inflammation was shown to be associated with delirium in a study of 41 
elderly post-operative hip-fracture patients (Beloosesky et al., 2007).  
It is not yet known if there is a further link from sepsis-related brain inflammation 
and delirium to psychological morbidity such as PTSD or depression. Although it has 
not previously been tested in research, there are fragments of evidence. First, 
cognitive deficits in attention, executive function, memory and learning are known 
to be associated with PTSD in general (Vasterling et al., 2002; Bustamante et al., 
2001). In the post-ICU context, depression has been associated with cognitive 
impairment at 6 months (36% impaired vs 17% non-impaired, Jackson et al., 
2003). It is also known that longer hospital stay is a consequence of delirium (Ely 
et al., 2001a) and in my study longer hospital stay was a risk factor for 3-month 
depression. My cohort study found, for the first time, that ICU delirium was a risk 
factor for all psychological outcomes. Effect sizes were large in the case of delirium 
195 
 
and PTSD (r=0.402, p<0.001), medium for delirium and depression (r=0.252, 
p=0.014) and small for anxiety (r=0.196, p=0.05). Almost identical results were 
obtained for associations between a similar variable (the confusion subscale of 
mood) and outcomes.  
 
Furthermore it is known the activation of pro-inflammatory cytokines and impaired 
immune function can also be triggered by psychosocial stress. Repeated activation 
of the hypothalamic-pituitary-adrenal axis (due to chronic psychosocial stress) 
made people more susceptible to infection and led to inflammatory processes (Zhou 
et al., 1993). Therefore it can be argued that the psychological stress of being in 
ICU combined with the physiological stress of critical illness would be a potent 
milieu for the development of inflammation-related brain dysfunction, delirium and 
subsequent psychological morbidity.  
 
6.3.4 Effects of ICU on neurotransmitters  
A further related physiological hypothesis is that long-term psychological outcomes 
of ICU are related to imbalances in neurotransmitters (Meyer & Hall, 2006; 
Milbrandt & Angus, 2005; Weinert, 2005). Likely affected neurotransmitter systems 
could include acetylcholine, GABA, dopamine, serotonin, glutamate and 
noradrenaline, although detailed evidence is lacking. Neurotransmitter 
dysregulation is probably caused both by critical illness itself, and by the effects of 
ICU drugs. Acetylcholine is thought to inhibit the synthesis of pro-inflammatory 
cytokines (Czura et al., 2003), a process that could be disrupted by many drugs 
commonly used in the ICU that have high anticholinergic effects. These include 
opiates, glucocorticoids and benzodiazepines. The reduction in cholinergic activity is 
thought to result in overproduction of dopamine, an excitatory neurotransmitter 
which may contribute to the development of delirium (Sommer et al., 2002). Other 
potential neurotransmitter systems worth investigating would be abnormalities in 
serotonin, excess GABA activity after benzodiazepine withdrawal causing delirium, 
excessive noradrenergic function that might be associated with panic attacks and 
delusions and the role of glutamate in causing confusion (Milbrandt & Angus, 2005). 
It is thought that the inflammatory stress of critical illness could also have effects 
on a network of neurotrophins, neurotransmitters and receptors leading to 
problems with memory consolidation and retrieval (Weinert & Mellor, 2007). 
 
Having discussed the general mechanisms that could link the overall burden of 
critical care illness and treatment to psychological morbidity, I would now like to 
consider the more specific links that were found. All the strongest clinical predictors 
of psycho-social outcomes were drug-related. Days of sedation, benzodiazepines 
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and inotropes all had a detectable effect on PTSD, depression, anxiety and 
outcomes, but each had a stronger effect on one specific outcome. Steroids had a 
positive effect on physical HRQL, while there was a trend that opioids were 
associated with better psychological outcomes. 
 
6.3.5 Days of sedation and PTSD 
Duration of sedation was a stronger predictor of PTSD than any specific drug, and 
sedation may involve a number of benzodiazepines or anaesthetic agents such as 
propofol. Therefore I would suggest that any mechanisms involved would be linked 
to shared properties of sedative drugs rather than specific structures of specific 
drugs. According to Ghoneim (2004a) most drugs that cause sedation also cause 
amnesia. These drugs may have different molecular structures and involve different 
neurotransmitters and binding areas in the brain but they produce similar patterns 
of memory impairment. Amnesic drugs, with the exception of general anaesthetics, 
tend to spare short-term memory and impair long-term memory. They have most 
effect on explicit and episodic memory by impairing the encoding and consolidation 
of new information (Ghoneim & Mewaldt, 1990). Implicit memory, associative 
memory, procedural learning and semantic memory are generally less affected. 
 
Having impaired explicit memories of a trauma along with heightened associative, 
emotional memories has been linked with the development of PTSD (Brewin & 
Holmes, 2003). A similar memory pattern was arguably seen in studies such as 
Jones et al., (2001) where patients with delusional memories and few factual 
memories were more likely to develop PTSD. My cohort study also showed that 
having little “real” memory for the ICU was a risk factor for PTSD. It is likely that 
the longer a patient spends sedated, the less they will remember about real ICU 
events and the more they will have fragmentary emotional memories or unreal 
memories of hallucinations. It has been assumed that the effects of sedative drugs 
on memory result from disruption of the medial temporal lobe system, including the 
hippocampal formation (Longo, 1966; Ghoneim, 2004) but few investigations have 
been carried out to my knowledge. It may be hypothesised that the longer the 
patient is sedated, the more hippocampal structures are impaired, resulting in 
worse effects on memory and a greater likelihood of developing intrusive memories 
and PTSD. However this may be a simplistic picture as recent research suggests 
that damage occurring to different regions of the hippocampus results in different 
effects. It is thought that damage to the dorsal hippocampus affects learning and 
memory, whereas damage to the ventral hippocampus results in behavioural 
disinhibition and reduced anxiety (Bannerman et al., 2004). It might be fruitful to 
investigate whether the disinhibited behaviour exhibited by sedated, delirious, ICU 
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patients involves ventral hippocampal structures. It is also now believed that fear 
and anxiety may be separate processes with fear mediated by the amygdala and 
anxiety behaviours by the ventral hippocampus. 
 
6.3.6 Benzodiazepines and depression 
This is the first study to find that benzodiazepines were a risk factor for depression 
in general ICU patients. However Dowdy et al., (2009) reported that 
benzodiazepines (mean daily ICU benzodiazepine dose of ≥75mg of midazolam-
equivalent) predicted 6-month depression in a subgroup of ICU patients with acute 
lung injury (ALI).  In the wider literature the link between benzodiazepines and 
depression is controversial. The DSM-IV (APA, 1994) includes a diagnosis of drug-
induced depression called substance-induced mood disorder and lists 
benzodiazepines as one of the potential causes. Depression is listed as a possible 
adverse reaction to benzodiazepines by American manufacturers. Finally a number 
of studies have reported depression to be a long-term effect of benzodiazepine use 
(Patten et al., 1996). However Patten (2008) concluded that there is a lack of 
evidence to substantiate the link. The mechanism by which benzodiazepines might 
cause depression is unknown but one theory is that they cause a reduction in 
central monoamine activity (Longo & Johnson, 2000). It is thought that depression 
is caused by deficiencies in three monoamines; serotonin, noradrenaline and 
dopamine (Stahl, 2000).   
 
Benzodiazepines are sedative drugs that primarily bind to receptors for GABA, the 
most prominent inhibitory neurotransmitter in the CNS. As well as therapeutic 
effects (anxiolysis) they are known to have adverse effects (Ashton, 1989; Ashton, 
1991; Ashton, 1997) including psychomotor retardation (with poor concentration 
and mental confusion), short and long term withdrawal effects (insomnia, anxiety, 
delirium) and paradoxical disinhibition and aggression. The elderly are particularly 
at risk of some adverse effects such as psychomotor retardation, cognitive 
dysfunction and paradoxical disinhibition (Longo & Johnson, 2000). Symptoms 
similar to these adverse effects have been well documented in the short-term in 
ICU patients, many of whom are elderly. It is feasible that psychomotor 
retardation, delirium and cognitive dysfunction in the ICU, if left untreated, could 
trigger serious depression in the longer term.  
 
6.3.7 Inotropes and anxiety 
No previous prospective study has highlighted inotropes as a risk factor for future 
psychological morbidity. But in this cohort study it was the most important 
predictor both of three-month anxiety and of three-month mental HRQL with a 
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substantial effect size of nearly eight points for anxiety. No mechanism has been 
proposed for this effect as it has not been seen before, but it intuitively makes 
sense as the inotropes used in ICU are primarily noradrenaline and adrenaline, the 
stress hormones. Often known as the “fight or flight hormones” adrenaline and 
noradrenaline prepare the body for strenuous activity or life-threatening situations 
(Axelrod & Reisine, 1984; Sapolsky, 2000). They produce effects such as increased 
heart rate, increased blood pressure, and production of glucose to prepare the body 
for action. These effects are helpful in response to one-off threats, but can become 
maladaptive if constantly reactivated. When given as medication, adrenaline and 
noradrenaline are known to cause anxiety symptoms or iatrogenic anxiety in the 
short term (House & Stark, 2002). Side effects include tachycardia, palpitations, 
anxiety, tremor, restlessness, sweating and other autonomic symptoms. These 
symptoms would not be expected to persist after short periods of medication, but it 
may be that the physical sensation of autonomic symptoms along with the intense 
fear experienced by many ICU patients, leads to a vicious circle of ever-increasing 
anxiety. If acute anxiety symptoms are not treated, persistent forms of anxiety 
may develop, such as generalised anxiety disorder (involving muscle tension, 
inability to relax, feeling on edge and irritability) or panic disorder (in which anxiety 
symptoms such as a pounding heart are mistaken for serious illness such as a heart 
attack; NICE, 2004).  
 
Furthermore, it is known that inotropes have many effects distant from their 
cardiovascular actions. They have metabolic effects, both pro- and anti-
inflammatory effects, and they can alter both immunity and mitochondrial function, 
which drives the body’s metabolic processes (Singer & Glynne, 2005). Thus, along 
with other drugs used in the ICU, such as sedatives and antibiotics, inotropes may 
cause harm by inhibiting mitochondrial function. Mitochondrial shut-down is 
believed to be part of the process leading to sepsis and multiple organ failure. This 
in turn increases the risk of septic encephalopathy or delirium and cerebral insults 
that may be lead to the development of later psychological morbidity in survivors.  
 
Another potential effect of the drugs noradrenaline and adrenaline is that unlike 
most ICU drugs that tend to cause amnesia, the catchecholamines are thought to 
enhance memory, particularly emotional memory (McGaugh et al., 1993). If they 
enhance traumatic memories at the time when a patient is most seriously ill, this 
would be likely to contribute to increased anxiety in the future. A series of studies 
were carried out to examine the effect of stress hormones on memory formation 
and PTSD in ICU patients (Schelling, 2002). It was found that the total number of 
traumatic memories recalled increased and that memory consolidation was better 
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with increasing numbers of stress hormones (adrenaline, noradrenaline and 
cortisol) administered exogenously in the ICU.  
 
6.3.8 Steroids and physical HRQL 
It is of interest that patients who received corticosteroids had much better physical 
HRQL at three months than those who did not, in my cohort study. ICU patients are 
given steroids such as hydrocortisone to modify the inflammatory reaction which 
often occurs in patients with critical illness such as sepsis (Schelling, 2001). In one 
study patients given hydrocortisone in the ICU had significantly lower levels of the 
pro-inflammatory cytokines interleukin-6 and interleukin-8 (Briegel et al., 2001). 
One explanation for the physical HRQL result in my cohort study is that steroids 
protected patients against the most harmful effects of inflammation and so they 
were less physically impaired at three months.  
 
Patients in Schelling et al. (2001) who received steroids in the ICU had a lower rate 
of PTSD in spite of having enhanced and better consolidated trauma memories. This 
might suggest that because the inflammatory response was reduced by steroids, 
the brain, in particular the hippocampus (interleukin-6 and its receptors are 
expressed on hippocampal neurons) was protected, and the risks of developing 
disorders such as PTSD was reduced. It could also suggest that having better 
consolidation of trauma memories (probably involving hippocampal structures) is 
protective against PTSD, as would be predicted by the dual representation theory of 
PTSD (Brewin et al., 1996). However no association between steroids and PTSD 
was found in my cohort study 
 
6.3.9 Opioids 
There was a trend for opioids to have a positive effect on all psychological 
outcomes except for PTSD in my cohort study. Although results were not 
significant, effect sizes for the associations with depression, anxiety and mental 
HRQL were large, of the order of 7-8 points. Although some studies found that 
sedation and opiates combined were a risk factor for psychological morbidity (e.g. 
Jones et al., 2007), studies where the effects of sedatives and opioids were looked 
at individually suggested different effects of the two drug groups. No studies were 
found that tested whether opiates were an independent risk factor for psychiatric 
morbidity, but a possible association between opiates and delirium has been 
investigated. Ouimet et al. (2007) found that patients without delirium had higher 
daily doses of opioids than patients with delirium. Morrison et al. (2003b) found 
that hip-fracture patients treated with larger doses of opioid analgesics 
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(>10mg/day parenteral morphine sulphate equivalent) were less likely to develop 
delirium than those who received less opioid analgesia.  
 
These studies and the effects of opioids in my cohort study point to possible 
protective psychological effects of adequate analgesia. Although pain has not 
previously been established as a risk factor for post-ICU psychological morbidity, 
my cohort study found that pain affected 73% of patients (43.4% at highest levels) 
and that physical stress (including pain, discomfort and difficult breathing) was a 
highly significant risk factor for PTSD, depression, anxiety and mental HRQL. Pain 
was consistently found to be one of the three main stressors (prevalence 43-56%) 
in studies that assessed ICU distress (see 6.2.2 above). Inadequate pain relief 
would be expected to lead to emotional reactions in the ICU such as fear and 
helplessness. If pain is also a risk factor for delirium as suggested by Girard et al. 
(2008), a combination of pain, fear, helplessness and delirium in the ICU might be 
a precursor for subsequent psychological morbidity. 
 
Nevertheless further research is needed into the effects of opioids on the 
psychological outcomes of ICU patients. Opioids are known to inhibit the release of 
acetylcholine in the brain (Michaelson et al., 1984) and to interfere with sleep 
patterns (Arankowsky-Sandoval & Gold, 1995). So arguably opioids could increase 
other risk factors for delirium and poor memory. Opioids have also been associated 
with hallucinations and delirium in a number of non-ICU studies (Bruera et al., 
1992; Williams-Russo et al., 1992). However associations were often weak and 
results contradictory.  A systematic review (Wheeler et al., 2002) found that CNS 
effects of post-operative opioid analgesia were idiosyncratic rather than dose-
related. One study (Saxe et al., 2001) found a significant association between dose 
of morphine and PTSD at six months with a greater reduction in PTSD symptoms in 
children who had higher doses of opioids. The authors hypothesised that opioids 
reduced consolidation of traumatic memories by inhibiting the production of 
noradrenaline at the level of the amygdala thus reducing fear conditioning and 
PTSD.  Thus the evidence of the effects of opioid analgesia on psychological 
outcomes need to be carefully weighed. 
 
6.4 Socio-demographic risk factors  
Age and sex did not predict psychosocial outcomes of intensive care although there 
was a trend for younger age (p=0.184, p=0.073) and female gender (p=0.075) to 
predict PTSD. This was a surprising result as age and gender are well-established 
risk factors for psychological morbidity and HRQL. It is possible that the 
psychological effects of ICU are so prevalent that they override individual 
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differences. The only socio-demographic risk factor found to predict post-ICU 
psychological outcomes was socio-economic circumstances. SEC was measured 
using NS-SEC (ONS, 2010), a self-coded occupational variable with six classes:  
 
1. professional/managerial occupations 
2. intermediate occupations 
3. small employers and own account workers 
4. lower supervisory and technical occupations 
5. semi-routine and routine occupations 
6. unclassified (including some retired/unemployed/students/spouse working). 
 
SEC was found to predict depression (p=0.008), anxiety (p=0.041) and mental 
HRQL (p=0.016) at three months. It did not predict PTSD, which is inconsistent 
with the finding by Brewin (2001) that SEC was a risk factor for PTSD, albeit a 
weak one. A significant difference of 15 points was found between group one 
(professional/managerial) and group two (intermediate occupations e.g. clerical) for 
post-ICU depression, with depression higher in group two. No significant 
differences in post ICU anxiety were found between NS-SEC groups but group 
two’s anxiety score was 13 points higher than group one’s and group six’s score 
was 11 points higher than group one. For mental HRQL a significant difference was 
found between groups one and five (one had better HRQL by 10 points).  
 
This was the first study to find that SEC was a predictor of post-ICU psychological 
morbidity or HRQL. Previously no studies have investigated this risk factor although 
two studies investigated the effect of educational level; Jackson et al. (2003) found 
that mean years of education was associated with post-ICU cognitive impairment 
(11.3 years of education if impaired vs 14.1 years if non-impaired) and Granja  et 
al. (2002) found that education predicted HRQL six months after ICU. Patients who 
did not continue education after minimum schooling (48% of the sample) had 
significantly more problems after ICU with mobility, self-care, usual activities and 
pain/discomfort.  
 
SEC has previously been found to be associated with non-psychological ICU 
outcomes such as mortality. Hutchings et al., (2004) demonstrated a social 
gradient for mortality among elective surgical patients, with lower SEC patients 
having a higher mortality, in a study of more than 51,000 admissions to 99 ICUs 
from 1995-2000. The authors speculated that the SEC gradient might result from 
unmeasured health differences at admission to the ICU mediated by factors such as 
stress and quality of social support. They also considered the possibility that 
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patients received different care according to SEC.  An association was found by 
Welch et al. (2010) between increasing deprivation and increased risk of mortality 
for all types of admission in a sample of 78,631 patients admitted to English ICUs 
from 2000-2002. Welch et al. (2010) found that indicators of illness severity such 
as physiology scores, levels of mechanical ventilation and severe sepsis were 
similar across quintiles of IMD, suggesting that severity of illness did not vary 
according to deprivation. Thresholds of admission were also found not to vary. No 
conclusion was reached about the reasons for the association found between SEC 
and ICU mortality. 
 
Similarly it was difficult to identify the reasons for differences in depression, anxiety 
and mental HRQL between NS-SEC groups in my study. Population-based studies 
have reported a social gradient in psychological disorders, with people with lower 
SEC having worse mental health problems. This has been demonstrated in 
psychotic illnesses and more common mental disorders such as anxiety and 
depression (Fryers et al., 2003). Therefore it would be expected that patients of 
lower SEC would be more likely to have anxiety or depression. However as the 
prevalence of post-ICU anxiety and depression was approximately 45%, compared 
to 16% pre-ICU, the issue here is not background mental health issues, but recent 
psychological morbidity occurring after intensive care. It could be argued that 
people with poorer SEC are more vulnerable to mental health problems. They may 
be more likely to react badly to stressors such as ICU and to develop subsequent 
problems with mental health. Few studies have looked at an SEC effect on 
psychological morbidity as a reaction to medical illness, but Simon & Wardle (2008) 
found that lower SEC patients with breast, prostate or colorectal cancer were more 
anxious and depressed and had worse HRQL two months after diagnosis. In a study 
of oral cancer surgical patients those with a lower annual family income had 
significantly worse physical and mental HRQL. SEC was also found by Clarke et al. 
(2000) to predict severe limitations of daily living in cardiac patients (with left 
ventricular dysfunction). 
 
There was no association between SEC and clinical (illness and treatment) factors  
in this study. No significant differences were found between SEC groups for illness 
severity, primary body system involved, sepsis markers, amount of intervention 
received, number of organs supported, days of mechanical ventilation or categories 
of drugs received. Mean group scores showed that group one patients 
(professional/managerial) had higher scores for illness severity, number of organs 
supported, intervention intensity and sepsis than all other groups (possibly because 
of the higher rate of attrition of more deprived patients between times one and 
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two). However the lack of significant results suggests that the SEC association with 
post-ICU psychological distress is not likely to be related to how ill a patient was or 
what type of intervention they received.  
There was an SEC association with ICU mood (p=0.046), with a much higher mean 
score (41.61 (8.16)) for group two (intermediate occupations) compared to group 
one (28.89 (14.83) and group five (24.8(8.53)). Additionally, although it was not a 
significant result, group two had higher ICU stress (40.68) compared to other 
groups (e.g. group one, 32.38). ICU memory and intrusions were not associated 
with NS-SEC in this study. Nor were any chronic factors including psychological 
history, chronic illness or alcohol use. The finding that NS-SEC was associated with 
total mood disturbance in the ICU suggested that there was more vulnerability to 
stress among some NS-SEC groups than others. This might help to explain the 
difference in three month outcomes. In this case patients with intermediate 
occupations (e.g. PAs, clerical officers and lower grade civil servants) had worse 
mood disturbance in the ICU and more depression and anxiety three months after 
the ICU than other groups. It is unclear why this should be. One possibility is that 
their jobs have characteristics thought to cause chronic stress or job strain; 
characteristics such as high demands with low control (Karasek, 1979), or an 
imbalance between effort put in and rewards received (Siegrist & Marmot, 2004) 
together with employment insecurity. Previous studies have shown that surgical 
patients with more life stress before coming in to hospital had worse post-operative 
recovery in terms of pain, drowsiness, and a number of indicators of post-operative 
morbidity (Liu et al., 1994). It is arguable that higher levels of work-related chronic 
stress could explain group two’s vulnerability to disturbed mood in the ICU and 
psychological morbidity at three months. However it is not clear why group two 
should have more chronic stress than other vulnerable groups such as group five 
(routine and semi-routine occupations). 
 
Another level of explanation is that three month psychological outcomes would be 
determined not just by experiences in the ICU, but by factors affecting patients 
after discharge from hospital. Some patients return to more difficult environments 
in which to recuperate – for example those with less money for food, heat and 
medicines, or less social support or more family conflict. Post-ICU factors were not 
measured in this study, with the exception of social support at three months which 
was not found to be associated with psychological outcomes. There were 
differences in levels of social support within NS-SEC groups (p=0.05). Social 
support was high in groups one (28) and five (29), and low in group four (14.67). 
However this result does not shed light on the prevalence of anxiety and depression 
in groups two and five. 
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    Table 6.2 Social support mean scores by NS-SEC 
 
 
 
 
 
 
 
6.4.1 Summary of SEC results 
SEC was associated with three outcomes; depression, anxiety and HRQL. Group 
two (intermediate occupations) was the most distressed group with higher rates of 
anxiety and depression at three months post-ICU in comparison with other 
occupational groups. Group five (routine, semi-routine occupations) had worse 
mental HRQL than other groups and group six had highest scores for anxiety. 
Groups one (professional/managerial) and four (technical/supervisory) had the 
best mean scores for both depression and anxiety. A significant association 
between ICU Mood and NS-SEC (and other trends) suggested that group two had 
worse emotional reactions to being in the ICU than other groups. This may have 
been exacerbated by chronic stress relating to their occupations, resulting in 
anxiety and depression at three months. Perhaps higher levels of control and 
autonomy in their occupations made patients from groups one and four more 
resilient in coping with the stressful ICU environment. 
 
6.5 Chronic factors 
Data on chronic physical illness, psychological history and alcohol use were 
collected. It was believed that these could be important confounding variables. A 
recent NICE guideline (Pilling et al., 2009) presented strong evidence that there 
was a high prevalence of depression in patients with chronic health conditions. In 
my systematic review five out of five studies that included chronic or pre-existing 
physical illness as a risk factor found it predicted depression (Weinert & Meller, 
2006) or HRQL (Cuthbertson et al., 2005; Granja et al., 2002; Orwellius, 2005; 
Ridley et al., 1997). There has been much debate about the causal role of previous 
mental health problems in PTSD after critical illness. In the systematic review three 
studies (Cuthbertson et al., 2004; Nickel et al., 2004; Weinert & Meller, 2006) 
found that psychological history was a predictor of PTSD or depression and two 
(Richter et al., 2006; Jones et al., 2001) found that it was not a predictor of PTSD 
or were inconclusive. Previous non-ICU studies have found that an existing or past 
mental health problem is a risk factor for PTSD (Ozer et al., 2003).  
 
1. (professional/managerial) 28.17 
2. intermediate 25.13 
3. small employers, own account workers 23.28 
4. lower supervisory and technical 14.67 
5. semi-routine and routine 29.00 
6. student, unemployed, retired, 
unclassified 
26.00 
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In this study chronic physical illness was found to predict depression, anxiety and 
HRQL. Psychological illness predicted PTSD, depression, anxiety and MCS. Past 
trauma did not predict psychological morbidity three months after ICU but there 
was a trend for it to predict PTSD (mean difference 4.41; 95%CIs: 0.53,9.36, 
p=0.080). Alcohol use was also a predictor of PTSD (mean difference 9.17; 95% 
CIs: 2.20, 16.15, p=0.011). When multiple regression was carried out with clinical, 
psychological and socio-demographic variables, chronic physical illness was found 
to be an independent predictor of depression, anxiety and mental HRQL. It did not 
confound the effects of days of sedation on PTSD; of benzodiazepines on 
depression; or the effects of inotropes on anxiety. It was of interest that chronic 
physical illness was correlated with psychological outcomes but not physical HRQL. 
Psychological history was associated with PTSD, depression and anxiety. It did not 
confound the effects of ICU mood, intrusions or timeline on PTSD or of ICU mood 
on Depression; but did reduce the effect of ICU mood on Anxiety. It was not an 
independent risk factor for mental HRQL.  
 
6.6 Evaluation of study 
6.6.1 Strengths of the study 
With 157 patients assessed at baseline and 100 who completed followed-up, the 
cohort study was fully powered to detect a correlation coefficient of 0.3 between a 
continuous risk factor and an outcome, according to an a priori power calculation 
that the minimum sample size was 95. This sample size had been inflated by 40% 
to allow for the detection of the same size of correlation coefficient in a multiple 
regression where all other variables explain 30% of the total variation in outcome. 
An adequate sample size was achieved by approaching every consecutive eligible 
level 3 patient admitted to ICU for a period of ten months. All ICU patients’ charts 
were checked every morning to identify patients who were receiving level 3 care by 
Intensive Care Society criteria regarding number of organs supported and other 
factors (Intensive Care Society, 2002), therefore the sample consisted of a very 
tightly defined group of intensive care patients. With an 86% participation rate, 
very few eligible patients declined to participate, and comparisons between recruits 
and non-recruits suggested the sample was representative.  
 A rigorous system for following up patients was in place ensuring a 64% follow-up 
rate, although 90% of patients who were contactable and capable of answering the 
questionnaires took part in the follow-up. The follow-up sample did not differ 
significantly from the baseline sample for psychological and clinical factors, but the 
rate of attrition between T1 (ICU discharge) and T2 (three months) was greater 
among men and among people living in the most deprived IMD quintiles. Sex was 
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not associated with post-ICU psychological morbidity in this study, therefore the 
change in the sample’s male-female ratio should not have affected results. As SEC 
was a risk factor for anxiety, depression and mental HRQL, the higher rate of 
attrition from the most deprived IMD quintiles could suggest that the prevalence of 
depression and anxiety at three months could have been higher if the whole sample 
had been followed up. However this cannot be argued with any certainty because it 
was decided that the IMD 2007 (Communities and Local Government, 2010) was 
not a useful measure of SEC in this study.  
 
Another strength was the prospective nature of the cohort study. All psychological 
and clinical risk factors were assessed at the time of patients’ discharge from the 
ICU. This was the first prospective study to assess patient’s psychological state in 
ICU and then follow it up at three months. I designed an ICU baseline questionnaire 
that covered all likely psychological risk factors but was not too long or burdensome 
for patients to complete. I visited all patients and read them the questionnaire as 
many were too sick to tackle it alone. All patients were then contacted by post after 
three months. The methods used for outcome assessment were robust. The PDS 
(Foa et al., 1997) is regarded as the gold-standard self-report measure for PTSD as 
it is based on specific and exact DSM-IV criteria (APA, 1994). The CES-D (Radloff, 
1977) is the mostly widely used questionnaire in community and epidemiological 
studies to detect likely clinical depression. As anxiety was a less important outcome 
than PTSD and depression, a short version of STAI (Spielberger et al., 1983) was 
used. This may be less reliable than the full version but it was used to reduce the 
length of the questionnaire and to make it more likely that patients would complete 
it in full. A short version of the SF-36, the SF-12 (Ware et al., 1996) was used for 
the same reason.  
 
A further strength is that prevalence rates, which are notoriously variable in 
psychiatric epidemiology and will vary according to methods used and other factors, 
were calculated using sensible and conservative methods so as not to under- or 
over- estimate the likely prevalence. I chose a three-month follow-up period 
because it was long enough for PTSD to be detected, but not so distant from the 
ICU experience that too many other factors had intervened. Three months was also 
a reasonable time by which patients might expect to be making a good recovery.  
Finally, a comprehensive set of risk factors was studied in this cohort study. Few 
risk factors had been identified to date, so I decided to examine three groups of 
likely risk factors and used appropriate statistical methods to identify the strongest 
independent risk factors.  Another strength was that potential confounding 
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variables were carefully considered and measured. These were chronic ill-health, 
previous psychological history, cancer, heavy alcohol use and recreational drug use.  
 
6.6.2 Limitations of the study 
The sample size may not have been large enough to detect all important 
associations. As a result of the number of potential risk factors investigated, many 
statistical associations were found in the study, introducing the risk of type one 
errors. In this situation it is important to differentiate between statistical artefacts 
and true associations. It is necessary to consider plausible biological or other types 
of mechanism by which associations might be explained, as I have outlined in this 
discussion. As a result of limited concentration and time for seriously ill ICU 
patients to complete the baseline questionnaire, I had to adapt and shorten existing 
questionnaires or create new ones. Thus I had to balance the potential loss of 
reliability and validity if full questionnaires were used, with the feasibility of the 
patients being able to complete questionnaires. I was also concerned not to exhaust 
seriously ill patients.  
 
Additionally I found that existing ICU stress or memory questionnaires were too 
long or did not address the specific risk factors I considered most important. 
Therefore I created my own ICU stress questionnaire and took advice from 
Professor Christopher Brewin from UCL, an expert on intrusive memories, to devise 
questions to elicit information on intrusive memories. After piloting the 
questionnaire I found that it was marginally too long and I reduced the number of 
items further. I cut some questions from the brief Illness Perception Questionnaire 
(Broadbent et al., 2006) that patients seemed to find confusing and thus lost 
information on some of the core illness perceptions. I also dropped the Mini-mental 
state exam (Folstein et al., 1975) as it made the baseline assessment too arduous, 
and therefore lost the opportunity to get more information about the patients’ 
cognitive function post-ICU.  
 
Another limitation was the possible inaccuracy in the measurement of socio-
economic circumstances. As patients filled in the NS-SEC (Office for National 
Statistics, 2008) questionnaire at home as the final part of the follow-up 
questionnaire, many people did not fill it in or did so incorrectly. In particular 
people who were retired or unemployed did not follow the instructions to answer 
the questions with reference to their last job. Also some people misclassified 
themselves as group one (professional/managerial). As a result of this, I decided to 
use postcodes to classify people’s SEC according to IMD (2007) areas of 
deprivation. However ultimately I decided that NS-SEC was a better indicator of 
208 
 
SEC in this cohort, and so used NS-SEC rather than IMD in the statistical analyses 
of the cohort study. My reasons for this decision were that the majority of the 
cohort came from two London boroughs, Camden and Islington, in which most 
areas are classified as being deprived. But area-level deprivation is not always an 
indicator of individual SEC. In Camden , according to the Association of Public 
Health Observatories (2010a) 69% of people live in areas of high deprivation 
(fourth and fifth quintiles) and none live in an area of least deprivation (first 
quintile). In Islington 97.3% of people live in areas of high deprivation (The 
Association of Public Health Observatories, 2010b). This could give rise to the 
ecological fallacy (Schwartz, 1994) that occurs when relationships between 
variables that hold at an area level are assumed to hold at the individual level. To 
improve the NS-SEC (Office of National Statistics, 2010) results I used information 
about patients’ occupation from the baseline questionnaire to reclassify some 
participants. However sometimes there was insufficient information to do so. 
6.7 Clinical and research implications 
Clinical: This study suggested that modifications could be made in clinical practice 
to reduce the intensity of ICU interventions, to use inotropes and sedatives 
judiciously and to prescribe appropriate opiate analgesia and steroids, and that 
these may improve psychological outcome. In the meantime, patients should be 
routinely assessed for psychological distress and offered support in ICU and post-
discharge, as has now been recommended by the NICE guideline on rehabilitation 
for intensive care patients (Tan et al., 2009). At present few ICUs have access to a 
psychologist, so psychological assessment and support would have to be provided 
by nursing staff. Nursing staff may feel they do not have adequate time or training 
for this role, and consideration should be given to a possible need for health 
psychology input in ICUs to provide support to patients as well as training and 
research consultancy for staff. 
 
Research: Ideally a much larger prospective study should be carried out to confirm 
the strongest clinical, psychological and socio-economic risk factors identified in this 
study. Data collection could include biological and physiological markers in order to 
assess possible biological mechanisms underlying the associations observed (i.e. 
between TISS and PTSD; benzodiazepines and depression; inotropes and anxiety; 
steroids and PCS and the suspected role of opioids). Follow-up should take place at 
three months, as in this study, but be repeated again at nine months or a year to 
detect the prevalence of long-term psychological morbidity or possible late-onset 
PTSD (occurring after six months; APA, 1994). It would be desirable to include 
physical as well as psychological outcomes. Studies of ICU survivors involving 
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functional imaging of the brain using PET (positron emission tomography) scans 
would be of particular interest. 
 
As the cohort study showed that level 3 ICU patients have considerable 
psychological morbidity both during and after intensive care, interventions to 
reduce levels of morbidity should be evaluated. Two types of intervention would be 
possible. A psychological intervention would involve assessment of all patients by a 
health psychologist in the ICU (using a tailored, validated version of the ICU 
baseline questionnaire from this study) followed up with psychological support in 
the ICU, on the ward after ICU discharge and after discharge from hospital for 
those in need. Examples of psychological support might include anxiety 
management in the ICU, reassurance about unexpected ICU symptoms such as 
hallucinations after transfer to the general wards, and management of intrusive 
memories or depression during the recovery period at home. Patients with poor 
psychosocial outcomes at three months are likely to make a worse physical as well 
as psychological recovery (Ballenger et al., 2000; Stansfeld et al., 1993). This could 
lead to increased hospital re-admissions as well as GP visits to access mental health 
services. Therefore preventative psychological interventions could prove cost-
effective as well as beneficial for patients. After piloting and testing the feasibility of 
such an intervention, it should be tested by a randomised controlled trial. Two 
strategies would be possible. Either patients could be psychologically assessed in 
ICU and those affected could be randomised to the new intervention or to usual 
care; or a cluster randomised controlled trial would be designed in which some ICUs 
delivered the psychological intervention and others did not.  
 
A second type of intervention would be a medical and pharmaceutical trial involving 
comparisons of different drug regimes. Psychological outcomes of patients receiving 
an “optimal” drug regime would be compared with those from patients receiving 
usual care. An optimal drug regime might involve adequate opioid analgesia 
combined with the judicious use of benzodiazepines and ionotropes, and steroid use 
where indicated. It would be designed with the help of  pharmacists and clinicians 
and be informed by existing knowledge of the effects of different sedatives and 
analgesics.  
 
6.8 Conclusion 
Previous research suggested that intensive care patients suffered from considerable 
psychological morbidity and poor HRQL in the months after ICU. However accurate 
rates of prevalence had not been established. Furthermore very few risk factors for 
post-ICU morbidity had been properly tested or identified. Building on a systematic 
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review of 45 previous studies, my study was the first prospective cohort study that 
tested for associations between a comprehensive set of clinical, psychological and 
socio-demographic risk factors and a full range of relevant psycho-social outcomes. 
Using sensible and appropriate methods I estimated that 44% of consecutive level 
3 ICU patients had clinical anxiety, 46% had clinical depression, and that 27% had 
PTSD (with a further 17% who had significant symptoms of PTSD) three months 
after ICU. In total, 55% of patients suffered from either PTSD, anxiety or 
depression after leaving intensive care. This compared to 16% of patients who had 
a history of psychological problems before admission to ICU.  
 
This is the first study to identify a group of clinical factors that were strongly 
associated with post-ICU distress. They included TISS score, sepsis biomarker 
scores, number of organs supported and increasing number of drug groups given. 
As well as finding a strong association between amount of intensive care received 
and outcomes, I identified specific risk factors such as duration of sedation for 
PTSD, benzodiazepines for depression, inotropes for anxiety and mental HRQL, and 
steroids and anaesthetics for better physical HRQL. Another new finding was that 
patients’ socio-economic circumstances were found to predict anxiety, depression 
and mental HRQL in ICU survivors. Adverse outcomes were also strongly predicted 
by patients’ acute reactions during ICU, including mood disturbance, extreme 
physical stress, delirium, control, illness beliefs, amnesia and intrusive memories. 
More sophisticated analysis showed that clinical factors had both a direct effect on 
three-month outcomes and an indirect effect as they were partially mediated by 
acute psychological reactions in the ICU. It is of particular interest that sepsis and 
delirium were found to be risk factors for post-ICU PTSD and other psychological 
outcomes as this had not been shown before. These findings have important clinical 
and research implications and point to a need for interventions to reduce the 
harmful psychological impact of intensive care and to help patients who suffer 
extreme psychological distress. 
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Chapter 7 Memory study 
 
7.1 Introduction 
Admission to ICU may have bizarre effects on memory. A number of alterations and 
distortions to memory processes have been reported in the psychological literature 
on intensive care. As many patients are sedated or unconscious when admitted to 
intensive care, few remember their admission to the unit, which adds to their 
disorientation when they wake up to find themselves immobilised in a strange 
environment (Capuzzo, 2001). Subsequently many patients say they remember 
little about the time they spent in intensive care (Compton, 1991). As they begin to 
recover and leave the ICU, patients often puzzle over frustrating gaps in their 
memory (Griffiths & Jones, 2001), while they try to recreate a meaningful narrative 
of what happened to them in intensive care. At the same time some patients start 
to be troubled by insistent thoughts or memories about intensive care. Even though 
the patient believes they remember little of intensive care, memories of 
experiences, some that occurred while they were unconscious, start coming back to 
them (Rundshagen et al., 2002). 
 
As well as “factual” memories of realistic events that could have occurred in  
intensive care, they may also have “unreal” memories of hallucinations or bizarre 
dreams that they had in intensive care (Jones et al., 2001). Both types of memories 
are known to occur at two and eight weeks after discharge (Jones et al., 2001) and 
even several years later (Schelling et al., 1998). As discussed in earlier chapters, 
PTSD and other psychological morbidity are highly prevalent in post-ICU patients. 
My cohort study found high levels of PTSD symptoms in 27% of patients as well as 
depression in 46% and anxiety in 44% three months after leaving  intensive care. 
The prevalence of PTSD is consistent with a review (Green, 1994) that found that 
around 30% of people get PTSD after a trauma. Green (1994) also found that half 
of the 30% are likely to have PTSD for a long time.  
 
The question arises whether the high prevalence of psychological morbidity after  
intensive care is related to the memory effects that appear to occur within  
intensive care due to a variety of illness and treatment factors. It is well known that 
alterations to memory processes are found in several psychological disorders. A 
significant stable association between memory impairment and depression was 
found by a meta-analysis of 147 studies of recall or recognition in depressed and 
non-depressed samples (Burt et al., 1995). Evidence has also been found of 
hippocampal volume reduction in major depression (Bremner et al., 2000b). As the 
hippocampus is believed to play an important role in the laying down of coherent 
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memories, hippocampal dysfunction could contribute to the well-known deficits in 
declarative memory found in depression.  
A range of unusual memory phenomena are thought to be the most characteristic 
symptoms of PTSD (Brewin & Holmes, 2003). Findings from my cohort study 
(reported in chapter five) suggested that two types of ICU memory effect - a) 
having very little memory for ICU and b) experiencing intrusive memories of the 
ICU around the time of ICU discharge - were significant predictors of PTSD, 
depression and anxiety. There were highly significant differences of seven points on 
the PTSD scale and 6.05 points on the depression scale between patients with and 
without memory of the ICU. Patients who had early intrusive memories of the ICU 
were 9.5 points higher on the PTSD scale and 7.10 points higher for depression. 
Mediational analysis suggested that both memory variables partially mediated the 
relationships between clinical factors such as intensity of treatment and number of 
days of sedation, and PTSD at three months. It is already known that amnesia for 
details of a traumatic event is a symptom of PTSD (American Psychiatric 
Association, 1994). Furthermore, an initial period of intrusive thoughts/memories 
immediately after a trauma was described as a sign that a fear network (a network 
of memories linking details about the trauma with cognitive, behavioural and 
physiological responses) was being activated (Creamer et al., 1992). Creamer et al. 
(1992) suggested that initial intrusions would be a predictor of successful recovery, 
whereas other studies found that prior levels of high intrusion were predictive of a 
worse outcome (McFarlane, 1989). 
In my third study, I wanted to explore further the effects of ICU on memory, and 
the memory processes that may underlie the development of ICU-related PTSD. I 
decided to interview patients who were troubled by intrusive ICU-related memories 
at three months about the nature and content of these memories. Before reporting 
this study, I will summarise previous findings about the effects of  intensive care on 
memory, possible causes for the memory effects, and existing knowledge about 
memory effects in PTSD after other sorts of trauma.  
 
7.1.1 Memory of intensive care 
Studies of memory in intensive care fall into two categories; those that tried to find 
out to what extent patients could recall the ICU and what ICU experiences they 
recalled; and those that were interested in categorising types of memory such as 
“traumatic”, “factual” or “delusional” (based on hallucinations or other unreal 
experiences) memories. Many of the latter studies were designed to find out which 
types of memory were predictors of PTSD. In line with anecdotal accounts and 
clinical beliefs, a number of early studies showed that patients had little or no 
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memory for actual events during the intensive care stay (Compton, 1991; Jones et 
al., 1979). In my cohort study, 45.9% of patients said that they remembered very 
little of their stay in the ICU while 29.6% remembered some of the time, and only 
24.5% remembered most of the time. Only 34% of the cohort could remember 
being admitted to the ICU.  
 
However, although patients often believe they remember little about their ICU 
experience, when they are questioned about specific memories they appear to have 
some recall. A number of studies assessed patients’ recall around the time of 
discharge from the ICU. In Rotondi et al. (2002) 67% of a cohort of 150 patients 
who received mechanical ventilation for more than 48 hours remembered either the 
endo-tracheal tube or other aspects of being in intensive care. When interviewed in 
the hospital shortly after their discharge from ICU, they remembered the ICU 
experiences which had bothered them most, such as pain, anxiety, lack of sleep, 
nightmares and loneliness. In a qualitative study by Green (1996) only around 
eight per cent of patients who were interviewed 48 hours after ICU discharge had 
no recollection of the ICU at all. Others had quite vivid recollections, mainly of pain, 
the presence of tubes, panic or fear, and of not knowing where they were.  
Other studies examined patients’ long-term recall months or years after leaving 
ICU. In a study of patient’s recall two years after the ICU (Roberts et al., 2007) 
83% of them still had factual memories of the ICU. The factual memories were 
predominantly about procedures (including “breathing pipe”, CPAP mask, catheters, 
dialysis, dressing changes) comfort (including pain, thirst, fear, security) and staff 
(lovely nurse, hand-holding, snappy answers). Schelling et al. (1998) looked 
specifically at recall of “traumatic” memories. They found that 43% of patients 
recalled no or one traumatic experience (anxiety, respiratory distress, pain or 
nightmares) whereas 57% remembered multiple traumatic experiences. This study 
took place at varying times from six months to up to ten years after the ICU.  
In a study of 289 ICU patients, Rundshagen et al. (2002) discovered that 35% of 
patients had memories from the time before they regained consciousness in the 
ICU.  Around 17% remembered “real” events such as having an endo-tracheal tube 
or being on the ventilator. A further 21.1% of patients remembered dreams, 
nightmares and hallucinations from this time. Jones et al., (2001) was the first 
study to focus particularly on the distinction between factual and delusional 
memories, the latter being defined as memories of vivid nightmares, hallucinations 
or paranoid delusions. They assessed memory at two weeks after ICU discharge 
and found that 20% of patients had delusional memories alone; 18% had factual 
memories alone; 55.5% had both types of memory; and only 6.5% had no 
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memories. Furthermore delusional memories were retained over time, whereas 
factual recall of ICU events declined (16% of patients at two weeks failed to recall 
any factual event, which increased to 37% of patients at eight weeks). Having 
delusional memories without recall of factual events at two weeks was found to be 
a predictor of possible PTSD symptoms at eight weeks (p<.0001).  
Jones et al., (2001) hypothesised that there were two processes leading to 
delusional memories. The first was a general dampening of memory along with 
confusional state, caused by treatment and illness effects such as delirium, sleep 
deprivation and drugs known to affect memory such as opiates, benzodiazepines 
and corticosteroids administered in the ICU. Secondly they proposed that physical 
constraints and social isolation experienced by ICU patients caused an attentional 
shift away from external events and enhanced memory for internal events (such as 
hypnagogic hallucinations). 
Jones et al., (2001) was a small study of 30 fully followed-up patients. Two further 
studies found that early delusional memories of the ICU were a risk factor for PTSD 
(Jones et al., 2003; Jones et al., 2007) Additionally Rattray (2005) found that a 
lack of factual recall of ICU was a predictor for emotional distress at six or 12 
months. Roberts & Richard (2007) found that factual memories were significantly 
less common in delirious patients than non-delirious patients (66% vs 96%; OR 
0.09, 95% CI: 0.01-0.85, p=0.035). These findings began to suggest a 
hypothetical pathway leading from delirious symptoms such as hallucinations in the 
ICU to an absence of factual memories along with the presence of delusional 
memories post-discharge, to the later development of PTSD. 
However other studies did not support this hypothesis. A high quality study of 226 
intubated patients by Samuelson (2007), found that psychological distress two 
months after the ICU was not predicted by delusional memories or by amnesia for 
the ICU. In Schelling (1998), patients with multiple traumatic memories were more 
likely to have PTSD symptoms than patients with one or none (p=0.007). The 
traumatic memory scale used by Schelling (1998) and Stoll et al. (2000), included 
three types of factual memory (pain, respiratory distress, anxiety) and one type of 
delusional memory (nightmares). In my cohort study, although I found a difference 
in outcome between those with and without intrusive memories at discharge from 
the ICU, there was no difference in outcome between those whose intrusive 
memories were “unreal” (or delusional) or “factual”  (mean difference in PTSD 
scores = 0.85; 95% CIs: -6.98, 8.68, p=1.00). There should also be a degree of 
scepticism about whether patients’ “factual” memories genuinely were real or were 
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partly imagined, as there was no way of validating the reality of memories in mine 
or other studies. 
The results of cross-tabulating the two memory variables in my cohort study 
(memory for ICU and early intrusions about ICU) could shed light on the question 
of how and why PTSD develops in ICU patients. As can be seen in table 1.1, of the 
45 patients who said they had very little memory of the ICU, 62.2% of them had 
intrusive memories about intensive care on the point of discharge from the unit. 
Among the 54 patients who remembered some or most of the ICU, only 38.9% of 
patients experienced intrusive thoughts. The chi square test was significant 
(p=0.021). This would suggest that having some conscious memory for real events 
in the ICU was to an extent protective against intrusive memories whereas having 
little conscious memory of the ICU was associated with the presence of intrusions. 
Research in several areas of cognitive psychology supports the view that 
information processing takes place at both conscious and non-conscious levels 
(Epstein, 1994). Memories from  two different types of processing (perceptual and 
conceptual) is thought to be stored in different locations or by different codes 
(Tulving & Schacter, 1990). It may be that these distinctions (which may underlie 
normal and intrusive memories) are more important than the distinction between 
unreal and real memories in predicting psychological outcome after ICU 
Table 7.1: cross tabulation of ICU memory and ICU intrusive memory variables 
 
7.1.2 PTSD and memory systems 
These results suggest dual pathways for post-ICU memory and are consistent with 
the dual representation theory of PTSD (Brewin & Holmes, 2003) that was outlined 
in chapter three. According to this theory, two different types of memory system 
work in parallel using different pathways in the brain. At its most basic the theory 
posits that normal autobiographical memories are processed by the hippocampus 
which is responsible for laying down integrated, coherent representations of 
experience that are registered by the conscious brain (Brewin, 2001). However 
another type of more detailed, emotional memory may occur which bypasses the 
hippocampus, taking a direct route to the amygdala, an emotional centre of the 
   Intrusions - yes or no Total 
    No Yes   
ICU memory some or most 
memory of ICU 
Count 
33 21 54 
    % within ICU memory 61.1% 38.9% 100.0% 
  v little memory of ICU Count 17 28 45 
    % within ICU memory 37.8% 62.2% 100.0% 
Total Count 50 49 99 
  % within ICU memory 50.5% 49.5% 100.0% 
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brain that has an important role in activating fear responses (LeDoux, 1996). These 
emotional memories may come from a lower level processing of sights, sounds and 
physical sensations that were not consciously registered when the event occurred. 
Memories like this, such as intrusive memories, including flash-backs, may be 
triggered automatically by perceptual reminders of events. There is increasing 
evidence that intense stress accompanied by high levels of cortisol can impair the 
hippocampus and encourage processing by the amygdala (e.g. Elzinga & Bremner, 
2002). The narrowing of attention brought about by extreme stress as well as loss 
of hippocampal function means that less information about a traumatic event is 
stored in a consciously available form (Brewin & Holmes, 2003).  
 
This theory has recently been updated to incorporate the latest neuroscience 
relating to memory (Brewin et al., 2010). Key distinctions between types of 
memory that are relevant to the dual theory have been refined. One of these is the 
distinction between voluntary and involuntary memory (Berntsen & Rubin, 2008). 
In contrast to voluntary memory, which is a strategic effortful process, involuntary 
memory is seen as an associative process that is prompted by cues in the 
environment. A new distinction has also been made between autobiographical and 
episodic memory, two types of memory that were traditionally seen as one system. 
However Conway (2005) has proposed that they are separate. Episodic memory is 
seen as an image-based system retaining sensory and perceptual knowledge in the 
posterior temporo-occipital areas for fairly brief periods. To be retained for longer, 
it needs to be integrated with longer-term autobiographical memory, a conceptually 
organised system located in pre-frontal areas. Other key findings concern the 
neural mechanisms behind fearful memories. Involuntary fearful responses, such as 
freezing in rodents or the “startle” response in humans, depend on molecular 
processes in the amygdala (Monfils et al., 2009). These processes connect low-level 
sensory representations to internal representations of emotional states, probably 
supported by the insula.  
In the revised dual representation theory, (Brewin et al., 2010) episodic memory is 
equated with low-level sensation-based memory and is renamed as S-memory, 
with its representations known as S-reps. Flashbacks in PTSD are examples of 
involuntarily recalled S-reps. In a healthy individual, S-reps for an event are 
associated with abstract contextual memories (C-reps in C-memory) in the medial-
temporal lobe (MTL). This connection prevents memories from being re-experienced 
and provides top-down control of S-memories (such as deliberate suppression if 
required) from the pre-frontal cortex. But in PTSD this connection is weakened, so 
that strong sensation-bound memories (S-reps) occur without top-down control 
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from the C-system to provide contextualisation. Therefore vivid visual 
representations are activated and re-experienced as if happening in the present. 
It is currently believed that PTSD involves two different types of memory deficit. 
The first relates to impaired or fragmentary recall of the trauma (which may be 
explained by the dual representation theory, as above). However deficits in general 
memory functioning have also been found in PTSD patients. Deficits have been 
found in verbal and nonverbal memory and learning (Bremner et al., 2000), 
attention (Vasterling et al., 2002), and executive function (Beckham et al., 1998).  
7.1.3 Cognitive deficits after intensive care 
As we saw in earlier chapters, three studies found that cognitive deficits including 
memory impairment were present in more than 30% of general ICU patients six 
months after ICU discharge.  In one of these, a neuropsychological study of 34 
mechanically ventilated patients in a medical intensive care unit (Jackson et al., 
2003), 32% of patients were found to have significant cognitive impairment 6 
months after intensive care. Deficits were found in several domains including 
psychomotor speed, visual and working memory, verbal fluency and visuo-
construction. The rate of neuropsychological deficits in the ICU population was 
higher than population norms for mild dementia. A neuro-cognitive evaluation of 32 
critically ill medical patients who underwent mechanical ventilation for five days or 
more, found that 91% of patients at hospital discharge and 41% at 6 months, had 
cognitive impairments. The cognitive functions primarily affected were attention, 
memory, mental processing speed and executive function (Hopkins et al., 2005). In 
a study of 45 general ICU patients, Sukantarat (2005) found that three months 
after ICU 35% of the cohort scored at or below the level of the lowest 5% of the 
normal population on tests of executive function and fluid intelligence. At nine 
months, cognitive performance remained below normal but there had been 
improvements since three months. In an informal review of the evidence from nine 
cohorts of ICU patients (mainly with ARDS), Hopkins & Brett (2005) concluded that 
neuro-cognitive impairments were extremely common at hospital discharge, and 
that despite improvement between six and 12 months, many patients had 
significant cognitive impairment at time-points between six months and six years. 
Domains most commonly affected were memory, attention and executive function.  
Deficits in general memory functioning, in addition to other cognitive problems, are 
therefore not uncommon after the ICU. A case could be made that the formation of 
intrusive memories under conditions of extreme stress, along with general deficits 
in memory functioning, combine to make former ICU patients highly vulnerable to 
developing PTSD. Memory impairments that have been found in ICU patients such 
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as problems with psychomotor speed, attention and verbal memory, may also 
contribute to the high prevalence of depression after intensive care (Marazziti et al., 
2010). 
Jones et al., (2000) discussed many ICU factors that could contribute to 
fragmented memory and amnesia including delirium and sleep disturbance; 
physical restraint, visual deprivation and social isolation; and therapeutic drugs 
including anaesthetics such as propofol, benzodiazepines such as midazolam, 
opiates, adrenaline and corticosteroids. Many of these factors and their effects on 
the brain were considered in chapter three; However it is worth considering further 
the effects that many ICU drugs might have on memory. 
According to Ghoneim (2004b) a wide variety of drugs, including benzodiazepines, 
anticholinergic agents, anaesthetics and others impair memory. Many of these 
amnesic drugs are used in the ICU. Although the drugs have a wide diversity of 
chemical structures, they seem to produce similar profiles of memory impairment. 
Some general characteristics of amnesic drugs listed by Ghoneim (2004b) are: 
• Acquisition of new information is impeded – anterograde amnesia 
• Episodic but not semantic memory is impaired 
• Explicit memory is much more impaired than implicit memory 
• Learning of skills or procedures usually remains intact 
• The degree of amnesia is related to dosage, additive effects of other drugs 
and ageing 
These effects fit in with the evidence discussed above that conscious contextualised 
memory processing may be impaired in the ICU, while unconscious emotional 
memories are unaffected. This phenomenon may encourage the production of 
fragmentary, intrusive memories that break through into normal consciousness. But 
are there also any features of the action of ICU drugs that would contribute to the 
persistence of unreal (delusional) as opposed to real (factual) memories? Little is 
known about this area but in some studies it was noticed that when patients who 
had taken benzodiazepines (as with marijuana) were given memory tests they were 
more likely than others to falsely recall words that were not on the original list 
(Gorissen et al., 1998; Mewaldt & Ghoneim, 1979). It is possible that the action of 
benzodiazepines increased irrelevant associations from semantic memory or led to 
disinhibition in recall. Could this be linked to the memory distortions that occur in 
post-ICU patients, including the production of delusional memories?  
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7.1.4 Parallels with post-psychosis PTSD 
The experience of unreal (delusional) intrusive memories after intensive care has a 
parallel in the literature on post-psychotic PTSD. Acute psychosis is defined as the 
presence of delusions, hallucinations or marked formal thought disorder (World 
Health Organisation, 1990). Although the reasons for experiencing hallucinations 
and delusions are different for intensive care and psychotic patients, the distress 
they cause and subsequent mental impact may be similar. Shaner & Eth (1989) 
reported a PTSD-like reaction in a patient with schizophrenia and McGorry et al. 
(1989) found that the prevalence of PTSD after admission for an acute psychotic 
episode was 46% at four months and 35% at 11 months. Hypotheses for the 
aetiology of post-psychosis PTSD were that persecutory delusions would be 
associated with post-traumatic reactions because they were particularly frightening 
(Shaw et al., 2002), and that hospitalisation experiences (Shaw et al., 1997) such 
as seclusion, receiving involuntary treatment and ECT would be potentially 
traumatic. A study by Meyer et al. (1999) found that delusional symptoms were 
more traumatic than the coercive measures used to control them, as 69% of 
traumatic symptoms were related to psychosis and 24% to hospitalisation. In Shaw 
et al. (2002) memories of persecutory delusions and visual hallucinations were 
among the intrusions found with greatest frequency in a post-psychotic PTSD group 
compared to a non-PTSD group.  
The brief review of the literature on memory in intensive care above (section 7.1.1) 
showed that findings were sparse and inconsistent. Most of the studies tended to 
define memories in different ways, to measure memories in different ways and at 
different times. It was not always clear whether memories were predictors or 
outcomes. Different authors focussed on traumatic memories, general recall, 
factual memories or delusional memories. As my cohort study found the most 
important distinction to be between those who had intrusive memories of the ICU 
(probably linked to emotional, involuntary, sensation-based memory systems) at 
the point of discharge from the ICU, and those who had no intrusive memories, I 
decided to carry out a further study to discover more about intrusive memories of 
the ICU. I wanted to look at the persistence and content of these memories at 
three months. As there has been little success to date in analysing the effect of 
patients’ memories on ICU outcomes using questionnaires, I decided to carry out a 
small interview study. The study was developed with guidance from a leading 
expert on psychological processes in PTSD, Christopher Brewin, professor of clinical 
psychology at UCL. A structured interview that has been used with other PTSD 
populations (Patel et al., 2007) was used for the first time to examine the content, 
vividness, frequency and emotions associated with patients’ memories of intensive 
care.  
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7.2 Methods 
 
7.2.1 Aims  
(i) To investigate the nature and content of intrusive memories of intensive care 
that patients experienced in the months after discharge from intensive care.  
(ii) To quantify levels of distress and impairment associated with post-ICU intrusive 
memories.  
(iii) To find out if patients require support in managing intrusive memories after   
intensive care, and what types of support would be helpful. 
 
7.2.2 Participants 
A sub-group from the main cohort of ICU patients and from the pilot of the follow-
up study was interviewed for this study. Patients were invited to participate in this 
study if they had positive scores (2 or 3 out of 3) on the first or second items of the 
PDS (Foa et al., 1997): 
 1. Have you had upsetting thoughts or images about your time in intensive care 
that came into your head when you didn’t want them to? 
2. Have you had bad dreams or nightmares about your time in intensive care? 
A total of 26 participants from the cohort study had these scores.  Three patients 
from the pilot follow-up study were also eligible for the interview study. Of the 29 
patients who were therefore eligible to participate in the study, 12 were not 
recruited. Five of them declined, either because they were physically ill around the 
time of the interviews, or because they found it upsetting to talk about the 
memories and were trying to put the experience behind them. Three patients did 
not reply to messages about the study, and one patient did not turn up for a pre-
arranged meeting. One further patient agreed to participate but when we spoke 
told me that he was no longer bothered by the memories at all. I did not manage to 
contact the last two patients before closing the study. However I already had a 
sample of 17, well within my projected sample size of 10-20 patients. 
7.2.3 Procedure 
When I received the postal follow-up questionnaires for the cohort study about 
three months after discharge from ICU, I phoned participants who gave a positive 
response to items 1 or 2 on the PDS, explained the memory study to them and 
asked them if they would be willing to do a phone interview with me about the 
nature of their memories of the ICU. This study had been described in the PIS they 
received in intensive care, although it is unlikely that any of them remembered it. If 
they agreed, I wrote them a letter enclosing a copy of the interview (appendix 14) 
and reminding them of the date and time that I would phone them. I then phoned, 
asked them to have their copy of the interview in front of them and carried out the 
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interview. I began by asking them to focus on two main memories of the ICU (if 
they had any). I took notes on their description of the memories, and marked their 
ratings scales with them. Conversations were tape recorded after seeking their 
permission. The length of time taken for interviews ranged from 30 minutes (as 
expected) to one and a half hours (as some patients found they had a lot to say 
about their memories). Two patients filled the interview form in on receipt and sent 
it back to me. This was a less successful method than carrying out an interview 
over the phone, and I phoned them in order to clarify their answers. The average 
time between ICU discharge and the interview was five months (range four to eight 
months). I will call the time at which interviews were carried out time three. 
 
7.2.4 Measure 
The Intrusions Interview (Patel et al., 2007). This is a structured interview 
designed to elicit the presence and content of intrusive memories, images and 
thoughts about a trauma. For simplicity I asked only about intrusive memories. I 
also adapted the interview to refer specifically to memories of intensive care (see 
appendix 14 for my version of the Full Intrusions Interview). It should take about 
30 minutes to administer. I asked patients if they had any spontaneous memories 
of their time in intensive care that came to mind repeatedly over the past week. If 
the last week was exceptional they were asked about a typical recent week. Only 
the two most frequent and distressing memories were explored further in the 
interview. Patients were asked to describe the content of their memories in as 
much detail as possible. Memories were defined as visual pictures of events that 
happened to the participant. Ratings scales were completed to assess the frequency 
and duration of each memory, vividness of the memory, emotions accompanying 
the memory, sense of “nowness” and re-experiencing of physical sensations and 
emotions that were present in the ICU. The impact of the memory was assessed by 
rating interference with daily activities, uncontrollability of the memory and distress 
caused by the memory in the past week. I made some further adaptations to the 
interview. First in order to simplify ratings that were being done over the phone, 
patients were given a choice of responses (e.g. not at all, a little, somewhat, very 
much so) rather than rating their experience from 0 to 100. Items were scored 
from 0-2 where three response options were given, or 0-3 if four response options 
were given. 
I also added a section on “help” with intrusive memories of the ICU as I was 
interested to find out if patients recovering at home had wanted or been able to get 
help with these memories if they found them distressing. I asked:  
1. Do you feel you need some help with these memories? 
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2. Have you been to the ICU follow-up clinic? Did it help with the memories? 
2. Have you tried to get any other type of help? If so, give details. 
4. What kind of help would you ideally like? 
 
7.2.5 Ethics 
Several patients felt they were becoming quite upset during the interview because 
it reminded them of memories or activated memories. I found that having the 
“help” section at the end of the interview was useful because it distracted their 
attention from the memories and brought us back to a more normal type of 
conversation. I would check with them several times that they were feeling “OK” 
and chat to them about lighter subjects before drawing the conversation to a close. 
If they felt they needed help with their intrusive memories I would offer to put 
them in touch with the follow-up clinic to get an appointment, or discuss other ways 
of getting help such as contacting their GPs if that was their preference. 
7.2.6 Analysis 
i) Content of memories The results of the qualitative section of the intrusions 
interview were analysed using a simple type of content analysis as recommended 
by Patel et al. (2007) in which all memories were assigned to particular categories. 
In the present study categories were not pre-decided. As little is known about the 
type of intrusive memories experienced by patients in the months after intensive 
care, it was important that categories should emerge from, rather than be imposed 
on patients’ interviews. Therefore I carefully scrutinised all seventeen interviews 
and extracted the most common categories. This initial analysis revealed a clear 
distinction between intrusive memories of hallucinations and delusions experienced 
in the ICU (which I labelled unreal memories rather than delusional memories) and 
memories of real events in the ICU (labelled factual memories).  Results of the 
content analysis are seen in table 6.4. First, the number of memories or images 
described and the types of memories (factual, unreal, both/unsure) were 
recorded. Second, content was categorised in the following ways:  
1. Memories of medical or care procedures 
2. Memories of pain or physical horror  
3. Memories of ICU environment 
4. Memories of visual hallucinations or delusions  
5. Memories concerning inter-personal relationships 
6. Memories involving shame or guilt  
7. Memories relating to control and information 
8. Memories concerning death and the afterlife. 
 
 
223 
 
ii) Characteristics of memories 
Results for characteristics of memories such as vividness, associated emotions, 
“nowness”, duration, frequency, distress, uncontrollability and interference in daily 
life were calculated as mean scores out of three with standard deviations, and then 
multiplied by 100 to give percentages, to aid comprehension.   
iii) Help 
Content analysis was used to interpret the four questions about patients’ perceived 
need for help with intrusive memories and help-seeking. 
 
7.2.7 Statistical analysis 
Although this was a small interview study designed to generate rather than test 
hypotheses, a limited amount of statistical analysis was carried out to look for 
possible associations between memory data from the interviews, and previously 
collected data such as delirium at time one, intrusive memories at time one and 
PTSD at time two. However I recognised that the study was not powered to detect 
these associations. 
7.3 Results 
7.3.1 Socio demographic and clinical characteristics of participants 
In table 6.2 it can be seen that the 17 participants in the memory study were 
younger than the rest of the original ICU cohort (53 vs 58 years), more likely to be 
women (53% vs 47%) and more likely to be in the most deprived quintile of the 
population (60% vs 33%). Their average illness severity score at admission to the 
ICU (19.27) was approximately three points lower than the rest of the cohort, but 
the intensity of intervention score was the same (24.60). A much larger proportion 
of memory study participants were surgical admissions than the original cohort 
(53.4% v 34.2%). The respiratory system was the primary body system affected in 
40% of the memory patients compared to 28.2%. Memory study participants spent 
fewer days in the ICU than the rest (11.40 vs 13.94) but had more days of sedation 
(3.80 v 3.13 days). More had received anxiolytics (73.3% vs 56.5%), inotropes 
(53.3% vs 45.9%) and opiates (100% vs 91.8%) than the original cohort. None of 
these comparisons were statistically significant, but the sample size was small.  
Summary: The 17 participants in the memory study were younger, female and 
more likely to come from the most deprived quintile than the rest of the cohort. 
They were more likely to be surgical patients with the respiratory system as the 
primary body system involved. They were less sick on admission to the ICU but 
received as much therapeutic intervention and were sedated for longer than the 
rest of the cohort. More of them received anxiolytics, opiates and ionotropes. 
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7.3.2 Psychological scores of participants in ICU and at 3-month follow-up 
In table 7.3 it can be seen that memory study participants had worse total mood 
disturbance in the ICU (32.13 vs 28.48), worse total ICU stress (36.6 vs 32.23) and 
a higher mean delirium score (8.53 vs 8.10) than the original cohort. The mean 
differences were not significant, probably due to the small sample size. The 
proportion who remembered very little of their ICU experience was about the same 
in both groups (46.7% vs 45.2%). Many more of the memory study participants 
had had intrusions while still in intensive care than the rest of the cohort (73.4% vs 
45.2%). More memory study participants had also had “unreal” intrusions in ICU 
than the rest (33.4% vs 22.6%). Furthermore memory participants were 
significantly more distressed by the intrusive memories they experienced in 
intensive care than others (4.18 vs 1.89, p=0.004). At time two their PTSD scores 
were significantly higher than the rest (23.07 v 12.47) and their depression (25.70 
vs 19.58) and anxiety scores were also higher (48.36 vs 42.88). The prevalence of 
PTSD (46.7% vs 23.5%), depression (60% vs 43.7%) and anxiety (66.7% vs 
43.5%) was higher among these participants than the rest of the cohort.  
Summary: The participants in this study had more psychological distress and 
problems with intrusive memories than the rest of the cohort at both time one and 
time two.  
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Table 7.2 Sociodemographic and clinical characteristics of interviewees 
 
 
 
 age Deprivation 
(IMD) a 
Sex Admission 
type b 
Primary 
body 
system c 
Apache 
II 
 TISS LoS in 
ICU 
Drugs Days  
sedation 
Mean - 
interviewees 
 
53.1     19.27 24.60 11.40  3.87 
SD 15.96     6.39 3.66 8.19  6.28 
Minimum 29.00     12.00 18.00 2.00  0.00 
Maximum 89.00     31.00 32.00 31.00  24.00 
Mean – rest of 
cohort  
58     22.49 24.61 13.94  3.00 
 
p-significance of 
mean difference 
0.314     0.109 0.993 0.551  0.468 
N (%) - 
interviewees 
 1 2(13.3%) 
2 2(13.3%) 
3 2(13.3%) 
5 9(60%) 
Men 
7(46.7) 
Women 
8(53.3) 
0 4(26.7%) 
1 4(26.7%) 
2 7(46.7%) 
1 6(40%) 
2 2(13.3%) 
3 5(33.3%) 
 
   Anxiolytics 
11 (73.3) 
Opiates 
15 (100%) 
Ionotropes 
8 (53.3) 
 
N(%) - rest of 
cohort 
 1 10(12.2%) 
2 8(9.8%) 
3 20(24.4%) 
417(20.7%) 
5 27(32.9%) 
Men 45 
(52.9%) 
Women 
40 
(47.1%) 
0 19(22.4%) 
1 10(11.8%) 
2 56(65.9%) 
1 24(28.2%) 
2 15(17.6%) 
3 24(28.2%) 
 
   Anxiolytics 
48 (56.5%) 
Opiates  
78(91.8%) 
Ionotropes
39 (45.9%) 
 
p-significance of 
mean difference 
 0.167 0.654 0.238 0.937    0.221,0.249 
0.594 
 
 
 
a) Index Multiple Deprivation (Communities and Local Government, 2010). Quintile 1= least deprived, quintile 5=most deprived 
b) Type of admission 0=elective surgical, 1=emergency surgical, 2=non surgical 
c) Primary body system, 1=respiratory, 2=cardiovascular, 3=gastro-intestinal 
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Table 7.3: Interviewees’ psychological scores at time one (discharge from ICU) and time two (3 months) 
 
 Mood  
ICU 
Stress  
ICU 
Delirium 
ICU 
Memory of ICU 
at discharge 
ICU Intrusive 
memories (IMs) 
at discharge 
Distress re 
IMs in  ICU 
PTSD 3m Depression 
3m 
Anxiety 
3m 
Mean this 
study 
32.13 36.60 8.53   4.18 23.07 25.70 48.36 
SD 10.30 12.70 3.80   1.78 10.70 16.39 15.03 
Poss min 0.00 00.00 0   0  0.00 0.00 0.00 
Poss max 60.00 72.00 20   7 51.00 60.00 80.00 
Mean 
rest of 
cohort 
28.48 32.23 8.10   1.89 12.47  19.58 42.88 
p-values 0.366 0.225 0.762   0.004 0.001 0.121 0.188 
N(%)    Very little 
7 (46.7%) 
Some/most  
8 (53.3%) 
None     4 (26.7%) 
Factual  6 (40%) 
Unreal   5 (33.4%) 
 
 Prevalence 
46.7% 
Prevalence 
60% 
Prevalence 
66.7% 
% Cohort    Very little  
38 (45.2%) 
Some/most   
46 (54.8%) 
 
None    46 (54.8%) 
Factual 19(22.6%) 
Unreal  19(22.6%) 
 Prevalence 
23.5% 
 
Prevalence 
43.7% 
Prevalence 
40.5% 
p-values    0.918 0.128     
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7.3.4. Content Analysis of Intrusive Memories 
(i) Number of patients with factual or unreal intrusive memories at time of interview 
Seven patients had only unreal intrusive memories.  
Two patients had only factual intrusive memories. 
Eight patients had both factual and unreal memories. 
 
(ii) Number of types of memory 
 
The total number of unreal memories recorded was 21. 
The total number of factual memories recorded was 15. 
The total number of mixed unreal/factual memories was five. 
 
(iii) Content of Intrusive Memories 
 
a)  memories of ICU procedures. 
 
Ten people had memories relating to ICU procedures.  
Four memories concerned feelings of panic and suffocation when wearing ICU face 
masks. Patients remember fighting the masks and having them forced on them. 
Three memories were related to tubes that were inserted in the ICU, either breathing 
tubes connected to the ventilator or feeding tubes. 
Other memories about ICU procedures included choking during suctioning, having 
injections, having a stoma bag fitted, being constantly tested. 
 
b) memories of physical horror or pain 
 
Four people had memories or images of physical horror or pain.  
Three memories were about being covered with blood or coughing up blood.  
Two were about cannulae: Fear of having them inserted, or being covered in them.  
Three memories were of extreme pain. 
 
c) memories about the ICU environment 
 
Five people had memories concerning the ICU environment. 
In four of these memories, ordinary aspects of the ICU environment including noises, 
lights, machines or curtains kept turning into shapes, faces or animals. One memory 
was of the belief that the air conditioning unit was pumping out poison. 
One environmental memory was a view from the window of the ICU that triggered a 
fear of the outside world. 
 
Table 7.4: Nature and content of patients’ intrusive memories at time of 
interview(T3) (see next three pages) 
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Name 
(Not 
real 
name) 
Number/ type 
memories: 
F=factual 
U=unreal 
B=both 
Content:  
ICU 
Proced-
ures 
Content: 
Physical 
horror/ 
pain 
Content: 
Environ-
ment 
Content: 
Hallucinations
/delusions 
Content: 
Inter- 
personal 
Content: 
Shame 
Guilt 
 
Content : 
Control/ 
Informed 
Content: 
Death/ 
afterlife 
Anna 1. Money 
laundering U 
2. Poisoned air-
con U 
3. Man with 
nurses harem U 
4. Same man in 
her bed U 
  Air-con is 
morphine 
poisoning 
me. 
Refusing to 
drink or 
clean 
teeth. 
Nurses after 
organs; doctors  
operating and 
taking patients’ 
money. If you 
pay more you 
get more 
anesthetic.  
Nurses  
dressing 
up, getting 
in bed with 
patient. 
Same man 
in my bed 
behind me. 
   
Franco 1.About to die B 
2.Procedures  F 
Daily 
events in  
intensive 
care, 
pleasant or 
unpleasant 
      Ready to 
meet the 
Lord and 
souls of 
relatives. 
Mysteries 
of life. 
Sally 1. Noise, lights,  
    smells B 
2. people saying  
“she is dying” B 
  Lights 
on/off all 
the time.  
Machines 
+ alarms. 
Smells 
    Nurses, 
doctors 
saying I’m 
going to 
die 
Colin 1. Coughing up 
blood F 
2. Tube in neck 
F 
3. Universal 
logo U 
Coming 
round on 
the 
respirator. 
Feeling of 
choking 
during 
suctioning. 
Having to 
cough up 
blood. Pain 
wakes me 
from coma 
when tube 
sticks in 
ambulance 
man’s coat  
 Keep seeing 
psychedelic sign 
like Universal 
film logo– 
orange, yellow, 
blue, 
    
Karen 1. Dead, in 
purgatory U 
2. Warning 
patient about a 
trial U 
 
   Am a prisoner 
tied down by 
tubes. Going to 
be killed. Nurses 
using a bay as 
mock courtroom 
to put patient 
on trial. 
 
 
 
Embarra-
ssment - 
shouting 
to patient 
to escape 
from  
trial 
 Already 
dead  in 
purgatory 
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Name 
Number/type 
memories 
Proced-
ures 
Physical 
horror 
Environ-
ment 
Hallucinations Inter- 
personal 
Shame 
Guilt 
Control/ 
Informed 
Death/ 
afterlife 
John 1. Very detailed 
hallucination  - 
nurses being 
paid to turn 
patients into 
zombies and kill 
them.         U 
Trigger: 
Nurses 
giving an 
injection to 
put me to 
sleep. 
  Pushed in trolley 
to basement of 
dying people. 
Family in abbot 
cloaks taking 
souls. Jumped 
out but ended 
back in ward. 
Shaking 
feet at 
nurses to 
repel 
them.  
  In coffin; 
tell wife-
she can 
remarry 
but she 
asks me to 
stay  
Paul  1. Nurse 
shaving Indian 
boy   U 
2. Was paid 
assassin      U 
   Going on bus in 
dressing gown 
to post office. 
Want nurse 
shaving Indian 
boy to shave me 
too. Fly to 
Brazil, shoot 3 
people on roof 
then fly back 
 “I am 
guilty” –
an 
assassin 
  
Dora 1. Hallucinations 
– several         
U 
2. Endless 
procedures. 
3. Isolation   F 
Refusing 
refit of 
feeding 
tube that 
punctured 
lung. 
Fighting 
mask. 
Pulling 
tubes. 
  Tropical beach 
bar. On a train 
at Checkpoint 
Charlie in 
Eastern bloc 
during WW2.  
Feeling  
apart from 
visitors, 
unable to 
communic-
ate and 
irritated. 
 Sense of 
dependen-
cy. Having 
to ask for 
bedpans 
etc 
Can’t sleep 
or breathe, 
temper-
ature up, 
down, 
think I’m 
dying 
Aysha 1.Distress at 
nasal breathing 
tube F 
Pain from 
tube 
Pain from 
tube 
    Nurse 
making me 
keep tube 
but doctor 
removes it 
 
Raj 1. Row with wife 
F 
2. Being 
attacked by 
religious cult U 
3. Stomas bags  
F 
Waking up 
to see 
nurse 
cutting up 
stoma 
bags. 
Nurse 
making me 
wear mask 
  Bahai cultists 
attacking me. 
Friend of mine 
ordering staff to 
sell NHS drugs 
to fund religion, 
lifestyle. I have 
to endorse it.  
 
Re-stoma, 
nurse not 
nice or 
caring. 
Unsympa-
thetic. 
Tell wife 
to drive 
me home 
from 
UCH or 
“me and 
you are 
finished” 
Didn’t 
know I  
had a 
stoma bag. 
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Name 
Number/type 
memories 
Proce-
dures 
Physical 
horror 
Environ-
ment 
Hallucinations Inter- 
personal 
Shame 
Guilt 
Control/ 
Informed 
Death/ 
afterlife 
Laura 1. Windows fear 
of life outside F 
2. Told off by 
nurses B 
3. Covered in 
cannulae      F 
Walking to 
window - 
v. weak.  
Prodded 
and poked 
 
Covered in 
cannulae 
leaking. 
Swollen feet, 
felt removed 
from body 
Seeing 
buildings -
scared  at 
life going 
on outside. 
 Calling for 
help.Told 
off, buzzer 
taken 
away 
   
Isaac 1. Square mask  
F 
2. Hallucinatory   
    visions       U 
Panicking 
about 
mask- had 
to be 
forced on. 
 Lights 
noise  
mixed up 
with unreal 
imagery 
Lots of vivid 
shapes and 
colours. Ward 
looks like 
seaside posters. 
Nurses’ 
banter – 
finding it 
funny. 
   
Owen 1. In America, 
felt threat      U 
2. Violent 
fighting in 
Denmark     U 
   1920s USA-kind 
people yet feel a 
threat. Also in 
Danish village 
avoiding fights 
Youngest 
son in the 
dreams- 
makes me 
feel happy. 
   
Kate 1. Heard mum 
outside sobbing 
U 
2. Puffins firing 
blood with 
plastic guns  U 
   Puffins jumping 
out of curtains 
firing blood at 
me. Crazy birds 
jumping on  bed 
laughing 
Hearing 
voices 
from past, 
mum 
sobbing  
  Nurse  
between 
curtains 
saying 
“she’s 
gone” 
Nora 1. Face mask   F 
2. Having a tube 
inserted        F 
 
Suffocating 
with mask 
- air forced 
in fast 
Fear /pain of 
tube going 
deep into 
artery 
   Double 
inconti-
nence. 
Burden  
  
Magda 1 Begging to go  
to toilet    B 
2 V. pain F 
3  Blood leak  F 
4 Nurse alien  U 
Extreme 
pain clean-
ing “nappy 
rash”  
every few 
minutes 
Screaming in 
extreme 
pain. Wake 
up covered 
in blood. 
 Nurse alien with 
staring eyes, 
head pecking up 
and down like 
chicken. 
Nurses 
torturing 
me, 
putting 
knives in 
my bottom 
Having to 
go to 
toilet in 
bed. Lack 
of dignity 
Desperate 
to walk to 
toilet.Don’t 
realise I 
can’t walk. 
 
Terry 1 Killing Amy 
Winehouse     U 
2.Body parts  U 
3 Scary faces U 
  Bottle 
racks in 
turn into 
figures. 
Faces in  
curtains 
Animals 
running 
across 
floor 
See Amy Wine- 
house and baby 
- car sliding into 
water. Staff 
stealing family’s 
body parts. 
Porters take me 
to gas chamber. 
 I am 
respons-
ible for  
death of 
AW -
police 
are after 
me. 
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(iii) Content of  intensive memories continued…. 
d)  memories of hallucinations and delusions 
 
Twelve patients had memories of hallucinations or delusions.  
Five were memories of persecutory delusions involving hospital staff. They were 
detailed, terrifying narratives about doctors and nurses stealing organs and money, 
and trying to kill patients or turn them into zombies. Imagery of emprisonment, trials, 
religious cults, poisoning and torture recurred.  
Three memories were exotic foreign adventures. Two were frightening and violent. 
Two memories were bizarre as well as frightening – one about Amy Winehouse and 
her baby drowning; one about puffins firing blood at the patient from plastic guns. 
Two memories were simple sensory hallucinations of colours and shapes. 
One memory was a frightening image of a nurse turning into an alien. 
 
e) memories involving interpersonal relationships  
 
Eleven memories involved interpersonal encounters or relationships. 
Seven memories were about nurses: three were sexual or persecutory delusions, 
three were negative memories of nurses being unsympathetic, and one was a  
positive memory of hearing nurses bantering and finding it funny and enjoyable. 
Three memories were about family members; two sad ones in which the patient felt 
distant from their family; one happy one in which they felt safe and close.  
One memory was a sexual/persecutory delusion about another patient. 
 
f)  memories involving shame or guilt 
 
Six memories were coloured by a sense of shame or guilt.  
Two related to incontinence, two were about behaviour the patients felt had been 
inappropriate such as shouting, and two featured guilt as part of delusions. 
 
g)  memories about loss of control or information 
 
Four memories related to loss of control or lack of information.  
Two were about feeling dependent on staff for toileting. One was about a lack of 
information about stoma bags. One was about feeling in control, after persuading a 
doctor to remove an uncomfortable tube against the nurse’s wishes. 
 
h)  death/afterlife   
 
Six memories featured death. In two memories, people saw themselves as dead – 
one was in his coffin, one was in purgatory. 
Three memories were snapshot images of doctors or nurses saying the patient was 
going to die (patients were unsure if this was real or imagined) 
One memory was mystical; about many people preparing for the after-life. 
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7.3.5 Summary of content analysis of memories 
Unreal intrusive memories of hallucinations or delusions were predominant among 
this group of patients. These included persecutory delusions, bizarre delusions and 
visual hallucinations. Most of the memories were extremely frightening and some 
were also coloured by a sense of shame, guilt or loss. Memories concerning 
interpersonal relationships were mainly persecutory or sad (due to a lack of sympathy 
or understanding from others). Factual memories were much less common than 
unreal memories. They were concerned with pain, fear of face-masks or tubes, or 
horror at blood and needles. In some memories real and unreal experiences were 
confused, as when features of the intensive care unit changed into unusual sights and 
sounds. 
7.3.6   Ratings of features of intrusive memories  
In this section ratings are given as mean scores out of 3 (except frequency, rated 1-
4) and also as a percentage of 100. For other descriptive statistics see table 7.5. First 
memory was the one that patients chose to discuss first in the interview. 
 
First memory: The first memory that patients chose to describe was very vivid and 
clear (mean =2.12, equivalent to 69%). The most intense accompanying emotions 
were anxiety (1.65, equivalent to 55%) and helplessness (1.89, 63%).  Sadness and 
anger were also present (1.18 or 39.3% each). The extent to which the memory was 
felt to be re-experienced was scored 1.00 (33%). Emotional re-experiencing was 
rated at 1.18 (39.3%); reliving physical sensations at 0.47 (15.6%). The average 
duration of the memory was 5.86 minutes. The frequency of experiencing memories 
was 1.75 (44%). Interference with daily life was rated quite low at 0.65 (22%). 
Memories were rated as 1.25 (42%) uncontrollable and caused much distress (1.75, 
58.3%). Finally 47% of first memories were of hallucinatory or delusional 
experiences, 35% were of factual events, and 17% were a mixture of both. Therefore 
64% of first intrusive memories were wholly or partly unreal.  
 
Second memory: Again the memory was very vivid (0.64, 65%). Most notable 
emotions accompanying the memory were anxiety (1.65, 55%) and helplessness 
(1.93, 64.3%). The extent to which the memory was felt to be re-experienced (0.64, 
21%) was less than the first memory. Emotional re-living was rated as 0.93 (31%) 
and physical re-experiencing was 0.54 (18%). The second memory was shorter than 
the first and lasted 2.32 minutes on average. It was also less frequent (1.23, 
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33%). Interference was higher (0.71, 23%), but memories were less uncontrollable 
(0.93, 31%) and distressing (1.29, 43%). Compared to first memories recalled, a 
higher proportion of second memories recalled were of factual events (40%). 
Therefore 60% of second memories recalled were wholly or partly unreal. 
Prevalence of re-experiencing memories 
Six out of 17 patients had a high rating (scores of either 2 or 3) for re-experiencing 
the first ICU memory as if it were happening to them now. Nine patients said the 
feeling of re-experiencing their memories had been much stronger in previous weeks, 
before the week of the interview. But this included two patients who rated re-
experiencing at 2 out of 3 at the time of the interview. Therefore 13 (76.4%) of the 
17 patients interviewed for the memory study had a strong sense of re-experiencing 
their main memory during the week of their interview or in the weeks before the 
interview. 
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      Table 7.5 Ratings for characteristics of post-ICU intrusive memories at time of interview  
 
 
 
 
 
 
 
      
 Vivid
-ness 
Emotions 
associated 
with 
Intrusive 
Memories 
Extent 
of 
reliving 
Reliving 
emotion 
Reliving 
physical 
Duration 
of IMs 
now  
Frequency 
of IMs now 
Interf-
erence 
 
Control-
lability 
Distr-
ess 
Unreal 
Factual or 
both  
    N %) 
Memory 
one 
Mean    
2.12 Sad 1.18 
Guilty 0.65 
Ashamed 1.06 
Angry 1.18 
Anxious 1.65 
Helpless 1.89 
1.00 1.18 0.47 5.86 1.75 0.65 1.25 1.75 8 (47%) U 
6 (35.%) F 
3 (18%)B 
 
SD 0.781  1.23 1.05 0.94 6.24 0.93 0.93 1.24 1.18  
Minimum 0 0 0 0 0 0.25 1 – once or 
twice weekly 
0 0 0  
Max-
imum 
3 3 3 3 3 20 4  - many 
times a day 
3 3 3  
Memory 
two 
 Mean 
1.93 Sad: 0.79 
Guilt: 0.57 
Shame: 0.64 
Anger: 1.29 
Anxious:1.65 
Helpless:1.93 
0.64 0.93 0.54 2.32 1.23 0.71 0.93 1.29 7 (46%) U 
6(40%)   F 
2 (13%)  B 
 
SD 0.917  1.15 0.99 0.78 3.27 0.60 0.73 1.21 0.99  
Minimum  0 0 0 0 0.25 1 0 0 0  
Max-
imum 
 3 3 3 3 10 4 3 3 3  
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     Table 7.6 Memory, delirium and intrusions in ICU, and intrusions and outcomes in the months after ICU 
                      (U=Unreal, F=factual, B=both) 
Name 
  
Delirium 
at T1 
(0-20) 
Memory 
of ICU 
at T1 
Intrusive 
memories 
of ICU at T1 
Content of IMs 
at T1 
Frequency 
of IMs at 
T1 
Distress 
at IMs at 
T1 
Number/Content of IMs 
at T3 
PTSD 
score 
at 3m 
Depression 
score at 
3m 
Anxiety  
score 
at 3m 
Anna (4)     5.00 Some 
/most 
 None                                  1. Money laundering U 
2. Poisoned air-con   U         
3/4. Man with harem U 
 9.00     5.00  40.00 
Franco(10)    12.00 Some/ 
most 
None                                     1. About to die          B 
2. Meaning of life      B 
18.00    37.78  73.33 
Sally (9)     9.00 Some 
/most 
Yes, U Unreal voices 
no sense          
2.00      5.00 1. Noise lights smells B 
2. “She is dying”        B 
34.00    48.00  63.33 
Colin (34)     5.00 V.little Yes F Tubes, shock, 
suctioning 
 2.00      3.00 1. Coughing up blood F 
2. Tube in neck          F 
11.00      .00  30.00 
Karen(39)    17.00 Some 
/most 
Yes, B CT scan, 
hallucinations          
3.00      3.00 1. Being a prisoner    U 
2. Patient  on trial     U 
32.00    26.00  56.67 
John (44)     6.00 Some 
/most 
 Yes U Dream noises              1.00     5.00 1. Nurses turning 
patients into zombies U 
14.00     5.00   36.67 
Paul (61)     5.00  V. little Yes, U Assassin, 
opium dens 
1.00      5.00 1. Nurse shaving boy U 
2. Was paid assassin  U 
36.00    28.00  30.00 
Dora (48)    12.00  Some/ 
most 
 Yes F Struggling to 
breathe. Fear 
1.00      5.00 1. Hallucinations        U 
2. Endless procedures F 
35.00    52.00  56.67 
Aysha 
(57) 
    3.00  Some/ 
most 
 Yes F Tubes, hard to 
breathe.         
1.00       3.00 1. Pain from nasal  
Tube                         F 
10.00    15.79 52.00 
Raj (31)    10.00 V. little  Yes U Trying to 
escape home 
in car     
3.00      6.00 1. Row with wife        F 
2. Religious cults      U 
3. Stomas bags         F 
30.00    31.00 46.67 
Laura (82)     7.00  V.little Yes  F Procedures 
Conversations        
4.00      5.00 1. Trying to walk.      F 
2. Told off by nurses  B 
3. Multiple cannulae   F 
16.00    13.00 30.00 
Isaac(88)    11.00  Some/   
most 
 None                                 . .  1. Square mask      F 
2. Visual hallucinationU 
 36.00    27.00 50.00 
Owen (93)    11.00   V.little  Yes  F Operation 
went wrong 
. . 
 
1 In US,felt threats  U 
2.Violence in Denmark 
 33.00    33.00  50.00 
Kate (100)     5.00  V. little  None   . . 1. Mum sobbing       U 
2. Puffins firing blood 
with plastic guns     U 
14.00    13.00 20.00 
Nora (96)    10.00  V. little  Yes  F Mask pressure 
suffocation 
3.00      6.00 1. Face mask        F 
2. Tubes inserted  F 
18.00    36.00 70.00 
Magda No data No data No data  No data                          No data No data 1. Begging for toilet B 
2. pain F 3. Blood  F 
4. Nurse alien U 
No 
data?? 
  
Terry No data No data     1. Amy Winehouse U 
2. Body parts  U 
3. Scary faces U 
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7.3.7 Delirium, persistence of intrusive memories and psychological morbidity 
Table 7.6 summarises data about delirium at T1, intrusive memories at T1 and T3 and 
psychological morbidity scores at T2. The presentation of the table suggested possible 
connections between these phenomena and prompted further analyses that I report in 
this section. The sample was too small to detect significant associations, and analyses 
were carried out with the sole purpose of identifying interesting trends that could 
suggest hypotheses to be tested in future.  
a) Delirium and nature of memories  
Looking across table 7.6 patients with higher rates of delirium at T1 appeared to have 
higher rates of psychological morbidity in T2. This fits in with results of the cohort 
study. Table 7.7 shows that patients with mixed unreal and factual memories at T3 had 
higher delirium scores at T1 (9.83) than patients with unreal memories only (8.17) or 
factual memories only (6.67).  
          Table 7.7 Nature of memories and delirium 
 
 
 
 
 
b)  Persistence of unreal memories/loss of factual memories 
Table 7.8 shows that more patients had intrusive memories (of any type) at T3 than at 
T1 (15 vs 11). It also shows that by T3 the number of patients with factual memories 
only declined while patients with unreal memories (alone or mixed with factual 
memories) increased. Four patients who had no IMs at T1 had unreal memories at T3. 
Three of the six people who had factual memories at T1 had unreal memories at T3. 
The five patients with unreal memories at T1 still had unreal memories at T3.  
        
      Table 7.8  Change in memories over time 
 
 
 
 
c) Nature of memories and psychological morbidity 
Patients with mixed unreal and factual memories at T3 had the worst mean scores for 
PTSD, depression and anxiety at 3 months (table 7.9). Patients with factual memories 
had the best (lowest) mean PTSD score. However patients with unreal memories only 
had the best (lowest) depression and anxiety scores. 
Delirium score in ICU  
(0-20) 
nature of memories after ICU 
9.83 (2.64) unreal and factual memories at T3 
8.17  (3.51) unreal memories only at T3 
6.67  (4.92) factual memories only at T3 
p-value (Anova) =0.510  
Number of patients 
with IMs at T1 
Factual IMs only 
at T3 
Unreal  IMs only 
at T3 
Unreal and 
factual IMs at T3 
None                         4 0 2 2 
Factual IMs only         6 3 1 2 
Unreal IMs only          4 0 2 2 
Both unreal/factual    1 0 1 0 
Total                        15 3 6 6 
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Table 7.9 Types of memory and psychological morbidity 
 PTSD 
Mean(SD) 
Depression 
Mean(SD) 
Anxiety 
Mean(SD) 
Unreal memories only at 
T3 
23.00(11.90) 18.33 (12.26) 38.89 (13.28) 
Factual memories at T3 14.67 (4.16) 21.60 (12.55) 50.67(20.03) 
unreal and factual at T3 27.33 (10.39) 32.63 (18.64) 53.33 (14.91) 
p-value 0.262 0.286 0.273 
 
d) Re-experiencing and psychological morbidity 
 Patients with high levels of re-experiencing an intrusive memory (scores of 2/3 at T3 
or in previous weeks) had considerably higher PTSD, depression and anxiety scores 
(table 7.10) than patients who had low levels of re-experiencing (scores 0/1). 
Table 7.10 Re-experiencing and psychological morbidity 
 
 PTSD (mean, SDs) Depression (mean,SD) Anxiety (mean, SD) 
High re-experiencing 26.73(10.02) 28.62(13.95) 49.27(12.86) 
Low re-experiencing 13.00(3.92) 13.95(16.77) 40.83(23.15) 
p-value 0.002 0.112 0.378 
 
e) Characteristics of unreal v factual memories 
 In an analysis of characteristics of both types of memories (see table 7.11), unreal 
memories were more vivid than factual memories, lasted nearly four times longer, 
were associated with more guilt and shame, were more uncontrollable and interfered 
more with daily life. Factual memories involved more sense of re-experiencing, were 
shorter, were accompanied by more anxiety and caused more distress than unreal 
memories. (None of these differences were significant, probably due to the very small 
sample size). In some respects (re-experiencing, duration) the factual memories were 
more like typical PTSD flashbacks than the unreal memories. Yet, as seen above, those 
with unreal memories had higher PTSD scores.  
Table 7.11: Characteristics of unreal v factual intrusive memories 
 
 Unreal memory Factual memory 
vividness 2.33 (0.71) 1.88 (0.84) 
anxiety 1.55 (0.88) 1.75 (1.16) 
helplessness 1.89 ((1.05) 1.88 (1.25) 
guilt 0.67 (1.32) 0.63 (0.92) 
Shame 1.22 (1.30) 0.88 (1.36) 
Re-experiencing 0.89 (0.93) 1.13 (1.44) 
frequency 1.88 (0.99) 1.62 (0.92) 
duration 8.26 (6.84) minutes 2.66 (3.77) minutes 
Interference  0.78(0.97) 0.50(0.93) 
uncontrollability 1.63(1.30) 0.88(1.13) 
distress 1.63(1.06) 1.88(1.36) 
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f) ICU drugs and nature of IMs 
A trend was found for a relationship between receiving benzodiazepines in the ICU and 
the nature of IMs at T3 (χ²=5.25, 0.072). Of the benzodiazepine group 90% (nine) 
had unreal memories (with or without factual memories) compared to 60% (three) of 
the non-benzodiazepine group. Factual memories only were found in 10% (one) of the 
benzodiazepine group and 40% (two) of the non-benzodiazepine group. All patients 
(six) who had both unreal and factual memories were in the benzodiazepine group. No 
possible relationship was observed between opiates or inotropes at T1 and type of IM 
at T3. 
7.3.8 Summary: Nature of memories and outcome 
The patients who were most delirious in the ICU were most likely to have “unreal” 
memories at T3. Additionally patients who received benzodiazepines in ICU were more 
likely to have unreal IMs at T3. The number of total IMs increased between T1 and T3. 
Patients developed more unreal memories and fewer factual memories over time. 
Patients’ factual memories at T3 often had the same memory content as at T1 (see 
table 7.6). The content of unreal memories was usually vague at T1 and more specific 
at T3. Patients with mixed unreal and factual memories had the worst scores for PTSD, 
anxiety and depression. Patients with unreal IMs only had lower depression and 
anxiety scores than patients with factual IMs, but patients with factual IMs had lower 
PTSD scores. However factual memories seemed to have more characteristics of PTSD 
flashbacks, as they were shorter with more sense of re-experiencing and more 
association with anxiety and distress. The unreal memories were longer, more vivid, 
associated with shame and were uncontrollable. Overall it seemed that patients with 
both unreal and factual intrusive memories at T3 had the worst outcomes. 
7.4 Results: Help with management of intrusive memories after  
       intensive care  
 
The following is the content analysis of the answers patients gave to four questions 
about the need for help. Table 7.12 contains fuller quotations from patients. 
1. Do you need help managing your intrusive memories of ICU? 
Five wanted help now because they were still troubled by emotions, memories and 
nightmares.  
Three did not want help right now but thought they had needed it during the first 
three months at home, or were likely to need it in future. 
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Nine did not want outside help with intrusive memories. Two of these said they could 
help themselves. 
2. Did you attend the ICU follow-up clinic and was it helpful for dealing with 
intrusive memories? 
Eight attended follow-up clinic. Four found it helpful. Four either did not talk about 
their memories at the clinic or did not find it helpful. 
Nine did not attend the clinic. Of these, two would like to attend. 
3. Have you tried to get help with intrusive memories from any other source? 
Six have tried to get another form of professional help including seeing their GP, being 
referred to a counsellor by their GP, getting access to medical records via the GP, 
trauma counselling, occupational therapy or seeing the UCH psychologist. One patient 
had counselling and did not find it helpful; others had not yet seen their counsellor. 
Four patients have been able to rely on help from their family or self-help.  
Seven have had no other help: of these one would like to get help but did not know if 
any was available, and one now believes that he should have got help.  
4. What kind of help would you like/would you have liked? 
Four patients said none. Three said that talking to family or self-help was enough.  
Nine people suggested forms of help and one woman thought there should be help 
but was unsure what it could be. The help suggested was specialist intensive care 
counselling when you get home; phone counselling when you get home; counselling 
arranged through the GP, help from the follow-up clinic, help from the medical team 
who treated you and seeing a psychiatrist. Three patients suggested that counselling 
about the effects of hallucinations and treatments would be most useful after transfer 
from the ICU to the ward.  
 
In summary, eight patients tried to get help for intrusive memories. Three were fairly 
or very satisfied with the help they received. Five thought they still needed help with 
intrusive memories. Ten people thought help should be available for distressing post-
ICU memories. Some patients said the most useful time for psychological support 
would be after intensive care discharge, either on the general or surgical wards, or 
soon after arriving home. The emphasis of support immediately after ICU discharge 
should be receiving information and reassurance about unusual ICU symptoms such as 
hallucinations; After hospital discharge, support should focus on intrusive memories 
and aspects of physical recovery. One patient who did not need help said she had been 
helped enormously by her interaction with nurses in the ICU, “They were lovely. It was 
chat, chat, chat all day long”. Several patients mentioned that the help available from 
the follow-up clinic three or four months after discharge was too late for them. 
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       Table 7.12  Content analysis: Patients’ answers to help questions 
 
Name 
 
Do you need help for 
intrusive memories? 
Did you attend ICU follow-up 
clinic? Was it helpful? 
Have you tried to get other 
help for intrusive 
memories? 
What kind of help would you 
like/have liked for this 
problem? 
Magda “Yes. This has changed my life. 
My personality has changed. 
I’m OK but go through periods 
when I’m very emotional. I 
would love to erase the 
memories.” 
Yes. “I found the leaflet useful, 
but the follow up clinic did not 
help. They just asked more 
questions.” 
She had trauma counselling at 
home and occupational therapy 
at work. She did not find them 
helpful. 
“Specialist  intensive care 
counselling when you first get 
home.  That’s when the impact hits 
you. I had severe insomnia, saw 
needles coming at me. Eight 
months on I still can’t deal with it” 
Terry “Not at present. I’m getting my 
mind round it and beginning to 
cope.  
Yes. “They tried to organise 
support locally but I went back 
into hospital so it didn’t 
happen.” 
He tried to get help with 
hallucinations after ICU 
discharge. Left hospital before 
seeing psychologist.  
“I would have liked anything 
available. Somebody over the 
phone would have been ideal. I 
don’t like going back to UCH, it 
brings back memories” 
Anna “No. But if I get worse I might. 
The memories are not getting 
less. As I recover I’m thinking 
about them more and feeling 
more upset.” 
No. No. Her GP and her vascular surgeon 
would get her help if necessary. 
She feels adequately supported. 
Franco No. “Any problem can be 
solved with a positive 
approach.” 
No. “No. I have to find the trouble 
with me and apply the right 
remedy.” 
“If one learns to control instinct 
and emotions one can be one’s 
own master and help oneself in 
every situation.” 
Sally No.  
 
No. Yes. Talking to family.  “Just talking to the family.” 
Colin No 
 
No No No 
Karen Yes.  “Yes. It was really helpful. I 
have a second appointment with 
them. That is sufficient. 
She talked to her GP about it 
once. He was very supportive. 
“Seeing the whole team at the FU 
clinic was very helpful. Hearing 
other people felt the same way 
helped.” 
Dora “Yes. The memories are not far 
from my mind all the time.” 
Yes, twice. “I found it very 
useful and reassuring to see 
some of the doctors again. They 
recommended counselling for 
PTSD”. 
She talked to her GP and 
asked to see a counsellor. Now 
unsure - thinks counselling 
may be too general, too far 
removed from the specific 
experience. 
“Help from someone who treated 
you. Help from the doctors who 
wrote the notes. Help with the fear 
of dying.”  
Paul  “I’m not sure. Will the 
memories just disappear? I 
don’t get them as much as I 
did at first.” 
Yes. “I went to the clinic but 
didn’t tell them about the 
memories. They said I was 
depressed.” 
Going to GP re-depression on 
advice of follow up clinic. Will 
tell GP about the memories. 
“I’d like to speak to a psychiatrist 
to find out why the memories keep 
coming back. People should get 
help if memories are affecting 
them.” 
Isaac No. “The memories are fading 
but I still panic about 
breathing”. 
Yes. Went to the clinic but didn’t 
discuss the memories. 
No “Not really. I’ve just got to get on 
with it. I practise self cognitive 
therapy.” 
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Raj “I would have liked help. When 
I came home I kept the lights 
on for two months. I thought 
I’d be dragged back to ICU”. 
No. He has not heard from the 
follow up clinic but thinks it 
would have helped him. 
No. But he thinks he needed 
counselling for the first two or 
three months. 
“You need a therapist on the 
wards. I was anxious and angry 
but nobody asked.” He needed 
help to cope with emotions and  
explanations about the effects of 
drugs  
John No. No No. He is “stern-minded and 
self-disciplined” 
“Someone to talk to in hospital 
about the hallucinations. It would 
help to get it off your chest and 
explain to your family what you 
really went through. 
Laura No. Follow up booklet was helpful. 
Went to follow up clinic. “It was 
helpful, but it came a bit too 
late. It would be more helpful to 
see the person who treated me. 
Her GP has given her a 
photocopy of her medical 
records in ICU so she can fill in 
the memory gaps. This has 
helped a bit. 
“The transfer to the ward was very 
distressing, I felt “dumped”. I 
would have liked a visit from 
someone from ICU to chat about 
psychological effects. It is useful to 
have a timeline of what 
happened”.  
Kate No No No Doesn’t need anything now.  She 
says she was helped by the nurses 
in ICU who were “very nice, 
caring, what a team. I got talking 
to the nurse, it was chat, chat all 
day long.” 
Nora Yes. “I didn’t think I’d 
remember so much detail.” She 
has nightmares about ICU and 
wakes up panicking and 
sweating. 
No. Would like to go.  No. Not sure what could help 
her. 
Thinks there should be help but 
she’s not sure what it would be – 
she has too many physical 
problems including disability to 
focus on  psychological help right 
now. 
Owen “No. I feel quite comfortable. 
I’m in my environment, I can 
do what I want.” 
Yes. “I was quite settled and I 
didn’t need help. They asked me 
about memories and dreams 
and I said they weren’t 
bothering me”. 
No None 
Aysha No No No None needed. 
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7.5 Discussion 
7.5.1 Summary of findings 
I interviewed 17 patients (15 from the cohort study; two from the pilot) who had 
intrusive memories about intensive care at three months. Interviewees were more 
likely to be young, female and from the most deprived areas, than others in the cohort 
study. During intensive care they were more likely to have received benzodiazepines, 
ionotropes and opiates, and had worse stress, mood and delirium scores than the rest 
of the cohort. None of these results were significant. Of the 15 cohort participants, 
eleven had already experienced intrusive memories of intensive care by the time of 
discharge from the ICU. Content analysis revealed a clear distinction between intrusive 
memories of hallucinations and delusions experienced in intensive care (“unreal 
memories”), and intrusive memories of real events that take place in intensive care 
(“factual memories”). However although “factual” memories were of real procedures 
that might happen in intensive care, we cannot be sure that the patients’ memories 
are accurate. Early intrusive memories (at T1) were more likely to be factual; by T3 
patients had fewer factual memories and more unreal or mixed unreal/factual 
memories.  
Eight categories emerged from the content analysis of intrusive memories:  
• Medical and care procedures 
• Physical horror/pain 
• ICU environment 
• Visual hallucinations and delusions 
• Inter-personal 
• Shame and guilt 
• Control and information 
• Death and afterlife. 
Ten people had factual memories concerning procedures or physical horror. Memories 
of medical and care procedures were mainly related to tight-fitting oxygen masks 
(CPAP masks) and endo-tracheal or naso-gastric tubes. Some remembered (or 
believed they remembered) resisting a mask being fitted and having it forced on them 
and associated it with feelings of panic and suffocation. Tubes were associated with 
discomfort and choking sensations. Memories of physical horror were of extreme 
pain, blood or being punctured all over by cannulae. The largest category (12 people) 
was of IMs of delusions and hallucinations. These were memories of persecutory 
and bizarre delusions or visual hallucinations of colours and shapes. The content of 
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delusions included medical staff as torturers or kidnappers, with patients as victims 
turned into zombies. Another category, ICU environment, also included mainly 
hallucinatory memories of real items such as curtains or bottles turning into faces, 
insects or animals. Lesser categories were memories focusing on interpersonal 
relationships (mainly negative) with nurses or family; memories intensely suffused 
with shame or guilt; memories about lack of control and information; and memories 
concerning thoughts or visions of death and the afterlife. 
Patients also rated characteristics of their memories. Overall, memories were rated as 
very vivid and clear, frequent and long-lasting. They were uncontrollable, distressing 
and evoked feelings of anxiety and helplessness. Most patients said the memories had 
a strong sense of “nowness” either around the time of interview or in previous weeks. 
Factual and unreal memories had some different characteristics. Factual memories 
were more like classic PTSD intrusive memories (APA, 1994); They were shorter, with 
more “nowness” and anxiety, and caused more distress. Unreal memories were more 
vivid, longer, more associated with guilt and shame, more uncontrollable and 
interfered more with daily life. However patients with factual memories only had the 
lowest PTSD scores of the group. 
Patients who had a mixture of both unreal and factual memories of intensive care had 
the worst outcomes, with highest mean scores for PTSD, depression and anxiety. 
Perhaps having both type of intrusive memories made it difficult to tell real events and 
hallucinations/delusions apart and caused greater distress and confusion. Patients with 
both types of memory had been more delirious in the ICU and were more likely to have 
been given benzodiazepines in the ICU. This is in line with the results of the cohort 
study suggesting a link between sedation and delirium in intensive care and worse 
psychological morbidity at three months. Alternatively, having both unreal and factual 
memories could mean just having a greater number of memories altogether and 
therefore be a marker of severity of PTSD. 
7.5.2 Discussion of the nature of memories 
Several studies have reported long lists of stressors in the ICU (Novaes et al., 1997) or 
experiences which patients recalled most frequently (Green, 1996; Roberts & Richard, 
2007; Rotondi et al., 2002;). However this is the first study to show that patients had 
intrusive memories that recurred months after ICU discharge consistently featuring the 
same aspects of intensive care (primarily tight-fitting face-masks, endo-tracheal or 
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naso-gastric  tubes, pain and blood). These PTSD-like memories were characterised by 
fear, panic, suffocation and physical horror.  
 
Unreal memories have also been reported in several studies, notably Jones et al. 
(2001) and Jones et al. (2007). As in Jones et al. (2001), my study found that realistic 
memories of intensive care tended to decline over time while unreal memories 
increased. This study was the first to report that unreal memories recurred several 
months after intensive care as intrusive memories. Jones et al. (2001) found that 
patients with “factual” memories of ICU as well as unreal memories at two weeks had 
lower PTSD scores at eight weeks and hypothesised that factual memory of ICU was 
protective against psychological morbidity. However the present study found that 
patients with both realistic and unreal memories at four months had worse outcomes 
for both PTSD, depression and anxiety. Having both types of memory might be a 
marker for PTSD severity, or might increase patients’ difficulty in distinguishing 
between real events and hallucinations in intensive care, leading to even more 
confusion and distress.  
Where does the content of ICU survivors’ unreal memories come from? Patients in this 
study said their memories were of hallucinations, delusions or nightmares they had in  
intensive care. Indeed some patients reported similar content when I talked to them in  
intensive care as they reported in their interview with me four or five months later (see 
table 7.6). For example “Paul” said in ICU that he’d had hallucinations about opium 
dens and being an assassin; Four months later he recounted a long narrative about 
flying into Brazil to shoot three people on a roof. Often patients gave a vague 
description of their hallucinations in intensive care, and a more detailed account of 
similar visions and stories months later. For example “Raj” told me in intensive care 
that he’d been threatening to leave his wife because she would not bring the car to the 
front of the hospital to allow him to escape: five months later he explained that he 
wanted to escape from Bahai cultists whom he believed were trying to attack him and 
steal NHS drugs to fund their lifestyle. 
The main themes of the “dreams” included being poisoned (by the air conditioning, 
refusing to drink water or brush teeth); being tortured, being threatened with death or 
being put on trial in hospital court-rooms. Patients believed in conspiracies by nurses 
and doctors to harvest organs through operations, to steal patients’ money or to sell 
drugs to fund religious cults. They thought porters were wheeling patients to gas 
chambers or basements to turn them into zombies or give them to cloaked abbots who 
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would steal their souls. Others saw themselves as the guilty ones; the man who 
drowned Amy Winehouse and her baby, or the assassin swooping into Brazil. Some 
dreams involved travel in space and time to Denmark, 1920s USA or the Eastern bloc 
during world war two. Some were simply bizarre visions such as puffins jumping crazily 
on beds and firing blood from plastic revolvers, or a harem of nurses in gauzy outfits 
slipping in and out of bed with a large man. The patients seemed to be elaborating on 
the real material of their ICU experience - beds, nurses, doctors, surgery, needles, 
blood – with the iconography of popular culture such as thrillers, gothic horror or war-
time films.     
It is difficult to know where to place the unreal experiences that led to intrusive 
memories. They have similarities to psychotic experiences, yet there are certain 
differences. Acute psychosis is defined by hallucinations, delusions and marked formal 
thought disorder (World Health Organisation, 1990). Hallucinations are disorders of 
perception that have a compelling sense of reality. Some patients’ IMs were clearly of 
simple visual hallucinations – a psychedelic film logo, faces appearing in the ICU 
curtains, spiders crawling up the walls or the ward decked out as a seaside poster. 
Delusions are defined as false unshakeable ideas or beliefs (Sims, 1995). There are 
many sub-types of delusions; for example persecutory, grandiose, guilty, sexual or 
bizarre delusions. Persecutory delusions are about others causing the individual 
physical, social or psychological harm (Freeman & Garety, 2000). The delusional 
experiences reported in the paragraph above were mainly persecutory although other 
sub-types can also be identified. Compare them with a  clinical account of patients with 
persecutory delusions written in 1913 (Jaspers, 1979): “He is persecuted…for crimes of 
which he is falsely accused by gangs, Jesuits, Freemasons etc. There are also delusions 
of physical persecution on the bases of bodily influences (false perceptions) and … 
querulant delusions about injustices, plots and treacherous manipulations.” 
However whereas people with psychotic disorders such as schizophrenia tend to hold 
delusional beliefs over a period of time, ICU patients seemed to experience the 
delusions only in a delirious state as dreams, hallucinations and nightmares, and began 
to understand after leaving intensive care, that the experiences were unreal. The 
delusions were less like persecutory beliefs and more like dreams or hallucinations with 
a persecutory theme. As discussed in more detail in chapter three, these dream-like 
experiences in ICU may be caused by drugs such as benzodiazepines, opiates, sensory 
deprivation, sleep deprivation or by drug- or illness-induced delirium or 
encephalopathy. The role of dopamine has been highlighted in the development of 
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delirium (Meyer & Hall, 2006) and it may be that dopamine dysregulation contributes 
to the bizarre dreams and delusions of intensive care patients. It is believed that 
critical illness such as sepsis and respiratory failure, and intensive care treatment can 
lead to an imbalance of neurotransmitters with a depletion of acetylcholine and an 
excess of dopamine (Trzepacz, 1999). Furthermore the intense stress of an ICU 
admission could give rise to hippocampal dysfunction which also favours 
overproduction of dopamine (Gray et al., 1991). Dopamine is thought to provide 
special significance or salience to stimuli that would otherwise be neutral, and to create 
meaningful connections between coincident events (Hemsley, 1993). This would 
provide a possible explanation for patients noticing real events such as nurses taking 
blood or giving injections and weaving them into paranoid fantasies. 
The dopamine hypothesis could also help to explain why such delusions become 
embedded in long-term memory. First, because dopamine lends salience to events, 
these events will naturally be more memorable. Second, it is known that dopamine is a 
modulator of emotional memory in animals, mediated via the amygdala (Greba et al., 
2001). An experimental study using 33 healthy male volunteers suggested that 
dopamine also plays a significant role in biasing memory toward emotionally salient 
information in humans (Gibbs et al., 2007). Drugs and other ICU phenomena may also 
favour long-term memory of psychotic dreams by causing amnesia for much of ICU 
along with enhanced memory for the most traumatic aspects (Jones et al., 2000). The 
amnesia may be due to benzodiazepines, opiates, anaesthetics or sleep deprivation, 
while enhanced memory may be attributed to IV glucose infusions (Korol & Gold, 
1998), to the administration of stress hormones in the ICU (Roozendaal et al., 2006) 
or actual stress responses releasing endogenous stress hormones while in the ICU. 
Alternatively patients’ unreal memories from intensive care may be something like the 
drug “flashbacks” that can occur after taking any hallucinogenic drug. They are 
particularly well-known in relation to LSD, particularly if users had a “bad trip” 
(Ashton, 2002). Drug flashbacks may occur spontaneously or may be triggered by 
fatigue, stress or taking other drugs. They may be very disturbing and are more 
common after taking multiple rather than single hallucinogenic drugs. They may last 
for several months or continue episodically for years (Halpern & Pope, 2003). 
Flashbacks known to occur after taking MDMA (ecstasy) include contorted and 
menacing faces as well as visual illusions. The neurochemical causes of drug flash-
backs are not well understood, but one mechanism is thought to be the failure of 
inhibition in the visual pathways, related to serotonin deficits (Abraham et al., 1996), 
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1996. It has also been suggested that flashbacks after a bad LSTD trip are a form of 
PTSD (Ashton, 2002), thus bringing us back full circle. 
Another parallel with the unreal memories of intensive care patients is suggested by 
the small but growing literature on post-psychosis PTSD. Several studies have found 
that patients develop PTSD months after a psychotic episode. A review (Morrison et 
al., 2003a) reported on a number of studies that had found prevalence rates of 
between 11%- 67% for  PTSD in patients who suffered a psychotic episode months 
before. It is argued that hallucinatory and delusional disturbances can shatter the 
person’s experience of themselves, the world and others in a similar way to non-
psychotic trauma (Morrison et al., 2003). The experience of psychosis may have a 
similar capacity as other trauma to confront a person with horror, fear and 
helplessness. A counter-argument has been that PTSD in post-psychotic patients was 
due to other distressing experiences such as enforced hospitalisation or treatment, but 
most studies have found that psychosis itself was the most important stressor. For 
example a study by (Meyer et al., 1999) found that 69% of traumatic symptoms were 
related to psychosis, while 24% were related to hospitalisation.   
Psychotic episodes, drug flash-backs or an ICU patient’s unreal memories, do not fulfil 
the classic PTSD criterion that the traumatic event must include the threat of death, 
serious injury or physical integrity. These criteria do apply to the ICU patient’s real 
situation (they suffered life-threatening illness) but their intrusive memories are 
frequently of the delirious dreams caused by their medical experiences rather than of 
the actual medical experiences. Does this then constitute PTSD? DiMartini et al.,(2007) 
presented four cases of transplant patients who experienced delusions and 
hallucinations during delirium who later re-experienced them as memories and met all 
the criteria for PTSD diagnosis. DiMartini argued that PTSD criteria should be expanded 
to include psychically induced experiences such as those that stem from a medical 
event.  
7.5.3 Strengths and limitations of the study 
Strengths This is the first study to investigate former ICU patients’ intrusive 
memories of intensive care. No other study has provided such a rich description of the 
categories and nature of memories that patients had of intensive care. A sample size of 
17 was a large number for a qualitative study. It has been recommended that six to 
eight participants may be sufficient for a qualitative study (Smith, 2010). The sample 
was a purposeful sample in that the best participants were selected to answer the 
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research question, a superior strategy to that of the convenience sample (Marshall, 
1996). The study was designed to generate rather than test hypotheses.  
Limitations This study shares the limitations of all qualitative studies in that they 
entail the risk of subjectivity, interviewer bias, and a lack of generalisability. Although 
the interview included ratings scales as well as qualitative content, the sample size was 
too small to detect statistical associations between different factors. Therefore any 
quantitative results should only be used to suggest future hypotheses that could be 
tested using robust quantitative methods. It may be that interviews were carried out 
too late, as for some patients the period of worst intrusive memories had already 
passed.  
Clinical and research implications 
This study would be of interest to clinicians who are interested in understanding the 
psycho-social outcomes of intensive care patients. Former ICU patients’ experiences of 
disturbing intrusive memories occurring months after intensive care have not 
previously been described in the literature. The survey of patients’ ideas about help 
needed after intensive care could help to guide planning for supportive interventions 
for patients in the ICU, after transfer to other wards and after hospital discharge. 
Future research in this area could include the evaluation of medical, pharmacological or 
psychological interventions to reduce intrusive memories after intensive care. It would 
also be of interest to administer cognitive psychological tests in conjunction with the 
intrusive memories interview to discover more about the neuro-psychological 
mechanisms underlying the observed memory dysfunction. Studies could also be 
carried out to test some of the hypothesised relationships between drugs and delirium 
in intensive care and intrusive memories after intensive care.  
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Conclusions of thesis 
 
As each study had a separate discussion, and chapter six provided a full discussion of 
the main themes of this PhD, I will conclude the thesis with some reflections about 
future directions for clinical practice and research.  The results of the thesis suggest 
that a high proportion of patients suffer considerable mood disturbance, cognitive 
dysfunction and physical stress in intensive care, and a significant burden of poor 
mental health and HRQL three months after leaving the ICU. A large epidemiological 
study is needed to find out if the prevalence rates found in my study – 27% PTSD, 
46% depression, 44% anxiety, and 55% with at least one of these disorders – would 
be found in a wider level 3 ICU population. If similar prevalence was found in the wider 
population, this would represent 55,000 people with mental health problems, out of 
the estimated 100,000 admissions to ICUs in the UK every year. As well as being 
highly distressing and stressful for patients and their families, PTSD, depression and 
anxiety are likely to impede physical recovery and even to increase risk of further 
illness such as heart disease (Frasure-Smith & Lesperance, 2006). This has 
considerable cost implications for the health service as it could lead to hospital re-
admissions and extra GP visits to get access to mental health services. 
 
It is worth considering if preventative measures can be taken to reduce the high 
prevalence of serious psychological disorders after intensive care. Any preventative 
interventions would need to take into account identified risk factors to find out who is 
most likely to be affected and which risk factors can be modified. After establishing 
accurate prevalence estimates of post-ICU distress, the other major aim of my PhD 
was to identify risk factors for these outcomes, as my systematic review found that 
consistent risk factors had not previously been found. It was of great interest that in 
my cohort study a number of clinical risk factors were found to predict PTSD. The 
finding that global ICU factors such as “TISS” (a score that sums up the totality of  
intensive care received, from dressings to mechanical ventilation) and “numbers of 
organs supported” predicted PTSD, but not anxiety and depression, suggested that  
intensive care was a traumatic stressor for some patients ( and not just a source of 
general distress). The more intensive care received, the more a patient was at risk of 
PTSD. It was also of considerable interest that sepsis biomarkers were found to predict 
PTSD in this study, as this was not previously known.  
 
Additionally very specific predictor-outcome relationships were found, many for the 
first time; between days of sedation and PTSD; benzodiazepine usage and depression 
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at three months; inotropes and vasopressors and anxiety at three months; and 
steroids and anaesthetics and better physical HRQL. These clinical risk factors 
remained significant after controlling for socio-demographic factors and chronic 
physical ill health. There was also an interesting trend for opioid usage to improve all 
anxiety, depression and mental HRQL outcomes, with large effect sizes. These results 
point to an important role for drugs in the development of post-ICU psychological 
morbidity, as the global variable “number of drug groups given” was also found to 
predict PTSD.  
 
These findings should be carefully considered by clinicians as they suggest possible 
modifications to clinical practice in intensive care. Although intensive care interventions 
are undertaken to save lives, likely psychosocial outcomes for patients should be taken 
into account during clinical decision-making and the conservative “doing less” approach 
that has already been recommended (Singer, 2006), could be warranted. Invasive 
monitors, catheters and other equipment should be removed in a timely fashion and 
weaning from mechanical ventilation should be attempted at the earliest opportunity. 
Perhaps the key area for clinical change to be considered is in administration of drugs. 
It is increasingly realised that benzodiazepines may have harmful effects on patients 
and this study suggests that inotropes and vasopressors should also be used 
judiciously. This study also confirms findings from other studies that opiates and 
steroids may have a beneficial effect on patient’s eventual well-being. The total 
numbers of drugs being used, particularly those with known psychoactive side-effects, 
should also be monitored as increasing numbers of drugs used predicted worse 
outcomes. 
 
Further research should be carried out to compare the relative effects on psychosocial 
outcomes of treating ICU patients with different drugs and drug regimes. However 
recent studies have been inconclusive. Sackey et al. (2008) followed up patients 
randomised to isoflurane (a non-GABA agonist sedative agent) or midazolam at six 
months and found a non-significant decrease in hallucinations and delusional memory 
in the isoflurane group. A study of an alternative strategy, ‘light’ versus ‘deep’ 
midazolam sedation strategy by Treggiari et al. (2009) found that the light group had 
reduced length of mechanical ventilation and LoS in the ICU but no difference in 
anxiety, depression and PTSD after four weeks.  Further investigation should also take 
place into the biological and psychobiological mechanisms that are hypothesised to be 
causal processes in post-ICU psychological morbidity. These include the long-term 
effects of sepsis and septic encephalopathy or delirium on the brain, the effects of 
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neurotransmitter imbalances caused by drugs and critical illness, the effects of a range 
of ICU drugs on memory, and the processes by which extreme stress, triggering the 
release of stress hormones,  may impair hippocampal function, leading to a range of 
emotional and memory problems. 
 
This PhD also suggests the need for enhanced psychosocial support to be offered to 
current and former ICU patients. This has already been recommended in the 2009 
NICE guideline: Rehabilitation after critical care illness. The cohort study demonstrated 
that there were extremely high rates in the ICU for mood disturbance (78%), delirium 
(66%) and physical stress such as pain, dyspnea and discomfort from tubes (77%). 
Patients also suffered from sleep deprivation (80%), hallucinations (65%), nightmares 
(48%), agitation (75%), inability to communicate (57%) and loss of personal control 
(86%). There was a group of around 40-45% of patients who suffered particularly 
badly from these symptoms. As well as being highly unpleasant states, most of these 
variables were also risk factors for worse outcome at three months. Some 
psychological factors (ICU mood, ICU stress, and ICU intrusive memories) were also 
found to be variables that mediated the clinical effects on outcome. This would suggest 
that if psychological reactions in the ICU were addressed it might be possible to 
mitigate the effects caused by intensive care interventions and improve outcomes. 
Therefore acute psychological reactions in the ICU should not simply be treated as 
transient, irrelevant or a nuisance, as is often the case.  Furthermore, as delirium was 
also a mediating risk factor for psychological morbidity, all efforts should be made to 
assess for delirium in ICUs using the Confusion Assessment Method for the ICU (CAM-
ICU; Ely et al., 2001b). A new NICE guideline on delirium advises on the prevention 
and management of delirium (Young et al., 2010). 
 
Another important result, seen for the first time in this PhD, was that socio-economic 
circumstances of patients were a strong independent predictor of anxiety, depression 
and mental HRQL, but not of PTSD, after ICU. There was no variation in interventions 
received or illness severity linked to socio-economic circumstances. However it was 
found that total mood disturbance in the ICU varied by SEC. The group who had worst 
mood disturbance in the ICU and worse psychological outcomes at three months, in 
comparison with other occupational groups, was NSSEC group two (intermediate 
occupations) which consists of people with clerical, secretarial or administrative 
occupations. It is unclear why this should be. Perhaps this group has more chronic 
background stress than others, making them more vulnerable when faced with a highly 
stressful experience such as intensive care. Further research is needed with other 
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indicators of socio-economic circumstances to find out if particular social groups are 
more likely to have poor psycho-social outcomes and may need extra access to 
support. 
 
My third study, a qualitative study of 17 patients with intrusive memories of ICU at 
three months, revealed that an important manifestation of post-ICU psychological 
morbidity was the presence of highly disturbing hallucinatory flash-backs or distressing 
snap-shot memories of bleeding, choking on tubes and pain. This study also suggested 
a possible pathway between ICU drugs, delirium, delusional intrusive memories and 
higher rates of all adverse psychological outcomes. The study also found that intrusive 
memories caused considerable distress and impairment, and that patients had not 
known where to seek help. 
 
The NICE guideline on ICU rehabilitation (Tan et al., 2009) requires that patients 
should be assessed for the risk of future psychological morbidity and if necessary 
offered support at several time-points including a) in the ICU b) shortly after discharge 
from the ICU, c) before leaving the hospital and d) three months after leaving hospital. 
No assessment tool is currently available to assess the key risk factors for future 
psychological outcomes, However the ICU baseline questionnaire that I developed for 
this study (appendix 12) covers all the key items recommended by NICE and has been 
designed to be administered to level 3 ICU patients. It could potentially be shortened 
for daily ICU use and validated for this purpose among level 3 ICU patients. 
Further work is needed to develop, pilot and evaluate psychological interventions for 
the ICU. Helpful interventions in the ICU would include giving information about 
treatment and progress; increasing patient control and self-efficacy; and giving 
explanations and reassurance about unexpected symptoms such as hallucinations in 
the ICU.  
 
Training to enhance key skills such as anxiety management and communication should 
be given to all ICU staff.  Access to physical exercise programmes may also help ICU 
patients psychologically. When a recent structured exercise and mobility package was 
compared to standard care in a study of 104 medical ICU patients in the USA 
(Schweickert et al., 2009), the intervention group had lower rates of delirium as well 
as less time spent on the ventilator and better physical HRQL at hospital discharge. 
Access to a psychologist or therapist may be necessary if a patient is particularly 
anxious or depressed. Anti-depressants should be used with care as they may affect  
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neurotransmitter systems and so increase the risk of delirium or subsequent 
psychological morbidity. 
 
After transfer from the ICU to other wards, patients may need to be given additional 
support by relatives, nurses or a psychologist as this is often a stressful time. After 
hospital discharge some patients may need the opportunity to speak to someone by 
telephone about managing emotional distress and intrusive memories or flash-backs. 
They may also need follow-up appointments with a psychologist for evidence-based 
treatment of depression, anxiety, hallucinatory intrusive memories or PTSD, if they 
should occur. When this model of stepped care has been designed and piloted it should 
be evaluated in randomised controlled trials. If these new services can be generally 
introduced in intensive care units, there is hope that current levels of post-ICU 
psychological morbidity could be greatly reduced and the quality of patients’ recovery 
would be much improved. 
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APPENDICES 
 
Appendix 1  Systematic review: Draft protocol  
 
Protocol for a systematic review of studies of psychosocial outcomes after ICU 
Introduction/Background 
 
Psychological disturbances have been reported in patients in intensive care in many 
studies since the 1960s (e.g. Kornfeld 1969; Wilson, 1972; Tomlin; 1977). 
Psychological symptoms commonly experienced by ICU patients include anxiety, panic, 
depression, withdrawal, confusion, agitation, and distress caused by poor 
communication (e.g. Russell et al., 1999).  This constellation of symptoms has become 
known in the literature as Intensive care syndrome or ICU psychosis. The syndrome is 
believed to occur in response to multiple stressors that affect patients in the Intensive 
care Unit. (Dyer, 1995).   
 
It has also been reported that a large proportion of  survivors of Intensive care suffer 
from psychological morbidity and impaired quality of life after leaving the Intensive 
care Unit. According to a review by (Weinert, 2005), psychiatric symptoms and 
disorders including depression and PTSD, affect 15-35% of  patients in the months 
after intensive care unit discharge. A systematic review (Dowdy et al., 2005) found 
that QoL in ICU survivors is lower than in the general population. However over 1-12 
months of follow-up, QoL tends to improve in ICU patients in most domains except 
mental health. 
 
A number of studies have investigated whether there is an association between these 
two phenomena. Do psychological reactions and difficult experiences in Intensive care 
predict the development of psychological morbidity and poor quality of life in the 
months after Intensive care? If this relationship exists, is it moderated by social 
differences such as class, gender or ethnicity? 
 
Socioeconomic status has been shown to be a determinant of outcome in various types 
of severe illness such as myocardial infarction (Shen et al., 2001) and cancer 
(Kogevinas et al., 1997). Furthermore a social gradient for mortality has been 
demonstrated within some ICU patient groups such as those who had elective surgery 
(Hutchings et al., 2004).  Gender differences have been found in some studies of ICU 
outcomes such as length of stay and length of mechanical ventilation but not in others. 
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It seems likely that psychological outcomes of ICU treatment are also affected by 
social inequality. 
 
To investigate these questions, a systematic review will be carried out assessing the 
proportion of ICU patients who suffer from poor psycho-social outcomes in the months 
after Intensive care, and the nature of relationships between different risk factors and 
psycho-social outcomes. Possible risk factors include psychological distress in the ICU, 
ICU treatment-related factors, ICU environmental factors, communication risk, age, 
gender and SES.  Psycho-social outcome is a broad category including psychological 
morbidity such as anxiety and depression, PTSD and health-related quality of life.  
 
Two previous systematic reviews; (Jackson et al., 2007) and (Griffiths et al., 2007) 
focused on the prevalence of PTSD in survivors of critical care treatment.  Both 
concluded that the true prevalence of PTSD after critical care illness or ICU treatment 
has not been established due to the poor quality of studies. In the studies reviewed, 
some but not all investigated risk factors of post-ICU PTSD, including younger age, 
female gender, delusional memories of ICU, anxiety while in the ICU, stressful 
experiences in the ICU, increased LOS in the ICU,  longer time on a ventilator, and 
greater levels of sedation while in the ICU. 
 
The present systematic review will build on this earlier work. There were 
methodological weaknesses in the review by Jackson et al. (2007), for example in the 
search strategies and quality assessment used. There have been recent guidelines to 
improve the methodological rigour of systematic reviews of observational studies (e.g. 
Khan et al., 2001). Griffiths et al. (2007) used appropriate methods, but the review 
examined outcome only and not association with risk factors.  
 
While both reviews estimated the prevalence of  PTSD, a more complete assessment  
is needed to determine the full extent of adverse psychological outcomes affecting ICU 
patients after discharge. Several prospective studies suggest that survivors of 
Intensive care may suffer from a range of  psychological symptoms and disorders, and 
lower quality of life after leaving hospital. Finally the effect of social inequality on 
psychological outcomes of Intensive care has not been looked at in a systematic 
review. 
 
In conclusion, our proposed systematic review will draw on recent recommendations to 
improve the quality of  reviews of observational studies, to assess a range of adverse 
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psychological outcomes and quality of life in the months after Intensive care. The ideal 
follow-up period to detect the presence of outcomes such as PTSD and to allow for 
some physical recovery, would be three months (REF) but studies may have followed 
patients up at different time-points. The review will also examine whether these 
outcomes are related to risk factors such as psychological reactions to the Intensive 
care environment, and social differences such as SES, age and gender. 
  
Review questions 
1. What proportion of ICU survivors suffer to what extent from adverse psycho-
social outcomes ( including PTSD symptoms, anxiety, depression and low 
health-related quality of life) in the months after Intensive care?  
2. What are the risk factors (within 3 categories – psychological, socio-
demographic and health-care use) for adverse psychosocial outcomes three 
months after ICU treatment? 
3. Is there evidence of social variation  in psychological outcomes following  
      treatment in Intensive care? 
 
Criteria for study selection 
Type of studies:  Cohort studies (prospective and retrospective prospective). Cross-
sectional studies. Experimental studies (control groups). 
Types of participants: General ICU patients who receive Intensive care >24 hours. 
Includes studies of mechanically ventilated patients in ICU, but not other sub-groups. 
Types of outcome measures: Inventories or interviews for PTSD, anxiety and 
depression questionnaires or clinical interviews, other reliable, validated measures of 
psychological morbidity or well-being. Reliable and validated health-related quality of 
life instruments. 
 
Methods 
The search strategy for identification of studies is based on MOOSE guidelines (Stroup 
et al., 2000). Studies will be identified using the following databases: 
 Medline,              (Ovid, 1950-2007) 
 Embase,               (Ovid, 1980-2007) 
 Psycinfo,              (Ovid, 1806- 2007) 
 Cinahl                   (EBSCO Host, 1982 – 2007) 
 Web of Science.    (ISI Web of Knowledge, 1981-2007) 
 
The initial search will be carried out on Medline using the following strategy. Similar 
searches will be carried out on the other four databases. However thesaurus terms 
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may differ from database to database. For example, Psycinfo has a wider range of 
thesaurus terms to describe psychological morbidity than Medline or Embase .  
 
1. MEDLINE 
 Search terms 
 1950 to December 2007 
#1 (Explode “Critical Care” in MIME, MJME, PT) or (explode “Intensive care-+”) in 
MIME, MJME, PT) 
#2 ((Critical Care) in ti, ab) or ((Intensive care) in ti, ab)  
#3 #1 or #2 
#4 “Stress-Disorders-Post-Traumatic”/all SUBHEADINGS in MIME, MJME, PT 
#5 ((Post*traumatic stress or PTSD) in ti, ab) 
#6 Explode Stress, Psychological or Psychopathology or Depression or Anxiety or 
Affective disorders in MIME, MJME, PT) 
#7 ((psycholog* or  psychiatr* or psychopathology or psycho*social or anxi* or 
depressi* or mental or emotion*) in ti, ab) 
#8 “Quality of Life”/ all SUBHEADINGS in MIME, MJME, PT) 
#9 ((SF-36 or NIP or EuroQol* or HRQL) in ti, ab) 
#10 #4 or #5 or #6 or #7 or #8 or #9 
#11 Explode “Cohort” in MIME, MJME, PT 
#12 ((cohort or prospective or follow-up or long-term or longitudinal) in ti, ab) 
#13 #11 or #12 
#14 #3 + #10 + #13 
#15 (#14) and (AGE:MEDS = ADULT) 
 
Reference lists of  selected papers and personal files will also be scanned for additional  
papers not retrieved through searching  electronic databases. 
 
 Study quality assessment 
It has been reported that 50% of systematic reviews of observational studies do not 
carry out a quality assessment, i.e. a systematic appraisal of the internal and external 
validity, of the studies included (Mallen et al., 2006). Researchers may have ignored 
this issue because there is no accepted method of assessing the quality of non-
randomised trials. A multiplicity of methods and checklists have been used but none of 
the latter have been validated or tested for comparability. However without assessing 
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the methodological rigour of each study, all are given equal weight regardless of 
quality, which may lead to inaccurate conclusions.  
 
In the absence of a gold standard for quality assessment of observational studies, the 
Centre for Reviews and Dissemination (Khan et al., 2001) recommend that reviewers 
select components from available checklists that are most relevant to the topic and 
purpose of the systematic review. The CRD also recommends that numerical values are 
not given to checklist items to comprise a summary score. Instead each component 
may be assessed in a qualitative manner e.g. “well covered, adequately addressed or 
poorly addressed.” 
 
As the proposed systematic review will focus particularly on psycho-social outcomes of  
ICU survivors, quality criteria regarding the robustness of outcome data will be used. 
Another criterion - controlling for other factors which may be relevant to the outcomes 
- is particularly important  in assessing follow-up studies.  To determine the strength of 
the association between risk factors and outcome, another criterion will be the use of 
an appropriate statistical analysis. After reviewing several commonly-used check-lists I 
have decided to use the Scottish Intercollegiate Guidelines Network checklists for study 
designs including cohort studies (SIGN, 2004). Although SIGN checklists were 
designed for reviewing papers for the preparation of clinical guidelines rather than for 
systematic reviews, I chose them because of their clear description of each quality 
criterion. For example rather than simply asking what is the “representativeness of the 
sample”, as in other checklists, SIGN spells out exactly what has been assessed for 
representativeness: “A clear definition of source population and clear eligibility criteria 
for selection of subjects are used, to ensure the sample is representative.”  This will 
guide me in making the assessment and should also help to make the assessment of 
quality I have made more transparent to readers 
Data extraction strategy 
I will extract data from each study using the attached form. 
       
Synthesis of extracted evidence 
Methods for synthesising extracted data will be determined on the basis of the quality 
of  studies retrieved. If possible a meta-analysis will be performed to combine data 
from the highest quality studies. 
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Appendix 2   Systematic review data extraction form  
 
Systematic review:  Psychological outcomes after Intensive care 
             
ID no:  
Author/date  
Title  
Source  
Aim  
Methods  
      Study design  
      Demographic data collected  
      Clinical data  
      Health care use data collected  
      Risk factors/measures used  
1. 
2. 
3. 
4.       
 
     Timing of assessment of risk factors  
     Timing of  follow-up(s)  
      Psychological outcomes/ measures   
      Quality of life outcome/measure             
      Other outcomes/measure  
      Statistical analysis  
      Has power been calculated?  
       Confounding factors considered for  
       each risk factor 
 
      Adjustment for confounding?  
Participants  
        Number of participants  
        Socio-demographics:    Age  
                                             Ethnicity  
                                             Gender   
                                             SES  
        Inclusion criteria   
        Exclusion criteria  
        Setting  
        Time spent in ICU  
        Apache score (or similar)  
        How participants recruited  
        Participation rate   
        Drop outs/attrition rate  
        Details of control group, if included  
         Incidence/prevalence rates  
 
Results:  
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Quality assessment: Adapted from SIGN methodology checklist 
 
The sample  
1.  A clear definition of source population and      
clear eligibility criteria for selection of subjects 
are used, to ensure the sample is 
representative. 
 
2. Comparison is made between full 
participants and those lost to follow up 
 
3. A power calculation is reported. If not, 
sample size is small, medium or large 
 
Outcome  
4. The likelihood that some subjects might 
have the outcome at baseline is accounted for. 
 
5. The outcomes are clearly defined.  
6. Evidence is used to demonstrate that   
measure of outcome is valid and reliable. 
 
7. Follow-up is long enough for outcome to 
occur. 
 
Risk factors-outcome analysis   
8. The study addresses an appropriate and 
clearly focused question (in terms of 
riskfactor/outcome). 
 
9. Any measures of risk factors are reliable  
10. Main potential confounders are identified 
and taken into account in design and analysis. 
 
11. Confidence intervals have been provided.  
12. Appropriate statistical analyses have been 
carried out. 
 
Overall assessment  
How well was study done to a) minimise risk of 
bias and b) to establish a causal relationship 
between exposure and effect. 
 Code ++ All or most of the criteria fulfilled 
            +  Some of the criteria fulfilled 
             -  Few or no criteria fulfilled 
a) Rating for prevalence estimate: 
 
b) Rating for association   - 
Dorothy Wade,  April 2008 
 
Rating quality criteria: 
Good, adequate, poor.  Not addressed, Not reported, Not applicable                                                                           
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Appendix 3  First page of ethics approval letter for ICU studies 
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Appendix 4  Questions used to pilot the baseline questionnaire 
 
 
PILOT Questions for ICU Baseline questionnaire/Dorothy Wade/ 11.11.08. 
1. How long did it take to complete?  
2. Were the instructions clear?  
3. Were any questions unclear or ambiguous?  
4. Did you object to answering any questions?  
5. Was the layout clear and attractive?  
6. Any other comments?   
7. Is there anything else you think should be in the questionnaire? 
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Appendix 5  Letter to ethics committee requesting amendments after 
pilot study 
 
 
 
 
 
 
HEALTH CARE EVALUATION GROUP 
DEPARTMENT OF EPIDEMIOLOGY AND  
PUBLIC HEALTH 
 
                                                                                                    April 8, 2009 
 
                                                                                               T: 0207 679 1702                                                                                                       
07734544512 
                                                              Dorothy.Wade@ucl.ac.uk 
 
Tom Lucas 
The Joint UCL/UCLH Committees on the Ethics of Human Research 
Committee Alpha 
Institute of Child Health 
Guildford Street 
London, WC1N 1EH. 
 
 
Dear Mr Lucas, 
 
Piloting baseline and follow-up questionnaires 
Ref: 08/H0715/75 
 
 
As set out in the protocol for the above study, I have now piloted both questionnaires. 
I am writing to inform you of the results of the pilot and of subsequent minor changes 
I have made to the questionnaires. 
 
ICU BASELINE QUESTIONNAIRE PILOT 
I piloted the baseline questionnaire with the first ten patients in the study. All 10 
patients said they found the questionnaire acceptable, clear and not too burdensome. 
They did not object to answering any of the questions. The average time taken to 
complete the questionnaire was 25 minutes, within the maximum time set out in the 
protocol. This included the time taken to complete the mini mental state exam 
(MMSE). 
 
However two patients among the next ten patients I interviewed had comments about 
the questionnaire. One patient found two of the questions upsetting, and another 
found it tiring to complete the questionnaire. My own instinct when helping patients 
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complete the questionnaire was that it was a little too long and that patients were 
becoming tired during the last part of the questionnaire. 
 
 
I have therefore amended the questionnaire slightly with guidance from my supervisor 
John Weinman, professor of health psychology at Kings College London. I have 
removed two items from the EICUQ, three items from the POMS and four items from 
the BIPQ. The removal of these items and other minor changes do not jeopardize the 
measurement of constructs, as there remain sufficient items to generate reliable 
measures and assess scale reliability. 
 
The items that potentially cause upset seemed to be Q14 of the EICUQ (below) and Q2 
of the BIPQ. I have removed the former item, and amended one of the responses to 
the latter from “forever” to “a very long time”. 
 
Q14 of the EICUQ: Have you felt frightened of dying? 
 
Not at all  A little  Moderately       Quite a bit Extremely 
 
 
Q2 of the BIPQ How long do you think your medical condition will continue? 
             
              
          0     1     2    3    4    5    6    7    8    9    10 
A very                                                               forever 
short time                                                                                 
 
 
I also decided after the pilot stage that administering the mini mental state exam 
(MMSE) was not worth the extra time it was taking. Some elderly patients were unable 
to complete it because of current difficulties with reading or writing, or physical 
weakness (the MMSE involves writing, spelling and drawing). Those patients who were 
able to complete it, all gained very similar scores (in the normal range). Leaving out 
the MMSE reduces the time taken to complete the questionnaire to 15 minutes on 
average. 
 
After the Viva exam for my PhD upgrade, it was suggested that I should include 
questions in the baseline questionnaire on patient’s recall of the ICU as a potential 
mediating variable. I have added three questions (and three optional questions) as a 
result of this. 
 
FOLLOW-UP QUESTIONNAIRE PILOT 
 
After the Viva exam for my PhD upgrade, it was also suggested that I should include 
questions in the follow-up questionnaire on social support as an important confounding 
variable. In order to accommodate these questions, I shortened the questionnaire 
overall by using the SF-12 instead of the SF-36, and the brief six-item STAI rather 
than the longer 20-item version.  
 
Having piloted the follow-up questionnaire, the results were as follows:  
 
 
1. Response Rate: 65% 
 
Questionnaires sent out:     17 
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Questionnaires sent back:  11 
 
6 non-responses: 2 patients back in ICU, 1 going for surgery, 3 did not respond. 
 
 
2. Time taken to complete questionnaire (median 15 mins, mean 21  mins). 
 
10 minutes – 3 patients 
 
15 minutes – 5 patients 
 
30 minutes – 1 patient 
 
40 minutes – 1 patient 
 
> 1 hour –     1 patient 
 
 
3. Issues raised about the content of the questionnaire 
 
7 patients – no issues with questionnaire. 
 
1 patient objected to some questions.  “I thought the questions were meaningless. My 
answers relate to other problems in my life, not ICU”  
 
2 patients found some of the response options of the validated questionnaires 
confusing. 
 
1 patient found the layout was unclear. 
 
Nobody found the questions unclear or ambiguous. 
 
 
4. “Results” 
 
6 patients – no psychological symptoms 
 
4 patients – depression and post-traumatic stress related to ICU 
 
1 patient – depression unrelated to ICU 
 
 
In response to patient comments, I have slightly amended the layout of the 
questionnaire to make it as clear and easy to fill in as possible. 
 
I have attached the amended questionnaires for your records. 
 
 
Yours sincerely, 
 
 
 
Dorothy Wade 
MRC-funded PhD student 
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Appendix 6  Letter from ethics committee approving amendments 
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Appendix 7 Patient information sheet (full version/cohort study) 
 
 
 
PARTICIPANT INFORMATION        Version 3. September 1, 2008 
 
1. Subject of research:  The psychological recovery of Intensive care patients. 
2. Invitation  
You are being invited to take part in research by a doctoral health psychology student. 
First I should explain why the study is being done and what will happen.  
 
3. Why am I doing the study? 
I am interested in finding out about people’s recovery after they leave the intensive 
care unit. I am particularly interested in their emotional health and psychological well-
being after they go home from hospital.  I am trying to find out if there are social and 
medical factors that affect their psychological recovery. 
 
4. Do you have to take part? 
No, you do not have to take part in this research. If you decide not to take part, your 
health care will not be affected in any way. If you want to be in the study, you will be 
asked for written consent. Nurses and family members will be told that you are taking 
part in the study. 
 
5. If you take part, what would be involved?   
a) I will come to see you in the unit, to give you a questionnaire to fill in. The 
questionnaire is about feelings and experiences you’ve had in Intensive care and will 
take about 30 minutes. If you are tired, we can stop and complete it at another time.  
b) Three months later I will phone to see how you are getting on, and send a follow-up 
questionnaire about your psychological recovery and your quality of life since leaving 
hospital. You can fill it in at home and send it back to me. If you have questions about 
filling in the questionnaire I may be able to help on the phone or, if you prefer, at your 
home. If you no longer wish to participate, you can let me know. 
c) Finally, I am interested in talking to a few patients about the way they remember 
the Intensive care Unit. If you agree, we may also talk about this.  
6. What information will be held about participants? 
As well as the questionnaires, I will write down some details from medical notes 
including age, gender, address and diagnosis. I will also ask for a mobile phone 
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number and a relative’s number so that we can contact you to arrange further follow-
up. All of these will be kept confidential and never given out. I will store the 
questionnaires and other data in a locked filing cabinet and your name will be removed 
from all documents so it will not be possible to identify you.  It is possible that 
inspectors from the NHS and other authorities could look at the data to check that I 
have done my research properly. 
 
7. What will happen to the results of the study? 
I will write a report about the findings so that healthcare staff can learn about the 
experiences and feelings of intensive care patients in hospital and after discharge. 
 
8. Can you change your mind later about taking part in the project? 
Yes, of course. If you feel unhappy with any aspect of the research, you can pull out of 
the study at any time without having to explain your reasons.  
 
9. What to do if you wish to make a complaint about the research. 
If you wish to complain about any aspect of the research, you should contact me, 
Dorothy Wade (see below). If you still feel you have not received a satisfactory 
response and you wish to take the matter further you should contact the UCLH 
Complaints Manager (see below) giving the project title and the researcher’s contact 
details.   
 
10. Extra support If you became upset when filling in a questionnaire, it would be 
possible to inform an Intensive care doctor who could arrange for you to talk to a 
psychologist. If your answers to the follow-up questionnaire showed that you might 
benefit from psychological support, the psychologist might contact your GP to arrange 
this. If any illegal behaviour is detected in the course of research, the researcher has a 
professional duty to report it to relevant authorities. 
11. Researchers’ contact details 
You can keep this information and think about whether you want to take part in the 
study. If you have questions, I’ll be happy to answer them.   
Researcher                            Complaints Manager UCLH: 
Dorothy Wade                                     Complaints Department 
Department of Epidemiology  & Public Health           2nd floor West,  50 Euston Rd     
1-19 Torrington Place         London NW1 2PQ 
London  WC1E 6BT                          0845 1555 000 ext. 3413 
 Email: Dorothy.Wade@ucl.ac.uk                             020 7380 9655 07734 
544512                                                   Fax: 020 7380 9595 
Thank you for reading about my research project,  Dorothy Wade 
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Appendix 8  Verbal version of patient information sheet  
 
 
PARTICIPANT INFORMATION (short verbal version)      January 12, 2009 
 
1. Subject of research:  The psychological recovery of Intensive care patients. 
2. Invitation  
You are being invited to take part in research by a health psychologist. We are 
interested in finding out about patients’ experiences and feelings during their 
treatment in Intensive care. We will also be following their progress after they leave 
this Unit.   
3. Do you have to take part? 
No, you do not have to take part in this research. If you decide not to take part, your 
health care will not be affected in any way.  
4. If you take part, what would be involved?   
a) The researcher will help you fill in a questionnaire about feelings and experiences 
you’ve had in Intensive care. It takes about 15 minutes.  
b) After three months you will be sent a follow-up survey about your quality of life and 
emotional well-being since leaving hospital. This will take about 30 minutes to 
complete. 
5. Medical notes The researcher will also write down a few details from your medical 
notes. These will be kept confidential and never given out.  
6.  What will happen to the results of the study? 
The researcher will write a report about the findings so that Intensive care staff can 
learn more about the experiences and feelings of patients. Your name will not be used. 
7. If you want to make a complaint. 
If you wish to complain about the research, you can contact the researcher Dorothy 
Wade or the UCH complaints manager. The phone numbers are on the information 
sheet we are giving you to keep.  
Thank you for listening 
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Appendix 9  Script used during recruitment for cohort study 
 
Script to use when approaching patients for recruitment into ICU psychology study 
 
Dorothy Wade, 12/09/08 
 
We are inviting all intensive care patients to take part in a study about people’s 
emotional health and well-being during their stay in intensive care and later, when 
they are recovering at home. This will give us valuable information about the care we 
give patients in the Unit and the follow-up care we provide after patients are 
discharged from the Unit. 
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Appendix 10  Consent form for cohort study  
 
 
 
CONSENT FORM   Version 2.  July 30, 2008 
 
Title of Project: The psychological recovery of Intensive care Unit patients. 
Researcher: Dorothy Wade  T: 07734 544512(m) 
           
 
  
Please 
tick 
each 
box: 
 
1. I confirm that I have read and understood the patient information 
sheet   
 
  
2. I have had time to think about the research project and ask   
     questions. The researcher has answered any questions. 
 
 
3. I know that I do not have to take part in the study.  I can 
decide to leave the study at any time without giving a reason. 
 
 
4. I understand that you may publish results from this study but 
you will not give out my name and identification. 
 
 
5. I know that some information from my medical notes will be 
written down. Inspectors from the NHS or other authorities 
could ask to look at this to check the researcher’s work.  
  
6. I agree to take part in this research project.  
7. I agree that you can keep my name, address and phone 
numbers on file to send me the follow-up questionnaires. 
 
 
8. I understand that a member of hospital staff may contact 
my GP to arrange further support. 
 
 
 
 
9. I would like you to send me a summary of the findings when 
they are ready.  
Please 
tick: 
    Yes  /   
 No 
 
 
                              Continued over the page  
 
 
 
 
 
 
 
 
 
302 
 
 
 
 
Once you have ticked the boxes on page 1, please sign below:  
 
________________________ _____________________ ____________ 
Name of participant Signature Date 
 
 
________________________ _____________________ ____________ 
Name of researcher Signature Date 
 
 
 
Comments or concerns about this study  
If you have any comments or concerns you may discuss these with the researcher (see 
below).  If you wish to go further and complain about any aspect of the way you have 
been approached or treated during the course of the study, you should write or get in 
touch with the Complaints Manager, UCL hospitals (see below) giving the project title 
and the name of the Principal Investigator.   
 
 
Researcher: 
Dorothy Wade 
Department of Epidemiology & Public Health 
1-19 Torrington Place 
London    WC1E 6BT 
Tel: 020 7679 1704 
E-mail: dorothy.wade@ucl.ac.uk 
 
 
Complaints Manager: 
Complaints Department 
2nd Floor West,  
250 Euston Road,  
London 
NW1 2PQ 
Tel: 0845 1555 000 ext. 3413  or  020 7380 9655 
Fax: 020 7380 9595 
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Appendix 11  Patient data form (cohort study) 
 
 
PATIENT DATA FORM/ ICU PSYCHOLOGY STUDY/ DOROTHY WADE 
                                   
Patient Details 
 
Patient ID No.        
 
 
Name                                                                                                    
 
 
Hospital  
Number    
 
Home Address 
 
                            __________________________________________________ 
 
Post Code 
 
 
Home phone           ____________________________________ 
 
Mobile phone         ____________________________________ 
 
Next of Kin            ____________________________________ 
 
NoK phone            ________________________________________ 
  
GP’s name          
  
GP’s phone  
 
Age                      
  
 
Date of birth 
 
 
 
Sex                   Male = 0                          
                         Female = 1 
 
 
 
 
 
 
 
 
Consultant’s speciality               _______________________________________ 
 
Admission from     Theatre and Recovery          0 
   
        
       
      
Admission 
details 
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                                        Ward                             1 
                                        A&E                               2           
                                        Other ICU                      3 
                                  Other hospital/non-ICU         4    
                                  Other  _____________         5                                                                
 
 
Date of CCU admission 
 
Date of CCU discharge  
 
 
Days in Critical Care Unit              ___________________________________ 
 
Critical Care Discharge Location 
          0 = ward 
          1 = home 
          2  = another hospital 
          3= other _______________________ 
 
 
 No. of days during which sedated        __________________      
 
Drugs        No = 0  for each category.   
 
 Hypnotics 
 
Temazepam = 1 
 
 Zopiclone = 2 
 
Other  = 3   ________________________ 
 
 
Anxiolytics                    
 
Midazolam = 1 
 
Diazepam = 2 
 
Lorazepam = 3 
 
Chlordiazepoxide = 4 
 
Propanolol = 5 
 
Other = 7 _________________________ 
 
 
Other sedatives (anaesthetics) 
 
Propofol = 1 
 
Ketamine = 2 
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Isoflurane = 3 
 
Remifentanil = 4 
 
Clonidine = 5 
 
Anti-psychotics 
 
Haloperidol = 1 
 
Chlorpromazine hydrochloride = 2 
 
Other = 3   _____________________ 
 
Opioids 
 
Fentanyl = 1 
 
Methadone hydrochloride = 2 
 
Morphine sulphate = 3 
 
Tramadol = 4 
 
Diamorphine hydrochloride = 5 
 
Dihydrocodeine = 6 
 
Other = 7   _______________________ 
 
 
 Non-opioid analgesic 
 
Gabapentin = 1 
 
 
Antidepressants      
 
Tricyclics = 1 
 
MAOIs = 2 
 
SSRIs = 3  (Fluoxetine, Paroxetine, Citalopram) 
 
Other = 4 (eg Velafaxine) 
 
 
 Ionotropes/vasopressors 
 
Adrenaline = 1 
 
Noradrenaline = 2 
 
Dobutamine = 3 
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Enoximone = 4 
 
Vasopressin/Argipressin = 5 
 
Terlipressin = 6 
 
Other = 7 ___________________ 
 
 
Steroids 
 
Meythyl Prednisolone = 1 
 
Prednisolone = 2 
 
Hydrocortisone = 3 
 
Dexamethazone = 4 
 
 
Antiepileptics 
 
Phenytoin = 1 
 
Leviracetam = 2 
 
Carbamazepine = 3 
 
Phenobarbitone = 4 
 
Sodium Valproate = 5 
 
 
Psycho-social issues (including confusion) recorded in CCU  
 
0=  none 
1 = confusion 
2 = depression, low mood 
3= anxiety 
4 = agitation 
5 = sleep problems 
6 = hallucinations or delusions  
7 = other 
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Appendix 12 ICU baseline questionnaire (cohort study) 
  
 
 
Patient…………………………     Date……………….Identifying number…………. 
 
 
 
 
 
 Intensive care questionnaire  
 
Study:  The psychological recovery of Critical care patients 
 
Researcher:   Dorothy Wade, 07734 544512 
 
 
1. This questionnaire is you about the way you have been 
feeling in Critical care and the experiences that you have had 
here.  
 
2. You can complete this questionnaire on your own, or we 
will help you. Please do whatever suits you best.  
 
3. When answering the questions, try to think how you have 
been thinking or feeling during the time that you’ve been in 
the Intensive care Unit. 
 
4. Your answers to this questionnaire will be kept confidential. 
The answers will be turned into numbers that will go into the 
study statistics. They will not be attached to your name.  
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Experience of intensive care 
 
Below are questions about experiences or feelings people 
sometimes have in intensive care. Please circle the answer that 
is closest to your own experience. 
 
1. Have you felt it was difficult to breathe? 
 
Not at all  A little  Moderately       Quite a bit Extremely 
 
2. Have you felt able to communicate? 
 
Not at all  A little  Moderately       Quite a bit Extremely 
 
3.  Have you had much pain? 
 
Not at all  A little  Moderately       Quite a bit Extremely 
 
4. Have you felt in control? 
 
Not at all  A little  Moderately       Quite a bit Extremely 
 
5. Have you had hallucinations? 
 
Not at all  A little  Moderately       Quite a bit Extremely 
 
6. Have you had emotional support from staff? 
 
Not at all  A little  Moderately       Quite a bit Extremely 
 
7. Have you had nightmares? 
 
Not at all  A little  Moderately       Quite a bit Extremely 
 
8. Have you felt confident that you would get better? 
 
Not at all  A little  Moderately       Quite a bit Extremely 
 
9.  Have you had a feeling of unreality? 
 
Not at all  A little  Moderately       Quite a bit Extremely 
 
 
10. Have you been able to sleep? 
 
Not at all  A little  Moderately       Quite a bit Extremely 
 
11. Have you felt isolated? 
 
Not at all  A little  Moderately       Quite a bit Extremely 
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12. Have you felt your dignity was respected?  
 
Not at all  A little  Moderately       Quite a bit Extremely 
 
13. Have you felt agitated? 
 
Not at all  A little  Moderately       Quite a bit Extremely 
 
14. Have you felt well-informed by staff? 
 
Not at all  A little  Moderately       Quite a bit Extremely 
 
15. Have you felt anxious about your breathing? 
 
Not at all  A little  Moderately       Quite a bit Extremely 
 
16. Have you felt discomfort from tubes or procedures? 
 
Not at all  A little  Moderately       Quite a bit Extremely 
 
17. Have you had emotional support from family or friends? 
 
Not at all  A little  Moderately       Quite a bit Extremely 
 
18. Have you felt disorientated? 
 
Not at all  A little  Moderately       Quite a bit Extremely 
 
Mood 
Below is a list of words that describe the way people sometimes feel in 
hospital. Please circle ONE answer for each question - that is nearest to 
the way you have been feeling while you’ve been in intensive care. 
1. Tense 
Not at all  A little  Moderately       Quite a bit Extremely 
2. Cheerful 
Not at all  A little  Moderately       Quite a bit Extremely 
3. Unhappy 
Not at all  A little  Moderately       Quite a bit Extremely 
4. Angry 
Not at all  A little  Moderately       Quite a bit Extremely 
5. Able to concentrate 
Not at all  A little  Moderately       Quite a bit Extremely 
6. Resentful 
Not at all  A little  Moderately       Quite a bit Extremely 
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7. Lively 
Not at all  A little  Moderately       Quite a bit Extremely 
8. Bad-tempered 
Not at all  A little  Moderately       Quite a bit Extremely 
9. Nervous 
Not at all  A little  Moderately       Quite a bit Extremely 
10. Confused 
Not at all  A little  Moderately       Quite a bit Extremely 
11. Helpless 
Not at all  A little  Moderately       Quite a bit Extremely 
12. Alert 
Not at all  A little  Moderately       Quite a bit Extremely 
13. Terrified 
Not at all  A little  Moderately       Quite a bit Extremely 
14. Panicky 
Not at all  A little  Moderately       Quite a bit Extremely 
15. Forgetful 
Not at all  A little  Moderately       Quite a bit Extremely 
Memory of intensive care 
 1. Do you remember being admitted to intensive care?       Yes/No 
2. How much of the time you’ve spent in the ICU do you remember? 
 
a) most of the time? 
b) a moderate amount of the time?  
c) very little of the time?      
 
3. Do you have any memories, images or thoughts that come back repeatedly about anything 
that happened just before or while you have been in intensive care?  Yes/ No.   
If you answered Yes to question 3, please answer the following questions: 
4. What’s the content of the memory or image? (Prompt: is there anything else you can tell me? 
Any other details?) 
5. How often do you get the memory or image? 
a) Less than once a day.  
b) Once or twice a day.  
c) Several times a day. 
d) Many times a day. 
 
6. How distressing is the memory or image? 
Not at all distressing   1    2    3    4    5    6    7   very distressing  
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ILLNESS PERCEPTIONS 
We are interested in your own personal views about your medical condition and its 
effects. For the following questions, please circle the number that is nearest to your 
view. 
 
1. How long do you think your condition will continue? 
             
              
          0     1     2    3    4    5    6    7    8    9    10 
A very                                                               a very 
short time                                                          long time                       
 
2. How much control do you feel you have over your condition? 
 
            
           0     1     2    3    4    5    6    7    8    9    10 
Absolutely                                                          complete                                     
No control                                                          control                        
 
3. How concerned are you about your condition? 
 
               
              0     1     2    3    4    5    6    7    8    9    10 
  Not at all                                                              extremely 
 concerned                                                             concerned                                              
 
4. How well do you feel you understand your condition? 
 
                
               0     1     2    3    4    5    6    7    8    9    10 
Don’t                                                                    understand 
understand                                                           very clearly 
at all                                                                                   
 
5. How much does your condition affect you emotionally? (e.g. does it make you 
angry, scared, upset or depressed? 
 
            
          0     1     2    3    4    5    6    7    8    9    10 
Not at all                                                            Extremely 
affected                                                              affected  
emotionally                                                         emotionally                                                                            
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BACKGROUND 
 
1.  What was your most recent occupation or job? 
 
2.  If you don’t (or did not) work, what was your spouse’s most recent  
      occupation or job? 
 
3. What is your highest educational qualification? Please circle 1 answer. 
1.   Degree or equivalent 
2.   Higher education (below degree level) 
3.   A-levels or equivalent 
4.   GCSEs or equivalent 
5.   No qualifications 
 
3. What is your ethnic group?  Please circle 1 letter (A to E), then circle a number 
below it. 
A. White  
1. British  
2. Irish  
3. Any Other White background, please write in 
 
B. Mixed  
4. White and Black Caribbean  
5. White and Black African  
6. White and Asian  
7. Any Other Mixed background, please write in 
 
C. Asian or Asian British  
8. Indian  
9. Pakistani  
10. Bangladeshi  
11. Any Other Asian background, please write in  
 
D. Black or British Black  
12. Caribbean  
13. African  
14. Any Other African background, please write in  
  
E. Chinese or other ethnic group  
15. Chinese  
16. Any other, please write in 
 
Contact Details 
Mobile phone:________________ Relative’s phone __________________ 
 
THANK YOU FOR COMPLETING THE QUESTIONNAIRE! 
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Appendix 13  Follow up (letter and questionnaire)  
 
 
  
The Critical Care Unit, 
University College Hospital, 
253 Euston Rd, 
                                                                                        London, NW1 2BU, 
United Kingdom. 
E-mail: dorothy.wade@ucl.ac.uk 
               
                                                                             January 21, 2010 
 
Dear             ,          
 
Re: The intensive care patient well-being and psychology study  
 
You may remember that I visited you in hospital. You answered a 
questionnaire about your experience of being in the Intensive Care Unit. 
 
I am now sending you a follow-up questionnaire to find out how you 
have been getting on since leaving intensive care. It is about the 
reactions and emotions people sometimes have during their recovery 
after Intensive care treatment.  
 
Please complete this questionnaire and send it back as soon as you can. 
Please try to fill in every question as well as you can, even if you are not 
completely sure of the answer.  
 
If you would like any further information, please ring me on 07734 
544512 or 020 7679 1702 
 
I’d like to thank you again for your help with this project and to wish 
you all the best. Your contribution is very important for the success of 
this research, 
 
Yours sincerely, 
Dorothy Wade, Medical Research Council-funded health psychology 
researcher  
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INTENSIVE CARE FOLLOW-UP QUESTIONNAIRE  
 
 
 
Study:  The psychological recovery of critical care 
patients 
 
 
Researcher:  Dorothy Wade, 
                      07734  544512 (m)  
                      0207 679 1702  (w) 
                      Email: Dorothy.Wade@ucl.ac.uk 
 
1. The following questionnaire is about your well-being since 
you left the Intensive Care Unit, particularly in this past week. 
You can complete the questionnaire on your own. If you 
prefer me to help you, just phone me and I will phone you 
back.  
2. I’d be very grateful if you could try to answer all the 
questions. If you are not sure of the answer, please mark the 
answer that is nearest to the way you feel. 
3. Your answers to this questionnaire will be kept confidential. 
The answers will be turned into numbers that will go into the 
study statistics. They will not be attached to your name.  
4. Answering this questionnaire will not affect any future 
medical care and treatment in any way. 
 
 
YOUR NAME: ___________________________ 
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YOUR HEALTH AND ACTIVITIES 
 
The first set of questions are about your health and daily activities. 
Read each item and circle one answer in the box for each. 
 
1. In general would you say your health is: 
 
2. The following two questions are about activities you might do 
during a typical day. Does your health now limit you in these 
activities? If so how much? 
 
• Moderate activities – such as moving a table, pushing a vacuum 
cleaner, bowling, or playing golf. 
 
Yes, limited a 
lot 
Yes, limited a 
little 
No, not 
limited at all 
• Climbing several flights of stairs. 
 
Yes, limited a 
lot 
Yes, limited a 
little 
No, not 
limited at all 
 
3. Have you had any of the following problems with your work or 
other regular daily activities as a result of your physical health? 
•      You accomplished less than you would like. 
 
 
•      You were limited in the kind of work or other activities. 
 
 
4. Have you had any of the following problems with your work or other 
regular daily activities as a result of any emotional problems (such 
as feeling depressed or anxious)? 
 
•      You accomplished less than you would like:   
 
 
•      You did work or other activities less carefully than usual 
 
5. How much did pain interfere with your 
normal work (including both work outside the home and housework)? 
Excellent Very 
good 
Good Fair Poor 
  Yes  No 
Yes  No 
Yes  No 
Yes  No 
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Not at all A little bit Moderately Quite a bit Extremely 
 
 
6. These questions are about how you feel and how things have 
been with you since you left hospital. How much of the time 
since you left hospital: 
 
• Have you felt calm and peaceful? 
 
All of the 
time 
Most of 
the time 
A good bit 
of the 
time 
Some of 
the time 
A little bit 
of the 
time 
None of 
the time 
 
• Did you have a lot of energy? 
 
All of the 
time 
Most of 
the time 
A good bit 
of the 
time 
Some of 
the time 
A little bit 
of the 
time 
None of 
the time 
 
• Have you felt downhearted and low? 
 
All of the 
time 
Most of 
the time 
A good bit 
of the 
time 
Some of 
the time 
A little bit 
of the 
time 
None of 
the time 
 
 
 
7. Since you left hospital, how much of the time has your physical 
health or emotional problems interfered with your social 
activities (like visiting friends, relatives, etc.)? 
All of the 
time 
Most of 
the time 
A good bit 
of the 
time 
Some of 
the time 
A little bit 
of the 
time 
None of 
the time 
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Emotional well-being (PART 1) 
Please read the statements below and circle the one that is closest to   
how you feel right now, at this moment. 
 
1.  I feel  calm 
 
 
2.  I feel secure    
 
 
3. I am tense 
 
 
4. I feel at ease 
 
  
5. I feel upset 
 
 
 6. I am worried 
 
   
 
Emotional well-being  (PART 2) 
 
How often you have felt any of the following during the past week: 
please circle one answer for each item. 
 
1.  I was bothered by things that usually don’t bother me 
Less than 1 day   
   
1- 2 days    3-4 days      5-7 days 
 
2. I did not feel like eating; my appetite was poor 
Less than 1 day   
   
1- 2 days    3-4 days      5-7 days 
 
3. I could not shake off the blues even with help from my family 
Less than 1 day   
   
1- 2 days    3-4 days      5-7 days 
 
4. I felt that I was just as good as other people 
Less than 1 day   
   
1- 2 days    3-4 days      5-7 days 
 
 
Not at all somewhat moderately Very much 
Not at all somewhat moderately Very much 
Not at all somewhat moderately Very much 
Not at all somewhat moderately Very much 
Not at all somewhat moderately Very much 
Not at all somewhat moderately Very much 
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5. I had trouble keeping my mind on what I was doing  
Less than 1 day   
   
1- 2 days    3-4 days      5-7 days 
 
6. I felt depressed  
Less than 1 day   
   
1- 2 days    3-4 days      5-7 days 
 
7. I felt that everything I did was an effort  
Less than 1 day   
   
1- 2 days    3-4 days      5-7 days 
 
8. I felt hopeful about the future  
Less than 1 day   
   
1- 2 days    3-4 days      5-7 days 
 
9. I thought my life had been a failure 
Less than 1 day   
   
1- 2 days    3-4 days      5-7 days 
10. I felt fearful  
Less than 1 day   
   
1- 2 days    3-4 days      5-7 days 
 
11. My sleep was restless 
Less than 1 day   
   
1- 2 days    3-4 days      5-7 days 
 
12. I was happy 
Less than 1 day   
   
1- 2 days    3-4 days      5-7 days 
 
13. I talked less than usual  
Less than 1 day   
   
1- 2 days    3-4 days      5-7 days 
14. I felt lonely 
Less than 1 day   
   
1- 2 days    3-4 days      5-7 days 
15. People were unfriendly  
Less than 1 day   
   
1- 2 days    3-4 days      5-7 days 
 
16. I enjoyed life 
Less than 1 day   
   
1- 2 days    3-4 days      5-7 days 
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17. I had crying spells 
Less than 1 day   
   
1- 2 days    3-4 days      5-7 days 
 
18. I felt sad 
Less than 1 day   
   
1- 2 days    3-4 days      5-7 days 
 
19. I felt that people disliked me 
Less than 1 day   
   
1- 2 days    3-4 days      5-7 days 
 
20. I could not “get going” 
Less than 1 day   
   
1- 2 days    3-4 days      5-7 days 
 
PAST MEDICAL HISTORY 
(your answers to these questions will be kept strictly confidential) 
 
1. Have you ever been to see a GP, therapist, counsellor or psychiatrist 
for mental health problems?     
 
2.  If you answered Yes, please answer these further questions:  
  a)  What kind of mental health problem(s) did (do) you have? 
  b)   Did you have mental health problems before or after being patient   
        in intensive care (or both)? 
    
 
  c) If you received any treatments for your mental health problems,  
      what  were they? 
    
 
 
d)  Please list any medication(s) you are currently taking for   
     depression or any other mental health problem? 
 
 
 
 
Yes  No 
Before being in 
intensive care 
Since being in 
intensive care 
Both before and 
after intensive care 
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INTENSIVE CARE MEMORIES AND REACTIONS, PART A     
     
Below are some reactions that people sometimes have after leaving 
     Intensive care.  Please circle the answer that describes how often 
     that problem has bothered you IN THE PAST MONTH.  
 
1.   Have you had upsetting thoughts or images about your time in 
      intensive care that came into your head when you didn’t want 
      them to ? 
 
   2.   Have you had bad dreams or nightmares about your time in  
  intensive care?  
              
 
  3.   Have you relived your time in intensive care, acting or feeling as if   
         it were happening again?  
    
 
  4.   Have you felt emotionally upset when you were reminded of your  
        time in intensive care (e.g. feeling scared, angry, sad, guilty)? 
 
  
  5.   Have you experienced physical reactions when you were  
        Reminded of your time in intensive care (e.g. breaking into a  
        sweat, heart  beating fast?) 
 
  6.   Have you tried not to think about, talk about, or have feelings 
        about your time in intensive care? 
 
  
  7.   Have you tried to avoid activities, people or places that remind  
         you  of your time in intensive care?              
        
 
 
 
Not at all Once per week or 
less 
2 – 4 times per 
week 
5 or more 
times per week 
Not at all Once per week or 
less 
2 – 4 times per 
week 
5 or more 
times per week 
Not at all Once per week or 
less 
2 – 4 times per 
week 
5 or more 
times per week 
Not at all Once per week or 
less 
2 – 4 times per 
week 
5 or more 
times per week 
Not at all Once per week or 
less 
2 – 4 times per 
week 
5 or more 
times per week 
Not at all Once per week or 
less 
2 – 4 times per 
week 
5 or more 
times per week 
Not at all Once per week or 
less 
2 – 4 times per 
week 
5 or more 
times per week 
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8.   Have you found that you were not able to remember an important 
      part of your time in intensive care?  
  
  9.   Have you had much less interest or participated much less often in 
        important activities?  
       
  10.   Have you felt distant or cut off from people around you?  
         
 
  11.   Have you felt emotionally numb (for example being unable to cry  
           or unable to have loving  feelings)? 
            
    12.   Have you felt as if your future plans or hopes will not come true? 
           
 13.   Have you had trouble falling or staying asleep?  
          
  14.   Have you felt irritable or had fits of anger?  
        
                                                    
         15.   Have you had trouble concentrating (e.g. forgetting what you  
          read, losing track of a storyontelevision)? 
          
   
    16.  Have you been overly alert (for example, checking to see who is  
         around you, not being comfortable with your back to a door)? 
       
 
   17.  Have you been jumpy or easily startled (for example, when 
           someone walks up behind you)?  
 
Not at all Once per week or 
less 
2 – 4 times per 
week 
5 or more 
times per week 
Not at all Once per week or 
less 
2 – 4 times per 
week 
5 or more 
times per week 
Not at all Once per week or 
less 
2 – 4 times per 
week 
5 or more 
times per week 
Not at all Once per week or 
less 
2 – 4 times per 
week 
5 or more 
times per week 
Not at all Once per week or 
less 
2 – 4 times per 
week 
5 or more 
times per week 
Not at all Once per week or 
less 
2 – 4 times per 
week 
5 or more 
times per week 
Not at all Once per week or 
less 
2 – 4 times per 
week 
5 or more 
times per week 
Not at all Once per week or 
less 
2 – 4 times per 
week 
5 or more 
times per week 
Not at all Once per week or 
less 
2 – 4 times per 
week 
5 or more 
times per week 
Not at all Once per week or 
less 
2 – 4 times per 
week 
5 or more 
times per week 
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    MEMORIES AND REACTIONS,PART B 
 
Have any of the problems you rated in Qs 1-17 (on pp7 and 8) 
interfered with any of the following areas of your life DURING THE PAST 
MONTH? (Not all areas may be applicable to you). 
 
 
1.          Work 
                                      
2.          Household chores or duties      
 
3.          Relationships with friends 
                                     
4.          Fun and leisure activities  
 
5.         Relationships with family        
                                
6.          Sex life   
                                     
7.         General satisfaction with life      
                             
8.       Overall level of functioning in 
             all areas of your life     
          
 
 
 
 
 
 
 
 
 
 
 
 
 
Yes No 
Yes No 
Yes No 
Yes No 
Yes No 
Yes No 
Yes No 
Yes No 
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MEMORIES AND REACTIONS, PART C 
 
Many people have lived through traumatic events at some point in 
their lives. This can affect the way they react to new challenges.  
 
Please tick the box next to ALL events that have happened to you or 
you have witnessed.  
 
(1)   Life-threatening illness  
 
(2)    Natural disaster (for example, flood, tornado, hurricane, or major    
               eathquake) 
(3)    Non-sexual assault by a family member or someone you know  
       (for example, being mugged, physically attacked, shot, stabbed or held at  
          gunpoint) 
(4)    Non-sexual assault by a stranger (for example, being mugged, physically  
                 attacked, shot, stabbed or held at gunpoint) 
(5)    Sexual assault by a family member or someone you know (for example,  
        rape or  attempted rape). 
(6)    Sexual assault by a stranger (for example, rape or attempted rape) 
(7)    Military combat or war zone 
(8)    Sexual contact when you were younger than 18 with someone who was   
               Five or more years older than you (e.g., contact with genitals, breasts) 
(9)    Imprisonment (for example, prison inmate, prisoner of war, hostage)  
(10)    Torture 
  (11)      Serious accident, fire, or explosion (for example, an industrial, farm,  
                  car, plane or boat accident) 
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SOCIAL SUPPORT 
These questions are about the support you get from other people. Please circle one 
answer to each question. 
1. Is there someone you can count on to listen to you when you need to talk? 
 None of 
the time 
A little of 
the time 
Some of 
the time 
Most of 
the time 
All of 
the time  
 
2. 
 
Is there someone who can give you good advice about a problem? 
 None of 
the time 
A little of 
the time 
Some of 
the time 
Most of 
the time 
All of 
the time  
 
3. 
 
Is there someone who shows you love and affection? 
 None of 
the time 
A little of 
the time 
Some of 
the time 
Most of 
the time 
All of 
the time  
 
4. 
 
Is there someone available to help with daily chores? 
 None of 
the time 
A little of 
the time 
Some of 
the time 
Most of 
the time 
All of 
the time  
 
5. Can you count on anyone to provide you with emotional support (talking over 
problems or helping you make a difficult decision)? 
 None of 
the time 
A little of 
the time 
Some of 
the time 
Most of 
the time 
All of 
the time  
 
6. Do you have as much contact as you would like with someone you feel close to, 
someone you can trust and confide in? 
 None of 
the time 
A little of 
the time 
Some of 
the time 
Most of 
the time 
All of 
the time  
 
7. 
 
Is there someone who reminds you to take your medication?  
 None of 
the time 
A little of 
the time 
Some of 
the time 
Most of 
the time 
All of 
the time  
 
8. 
 
Is there someone who reminds you or helps you to eat a healthy diet?  
 None of 
the time 
A little of 
the time 
Some of 
the time 
Most of 
the time 
All of 
the time  
 
9. 
 
Is there someone who reminds you or helps you to take some exercise? 
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 None of 
the time 
A little of 
the time 
Some of 
the time 
Most of 
the time 
All of 
the time  
 
EMPLOYMENT QUESTIONNAIRE 
 
Please read the first four questions and tick the box if a question 
applies to you. Then answer the remaining questions.  
 
1. If you are retired, please tick this box.       
 Please answer all questions in reference 
 to your last main job (or spouse’s job  if you did not work). 
 
2. If you do not work, but your spouse works, please tick this  box.    . 
Please answer all questions with reference to your spouse’s job. 
 
3. If you are unemployed, please tick this box        
and answer all questions in reference to your last main job.  
 
4. If you are a student, please tick this box.   
 
The following questions refer to your current main job, or to 
your last main job.  Please tick one box only per question  
 
5.  Do (did) you work as an employee or are (were) you self-employed? 
       
                                                                            Employee           
  
            Self-employed with  employees    
 
       Self-employed / freelance without employees (go to q. 8.) 
 
6.  Number of employees  
     For employees: indicate below how many people work (worked) for  
     your employer at the place where you work (worked). 
      For self-employed: indicate below how many people you employ  
     (employed).  Go to Q. 8 when you have completed this question.            
                           1 to 24  
                                                                                                                          
                                                                                 25 or more                                          
7.  Supervisory Status 
     Do (did) you supervise any other employees?                       Yes                        
                                                
                                                                                               No                                                                   
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8. Occupation 
 
Please tick one box ONLY to show which best describes the sort of work you do. (If  
  you are not working now, please tick a box to show what you did in your last job). 
 
1. Modern professions 
such as: teacher - nurse - physiotherapist - social worker –  
welfare officer - artist - musician - police officer (sergeant 
or above) - software designer 
2. Clerical and intermediate occupations 
 such as: secretary - personal assistant - clerical work 
 office clerk - call centre agent - nursing auxiliary - nursery nurse 
3. Senior managers or administrators 
(usually responsible for planning, organising and co-ordinating work and for 
finance) such as: finance manager - chief executive 
4. Technical and craft occupations 
such as: motor mechanic - fitter - inspector - plumber - printer -  
tool maker - electrician - gardener - train driver 
5. Semi-routine manual and service occupations 
such as: postal worker - machine operative - security guard - caretaker - 
farm worker - catering assistant - receptionist –  
sales assistant 
 
6. Routine manual and service occupations 
       such as: HGV driver - van driver - cleaner - porter - packer - sewing 
machinist - messenger - labourer - waiter / waitress – 
         bar staff 
 7.  Middle or junior managers 
        such as: office manager - retail manager - bank manager –  
         restaurant manager - warehouse manager – publican 
         
         8. Traditional professional occupations 
 such as: accountant - solicitor - medical practitioner – 
 scientist - civil/mechanical engineer 
 
 
      THANK YOU FOR COMPLETING THE QUESTIONNAIRE! 
      If you are interested in hearing about the results of this study,   
      please tick the box     
 
 
 
1 
2 
4 
3 
5 
6 
7 
8 
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Appendix 14  Letter and interview for intrusive memory study 
 
 
 
                                                                                                                                              
                                                                                                                                   
,                                   
 
 
 
 
 
Dear           , 
                                                                                                                                         
Research project 
 
 
Thanks for agreeing to take part in this research project. The interview I mentioned to 
you on the phone is about the nature of patient memories of intensive care. I’m 
sending you a copy of the interview questions to make it easier when we talk on the 
phone. There is no need to write any answers down, it is just for your reference. 
 
I will ring you at a time of your convenience on         . The best number to be sure of 
reaching me is my mobile number, 07734 544512. 
 
 
Thanks so much for your help at all stages of this research. I look forward to talking to 
you, 
 
 
Yours sincerely, 
 
 
Dorothy Wade 
PhD psychology researcher 
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ICU memories interview 
 
 Section A: memories 
 
1. Have you had any particular memories from your time in  
intensive care that keep coming  into your mind?  
             YES/NO 
 
 
        
 Memory One  
 
1. Can you briefly describe the memory that you have from intensive 
care? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2. Please rate the vividness of this memory of intensive care: 
 
3. What are the emotions that you associate with this memory?  
     a)Sad: 
Not at all A little somewhat Very much so 
 
    b)Guilty:  
Not at all A little Somewhat Very much so 
 
     c)Ashamed: 
Not at all A little Somewhat Very much so 
 
     d)Angry: 
Not at all A little Somewhat Very much so 
2.  Are there TWO memories from intensive care that stand out 
most? 
   Memory 1 
 
   Memory 2 
 
Hazy memory Normal memory  Very clear and 
vivid memory 
Most clear & vivid 
memory 
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   e)Anxious: 
Not at all A little Somewhat Very much so 
 
   f)Helpless: 
Not at all A little Somewhat Very much so 
 
  g) If there is another emotion you associate with the memory please write it 
down here: _________________  How much do you associate this emotion 
with the memory? 
 
 
      
    
4. When you have this memory, does it feel like it is not just a past event but 
is happening all over again?  
 
 
 
 
5. When you have this memory, do you have emotions that are the same  or 
similar to how you felt when you were really in Intensive care? 
  
 
 
 
6. When you have this memory, do you have physical feelings that are the 
same or similar to how you felt when you were  in Intensive care? 
 
    
  
    
7. How many times did you experience this memory in the last week? 
 
 
8.  When you remember this memory how long does it last? (write in the 
number below and circle the amount of time) 
 
 
 
9.  How much does the memory interfere with your daily life?  
       
 
 
 
10. How uncontrollable was this memory in the last week? 
  
 
   
       
 
11.   How distressing was this memory? 
     
A little Somewhat Very much so 
Not at all A little somewhat Very much so 
Not at all A little somewhat Very much so 
Not at all A little somewhat Very much so 
Once or twice a 
week 
Several times a 
week 
Every day Many times a day 
  ____   seconds   /  minutes  /  hours 
Not at all A little somewhat Very much  
Not at all A little somewhat Very much  
Not at all A little somewhat Very much  
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Memory 2   
 
 
1. Can you briefly describe the second memory that you have from 
intensive care? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2. Please rate the vividness of this memory of intensive care? 
 
 
 
3. What are the emotions that you associate with this memory?  
 
a) Sad: 
Not at all A little somewhat Very much so 
 
b) Guilty:  
Not at all A little Somewhat Very much so 
 
c) Ashamed: 
Not at all A little Somewhat Very much so 
 
d) Angry: 
Not at all A little Somewhat Very much so 
 
e) Anxious: 
Not at all A little Somewhat Very much so 
 
f) Helpless: 
Not at all A little Somewhat Very much so 
 
g) If there is another emotion you associate with the memory please write it 
down here: _________________  How much do you associate this emotion 
with the intensive care memory? 
 
A little Somewhat Very much so 
 
Hazy memory Normal memory  Very clear and 
vivid memory 
Most clear & vivid 
memory 
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4. When you have this memory, does it feel like it is not just a past event but 
is happening all over again?  
 
Not at all A little somewhat Very much so 
 
 
5. When you have this memory, do you have emotions that are the same or 
similar to how you felt when you were really in Intensive care? 
  
Not at all A little somewhat Very much so 
 
 
6. When you have this memory, do you have physical feelings the same or 
similar to feelings that you had in Intensive care? 
 
Not at all A little somewhat Very much so 
    
  
7. How many times did you experience this memory in the last week? 
 
Once or twice a 
week 
Several times a 
week 
Every day Many times a day 
 
 
8. When you remember this memory how long does it last? (write in the number 
below and circle the amount of time) 
 
  ____   seconds   /  minutes  /  hours 
 
 
9.  How much does the memory interfere with your daily life?  
       
Not at all A little somewhat Very much  
 
 
10. How uncontrollable was this memory in the last week? 
  
Not at all A little somewhat Very much  
 
 11.   How distressing was this memory? 
  
Not at all A little somewhat Very much  
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Section B: Help    
 
1. Do you feel that you need some help with this problem?  
 
 YES   NO 
 
2. Did you attend the ICU follow-up clinic? Did you find it helpful? Did you 
discuss your memories with them? 
 
 
3. Have you tried to get help? (if so, give details) 
 
 
 
 
 
4. What kind of help would you like? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
